H number,Name,Description,Category,Gene,Pathogen,Env factor,Carcinogen,Marker,Drug,Comment,Other DBs,Reference,DB REF,Code_1,Code_2,Code_3,Code_4,Code_5,Code_6,Code_7,Code_8,Code_9,Code_10,Code_11,Code_12,Code_13,Code_14,Code_15,Code_16,Code_17,Code_18,Code_19,Code_20,Code_21,Code_22,Code_23,Code_24,Code_25,Code_26,Code_27,Code_28,Code_29,Code_30
H01096,"Pyruvate kinase (PK) deficiency, including:
Red cell pyruvate kinase (PK) deficiency;
Pyruvate kinase hyperactivity","Pyruvate kinase (PK) deficiency is inherited metabolic disorder caused by mutations in PKLR that encodes both L-PK (expressed in liver, renal cortex, and small intestine) and R-PK (restricted to erythrocytes). The symptoms include jaundice, enlargement of the spleen, and hemolysis, leading to anemia. One hundred fifty-eight mutations associated with non-spherocytic haemolytic anaemia and eight polymorphic sites have been so far reported in the PKLR gene. It has also been found that a specific mutation in the PKLR gene causes hereditary increase of red blood cell ATP.",Inherited metabolic disease; Hematologic disease,PKLR [HSA:5313] [KO:K12406],,,,,,,"ICD-10: D55.2
OMIM: 266200 102900","PMID:17550841
  AUTHORS   Zanella A, Bianchi P, Fermo E
  TITLE     Pyruvate kinase deficiency.
  JOURNAL   Haematologica 92:721-3 (2007)
DOI:10.3324/haematol.11469

PMID:15982340
  AUTHORS   Zanella A, Fermo E, Bianchi P, Valentini G
  TITLE     Red cell pyruvate kinase deficiency: molecular and clinical aspects.
  JOURNAL   Br J Haematol 130:11-25 (2005)
DOI:10.1111/j.1365-2141.2005.05527.x

PMID:9090535
  AUTHORS   Beutler E, Westwood B, van Zwieten R, Roos D
  TITLE     G--&gt;T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP.
  JOURNAL   Hum Mutat 9:282-5 (1997)
DOI:10.1002/(SICI)1098-1004(1997)9:3<282:AID-HUMU13>3.0.CO;2-Z",OMIM,266200,102900,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00956,"Lattice corneal dystrophies (LCD), including:
Biber-Haab-Dimmer dystrophy;
Familial amyloid polyneuropathy type IV;
Meretoja syndrome","Lattice corneal dystrophy (LCD), the most common of the stromal cornea dystrophies, is an autosomal dominant dystrophy with variable expression. Clinical findings include the presence of a linear network of subepithelial opacities (lattice lines). Clinically and histologically there are several types of two genetically distinct inherited LCD so far. One with no systemic manifestations is caused by specific mutations in the TGFBI gene (LCD type I and its variants); the other resulting from a mutation in the GSN gene (LCD type II) has systemic manifestations.",Eye disease,"(LCDI, LCDIII) TGFBI [HSA:7045] [KO:K19519]
(LCDII) GSN [HSA:2934] [KO:K05768]",,,,,,"For LCD type II, see also [DS:H00845].","ICD-10: H18.5
OMIM: 608471 105120 122200","PMID:19236704 (description, gene)
  AUTHORS   Klintworth GK
  TITLE     Corneal dystrophies.
  JOURNAL   Orphanet J Rare Dis 4:7 (2009)
DOI:10.1186/1750-1172-4-7

PMID:18214787 (description, gene)
  AUTHORS   Poulaki V, Colby K
  TITLE     Genetics of anterior and stromal corneal dystrophies.
  JOURNAL   Semin Ophthalmol 23:9-17 (2008)
DOI:10.1080/08820530701745173

PMID:16900028 (description, gene)
  AUTHORS   Pieramici SF, Afshari NA
  TITLE     Genetics of corneal dystrophies: the evolving landscape.
  JOURNAL   Curr Opin Ophthalmol 17:361-6 (2006)
DOI:10.1097/01.icu.0000233955.94347.84",OMIM,608471,105120,122200,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01006,Hereditary angioedema,"Hereditary angioedema (HAE) is a rare genetic disorder, manifested by recurrent episodes of angioedema localized to the skin or mucosa of the gastrointestinal tract or larynx. The laryngeal angioedema is potentially lethal. The classic forms, HAE types I and II, result from deficiency of the plasma protease inhibitor, C1 inhibitor (C1INH). Type I HAE is caused by decreased expression of C1INH in the plasma whereas type 2 HAE, consisting approximately 15% of patients with HAE, is due to expression of a dysfunctional C1INH protein. HAE type III has been observed exclusively in women and appears to be correlated with high estrogen levels.",Vascular disease,"(type I and II) C1NH [HSA:710] [KO:K04001]
(type III) F12; coagulation factor XII [HSA:2161] [KO:K01328]",,,,,"Ecallantide [DR:D03931]
Icatibant [DR:D04492] 
Berinert-P; human plasma-derived C1-INH
Rhucin; recombinant C1-INH produced in transgenic rabbit",,"ICD-10: D84.1
OMIM: 610618 106100","PMID:14572810 (description, gene)
  AUTHORS   Davis AE 3rd
  TITLE     The pathogenesis of hereditary angioedema.
  JOURNAL   Transfus Apher Sci 29:195-203 (2003)
DOI:10.1016/j.transci.2003.08.012

PMID:15596403 (description, gene)
  AUTHORS   Davis AE 3rd
  TITLE     The pathophysiology of hereditary angioedema.
  JOURNAL   Clin Immunol 114:3-9 (2005)
DOI:10.1016/j.clim.2004.05.007

PMID:21279474 (drug)
  AUTHORS   Antoniu SA
  TITLE     Therapeutic approaches in hereditary angioedema.
  JOURNAL   Clin Rev Allergy Immunol 41:114-22 (2011)
DOI:10.1007/s12016-011-8254-2

PMID:19160940 (drug)
  AUTHORS   Reshef A, Leibovich I, Goren A
  TITLE     Hereditary angioedema: new hopes for an orphan disease.
  JOURNAL   Isr Med Assoc J 10:850-5 (2008)

PMID:17186468 (description, gene)
  AUTHORS   Cichon S, Martin L, Hennies HC, Muller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renne T, Drouet C, Bork K, Nothen MM
  TITLE     Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III.
  JOURNAL   Am J Hum Genet 79:1098-104 (2006)
DOI:10.1086/509899",OMIM,610618,106100,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00749,Episodic ataxias,"Episodic ataxias (EAs) are a group of rare autosomal-dominant diseases characterized by recurrent, discrete episodes of ataxia, giddiness, and vertigo. EA1 and EA2 are the most widely recognized of the autosomal-dominant EAs and are caused by dysfunction of neuronal voltage-gated ion channels. There are central and peripheral nervous system manifestations in both conditions. The current classification is based on genetics and actually includes seven distinct subtypes. But these variants other than EA1 and EA2 are rare, some only occurring in single families, and gene mutations have not been identified in all. It is quite likely, however, that the number of phenotypes and mutated genes will grow further.",Nervous system disease,"(EA1) KCNA1 [HSA:3736] [KO:K04874]
(EA2) CACNA1A [HSA:773] [KO:K04344]
(EA5) CACNB4 [HSA:785] [KO:K04865]
(EA6) SLC1A3 [HSA:6507] [KO:K05614]",,,,,"Carbamazepine [DR:D00252]
Phenytoin [DG:DG00846]
Sulthiame [DR:D01787]
Acetazolamide [DG:DG01134]
4-Aminopyridine [DR:D04127]",,"ICD-10: G11.8
OMIM: 160120 108500 613855 612656","PMID:19650351 (description, gene)
  AUTHORS   Finsterer J
  TITLE     Ataxias with autosomal, X-chromosomal or maternal inheritance.
  JOURNAL   Can J Neurol Sci 36:409-28 (2009)
DOI:10.1017/S0317167100007733

PMID:19734086 (description, gene, drug)
  AUTHORS   Tomlinson SE, Hanna MG, Kullmann DM, Tan SV, Burke D
  TITLE     Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.
  JOURNAL   Clin Neurophysiol 120:1768-76 (2009)
DOI:10.1016/j.clinph.2009.07.003",OMIM,160120,108500,613855,612656,,,,,,,,,,,,,,,,,,,,,,,,,,
H00292,Hypertrophic cardiomyopathy (HCM),"Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in the genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myfilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction.",Cardiovascular disease,"MYH7 (mutation) [HSA:4625] [KO:K17751]
TNNT2 (mutation) [HSA:7139] [KO:K12045]
MYBPC3 (mutation) [HSA:4607] [KO:K12568]
TPM1 (mutation) [HSA:7168] [KO:K10373]
TNNI3 (mutation) [HSA:7137] [KO:K12044]
MYL2 (mutation) [HSA:4633] [KO:K10351]
MYL3 (mutation) [HSA:4634] [KO:K12749]
ACTC1 (mutation) [HSA:70] [KO:K12314]
TTN (mutation) [HSA:7273] [KO:K12567]
MYH6 (mutation) [HSA:4624] [KO:K17751]
PRKAG2 (mutation) [HSA:51422] [KO:K07200]
CSRP3 (mutation) [HSA:8048] [KO:K09377]
TNNC1 (mutation) [HSA:7134] [KO:K05865]
VCL (mutation) [HSA:7414] [KO:K05700]",,Athletic training,,,"Beta-blockers
Disopyramide [DG:DG00194]
Verapamil [DG:DG00329]
Diltiazem [DG00331]",,"ICD-10: I42
OMIM: 192600 115195 115197 115196 613690 608758 608751 612098 188840 613251 612098 600858 612124 613243 613255","PMID:12270949 (gene)
  AUTHORS   Fatkin D, Graham RM
  TITLE     Molecular mechanisms of inherited cardiomyopathies.
  JOURNAL   Physiol Rev 82:945-80 (2002)
DOI:10.1152/physrev.00012.2002

PMID:12844200 (gene)
  AUTHORS   Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA
  TITLE     Molecular genetics of cardiomyopathy: changing times, shifting paradigms.
  JOURNAL   Cardiovasc J S Afr 14:145-55 (2003)

PMID:11716909 (gene)
  AUTHORS   Franz WM, Muller OJ, Katus HA
  TITLE     Cardiomyopathies: from genetics to the prospect of treatment.
  JOURNAL   Lancet 358:1627-37 (2001)
DOI:10.1016/S0140-6736(01)06657-0

PMID:11273720 (gene)
  AUTHORS   Marian AJ, Roberts R
  TITLE     The molecular genetic basis for hypertrophic cardiomyopathy.
  JOURNAL   J Mol Cell Cardiol 33:655-70 (2001)
DOI:10.1006/jmcc.2001.1340

PMID:18572189 (gene)
  AUTHORS   Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ommen SR, Potter JD, Ackerman MJ
  TITLE     Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
  JOURNAL   J Mol Cell Cardiol 45:281-8 (2008)
DOI:10.1016/j.yjmcc.2008.05.003

PMID:16712796 (gene)
  AUTHORS   Vasile VC, Ommen SR, Edwards WD, Ackerman MJ
  TITLE     A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy.
  JOURNAL   Biochem Biophys Res Commun 345:998-1003 (2006)
DOI:10.1016/j.bbrc.2006.04.151

PMID:15183628 (env_factor ,drug)
  AUTHORS   Elliott P, McKenna WJ
  TITLE     Hypertrophic cardiomyopathy.
  JOURNAL   Lancet 363:1881-91 (2004)
DOI:10.1016/S0140-6736(04)16358-7

PMID:18930982 (drug)
  AUTHORS   Soor GS, Luk A, Ahn E, Abraham JR, Woo A, Ralph-Edwards A, Butany J
  TITLE     Hypertrophic cardiomyopathy: current understanding and treatment objectives.
  JOURNAL   J Clin Pathol 62:226-35 (2009)
DOI:10.1136/jcp.2008.061655

PMID:19568388 (drug)
  AUTHORS   Marian AJ
  TITLE     Contemporary treatment of hypertrophic cardiomyopathy.
  JOURNAL   Tex Heart Inst J 36:194-204 (2009)

PMID:15123994 (drug)
  AUTHORS   Ommen SR, Nishimura RA
  TITLE     Hypertrophic cardiomyopathy.
  JOURNAL   Curr Probl Cardiol 29:239-91 (2004)
DOI:10.1016/j.cpcardiol.2004.01.001",OMIM,192600,115195,115197,115196,613690,608758,608751,612098,188840,613251,612098,600858,612124,613243,613255,,,,,,,,,,,,,,,
H00806,"Benign familial neonatal and infantile epilepsies, including:
Benign familial neonatal epilepsy (BFNE);
Benign familial neonatal infantile epilepsy (BFNIE);
Benign familial infantile epilepsy (BFIE)","Benign familial neonatal epilepsy (BFNE), benign familial neonatal infantile epilepsy (BFNIE), and benign familial infantile epilepsy (BFIE) are three benign epilepsy syndromes with autosomal dominant inheritance distinguished by ascending average ages of seizure onset (mean age at onset of 2-3 days; 11 weeks; and 6 months, respectively). They are a group of genetic (idiopathic) epilepsies which have a primary genetic background, usually no structural brain abnormalities and most of them have a benign course without additional neurological symptoms. For BFNE and BFNIE, genetic defects have already been identified. Whereas BFNE are caused by loss-of-function mutations in the two genes KCNQ2 and KCNQ3 encoding the voltage-gated K+ channels Kv7.2 and Kv7.3, mutations in the gene SCN2A encoding the voltage-gated Na+ channel Nav1.2 have been detected in BFNIE. There are as yet no known genes identified for BFIE.",Nervous system disease,"(BFNE) KCNQ2 [HSA:3785] [KO:K04927]
(BFNE) KCNQ3 [HSA:3786] [KO:K04928]
(BFNIE) SCN2A [HSA:6326] [KO:K04834]",,,,,,,"ICD-10: G40.3
OMIM: 121200 121201 607745","PMID:20196795 (name)
  AUTHORS   Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE
  TITLE     Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.
  JOURNAL   Epilepsia 51:676-85 (2010)
DOI:10.1111/j.1528-1167.2010.02522.x

PMID:21395569 (description, gene)
  AUTHORS   Mulley JC, Heron SE, Dibbens LM
  TITLE     Proposed genetic classification of the ""benign"" familial neonatal and infantile epilepsies.
  JOURNAL   Epilepsia 52:649-50 (2011)
DOI:10.1111/j.1528-1167.2010.02953.x

PMID:20371507 (description, gene)
  AUTHORS   Liao Y, Deprez L, Maljevic S, Pitsch J, Claes L, Hristova D, Jordanova A, Ala-Mello S, Bellan-Koch A, Blazevic D, Schubert S, Thomas EA, Petrou S, Becker AJ, De Jonghe P, Lerche H
  TITLE     Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy.
  JOURNAL   Brain 133:1403-14 (2010)
DOI:10.1093/brain/awq057",OMIM,121200,121201,607745,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01029,Cornea plana congenita,"Cornea plana congenita is a rare hereditary anomaly in which the normal protrusion of the cornea from the sclera is missing. Clinical features include hyperopia, slight microcornea, an extended limbus zone, and arcus lipoides seen even before the age of 20. Cornea plana congenita occurs in a mild autosomal dominant (CNA1) and a more severe autosomal recessive (CNA2) form. CNA2 has a high prevalence in the Finnish population due to strong founder effect.",Eye disease,(CNA2) KERA [HSA:11081] [KO:K08123],,,,,,,"ICD-10: Q13.4
OMIM: 217300 121400","PMID:8929947 (description)
  AUTHORS   Tahvanainen E, Forsius H, Kolehmainen J, Damsten M, Fellman J, de la Chapelle A
  TITLE     The genetics of cornea plana congenita.
  JOURNAL   J Med Genet 33:116-9 (1996)
DOI:10.1136/jmg.33.2.116

PMID:9591953 (description)
  AUTHORS   Forsius H, Damsten M, Eriksson AW, Fellman J, Lindh S, Tahvanainen E
  TITLE     Autosomal recessive cornea plana. A clinical and genetic study of 78 cases in Finland.
  JOURNAL   Acta Ophthalmol Scand 76:196-203 (1998)
DOI:10.1034/j.1600-0420.1998.760215.x

PMID:9228241 (description)
  AUTHORS   Sigler-Villanueva A, Tahvanainen E, Lindh S, Dieguez-Lucena J, Forsius H
  TITLE     Autosomal dominant cornea plana: clinical findings in a Cuban family and a review of the literature.
  JOURNAL   Ophthalmic Genet 18:55-62 (1997)

PMID:10802664 (gene)
  AUTHORS   Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe R, Kivela T, Kucherlapati R, Forsius H, de la Chapelle A
  TITLE     Mutations in KERA, encoding keratocan, cause cornea plana.
  JOURNAL   Nat Genet 25:91-5 (2000)
DOI:10.1038/75664",OMIM,217300,121400,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00432,"Hereditary dentine disorders, including the following three diseases:
Dentine dysplasia, type II;
Dentinogenesis imperfecta, types II and III","These three disorders comprise a group of autosomal dominant diseases characterized by opalescent teeth caused by abnormal dentine structure. The phenotype varies from mild and severe, affecting either deciduous or both deciduous and permanent dentition. These diseases arise from mutations of the dentine sialophosphoprotein gene (DSPP) that is involved in dentin matrix formation.",Mouth and dental disease,DSPP [HSA:1834],,,,,,,"ICD-10: K00.5
OMIM: 125490 125500 125420","PMID:19021896
  AUTHORS   Barron MJ, McDonnell ST, Mackie I, Dixon MJ
  TITLE     Hereditary dentine disorders: dentinogenesis imperfecta and dentine dysplasia.
  JOURNAL   Orphanet J Rare Dis 3:31 (2008)
DOI:10.1186/1750-1172-3-31

PMID:17452557
  AUTHORS   Kim JW, Simmer JP
  TITLE     Hereditary dentin defects.
  JOURNAL   J Dent Res 86:392-9 (2007)
DOI:10.1177/154405910708600502

PMID:16955410
  AUTHORS   MacDougall M, Dong J, Acevedo AC
  TITLE     Molecular basis of human dentin diseases.
  JOURNAL   Am J Med Genet A 140:2536-46 (2006)
DOI:10.1002/ajmg.a.31359",OMIM,125490,125500,125420,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00825,"Familial flecked retina syndrome, including:
Doyne honeycomb degeneration of retina (DHRD);
Basal laminar drusen (BLD);
Fundus albipunctatus (FA) [DS:H00819];
Retinitis punctata albescens (RPA);
Bietti crystalline corneoretinal dystrophy  (BCD)","The flecked retina syndrome is characterized by multiple deep, yellow to yellowish white fundus lesions of variable size and shape in eyes without vascular or optic nerve disease. Originally this group consisted of four diseases: fundus albipunctatus, fundus flavimaculatus, familial drusen and fleck retina of Kandori. Doyne honeycomb degeneration of retina (DHRD) and Basal laminar drusen (BLD) are included in familial drusen. However, there are far more diseases with fleck-like deposits in the retina, including primary hereditary ocular diseases such as retinitis punctata albescens (RPA) or Bietti's crystalline dystrophy (BCD), neuro-ophthalmologic syndromes such as Kjellin's syndrome, and secundary retinal flecks due to metabolic disorders.",Nervous system disease; Eye disease,"(DHRD) EFEMP1 [HSA:2202] [KO:K18262]
(BLD) CFH [HSA:3075] [KO:K04004]
(FA) RDH5 [HSA:5959] [KO:K00061]
(RPA) RLBP1 [HSA:6017] [KO:K19625]
(RPA) RHO [HSA:6010] [KO:K04250]
(BCD) CYP4V2 [HSA:285440] [KO:K07427]",,,,,,,"ICD-10: H35.5
OMIM: 126600 126700 136880 210370","PMID:19373677
  AUTHORS   Walia S, Fishman GA, Kapur R
  TITLE     Flecked-retina syndromes.
  JOURNAL   Ophthalmic Genet 30:69-75 (2009)
DOI:10.1080/13816810802654516

PMID:11913893
  AUTHORS   Haimovici R, Wroblewski J, Piguet B, Fitzke FW, Holder GE, Arden GB, Bird AC
  TITLE     Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy).
  JOURNAL   Eye (Lond) 16:7-15 (2002)
DOI:10.1038/sj.eye.6700018

PMID:7952338
  AUTHORS   De Laey JJ
  TITLE     Flecked retina disorders.
  JOURNAL   Bull Soc Belge Ophtalmol 249:11-22 (1993)

PMID:14767656
  AUTHORS   Tsuchiya T, Kato M, Tomita N, Koide K, Hata N, Sato M, Hotta Y, Ueno M, Nakamura M, Miyake Y
  TITLE     A case of sectorial benign flecked retina.
  JOURNAL   Jpn J Ophthalmol 48:72-4 (2004)
DOI:10.1007/s10384-003-0002-6",OMIM,126600,126700,136880,210370,,,,,,,,,,,,,,,,,,,,,,,,,,
H00231,Hereditary elliptocytosis (HE),"Elliptocytosis is an autosomal dominant hematologic disorder characterized by elliptically shaped erythrocytes and a variable degree of hemolytic anemia caused by fragility of the erythrocyte membrane skeleton due to defects in alpha-spectrin, beta-spectrin, or protein 4.1.",Hematologic disease,"(HE1) EPB41 [HSA:2035] [KO:K06107]
(HE2) SPTA1 [HSA:6708] [KO:K06114]
(HE3) SPTB [HSA:6710] [KO:K06115]
(HE4) SLC4A1 [HSA:6521] [KO:K06573]",,,,,,,"ICD-10: D58.1
OMIM: 611804 130600 182870 166900","PMID:18341630
  AUTHORS   An X, Mohandas N
  TITLE     Disorders of red cell membrane.
  JOURNAL   Br J Haematol 141:367-75 (2008)
DOI:10.1111/j.1365-2141.2008.07091.x

PMID:16730867
  AUTHORS   Delaunay J
  TITLE     The molecular basis of hereditary red cell membrane disorders.
  JOURNAL   Blood Rev 21:1-20 (2007)
DOI:10.1016/j.blre.2006.03.005

PMID:15071791
  AUTHORS   Gallagher PG
  TITLE     Hereditary elliptocytosis: spectrin and protein 4.1R.
  JOURNAL   Semin Hematol 41:142-64 (2004)
DOI:10.1053/j.seminhematol.2004.01.003",OMIM,611804,130600,182870,166900,,,,,,,,,,,,,,,,,,,,,,,,,,
H01307,Nonsyndromic congenital nail disorder (NDNC),"Nonsyndromic congenital nail disorder is rare and has been reported in only a small number of families. There is variable expression of nail phenotypes among individuals. It have identified that mutations in the RSPO4 and FZD6, components of the Wnt pathway, cause the hypoplastic nail disorders. Hereditary leukonychia is caused by mutations in PLCD1. Defects in COL7A1 can cause heterogeneous clinical phenotypes extending from simple toe nail dystrophy without skin fragility to typical dominant dystrophic epidermolysis bullosa.",Developmental disorder,"PLCD1 [HSA:5333] [KO:K05857]
RSPO4 [HSA:343637]
COL7A1 [HSA:1294] [KO:K16628]
FZD6 [HSA:8323] [KO:K02376]",,,,,,"Defects in RSPO4 are the cause of Anonychia congenita. [DS:H00683]
Dominant dystrophic epidermolysis bullosa is described in H00587. [DS:H00587]","ICD-10: L60.3
OMIM: 161050 151600 206800 607523 614157 161200","PMID:22211385
  AUTHORS   Naz G, Pasternack SM, Perrin C, Mattheisen M, Refke M, Khan S, Gul A, Simons M, Ahmad W, Betz RC
  TITLE     FZD6 encoding the Wnt receptor frizzled 6 is mutated in autosomal-recessive nail dysplasia.
  JOURNAL   Br J Dermatol 166:1088-94 (2012)
DOI:10.1111/j.1365-2133.2011.10800.x

PMID:21665001
  AUTHORS   Kiuru M, Kurban M, Itoh M, Petukhova L, Shimomura Y, Wajid M, Christiano AM
  TITLE     Hereditary leukonychia, or porcelain nails, resulting from mutations in PLCD1.
  JOURNAL   Am J Hum Genet 88:839-44 (2011)
DOI:10.1016/j.ajhg.2011.05.014

PMID:17041604
  AUTHORS   Blaydon DC, Ishii Y, O'Toole EA, Unsworth HC, Teh MT, Ruschendorf F, Sinclair C, Hopsu-Havu VK, Tidman N, Moss C, Watson R, de Berker D, Wajid M, Christiano AM, Kelsell DP
  TITLE     The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia.
  JOURNAL   Nat Genet 38:1245-7 (2006)
DOI:10.1038/ng1883

PMID:15113589
  AUTHORS   Nakamura H, Sawamura D, Goto M, Sato-Matsumura KC, LaDuca J, Lee JY, Masunaga T, Shimizu H
  TITLE     The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
  JOURNAL   J Dermatol Sci 34:195-200 (2004)
DOI:10.1016/j.jdermsci.2004.02.005",OMIM,161050,151600,206800,607523,614157,161200,,,,,,,,,,,,,,,,,,,,,,,,
H00535,"Lymphedemas, including:
Lymphedema, hereditary I;
Lymphedema-distichiasis syndrome;
Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS);
Hennekam syndrome","Lymphoedemas are developmental disorders characterized by chronic lesions of the extremities due to insufficient lymphatic drainage. The dilated lymphatic channels that are not connected to the lymphatic vessels cause these edemas. LD patients develop extra eyelashes, Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) is associated with sparse hair and cutaneous telangiectasias, and Hennekam lymphangiectasia-lymphedema syndrome (HLLS) patients have unusual facies and severe mental retardation, in addition to the lymphoedemas.",Developmental disorder,"(hereditary I) FLT4 [HSA:2324] [KO:K05097]
(LD) FOXC2 [HSA:2303] [KO:K09396]
(HLTS) SOX18 [HSA:54345] [KO:K09270]
(HLLS) CCBE1 [HSA:147372] [KO:K19638]",,,,,,,"ICD-10: Q82.0
OMIM: 153100 153400 607823 235510","PMID:17670762 (description, gene)
  AUTHORS   Brouillard P, Vikkula M
  TITLE     Genetic causes of vascular malformations.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R140-9 (2007)
DOI:10.1093/hmg/ddm211

PMID:16379592 (description, gene)
  AUTHORS   Wang QK
  TITLE     Update on the molecular genetics of vascular anomalies.
  JOURNAL   Lymphat Res Biol 3:226-33 (2005)
DOI:10.1089/lrb.2005.3.226

PMID:11371511 (gene)
  AUTHORS   Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, Dunlap JW, Ferrell RE
  TITLE     Truncating mutations in FOXC2 cause multiple lymphedema syndromes.
  JOURNAL   Hum Mol Genet 10:1185-9 (2001)
DOI:10.1093/hmg/10.11.1185

PMID:19935664
  AUTHORS   Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC
  TITLE     Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans.
  JOURNAL   Nat Genet 41:1272-4 (2009)
DOI:10.1038/ng.484",OMIM,153100,153400,607823,235510,,,,,,,,,,,,,,,,,,,,,,,,,,
H00729,"Sick sinus syndrome (SSS);
Sinus node dysfunction","Sick sinus syndrome (SSS) comprises a variety of conditions involving sinus node dysfunction and commonly affects elderly persons. Patients may experience syncope, pre-syncope, palpitations, or dizziness. SSS has multiple manifestations on electrocardiogram, including sinus bradycardia, sinus arrest, sinoatrial block, and alternating patterns of bradycardia and tachycardia. Autosomal recessive type (SSS1) can be caused by compound heterozygous mutation in the SCN5A gene, and autosomal dominant type (SSS2) can be caused by heterozygous mutation in the HCN4. SCN5A encodes an alpha-subunit of the cardiac sodium channel carrying the current to form a rapid upstroke of action potential, whereas HCN4 codes for an alpha-subunit of hyperpolarization-activated cation channel.",Cardiovascular disease,"(SSS1) SCN5A [HSA:6331] [KO:K04838]
(SSS2) HCN4 [HSA:10021] [KO:K04957]",,,,,Atrial or dual-chamber pacemaker placement,,OMIM: 608567 163800,"PMID:12725451
  AUTHORS   Adan V, Crown LA
  TITLE     Diagnosis and treatment of sick sinus syndrome.
  JOURNAL   Am Fam Physician 67:1725-32 (2003)

PMID:15123648
  AUTHORS   Ueda K, Nakamura K, Hayashi T, Inagaki N, Takahashi M, Arimura T, Morita H, Higashiuesato Y, Hirano Y, Yasunami M, Takishita S, Yamashina A, Ohe T, Sunamori M, Hiraoka M, Kimura A
  TITLE     Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
  JOURNAL   J Biol Chem 279:27194-8 (2004)
DOI:10.1074/jbc.M311953200",OMIM,608567,163800,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00230,Hereditary spherocytosis (SPH),Hereditary spherocytosis is a heterogeneous group of disorders characterized by rounded red cells and chronic hemolysis.,Hematologic disease,"(SPH1) ANK1 [HSA:286] [KO:K10380]
(SPH2) SPTB [HSA:6710] [KO:K06115]
(SPH3) SPTA1 [HSA:6708] [KO:K06114]
(SPH4) SLC4A1 [HSA:6521] [KO:K06573]
(SPH5) EPB42 [HSA:2038]",,,,,Folic acid [DG:DG00176],,"ICD-10: D58.0
OMIM: 182900 182870 270970 109270 612690","PMID:15287938
  AUTHORS   Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ
  TITLE     Guidelines for the diagnosis and management of hereditary spherocytosis.
  JOURNAL   Br J Haematol 126:455-74 (2004)
DOI:10.1111/j.1365-2141.2004.05052.x

PMID:15121908
  AUTHORS   Shah S, Vega R
  TITLE     Hereditary spherocytosis.
  JOURNAL   Pediatr Rev 25:168-72 (2004)

PMID:15071790
  AUTHORS   Eber S, Lux SE
  TITLE     Hereditary spherocytosis--defects in proteins that connect the membrane skeleton to the lipid bilayer.
  JOURNAL   Semin Hematol 41:118-41 (2004)
DOI:10.1053/j.seminhematol.2004.01.002",OMIM,182900,182870,270970,109270,612690,,,,,,,,,,,,,,,,,,,,,,,,,
H00520,"Type II collagenopathies, including:
Achondrogenesis II;
Hypochondrogenesis;
SED congenita;
SMED Strudwick type;
Kniest dysplasia;
Spondyloperipheral dysplasia;
Osteoarthritis with mild chondrodysplasia;
Stickler syndrome 1;
Platyspondylic skeletal dysplasia, Torrance type;
Epiphyseal dysplasia, multiple, with myopia and deafness;
Czech dysplasia","Type II collagenopathies are a spectrum of phenotypes which affect the skeletal and visual systems. The severity ranges from perinatal lethality (achondrogenesis II, hypochondrogenesis) to the milder conditions caused by reduced collagen content in cartilage (Kniest dysplasia).",Skeletal dysplasia,COL2A1 [HSA:1280] [KO:K19719],,,,,,,"ICD-10: Q77.8 Q87.8
OMIM: 200610 183900 184250 156550 271700 604864 108300 151210 132450 609162","PMID:12453309 (description)
  AUTHORS   Reginato AM, Olsen BR
  TITLE     The role of structural genes in the pathogenesis of osteoarthritic disorders.
  JOURNAL   Arthritis Res 4:337-45 (2002)
DOI:10.1186/ar595

PMID:8791509 (description, gene)
  AUTHORS   Francomano CA, McIntosh I, Wilkin DJ
  TITLE     Bone dysplasias in man: molecular insights.
  JOURNAL   Curr Opin Genet Dev 6:301-8 (1996)
DOI:10.1016/S0959-437X(96)80006-2

PMID:21332586 (description, gene)
  AUTHORS   Kannu P, Bateman J, Savarirayan R
  TITLE     Clinical phenotypes associated with type II collagen mutations.
  JOURNAL   J Paediatr Child Health 48:E38-43 (2012)
DOI:10.1111/j.1440-1754.2010.01979.x

PMID:15643621 (description, gene)
  AUTHORS   Zankl A, Neumann L, Ignatius J, Nikkels P, Schrander-Stumpel C, Mortier G, Omran H, Wright M, Hilbert K, Bonafe L, Spranger J, Zabel B, Superti-Furga A
  TITLE     Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.
  JOURNAL   Am J Med Genet A 133A:61-7 (2005)
DOI:10.1002/ajmg.a.30531",OMIM,200610,183900,184250,156550,271700,604864,108300,151210,132450,609162,,,,,,,,,,,,,,,,,,,,
H00978,"Thrombocytopenia (THC);
Familial platelet disorder with associated myeloid malignancy (FPDMM)","Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. Inherited syndromes are relatively rare causes of thrombocytopenia, but some genes underlying these disorders have been elucidated. Some inherited syndromes predispose to the development of bone marrow failure or leukemia. For example, familial platelet disorder with associated myeloid malignancy (FPDMM) is characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.",Hematologic disease,"(THC1) WASP [HSA:7454] [KO:K05747]
(THC2) ANKRD26 [HSA:22852]
(THC2) MASTL [HSA:84930] [KO:K16309]
(THC4) CYCS [HSA:54205] [KO:K08738]
(THC6) SRC [HSA:6714] [KO:K05704]
(X-linked) GATA1 [HSA:2623] [KO:K09182]
(FPDMM) RUNX1 [HSA:861] [KO:K08367]",,,,,,,"ICD-10: D69.4
OMIM: 313900 188000 612004 314050 601399 616937","PMID:21680804
  AUTHORS   Geddis AE
  TITLE     A POTEntial new gene for thrombocytopenia.
  JOURNAL   Blood 117:6406-8 (2011)
DOI:10.1182/blood-2011-04-348383

PMID:21606161
  AUTHORS   Liew E, Owen C
  TITLE     Familial myelodysplastic syndromes: a review of the literature.
  JOURNAL   Haematologica 96:1536-42 (2011)
DOI:10.3324/haematol.2011.043422

PMID:26936507 (gene)
  AUTHORS   Turro E, Greene D, Wijgaerts A, Thys C, Lentaigne C, Bariana TK, Westbury SK, Kelly AM, Selleslag D, Stephens JC, Papadia S, Simeoni I, Penkett CJ, Ashford S, Attwood A, Austin S, Bakchoul T, Collins P, Deevi SV, Favier R, Kostadima M, Lambert MP, Mathias M, Millar CM, Peerlinck K, Perry DJ, Schulman S, Whitehorn D, Wittevrongel C, De Maeyer M, Rendon A, Gomez K, Erber WN, Mumford AD, Nurden P, Stirrups K, Bradley JR, Raymond FL, Laffan MA, Van Geet C, Richardson S, Freson K, Ouwehand WH
  TITLE     A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.
  JOURNAL   Sci Transl Med 8:328ra30 (2016)
DOI:10.1126/scitranslmed.aad7666",OMIM,313900,188000,612004,314050,601399,616937,,,,,,,,,,,,,,,,,,,,,,,,
H00223,Inherited thrombophilia,Congenital thrombophilias are inherited disorders associated with an increased tendency to venous thromboembolism caused by mutation of genes affecting the anticoagulant pathways of blood coagulation.,Hematologic disease,"SERPINC1; antithrombin III [HSA:462] [KO:K03911]
PROC; protein C [HSA:5624] [KO:K01344]
PROS1; protein S [HSA:5627] [KO:K03908]
F2; coagulation factor II (thrombin) [HSA:2147] [KO:K01313]
F5; coagulation factor V (labile factor) [HSA:2153] [KO:K03902]
HRG; histidine-rich glycoprotein [HSA:3273]
PLG; plasminogen [HSA:5340] [KO:K01315]
SERPINE1; plasminogen activator inhibitor 1 [HSA:5054] [KO:K03982]
FGA; fibrinogen alpha chain [HSA:2243] [KO:K03903]
FGB; fibrinogen beta chain [HSA:2244] [KO:K03904]
FGG; fibrinogen gamma chain [HSA:2266] [KO:K03905]
SERPIND1; heparin cofactor II [HSA:3053] [KO:K03912]
THBD; thrombomodulin [HSA:7056] [KO:K03907]
F9; coagulation factor IX [HSA:2158] [KO:K01321]",,,,,"Warfarin [DG:DG00149]
Heparin [DG:DG00150]",,"ICD-10: D68.2
OMIM: 188050 188055 612336 107300 176860 188040 176860 612304 612356 300807 613116","PMID:18574041
  AUTHORS   Dahlback B
  TITLE     Advances in understanding pathogenic mechanisms of thrombophilic disorders.
  JOURNAL   Blood 112:19-27 (2008)
DOI:10.1182/blood-2008-01-077909

PMID:17024597
  AUTHORS   Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P
  TITLE     Inherited thrombophilia and venous thromboembolism.
  JOURNAL   Semin Thromb Hemost 32:700-8 (2006)
DOI:10.1055/s-2006-951298

PMID:16962914
  AUTHORS   Coppens M, Kaandorp SP, Middeldorp S
  TITLE     Inherited thrombophilias.
  JOURNAL   Obstet Gynecol Clin North Am 33:357-74 (2006)
DOI:10.1016/j.ogc.2006.05.011

PMID:15331254
  AUTHORS   Feero WG
  TITLE     Genetic thrombophilia.
  JOURNAL   Prim Care 31:685-709, xi (2004)
DOI:10.1016/j.pop.2004.04.014

PMID:12787534
  AUTHORS   Buchanan GS, Rodgers GM, Ware Branch D
  TITLE     The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation.
  JOURNAL   Best Pract Res Clin Obstet Gynaecol 17:397-411 (2003)
DOI:10.1016/S1521-6934(03)00010-5

PMID:19846852
  AUTHORS   Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR
  TITLE     X-linked thrombophilia with a mutant factor IX (factor IX Padua).
  JOURNAL   N Engl J Med 361:1671-5 (2009)
DOI:10.1056/NEJMoa0904377",OMIM,188050,188055,612336,107300,176860,188040,176860,612304,612356,300807,613116,,,,,,,,,,,,,,,,,,,
H00107,"Other well-defined immunodeficiency syndromes, including the following eight diseases:
Wiskott-Aldrich syndrome [DS:H01523];
DiGeorge syndrome [DS:H01524];
Hyper-IgE syndrome;
X-linked lymphoproliferative syndrome;
Lymphoproliferative syndrome, EBV-associated, autosomal, 1;
Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX);
Cartilage-Hair Hypoplasia;
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)","Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disease and characterized by immune dysregulation and microthrombocytopenia. Several nonsense and missense mutations as well as deletions and insertions of the WAS gene have been identified in WAS patients. DiGeorge/velocardiofacial syndrome (DGS) is a congenital immune disorder characterized by lack of embryonic development or underdevelopment of the thymus and surrounding organs. The DGS is a member of a group of disorders that have in common a chromosome deletion involving 22q11.2 (the DiGeorge syndrome chromosome region, or DGCR). Hyper-IgE syndrome (HIES) is characterized by atopic dermatitis associated with extremely high serum IgE levels and susceptibility to infections with extracellular bacteria. Dominant-negative mutations in the signal transducer and activator of transcription 3 (STAT3) gene result in the classical multisystem form of HIES, whereas a null mutation in the tyrosine kinase 2 (TYK2) gene causes an autosomal recessive HIES associated with viral and mycobacterial infections. X-linked lymphoproliferative syndrome (XLP) is a rare primary immunodeficiency, with manifestations ranging from fatal infectious mononucleosis to B cell lymphomas and hypogammaglobulinemia. Mutations in the X-linked inhibitor of apoptosis (XIAP) as well as in a distinct gene, SLAM-associated protein (SAP/DSP1/SH2D1A) have been identified in patients with XLP. Recently, it has been shown that a homozygous mutation in the SH2 domain of the IL-2-inducible T-cell kinase (ITK) gene is associated with fatal Epstein Barr virus associated lymphoproliferation, with a clinical picture similar to that seen in XLP. Immune dysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome and autoimmune polyendocrinopathy, candidiasis, ectodermal dysplasia (APECED) are examples of dysregulated immunity resulting in a disturbed tolerance and multiple autoimmune phenomena. IPEX is caused by mutations in the FOXP3 gene, and APECED results from mutations in the autoimmune regulator (AIRE) gene. Cartilage hair hypoplasia (CHH) is due to either the homozygous or compound heterozygous mutations in the nuclear encoded, non-coding RNA gene RMRP.",Primary immunodeficiency,"WAS [HSA:7454] [KO:K05747]
TBX1 [HSA:6899] [KO:K10175]
STAT3 [HSA:6774] [KO:K04692]
TYK2 [HSA:7297] [KO:K11219]
SH2D1A [HSA:4068] [KO:K07990]
XIAP [HSA:331] [KO:K04725]
ITK [HSA:3702] [KO:K07363]
AIRE [HSA:326] [KO:K10603]
FOXP3 [HSA:50943] [KO:K10163]
RMRP [HSA:6023] [KO:K14576]",,,,,,,OMIM: 301000 188400 147060 243700 308240 300635 613011 304790 250250 240300 611521,"PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:9737224 (gene)
  AUTHORS   Ten RM.
  TITLE     Primary immunodeficiencies.
  JOURNAL   Mayo Clin Proc 73:865-72 (1998)
DOI:10.4065/73.9.865

PMID:15096561 (description, gene)
  AUTHORS   Lim MS, Elenitoba-Johnson KS.
  TITLE     The molecular pathology of primary immunodeficiencies.
  JOURNAL   J Mol Diagn 6:59-83 (2004)
DOI:10.1016/S1525-1578(10)60493-X

PMID:19425169 (gene)
  AUTHORS   Huck K, Feyen O, Niehues T, Ruschendorf F, Hubner N, Laws HJ, Telieps T, Knapp S, Wacker HH, Meindl A, Jumaa H, Borkhardt A
  TITLE     Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
  JOURNAL   J Clin Invest 119:1350-8 (2009)
DOI:10.1172/JCI37901

PMID:21109689 (description, gene)
  AUTHORS   Stepensky P, Weintraub M, Yanir A, Revel-Vilk S, Krux F, Huck K, Linka RM, Shaag A, Elpeleg O, Borkhardt A, Resnick IB
  TITLE     IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
  JOURNAL   Haematologica 96:472-6 (2011)
DOI:10.3324/haematol.2010.033910

PMID:18264745 (description, gene)
  AUTHORS   Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD
  TITLE     Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.
  JOURNAL   J Clin Immunol 28 Suppl 1:S11-9 (2008)
DOI:10.1007/s10875-008-9176-5

PMID:19717292 (description, gene)
  AUTHORS   Minegishi Y
  TITLE     Hyper-IgE syndrome.
  JOURNAL   Curr Opin Immunol 21:487-92 (2009)
DOI:10.1016/j.coi.2009.07.013

PMID:16838329 (description, gene)
  AUTHORS   Hermanns P, Tran A, Munivez E, Carter S, Zabel B, Lee B, Leroy JG
  TITLE     RMRP mutations in cartilage-hair hypoplasia.
  JOURNAL   Am J Med Genet A 140:2121-30 (2006)
DOI:10.1002/ajmg.a.31331

PMID:19595300 (description, gene)
  AUTHORS   Rumble JM, Oetjen KA, Stein PL, Schwartzberg PL, Moore BB, Duckett CS
  TITLE     Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP).
  JOURNAL   Cell Immunol 259:82-9 (2009)
DOI:10.1016/j.cellimm.2009.05.017

PMID:18424339 (gene)
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,301000,188400,147060,243700,308240,300635,613011,304790,250250,240300,611521,,,,,,,,,,,,,,,,,,,
H00232,"Hereditary stomatocytosis (HSt), including:
Dehydrated hereditary stomatocytosis (DHS);
Overhydrated hereditary stomatocytosis (OHS);
Familial pseudohyperkalemia (FP);
Cryohydrocytosis (CHC)","Hereditary stomatocytosis describes a group of hemolytic anemias with mouth-shaped red blood cells which fail to transport monovalent cations, such as sodium and potassium.",Hematologic disease,"(OHS) RHAG [HSA:6005] [KO:K06580]
(DHS1) PIEZO1 [HSA:9780] [KO:K22128]
(DHS2) KCNN4 [HSA:3783] [KO:K04945]
(FP) ABCB6 [HSA:10058] [KO:K05661]
(CHC) SLC4A1 [HSA:6521] [KO:K06573]
(SDCHCN) SLC2A1 [HSA:6513] [KO:K07299]",,,,,,,"ICD-10: D58.8
OMIM: 185000 194380 616689 609153 185020 608885","PMID:19261491
  AUTHORS   Bruce LJ
  TITLE     Hereditary stomatocytosis and cation leaky red cells--recent developments.
  JOURNAL   Blood Cells Mol Dis 42:216-22 (2009)
DOI:10.1016/j.bcmd.2009.01.014

PMID:15071792
  AUTHORS   Delaunay J
  TITLE     The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations.
  JOURNAL   Semin Hematol 41:165-72 (2004)
DOI:10.1053/j.seminhematol.2004.02.005

PMID:10088641
  AUTHORS   Delaunay J, Stewart G, Iolascon A
  TITLE     Hereditary dehydrated and overhydrated stomatocytosis: recent advances.
  JOURNAL   Curr Opin Hematol 6:110-4 (1999)

PMID:27756835
  AUTHORS   Andolfo I, Russo R, Gambale A, Iolascon A
  TITLE     New insights on hereditary erythrocyte membrane defects.
  JOURNAL   Haematologica 101:1284-1294 (2016)
DOI:10.3324/haematol.2016.142463

PMID:21791420 (gene)
  AUTHORS   Flatt JF, Guizouarn H, Burton NM, Borgese F, Tomlinson RJ, Forsyth RJ, Baldwin SA, Levinson BE, Quittet P, Aguilar-Martinez P, Delaunay J, Stewart GW, Bruce LJ
  TITLE     Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome.
  JOURNAL   Blood 118:5267-77 (2011)
DOI:10.1182/blood-2010-12-326645",OMIM,185000,194380,616689,609153,185020,608885,,,,,,,,,,,,,,,,,,,,,,,,
H00259,"Apparent mineralocorticoid excess syndrome;
11-beta-ketoreductase deficiency","Apparent mineralocorticoid excess (AME) syndrome is characterized by hypertension, low plasma renin and aldosterone and hypokalaemia caused by deficiency of 11b-hydroxysteroid dehydrogenase type 2 which is a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone.",Endocrine disease; Metabolic disease,HSD11B2 [HSA:3291] [KO:K00071],,,,,Dexamethasone [DG:DG00011],,"ICD-10: E27.4 I15.2
OMIM: 218030 207765","PMID:16980198
  AUTHORS   Hammer F, Stewart PM
  TITLE     Cortisol metabolism in hypertension.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 20:337-53 (2006)
DOI:10.1016/j.beem.2006.07.001

PMID:15761540
  AUTHORS   Palermo M, Quinkler M, Stewart PM
  TITLE     Apparent mineralocorticoid excess syndrome: an overview.
  JOURNAL   Arq Bras Endocrinol Metabol 48:687-96 (2004)
DOI:10.1590/S0004-27302004000500015",OMIM,218030,207765,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00841,"Infantile progressive bulbar palsy, including:
Brown-Vialetto-Van Laere syndrome (BVVLS) [DS:H01903];
Fazio-Londe disease",Infantile progressive bulbar palsy is a rare neurological disorder that occurs in children. Infantile progressive bulbar palsy presents as following two forms. The Brown-Vialetto-Van Laere syndrome (BVVLS) is characterized by progressive pontobulbar palsy associated with sensorineural deafness. The same clinical presentation without deafness is also known as Fazio Londe disease. Both are caused by mutation in the RFT2 gene.,Neurodegenerative disease,RFT2 [HSA:113278] [KO:K14620],,,,,,See also H01903 Brown-Vialetto-Van Laere syndrome.,"ICD-10: G12.1 G12.2
OMIM: 211500 211530","PMID:12427524
  AUTHORS   Voudris KA, Skardoutsou A, Vagiakou EA
  TITLE     Infantile progressive bulbar palsy with deafness.
  JOURNAL   Brain Dev 24:732-5 (2002)
DOI:10.1016/S0387-7604(02)00085-2

PMID:21110228
  AUTHORS   Bosch AM, Abeling NG, Ijlst L, Knoester H, van der Pol WL, Stroomer AE, Wanders RJ, Visser G, Wijburg FA, Duran M, Waterham HR
  TITLE     Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
  JOURNAL   J Inherit Metab Dis 34:159-64 (2011)
DOI:10.1007/s10545-010-9242-z

PMID:18416855
  AUTHORS   Sathasivam S
  TITLE     Brown-Vialetto-Van Laere syndrome.
  JOURNAL   Orphanet J Rare Dis 3:9 (2008)
DOI:10.1186/1750-1172-3-9

PMID:16122634
  AUTHORS   Dipti S, Childs AM, Livingston JH, Aggarwal AK, Miller M, Williams C, Crow YJ
  TITLE     Brown-Vialetto-Van Laere syndrome; variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease.
  JOURNAL   Brain Dev 27:443-6 (2005)
DOI:10.1016/j.braindev.2004.10.003",OMIM,211500,211530,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00101,"Other phagocyte defects, including the following eight diseases:
Chediak-Higashi syndrome;
Griscelli syndrome, type 1 (GS1);
Griscelli syndrome, type 2 (GS2);
Griscelli syndrome, type 3 (GS3);
beta-actin deficiency;
Neutrophil-specific granule deficiency;
Myeloperoxidase deficiency;
Glucose 6-phosphate dehydrogenase deficiency;
Shwachman syndrome","Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized by partial skin and ocular albinism, increased susceptibility to infections, and progressive neuropathy. Clinical reports of CHS have identified mutations throughout the CHS1/LYST gene. Griscelli syndrome (GS) is a rare autosomal recessive disorder caused by mutations in either the myosin VA (GS1), RAB27A (GS2) or melanophilin (GS3) genes. GS is characterized by partial albinism, hepatosplenomegaly, progressive neurological deterioration, hypogammaglobulinemia and pancytopenia. Abnormal-beta-actin disease accompanies neutrophil chemotactic dysfunction. Neutrophil specific granule deficiency is a rare disorder of neutrophil function characterized by a lack of neutrophil secondary granule proteins and associated with recurrent bacterial infections. It has been linked to a defect in the transcription factor CCAAT/enhancer binding protein (C/EBP) epsilon. Myeloperoxidase deficiency is the most common inherited disorder of neutrophils. Heterogeneous mutations in the gene encoding myeloperoxidase have been described. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a X-chromosomally transmitted disorder. The most frequent clinical manifestations of G6PD deficiency are neonatal jaundice, and acute haemolytic anaemia, which is usually triggered by an exogenous agent. Shwachman-Diamond syndrome (SDS) is a rare autosomal-recessive, multisystem disease characterized by exocrine pancreatic insufficiency, impaired hematopoiesis, and leukemia predisposition. The only gene known to be associated with SDS is SBDS, which encodes a ribosome maturation protein.",Primary immunodeficiency,"CHS1 [HSA:1130]
MYO5A [HSA:4644] [KO:K10357]
RAB27A [HSA:5873] [KO:K07885]
MLPH [HSA:79083] [KO:K22235]
ACTB [HSA:60] [KO:K05692]
CEBPE [HSA:1053] [KO:K10051]
MPO [HSA:4353] [KO:K10789]
G6PD [HSA:2539] [KO:K00036]
SBDS [HSA:51119] [KO:K14574]",,,,,,"For Glucose 6-phosphate dehydrogenase deficiency, see H01375.",OMIM: 214500 214450 607624 245480 254600 260400,"PMID:15096561 (description, gene)
  AUTHORS   Lim MS, Elenitoba-Johnson KS.
  TITLE     The molecular pathology of primary immunodeficiencies.
  JOURNAL   J Mol Diagn 6:59-83 (2004)
DOI:10.1016/S1525-1578(10)60493-X

PMID:17498436 (description, gene)
  AUTHORS   Kharkar V, Pande S, Mahajan S, Dwiwedi R, Khopkar U
  TITLE     Griscelli syndrome: a new phenotype with circumscribed pigment loss?
  JOURNAL   Dermatol Online J 13:17 (2007)

PMID:11594510 (description, gene)
  AUTHORS   Nunoi H, Yamazaki T, Kanegasaki S
  TITLE     Neutrophil cytoskeletal disease.
  JOURNAL   Int J Hematol 74:119-24 (2001)
DOI:10.1007/BF02981993

PMID:11701548 (description, gene)
  AUTHORS   Dinauer MC, Lekstrom-Himes JA, Dale DC
  TITLE     Inherited Neutrophil Disorders: Molecular Basis and New Therapies.
  JOURNAL   Hematology Am Soc Hematol Educ Program 303-318 (2000)
DOI:10.1182/asheducation-2000.1.303

PMID:11964737 (description, gene)
  AUTHORS   Etzioni A
  TITLE     Novel aspects of phagocytic cell disorders.
  JOURNAL   Curr Opin Allergy Clin Immunol 1:535-40 (2001)

PMID:18177777 (description, gene)
  AUTHORS   Cappellini MD, Fiorelli G
  TITLE     Glucose-6-phosphate dehydrogenase deficiency.
  JOURNAL   Lancet 371:64-74 (2008)
DOI:10.1016/S0140-6736(08)60073-2

PMID:19102804 (description, gene)
  AUTHORS   Dror Y
  TITLE     Shwachman-Diamond syndrome: implications for understanding the molecular basis of leukaemia.
  JOURNAL   Expert Rev Mol Med 10:e38 (2008)
DOI:10.1017/S1462399408000938

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:9737224 (gene)
  AUTHORS   Ten RM.
  TITLE     Primary immunodeficiencies.
  JOURNAL   Mayo Clin Proc 73:865-72 (1998)
DOI:10.4065/73.9.865

PMID:18424339 (gene)
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,214500,214450,607624,245480,254600,260400,,,,,,,,,,,,,,,,,,,,,,,,
H00963,"Congenital hereditary endothelial dystrophy (CHED);
Congenital hereditary endothelial dystrophy type 1;
Congenital hereditary endothelial dystrophy type 2;
Corneal dystrophy and perceptive deafness (CDPD);
Harboyan syndrome","Congenital hereditary endothelial dystrophy (CHED) is a rare inheritable disorder of the corneal endothelium characterized by bilateral symmetric corneal clouding (edema) with varied severity from mild opacification to milky, ground-glass opacification without other anterior segment abnormalities, usually evident at birth or in the early years of life. Two subtypes of CHED based on differences in the mode of inheritance are known, an autosomal dominant (CHED1) and an autosomal recessive (CHED2) type. Clinically, both forms of the disorder are similar; the distinction between them is made by the age at onset and the presence or absence of associated symptoms. Both CHED1 and CHED2 have been mapped to chromosome 20. The Solute Carrier family 4 (sodium borate cotransporter) member 11 (SLC4A11) has been identified as the candidate gene for CHED2. Mutations in SLC4A11 are described in Harboyan syndrome, which is characterized as CHED2 with hearing loss. Most patients with CHED have severe visual impairment and often require penetrating keratoplasty.",Eye disease,(CHED2) SLC4A11 [HSA:83959] [KO:K13862],,,,,,,"ICD-10: H18.5
OMIM: 217700 217400","PMID:18097987 (description, gene)
  AUTHORS   Ciralsky J, Colby K
  TITLE     Congenital corneal opacities: a review with a focus on genetics.
  JOURNAL   Semin Ophthalmol 22:241-6 (2007)
DOI:10.1080/08820530701745157

PMID:21203343 (description, gene)
  AUTHORS   Paliwal P, Sharma A, Tandon R, Sharma N, Titiyal JS, Sen S, Nag TC, Vajpayee RB
  TITLE     Congenital hereditary endothelial dystrophy - mutation analysis of SLC4A11 and genotype-phenotype correlation in a North Indian patient cohort.
  JOURNAL   Mol Vis 16:2955-63 (2010)

PMID:18474783 (description, gene)
  AUTHORS   Hemadevi B, Veitia RA, Srinivasan M, Arunkumar J, Prajna NV, Lesaffre C, Sundaresan P
  TITLE     Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy.
  JOURNAL   Arch Ophthalmol 126:700-8 (2008)
DOI:10.1001/archopht.126.5.700",OMIM,217700,217400,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00917,Congenital dyserythropoietic anemias (CDAs),"Congenital dyserythropoietic anemias (CDAs) are rare hereditary disorders characterized by ineffective erythropoiesis and by distinct morphological abnormalities of erythroblasts in the bone marrow. Non-erythroid hematopoietic cell lineages are morphologically normal. Three types of the disease are known as type I, II and III, and there is also a huge group of congenital forms that cannot be included with any of the three canonical types. CDA type II is the most widely spread form. CDA type III is the rarest of the three classical types of CDA and both familial and sporadic cases have been reported.",Hematologic disease,"(CDAN1A) CDAN1 [HSA:146059] [KO:K19531]
(CDAN1B) C15orf41 [HSA:84529]
(CDAN2) SEC23B [HSA:10483] [KO:K14006]
(CDAN4) KLF1 [HSA:10661] [KO:K09204]",,,,,,"(CDAII) SEC23B most frequent mutations: the R14W, E109K, R497C and I318T","ICD-10: D64.4
OMIM: 224120 224100 613673 615631","PMID:21378561 (description, gene)
  AUTHORS   Iolascon A, Russo R, Delaunay J
  TITLE     Congenital dyserythropoietic anemias.
  JOURNAL   Curr Opin Hematol 18:146-51 (2011)
DOI:10.1097/MOH.0b013e32834521b0

PMID:21251457 (description, comment)
  AUTHORS   Iolascon A, Russo R, Esposito MR, Piscopo C, Asci R, De Falco L, Di Noce F
  TITLE     Congenital dyserythropoietic anaemias: new acquisitions.
  JOURNAL   Blood Transfus 9:278-80 (2011)
DOI:10.2450/2010.0085-10

PMID:20820969 (description)
  AUTHORS   Kamiya T, Manabe A
  TITLE     Congenital dyserythropoietic anemia.
  JOURNAL   Int J Hematol 92:432-8 (2010)
DOI:10.1007/s12185-010-0667-9

PMID:21055716 (gene)
  AUTHORS   Arnaud L, Saison C, Helias V, Lucien N, Steschenko D, Giarratana MC, Prehu C, Foliguet B, Montout L, de Brevern AG, Francina A, Ripoche P, Fenneteau O, Da Costa L, Peyrard T, Coghlan G, Illum N, Birgens H, Tamary H, Iolascon A, Delaunay J, Tchernia G, Cartron JP
  TITLE     A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.
  JOURNAL   Am J Hum Genet 87:721-7 (2010)
DOI:10.1016/j.ajhg.2010.10.010",OMIM,224120,224100,613673,615631,,,,,,,,,,,,,,,,,,,,,,,,,,
H00426,"Defects in the degradation of ganglioside, including:
GM1 gangliosidosis [DS:H00281];
GM2 gangliosidoses [DS:H00124];
Gaucher disease [DS:H00126]","Defects in the degradation of ganglioside is a group of autosomal recessive lysosomal storage diseases caused by deficient activty of enzymes or their activators that play important roles in the degradation of ganglioside. The lack of a single enzyme leads to the complete blockage of the catabolic chain and results in the accumulation of undegraded substrates such as keratan sulfate, gangliosides, glucosylceramide and glycopeptides in neurons and skeletal tissues. Deficiency of the GM2 activator protein causes the AB variant of GM2 gangliosidosis. And saposin C is an activator of beta-glucocerebrosidase.",Inherited metabolic disease; Lysosomal storage disease; Nervous system disease,"(GM1) GLB1; beta-galactosidase [HSA:2720] [KO:K12309]
(GM2 type1) HEXA; beta-hexosaminidase A [HSA:3073] [KO:K12373]
(GM2 type2) HEXB; beta-hexosaminidase B [HSA:3074] [KO:K12373]
(GM2 AB variant) GM2A; ganglioside GM2 activator [HSA:2760] [KO:K12383]
(Gaucher) GBA; glucosylceramidase [HSA:2629] [KO:K01201]
(Gaucher) PSAP; prosaposin [HSA:5660] [KO:K12382]",,,,"Urine oligosaccharides
(GM1) GM1 ganglioside [GL:G00110] [CPD:C04911]
(GM2) GM2 ganglioside [GL:G00109] [CPD:C04884]
(GM1, GM2) keratan sulfate [CPD:C00573]
(GM1) Chondroitin sulfate [CPD:C00607]
(Gaucher) Glucocerebroside [GL:G10238] [CPD:C01190]","(GM1)
Hematopoietic stem cell transplantation
Chemical chaperone therapy; N-octyl-4-epi-beta-valienamine (NOEV) (limited experience)
(GM2)
Enzyme replacement therapy, Gene therapy, Substrate reduction therapy (limited experience)
(Gaucher)
Hematopoietic stem cell transplantation
Enzyme-replacement therapy: Cerezyme [DR:D03020] Alglucerase [DR:D02810] Imiglucerase [DR:D03020]
Substrate reduction therapy: Miglustat, Zavesca [DR:D05032]","Morquio syndrome B is non-neuronopathic form of GM1-gangliosidosis (see, H00123).
Some diseases are described as some phenotypes.
(GM1) Type 1: the severe infantile form. Type 2: the juvenile form. Type 3 the mild adult form
(Gaucher) Type 1: non-neuronopathic form. Type2: acute infantile neuropathic form. Type3: the chronic neuropathic form.","ICD-10: E75.1 E75.2
OMIM: 230500 230600 230650 268800 272800 272750 230800 230900 231000 231005 608013","PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:19472408 (GM1)
  AUTHORS   Hofer D, Paul K, Fantur K, Beck M, Burger F, Caillaud C, Fumic K, Ledvinova J, Lugowska A, Michelakakis H, Radeva B, Ramaswami U, Plecko B, Paschke E
  TITLE     GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.
  JOURNAL   Hum Mutat 30:1214-21 (2009)
DOI:10.1002/humu.21031

PMID:18202827 (GM1/ therapy)
  AUTHORS   Suzuki Y
  TITLE     Chemical chaperone therapy for GM1-gangliosidosis.
  JOURNAL   Cell Mol Life Sci 65:351-3 (2008)
DOI:10.1007/s00018-008-7470-2

PMID:12019216 (GM2)
  AUTHORS   Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL
  TITLE     Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling.
  JOURNAL   Hum Mol Genet 11:1343-50 (2002)
DOI:10.1093/hmg/11.11.1343

PMID:16801539 (GM2)
  AUTHORS   Cachon-Gonzalez MB, Wang SZ, Lynch A, Ziegler R, Cheng SH, Cox TM
  TITLE     Effective gene therapy in an authentic model of Tay-Sachs-related diseases.
  JOURNAL   Proc Natl Acad Sci U S A 103:10373-8 (2006)
DOI:10.1073/pnas.0603765103

PMID:19595619
  AUTHORS   Maegawa GH, Banwell BL, Blaser S, Sorge G, Toplak M, Ackerley C, Hawkins C, Hayes J, Clarke JT
  TITLE     Substrate reduction therapy in juvenile GM2 gangliosidosis.
  JOURNAL   Mol Genet Metab 98:215-24 (2009)
DOI:10.1016/j.ymgme.2009.06.005

PMID:18339196 (Gaucher)
  AUTHORS   Platt FM, Jeyakumar M
  TITLE     Substrate reduction therapy.
  JOURNAL   Acta Paediatr Suppl 97:88-93 (2008)
DOI:10.1111/j.1651-2227.2008.00656.x",OMIM,230500,230600,230650,268800,272800,272750,230800,230900,231000,231005,608013,,,,,,,,,,,,,,,,,,,
H00224,"Bernard-Soulier syndrome;
Giant platelet syndrome","Bernard-Soulier syndrome is a bleeding disorder caused by a defect in or deficiency of the platelet membrane von Willebrand factor receptor which is composed of 4 proteins, GP1BA, GP1BB, GP9 and GP5. The clinical feature is characterized by variable thrombocytopenia and large defective platelets.",Hematologic disease,"GP1BA [HSA:2811] [KO:K06261]
GP1BB [HSA:2812] [KO:K06262]
GP9 [HSA:2815] [KO:K06263]",,,,,,,"ICD-10: D69.1
OMIM: 153670 231200","PMID:18081445
  AUTHORS   Pham A, Wang J
  TITLE     Bernard-Soulier syndrome: an inherited platelet disorder.
  JOURNAL   Arch Pathol Lab Med 131:1834-6 (2007)
DOI:10.1043/1543-2165(2007)131[1834:BSAIPD]2.0.CO;2

PMID:17109744
  AUTHORS   Lanza F
  TITLE     Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).
  JOURNAL   Orphanet J Rare Dis 1:46 (2006)
DOI:10.1186/1750-1172-1-46",OMIM,153670,231200,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00423,"Defects in the degradation of sulfatide, including:
Metachromatic leukodystrophy (MLD) [DS:H00127];
Krabbe disease/ Globoid cell leukodystrophy [DS:H00135]",Defects in the degradation of sulfatide is a group of autosomal recessive demyelinating lysosomal storage diseases including Metachromatic leukodystrophy (MLD) and Krabbe disease. MLD caused by deficiency of lysosomal arylsulfatase A (ARSA) and Krabbe disease caused by deficiency of galactosylceramidase. The enzyme defects result in the accumulation of sulfatide and galactocerebroside in the central and peripheral nervous systems and extensive white matter damage and loss of both cognitive and motor functions. Mutated PSAP gene resulting in sphingolipid activator proteins (saposin) Saposin B deficiency is known to cause MLD variant in which ARSA is normal. It is also known that saposin A and saposin C are able to stimulate the step of galactocerebroside degradation.,Inherited metabolic disease; Lysosomal storage disease; Nervous system disease,"(MLD)ARSA; arylsulfatase A [HSA:410] [KO:K01134]
(Krabbe) GALC; galactosylceramidase [HSA:2581] [KO:K01202]
(MLD, Krabbe) PSAP; saposin [HSA:5660] [KO:K12382]",,,,"(MLD) sulfatides [GL:G11122] [CPD:C06125]
(Krabbe) Galactocerebroside [GL:G11121] [CPD:C02686]
(Krabbe) Psychosine [CPD:C01747]","Enzyme-replacement therapy
Hematopoietic stem cell transplantation",,"ICD-10: E75.2
OMIM: 250100 249900 245200","PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:18465098
  AUTHORS   Eckhardt M
  TITLE     The role and metabolism of sulfatide in the nervous system.
  JOURNAL   Mol Neurobiol 37:93-103 (2008)
DOI:10.1007/s12035-008-8022-3

PMID:16854371
  AUTHORS   Kolter T, Sandhoff K
  TITLE     Sphingolipid metabolism diseases.
  JOURNAL   Biochim Biophys Acta 1758:2057-79 (2006)
DOI:10.1016/j.bbamem.2006.05.027

PMID:17347913 (MLD)
  AUTHORS   Sevin C, Aubourg P, Cartier N
  TITLE     Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
  JOURNAL   J Inherit Metab Dis 30:175-83 (2007)
DOI:10.1007/s10545-007-0540-z

PMID:19267410 (MLD variant)
  AUTHORS   Kuchar L, Ledvinova J, Hrebicek M, Myskova H, Dvorakova L, Berna L, Chrastina P, Asfaw B, Elleder M, Petermoller M, Mayrhofer H, Staudt M, Krageloh-Mann I, Paton BC, Harzer K
  TITLE     Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.
  JOURNAL   Am J Med Genet A 149A:613-21 (2009)
DOI:10.1002/ajmg.a.32712

PMID:10833326 (Krabbe)
  AUTHORS   Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E
  TITLE     Krabbe disease: genetic aspects and progress toward therapy.
  JOURNAL   Mol Genet Metab 70:1-9 (2000)
DOI:10.1006/mgme.2000.2990

PMID:18157819 (MSD)
  AUTHORS   Schlotawa L, Steinfeld R, von Figura K, Dierks T, Gartner J
  TITLE     Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency.
  JOURNAL   Hum Mutat 29:205 (2008)
DOI:10.1002/humu.9515",OMIM,250100,249900,245200,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00235,Methemoglobinemia,Hereditary methemoglobinemia is an autosomal recessive disorder characterized by NADH-cytochrome b5 reductase deficiency.,Hematologic disease,"CYB5R3 [HSA:1727] [KO:K00326]
CYB5A [HSA:1528]",,,,,,,"ICD-10: D74.0
OMIM: 250800 250790","PMID:18318771
  AUTHORS   Percy MJ, Lappin TR
  TITLE     Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.
  JOURNAL   Br J Haematol 141:298-308 (2008)
DOI:10.1111/j.1365-2141.2008.07017.x

PMID:18202104
  AUTHORS   Ewenczyk C, Leroux A, Roubergue A, Laugel V, Afenjar A, Saudubray JM, Beauvais P, Billette de Villemeur T, Vidailhet M, Roze E
  TITLE     Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum.
  JOURNAL   Brain 131:760-1 (2008)
DOI:10.1093/brain/awm337

PMID:2107882
  AUTHORS   Kobayashi Y, Fukumaki Y, Yubisui T, Inoue J, Sakaki Y
  TITLE     Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type.
  JOURNAL   Blood 75:1408-13 (1990)

PMID:8168836
  AUTHORS   Giordano SJ, Kaftory A, Steggles AW
  TITLE     A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism.
  JOURNAL   Hum Genet 93:568-70 (1994)
DOI:10.1007/BF00202825",OMIM,250800,250790,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00422,"Glycoproteinoses, including:
Sialidosis/ Mucolipidosis I [DS:H00142];
Galactosialidosis [DS:H00276];
alpha-Mannosidosis [DS:H00139];
beta-Mannosidosis [DS:H00140];
Aspartylglucosaminuria (AGU) [DS:H00145];
Fucosidosis [DS:H00141];
Schindler/ Kanzaki disease [DS:H00146]","Glycoproteinoses is a group of autosomal recessive lysosomal storage diseases caused by deficient activty of enzymes that play important roles in the degradation of glycoproteins such as N-linked or O-linked oligosaccharides. The lack of a single enzyme leads to the complete blockage of the catabolic chain and results in the accumulation of undegraded oligosaccharides in lysosomes. Glycoproteinoses share many clinical features such as mental retardation, coarse facies, and dysostosis multiplex. Cathepsin A-deficiency causes combined sialidase and beta-galactosidase deficiency (Sialidosis and Galactosialidosis) due to its function in stabilising these two hydrolases.",Inherited metabolic disease; Lysosomal storage disease; Nervous system disease,"(Sialidosis, Galactosialidosis) NEU1; lysosomal sialidase [HSA:4758] [KO:K01186]
(Galactosialidosis) CTSA; cathepsin A [HSA:5476] [KO:K13289]
(Galactosialidosis) GLB1; beta-galactosidase [HSA:2720] [KO:K12309]
(alpha-Mannosidosis) MAN2B1; lysosomal alpha-mannosidase [HSA:4125] [KO:K12311]
(beta-Mannosidosis) MANBA; lysosomal beta-mannosidase [HSA:4126] [KO:K01192]
(AGU) AGA; aspartylglucosaminidase [HSA:175] [KO:K01444]
(Fucosidosis) FUCA1; alpha-L-fucosidase [HSA:2517] [KO:K01206]
(Schindler/ Kanzaki) NAGA; alpha-N-acetylgalactosaminidase [HSA:4668] [KO:K01204]",,,,"(Sialidosis, Galactosialidosis) N-Acetylneuraminic acid (Sialic acid) [CPD:C00270]
(alpha, beta-Mannosidosis, AGU, Fucosidosis, Schindler/ Kanzaki) Urine oligosaccharides, Vacuolated lymphocytes
(Fucosidosis type 1) Increased sodium chloride content of sweat","(alpha-Mannosidosis, AGU, Fucosidosis) Hematopoietic stem cell transplantation","The diagnosis is confirmed by measuring enzyme activity in leukocytes or fibroblasts.
Some diseases are described as some phenotypes.
(Sialidosis) Type 1: the mild form with late-onset. Type 2: the severe form with infantile onset.
(Galactosialidosis) The early infantile type. The late infantile type. The juvenile/adult type.
(alpha-Mannosidosis) Type 1: a severe form with hepatomegaly and early death. Type2: a mild form with hearing loss and mental retardation.
(Fucosidosis) Type 1: a severe form. Type2: a mild form.
(Schindler/ Kanzaki) Type1 (Schindler disease): a severe form. Type2 (Kanzaki disease): an adult-onset disorder. Type3: an intermediate disorder with mild-to-moderate neurologic manifestations.","ICD-10: E77.1
OMIM: 256550 256540 248500 248510 208400 230000 609241 609242","PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:14517945
  AUTHORS   Seyrantepe V, Poupetova H, Froissart R, Zabot MT, Maire I, Pshezhetsky AV
  TITLE     Molecular pathology of NEU1 gene in sialidosis.
  JOURNAL   Hum Mutat 22:343-52 (2003)
DOI:10.1002/humu.10268

PMID:8985184 (Sialidosis, Galactosialidosis)
  AUTHORS   Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A
  TITLE     Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.
  JOURNAL   Genes Dev 10:3156-69 (1996)
DOI:10.1101/gad.10.24.3156

PMID:10571005
  AUTHORS   Michalski JC, Klein A
  TITLE     Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency.
  JOURNAL   Biochim Biophys Acta 1455:69-84 (1999)
DOI:10.1016/S0925-4439(99)00077-0

PMID:16712870 (Sialidosis)
  AUTHORS   Chen CM, Lai SC, Chen IC, Hsu KC, Lyu RK, Ro LS, Chang HS
  TITLE     First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.
  JOURNAL   J Neurol Sci 247:65-9 (2006)
DOI:10.1016/j.jns.2006.03.013

PMID:18651971 (alpha-Mannosidosis)
  AUTHORS   Malm D, Nilssen O
  TITLE     Alpha-mannosidosis.
  JOURNAL   Orphanet J Rare Dis 3:21 (2008)
DOI:10.1186/1750-1172-3-21

PMID:18980795 (beta-Mannosidosis)
  AUTHORS   Labauge P, Renard D, Castelnovo G, Sabourdy F, de Champfleur N, Levade T
  TITLE     Beta-mannosidosis: a new cause of spinocerebellar ataxia.
  JOURNAL   Clin Neurol Neurosurg 111:109-10 (2009)
DOI:10.1016/j.clineuro.2008.09.007

PMID:8405810 (AGU)
  AUTHORS   Mononen I, Fisher KJ, Kaartinen V, Aronson NN Jr
  TITLE     Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation.
  JOURNAL   FASEB J 7:1247-56 (1993)

PMID:10094192 (Fucosidosis)
  AUTHORS   Willems PJ, Seo HC, Coucke P, Tonlorenzi R, O'Brien JS
  TITLE     Spectrum of mutations in fucosidosis.
  JOURNAL   Eur J Hum Genet 7:60-7 (1999)
DOI:10.1038/sj.ejhg.5200272

PMID:17767638 (Fucosidosis)
  AUTHORS   Abdallah C, Hannallah R, McGill W
  TITLE     Anesthesia for fucosidosis.
  JOURNAL   Paediatr Anaesth 17:994-7 (2007)
DOI:10.1111/j.1460-9592.2007.02269.x

PMID:14685826
  AUTHORS   Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Nakada H, Fukushige T, Kanzaki T
  TITLE     Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease).
  JOURNAL   J Hum Genet 49:1-8 (2004)
DOI:10.1007/s10038-003-0098-z

PMID:19683538 (Schindler/ Kanzaki)
  AUTHORS   Clark NE, Garman SC
  TITLE     The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases.
  JOURNAL   J Mol Biol 393:435-47 (2009)
DOI:10.1016/j.jmb.2009.08.021",OMIM,256550,256540,248500,248510,208400,230000,609241,609242,,,,,,,,,,,,,,,,,,,,,,
H01277,"Vitamin B12 deficiency anaemia, including:
Hereditary intrinsic factor deficiency (IFD);
Imerslund-Grasbeck syndrome (IGS)/ Megaloblastic anemia 1","Vitamin B12 deficiency anaemia is caused by intestinal malabsorption of cobalamin. Imerslund-Grasbeck syndrome (IGS) is an autosomal recessive disorder characterized by juvenile megaloblastic anaemia and neurological symptoms such as peripheral neuropathy, cognitive problems, and dementia. If untreated, the disease is fatal. Biallelic mutations either in the cubilin (CUBN) or amnionless (AMN) gene cause IGS. Both proteins are involved in intestinal absorption and renal tubular reabsorption. Hereditary intrinsic factor deficiency (IFD) is a phenotype that is caused by mutations in GIF, the gene encoding intrinsic factor.",Hematologic disease,"(IFD) GIF [HSA:2694] [KO:K14615]
(IGS) CUBN [HSA:8029] [KO:K14616]
(IGS) AMN [HSA:81693] [KO:K18259]",,,,"Low serum Vitamin B12 [CPD:C05776]
Low urinary radioactive vit B12 excretion (Schilling test)",Vitamin B12 [DR:D00191],,"ICD-10: D51.0 D51.1
OMIM: 261000 261100","PMID:15738392
  AUTHORS   Tanner SM, Li Z, Perko JD, Oner C, Cetin M, Altay C, Yurtsever Z, David KL, Faivre L, Ismail EA, Grasbeck R, de la Chapelle A
  TITLE     Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene.
  JOURNAL   Proc Natl Acad Sci U S A 102:4130-3 (2005)
DOI:10.1073/pnas.0500517102

PMID:10080186
  AUTHORS   Aminoff M, Carter JE, Chadwick RB, Johnson C, Grasbeck R, Abdelaal MA, Broch H, Jenner LB, Verroust PJ, Moestrup SK, de la Chapelle A, Krahe R
  TITLE     Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1.
  JOURNAL   Nat Genet 21:309-13 (1999)
DOI:10.1038/6831

PMID:12590260
  AUTHORS   Tanner SM, Aminoff M, Wright FA, Liyanarachchi S, Kuronen M, Saarinen A, Massika O, Mandel H, Broch H, de la Chapelle A
  TITLE     Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia.
  JOURNAL   Nat Genet 33:426-9 (2003)
DOI:10.1038/ng1098

PMID:16722557
  AUTHORS   Grasbeck R
  TITLE     Imerslund-Grasbeck syndrome (selective vitamin B(12) malabsorption with proteinuria).
  JOURNAL   Orphanet J Rare Dis 1:17 (2006)
DOI:10.1186/1750-1172-1-17",OMIM,261000,261100,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00236,"Congenital polycythemia;
Familial erythrocytosis (ECYT)",Familial and congenital polycythemia/erythrocytosis includes a heterogeneous group of disorders with the common characteristic of an absolute increased red cell mass caused by inherited defects in hypoxia sensing. In primary polycythemias there is an innate defect in the hematopoietic progenitors which allows constitutive overproduction whereas in secondary polycythemias normal progenitors are acted on by serum erythropoietin.,Hematologic disease,"(ECYT1) EPOR [HSA:2057] [KO:K05079]
(ECYT2) VHL [HSA:7428] [KO:K03871]
(ECYT3) EGLN1 [HSA:54583] [KO:K09592]
(ECYT4) EPAS1 [HSA:2034] [KO:K09095]",,,,,,,"ICD-10: D75.0
OMIM: 133100 263400 609820 611783","PMID:18538455
  AUTHORS   Lee FS
  TITLE     Genetic causes of erythrocytosis and the oxygen-sensing pathway.
  JOURNAL   Blood Rev 22:321-32 (2008)
DOI:10.1016/j.blre.2008.04.003

PMID:17454194
  AUTHORS   Percy MJ
  TITLE     Genetically heterogeneous origins of idiopathic erythrocytosis.
  JOURNAL   Hematology 12:131-9 (2007)
DOI:10.1080/10245330601111979

PMID:15642677
  AUTHORS   Gordeuk VR, Stockton DW, Prchal JT
  TITLE     Congenital polycythemias/erythrocytoses.
  JOURNAL   Haematologica 90:109-16 (2005)",OMIM,133100,263400,609820,611783,,,,,,,,,,,,,,,,,,,,,,,,,,
H00425,"Lysosomal cysteine protease deficiencies, including:
Papillon-Lefevre syndrome (PLS) [DS:H00274];
Pycnodysostosis [DS:H00273]","Defects in lysosomal cysteine proteases (Cathepsins) are autosomal recessive lysosomal storage diseases. To date only following two human diseases cathepsin deficiencies have been described, though there are eleven lysosomal cystein proteases. Deficiency of cathepsin C leads to Papillon-Lefevre syndrome characterized by palmoplantar hyperkeratosis and severe early onset periodontitis. Deficiency of cathepsin K leads to pycnodysostosis characterized by osteosclerosis and short stature. Recent findings suggest a more expanded role for cathepsins in human biology.",Inherited metabolic disease; Lysosomal storage disease,"(PLS) CTSC; cathepsin C [HSA:1075] [KO:K01275]
(Pycnodysostosis) CTSK; cathepsin K [HSA:1513] [KO:K01371]",,,,,,"In mice, other Cathepsin deficiencies have also been generated. Deficiency of cathepsin F causes lysosomal storage defects and late-onset neurological disease. Lacking cathepsin L develop periodic hair loss. Recent findings suggest a more expanded role for cathepsins in human biology. These roles include apoptosis, MHC class II immune responses, prohormone processing, and extracellular matrix (ECM) remodeling important to cardiovascular or bone development. Cathepsins may also lead to accelerated collagen and elastin degradation and cause the diseases such as atherosclerosis.","ICD-10: Q82.8
OMIM: 245000 265800","PMID:1883197
  AUTHORS   Neufeld EF
  TITLE     Lysosomal storage diseases.
  JOURNAL   Annu Rev Biochem 60:257-80 (1991)
DOI:10.1146/annurev.bi.60.070191.001353

PMID:15647514 (Description)
  AUTHORS   Winchester B
  TITLE     Lysosomal metabolism of glycoproteins.
  JOURNAL   Glycobiology 15:1R-15R (2005)
DOI:10.1093/glycob/cwi041

PMID:9074757
  AUTHORS   Chapman HA, Riese RJ, Shi GP
  TITLE     Emerging roles for cysteine proteases in human biology.
  JOURNAL   Annu Rev Physiol 59:63-88 (1997)
DOI:10.1146/annurev.physiol.59.1.63

PMID:18401176 (PLS)
  AUTHORS   Nakajima K, Nakano H, Takiyoshi N, Rokunohe A, Ikenaga S, Aizu T, Kaneko T, Mitsuhashi Y, Sawamura D
  TITLE     Papillon-Lefevre syndrome and malignant melanoma. A high incidence of melanoma development in Japanese palmoplantar keratoderma patients.
  JOURNAL   Dermatology 217:58-62 (2008)
DOI:10.1159/000124340

PMID:19338743 (Pycnodysostosis)
  AUTHORS   Zhao Q, Jia Y, Xiao Y
  TITLE     Cathepsin K: a therapeutic target for bone diseases.
  JOURNAL   Biochem Biophys Res Commun 380:721-3 (2009)
DOI:10.1016/j.bbrc.2009.01.139

PMID:14756243 (Pycnodysostosis)
  AUTHORS   Goto T, Yamaza T, Tanaka T
  TITLE     Cathepsins in the osteoclast.
  JOURNAL   J Electron Microsc (Tokyo) 52:551-8 (2003)",OMIM,245000,265800,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00674,"Anemia due to disorders of nucleotide metabolism, including:
Adenylate kinase (AK) deficiency;
Uridine 5-prime monophosphate hydrolase (UMPH1) deficiency",Abnormalities in erythrocyte nucleotide metabolism are associated with hereditary nonspherocytic hemolytic anemia. Deficiency of adenylate kinase and pyrimidine 5'-nucleotidase shorten the red cell lifespan.,Hematologic disease,"AK1 [HSA:203] [KO:K00939]
UMPH1 [HSA:51251] [KO:K01081]",,,,,,,"ICD-10: D55.3
OMIM: 612631 266120","PMID:1646049
  AUTHORS   Lachant NA, Zerez CR, Barredo J, Lee DW, Savely SM, Tanaka KR
  TITLE     Hereditary erythrocyte adenylate kinase deficiency: a defect of multiple phosphotransferases?
  JOURNAL   Blood 77:2774-84 (1991)

PMID:11369620
  AUTHORS   Marinaki AM, Escuredo E, Duley JA, Simmonds HA, Amici A, Naponelli V, Magni G, Seip M, Ben-Bassat I, Harley EH, Thein SL, Rees DC
  TITLE     Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency.
  JOURNAL   Blood 97:3327-32 (2001)
DOI:10.1182/blood.V97.11.3327

PMID:16611302
  AUTHORS   Zanella A, Bianchi P, Fermo E, Valentini G
  TITLE     Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations.
  JOURNAL   Br J Haematol 133:113-23 (2006)
DOI:10.1111/j.1365-2141.2006.05992.x

PMID:19291420
  AUTHORS   Jurecka A
  TITLE     Inborn errors of purine and pyrimidine metabolism.
  JOURNAL   J Inherit Metab Dis 32:247-63 (2009)
DOI:10.1007/s10545-009-1094-z",OMIM,612631,266120,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00226,Glanzmann thrombasthenia,Glanzmann thrombasthenia is a rare autosomal recessive bleeding syndrome affecting the megakaryocyte lineage and characterized by lack of platelet aggregation. This disease is caused by mutation in the integrin family receptor genes encoding platelet glycoprotein alpha-IIb or platelet glycoprotein IIIa.,Hematologic disease,"ITGA2B [HSA:3674] [KO:K06476]
ITGB3 [HSA:3690] [KO:K06493]",,,,,Coagulation factor VIIa [DR:D00172],,"ICD-10: D69.1
OMIM: 273800 273800","PMID:16722529
  AUTHORS   Nurden AT
  TITLE     Glanzmann thrombasthenia.
  JOURNAL   Orphanet J Rare Dis 1:10 (2006)
DOI:10.1186/1750-1172-1-10

PMID:16427383
  AUTHORS   Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y
  TITLE     Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
  JOURNAL   Semin Hematol 43:S33-6 (2006)
DOI:10.1053/j.seminhematol.2005.11.009

PMID:12487785
  AUTHORS   Nair S, Ghosh K, Kulkarni B, Shetty S, Mohanty D
  TITLE     Glanzmann's thrombasthenia: updated.
  JOURNAL   Platelets 13:387-93 (2002)
DOI:10.1080/0953710021000024394",OMIM,273800,273800,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00238,Fanconi anemia,"Fanconi anemia (FA), a recessive syndrome with both autosomal and X-linked inheritance, features diverse clinical symptoms, such as progressive bone marrow failures, chromosomal instability and susceptibility to cancer. To date, 13 FA gene products have been identified, which cooperate in a common DNA damage-activated signaling pathway regulating DNA repair (the FA pathway).",Hematologic disease,"FANCA [HSA:2175] [KO:K10888]
FANCB [HSA:2187] [KO:K10889]
FANCC [HSA:2176] [KO:K10890]
BRCA2 [HSA:675] [KO:K08775]
FANCD2 [HSA:2177] [KO:K10891]
FANCE [HSA:2178] [KO:K10892]
FANCF [HSA:2188] [KO:K10893]
FANCG [HSA:2189] [KO:K10894]
FANCI [HSA:55215] [KO:K10895]
BRIP1 [HSA:83990] [KO:K15362]
FANCL [HSA:55120] [KO:K10606]
FANCM [HSA:57697] [KO:K10896]
FANCN [HSA:79728] [KO:K10897]
RAD51C [HSA:5889] [KO:K10870]
RAD51 [HSA:5888] [KO:K04482]
XRCC2 [HSA:7516] [KO:K10879]
MAD2L2 [HSA:10459] [KO:K13728]",,,,,,,"ICD-10: D61.0
OMIM: 227650 300514 227645 605724 227646 600901 603467 609053 609054 608111 609644 610832 614082 613390 617244 617247 617243","PMID:18995829
  AUTHORS   Cohn MA, D'Andrea AD
  TITLE     Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways.
  JOURNAL   Mol Cell 32:306-12 (2008)
DOI:10.1016/j.molcel.2008.10.009

PMID:18047734
  AUTHORS   Jacquemont C, Taniguchi T
  TITLE     The Fanconi anemia pathway and ubiquitin.
  JOURNAL   BMC Biochem 8 Suppl 1:S10 (2007)
DOI:10.1186/1471-2091-8-S1-S10

PMID:19101576
  AUTHORS   Rego MA, Kolling FW 4th, Howlett NG
  TITLE     The Fanconi anemia protein interaction network: casting a wide net.
  JOURNAL   Mutat Res 668:27-41 (2009)
DOI:10.1016/j.mrfmmm.2008.11.018

PMID:16493006
  AUTHORS   Taniguchi T, D'Andrea AD
  TITLE     Molecular pathogenesis of Fanconi anemia: recent progress.
  JOURNAL   Blood 107:4223-33 (2006)
DOI:10.1182/blood-2005-10-4240

PMID:26681308 (gene)
  AUTHORS   Ameziane N, May P, Haitjema A, van de Vrugt HJ, van Rossum-Fikkert SE, Ristic D, Williams GJ, Balk J, Rockx D, Li H, Rooimans MA, Oostra AB, Velleuer E, Dietrich R, Bleijerveld OB, Maarten Altelaar AF, Meijers-Heijboer H, Joenje H, Glusman G, Roach J, Hood L, Galas D, Wyman C, Balling R, den Dunnen J, de Winter JP, Kanaar R, Gelinas R, Dorsman JC
  TITLE     A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.
  JOURNAL   Nat Commun 6:8829 (2015)
DOI:10.1038/ncomms9829

PMID:22232082 (gene)
  AUTHORS   Shamseldin HE, Elfaki M, Alkuraya FS
  TITLE     Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation.
  JOURNAL   J Med Genet 49:184-6 (2012)
DOI:10.1136/jmedgenet-2011-100585

PMID:27500492 (gene)
  AUTHORS   Bluteau D, Masliah-Planchon J, Clairmont C, Rousseau A, Ceccaldi R, Dubois d'Enghien C, Bluteau O, Cuccuini W, Gachet S, Peffault de Latour R, Leblanc T, Socie G, Baruchel A, Stoppa-Lyonnet D, D'Andrea AD, Soulier J
  TITLE     Biallelic inactivation of REV7 is associated with Fanconi anemia.
  JOURNAL   J Clin Invest 126:3580-4 (2016)
DOI:10.1172/JCI88010",OMIM,227650,300514,227645,605724,227646,600901,603467,609053,609054,608111,609644,610832,614082,613390,617244,617247,617243,,,,,,,,,,,,,
H00664,"Anemia due to disorders of glycolytic enzymes, including:
Hexokinase (HK) deficiency;
Phosphoglycerate kinase 1 (PGK1) deficiency;
Triose-phosphate isomerase (TPI) deficiency;
Glucose phosphate isomerase (GPI) deficiency;
Bisphosphoglycerate mutase (BPGM) deficiency","Anemia due to disorders of glycolytic enzymes is a group of red cell disorders caused by inherited abnormality of glycolytic enzymes. Neurological phenotypes have been found to be associated only with specific mutations affecting TPI, PGK and, in rare cases, GPI. The symptoms of TPI deficiency are generally much more severe than those of any other glycolytic enzyme deficiency.",Hematologic disease,"HK1 [HSA:3098] [KO:K00844]
PGK1 [HSA:5230] [KO:K00927]
TPI1 [HSA:7167] [KO:K01803]
GPI [HSA:2821] [KO:K01810]
BPGM [HSA:669] [KO:K01837]",,,,(TPI deficiency) Elevation of DHAP [CPD:C00111] level in erythrocytes.,,,"ICD-10: D55.2
OMIM: 235700 300653 190450 613470 222800","PMID:10699493
  AUTHORS   Martinov MV, Plotnikov AG, Vitvitsky VM, Ataullakhanov FI
  TITLE     Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia.
  JOURNAL   Biochim Biophys Acta 1474:75-87 (2000)
DOI:10.1016/S0304-4165(99)00218-4

PMID:12393545
  AUTHORS   van Wijk R, Rijksen G, Huizinga EG, Nieuwenhuis HK, van Solinge WW
  TITLE     HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia.
  JOURNAL   Blood 101:345-7 (2003)
DOI:10.1182/blood-2002-06-1851

PMID:17222195
  AUTHORS   Beutler E
  TITLE     PGK deficiency.
  JOURNAL   Br J Haematol 136:3-11 (2007)
DOI:10.1111/j.1365-2141.2006.06351.x

PMID:16086671
  AUTHORS   Olah J, Orosz F, Puskas LG, Hackler L Jr, Horanyi M, Polgar L, Hollan S, Ovadi J
  TITLE     Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels.
  JOURNAL   Biochem J 392:675-83 (2005)
DOI:10.1042/BJ20050993

PMID:20516363
  AUTHORS   Rossi F, Ruggiero S, Gallo M, Simeone G, Matarese SM, Nobili B
  TITLE     Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency.
  JOURNAL   Ann Pharmacother 44:1327-9 (2010)
DOI:10.1345/aph.1P030

PMID:15054810
  AUTHORS   Hoyer JD, Allen SL, Beutler E, Kubik K, West C, Fairbanks VF
  TITLE     Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
  JOURNAL   Am J Hematol 75:205-8 (2004)
DOI:10.1002/ajh.20014",OMIM,235700,300653,190450,613470,222800,,,,,,,,,,,,,,,,,,,,,,,,,
H00982,"Sideroblastic anemia, including:
Pyridoxine-refractory autosomal recessive sideroblastic anemia (PRARSA);
X-linked sideroblastic anemia (XLSA);
X-linked sideroblastic anemia with ataxia (ASAT)","Sideroblastic anemias are a group of disorders characterized by anemia with the emergence of ring sideroblasts in the bone marrow. Inherited sideroblastic anemia is a rare and heterogeneous disease caused by mutations of genes involved in heme biosynthesis, iron-sulfur cluster biogenesis or transport, and mitochondrial metabolism.",Hematologic disease,"(PRARSA) SLC25A38 [HSA:54977] [KO:K15118]
(PRARSA) GLRX5 [HSA:51218] [KO:K07390]
(XLSA) ALAS2 [HSA:51218] [KO:K07390]
(ASAT) ABCB7 [HSA:22] [KO:K05662]",,,,,,Myopathy with lactic acidosis and sideroblastic anaemia (MLASA) is described in H00898. [DS:H00898],"ICD-10: D64.0 D64.3
OMIM: 205950 300751 301310","PMID:20848343
  AUTHORS   Harigae H, Furuyama K
  TITLE     Hereditary sideroblastic anemia: pathophysiology and gene mutations.
  JOURNAL   Int J Hematol 92:425-31 (2010)
DOI:10.1007/s12185-010-0688-4",OMIM,205950,300751,301310,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00832,"Core neuroacanthocytosis syndromes, including:
Chorea-acanthocytosis (ChAc);
McLeod syndrome (MLS);
Huntington's disease-like 2 (HDL2);
Pantothenate kinase associated neurodegeneration (PKAN)","Neuroacanthocytosis (NA) syndromes are a heterogeneous group of diseases in which nervous system abnormalities coincide with red blood cell acanthocytosis. Core NA syndromes are one of the broad groups of NA disorders characterized by degeneration of the basal ganglia, movement disorders, cognitive impairment, and psychiatric features. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known.",Nervous system disease,"(ChAc) VPS13A [HSA:23230] [KO:K19525]
(MLS) XK [HSA:7504] [KO:K19522]
(HDL2) JPH3 [HSA:57338] [KO:K19530]
(PKAN) PANK2 [HSA:80025] [KO:K09680]",,,,,,"McLeod syndrome is described in [HD:H00655].
Chorea-acanthocytosis is described in [HD:H01432].
PKAN is allelic with HARP syndrome.","ICD-10: G23.0
OMIM: 200150 300842 606438 607236","PMID:22027213 (description, gene)
  AUTHORS   Jung HH, Danek A, Walker RH
  TITLE     Neuroacanthocytosis syndromes.
  JOURNAL   Orphanet J Rare Dis 6:68 (2011)
DOI:10.1186/1750-1172-6-68

PMID:18567359 (description, gene)
  AUTHORS   Ichiba M, Nakamura M, Sano A
  TITLE     [Neuroacanthocytosis update].
  JOURNAL   Brain Nerve 60:635-41 (2008)
DOI:10.11477/mf.1416100292",OMIM,200150,300842,606438,607236,,,,,,,,,,,,,,,,,,,,,,,,,,
H01486,Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS),"The Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome (MCAHS) comprises three phenotypes caused by mutations in PIGN, PIGA and PIGT respectively. PIGN and PIGT mutations lead to autosomal recessive disorders whereas PIGA deficiency causes an X-linked lethal disorder. Clinical features are variable dependent on genotypes, often include (neonatal) hypotonia, seizures, various anomalies involving nervous system structural malformations, delayed or lack of psychomotor development, and various congenial organ anomalies.",Inherited metabolic disease,"(MCAHS 1) PIGN [HSA:23556] [KO:K05285]
(MCAHS 2) PIGA [HSA:5277] [KO:K03857]
(MCAHS 3) PIGT [HSA:51604] [KO:K05292]",,,,,,,"ICD-10: Q87.8
OMIM: 614080 300868 615398","PMID:26879448 (description and gene)
  AUTHORS   Jezela-Stanek A, Ciara E, Piekutowska-Abramczuk D, Trubicka J, Jurkiewicz E, Rokicki D, Mierzewska H, Spychalska J, Uhrynowska M, Szwarc-Bronikowska M, Buda P, Said AR, Jamroz E, Rydzanicz M, Ploski R, Krajewska-Walasek M, Pronicka E
  TITLE     Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis--The phenotype of two patients with novel mutations in the PIGN and  PGAP2 genes.
  JOURNAL   Eur J Paediatr Neurol 20:462-73 (2016)
DOI:10.1016/j.ejpn.2016.01.007

PMID:24259184 (description and gene)
  AUTHORS   van der Crabben SN, Harakalova M, Brilstra EH, van Berkestijn FM, Hofstede FC, van Vught AJ, Cuppen E, Kloosterman W, Ploos van Amstel HK, van Haaften G, van Haelst MM
  TITLE     Expanding the spectrum of phenotypes associated with germline PIGA mutations: a child with developmental delay, accelerated linear growth, facial dysmorphisms, elevated alkaline phosphatase, and progressive CNS abnormalities.
  JOURNAL   Am J Med Genet A 164A:29-35 (2014)
DOI:10.1002/ajmg.a.36184

PMID:23636107 (description and gene)
  AUTHORS   Kvarnung M, Nilsson D, Lindstrand A, Korenke GC, Chiang SC, Blennow E, Bergmann M, Stodberg T, Makitie O, Anderlid BM, Bryceson YT, Nordenskjold M, Nordgren A
  TITLE     A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT.
  JOURNAL   J Med Genet 50:521-8 (2013)
DOI:10.1136/jmedgenet-2013-101654",OMIM,614080,300868,615398,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00219,"Hemophilia, including:
Hemophilia A (HEMA);
Hemophilia B (HEMB);
von Willebrand disease (VWD);
von Willebrand disease, platelet-type","Hemophilia A and B are X-linked recessive disorders which are the most common hereditary hemorrhagic disorders caused by a deficiency or dysfunction of blood coagulation factor VIII (FVIII) and factor IX (FIX), respectively. Von Willebrand disease is caused by quantitative and/or qualitative defects of von Willebrand factor and inherited in both autosomal dominant and recessive manner.",Hematologic disease,"(HEMA) F8; coagulation factor VIII [HSA:2157] [KO:K03899]
(HEMB) F9; coagulation factor IX (Christmas factor) [HSA:2158] [KO:K01321]
(VWD) VWF; von Willebrand factor [HSA:7450] [KO:K03900]
(Platelet-type) GP1BA [HSA:2811] [KO:K06261]",,,,,"Blood-coagulation factor VIII [DR:D08798 D08793]
Blood-coagulation factor IX [DR:D08797 D08794]",,"ICD-10: D66 D67 D68.0
OMIM: 306700 306900 193400 613554 277480 177820","PMID:17178659
  AUTHORS   Franchini M
  TITLE     Advances in the diagnosis and management of von Willebrand disease.
  JOURNAL   Hematology 11:219-25 (2006)
DOI:10.1080/10245330600841311

PMID:16684001
  AUTHORS   Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya SM, Johnson MJ, Thompson AR, Goodeve A, Garagiola I, Lavoretano S, Menegatti M, Palla R, Spreafico M, Tagliabue L, Asselta R, Duga S, Mannucci PM
  TITLE     Genetic diagnosis of haemophilia and other inherited bleeding disorders.
  JOURNAL   Haemophilia 12 Suppl 3:82-9 (2006)
DOI:10.1111/j.1365-2516.2006.01263.x

PMID:16470522
  AUTHORS   Haberichter SL, Shi Q, Montgomery RR
  TITLE     Regulated release of VWF and FVIII and the biologic implications.
  JOURNAL   Pediatr Blood Cancer 46:547-53 (2006)
DOI:10.1002/pbc.20658

PMID:15205640
  AUTHORS   Lee JW
  TITLE     Von Willebrand disease, hemophilia A and B, and other factor deficiencies.
  JOURNAL   Int Anesthesiol Clin 42:59-76 (2004)

PMID:756222
  AUTHORS   Marzullo A, Masci P, Rovacchi G, Toti G, Dompe G
  TITLE     [Gastric leiomyoblastoma]
  JOURNAL   Arch De Vecchi Anat Patol 62:279-90 (1977)

PMID:21497427
  AUTHORS   Othman M
  TITLE     Platelet-type Von Willebrand disease: three decades in the life of a rare bleeding disorder.
  JOURNAL   Blood Rev 25:147-53 (2011)
DOI:10.1016/j.blre.2011.03.003",OMIM,306700,306900,193400,613554,277480,177820,,,,,,,,,,,,,,,,,,,,,,,,
H00547,"Atrioventricular septal defect;
Atrioventricular canal defect","Atrioventricular septal defect, also known as atrioventricular canal defect or endocardial cushion defect, is a congenital heart malformation involving the interatrial septum, interventricular septum, and atrioventricular valves. The defect is often associated with Down syndrome (trisomy 21).",Developmental disorder; Cardiovascular disease,"CRELD1 [HSA:78987]
GJA1 [HSA:2697] [KO:K07372]
GATA4 [HSA:2626] [KO:K09183]
GATA6 [HSA:2627] [KO:K17897]",,"Organic solvents
Anticonvulsants
Ibuprofen [CPD:C01588]
Sulfasalazine [CPD:C07316]
Thalidomide [CPD:C07910]
Trimethoprim-sulfonamide [DR:D00285]
Retinoic acid [CPD:C00777]
Maternal phenylketonuria
Maternal progestational diabetes
Maternal febrile illness
Maternal influenza
Maternal rubella
Maternal epilepsy",,,,,"ICD-10: Q21.2
OMIM: 606217 600309 614430 614474","PMID:15096951 (gene)
  AUTHORS   Maslen CL
  TITLE     Molecular genetics of atrioventricular septal defects.
  JOURNAL   Curr Opin Cardiol 19:205-10 (2004)

PMID:11376442 (description)
  AUTHORS   Vaughan CJ, Basson CT
  TITLE     Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus.
  JOURNAL   Am J Med Genet 97:304-9 (2000)
DOI:10.1002/1096-8628(200024)97:4<304:AID-AJMG1281>3.0.CO;2-#

PMID:17519397 (env_factor)
  AUTHORS   Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL
  TITLE     Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.
  JOURNAL   Circulation 115:2995-3014 (2007)
DOI:10.1161/CIRCULATIONAHA.106.183216

PMID:7805255 (description)
  AUTHORS   Payne RM, Johnson MC, Grant JW, Strauss AW
  TITLE     Toward a molecular understanding of congenital heart disease.
  JOURNAL   Circulation 91:494-504 (1995)
DOI:10.1161/01.CIR.91.2.494

PMID:11470490 (gene)
  AUTHORS   Dasgupta C, Martinez AM, Zuppan CW, Shah MM, Bailey LL, Fletcher WH
  TITLE     Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE).
  JOURNAL   Mutat Res 479:173-86 (2001)
DOI:10.1016/S0027-5107(01)00160-9

PMID:17643447 (gene)
  AUTHORS   Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V, Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB, Pu WT
  TITLE     Spectrum of heart disease associated with murine and human GATA4 mutation.
  JOURNAL   J Mol Cell Cardiol 43:677-85 (2007)
DOI:10.1016/j.yjmcc.2007.06.004

PMID:20581743 (gene)
  AUTHORS   Maitra M, Koenig SN, Srivastava D, Garg V
  TITLE     Identification of GATA6 sequence variants in patients with congenital heart defects.
  JOURNAL   Pediatr Res 68:281-5 (2010)
DOI:10.1203/00006450-201011001-00549",OMIM,606217,600309,614430,614474,,,,,,,,,,,,,,,,,,,,,,,,,,
H00293,Arrhythmogenic right ventricular cardiomyopathy (ARVC),"Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease that may result in arrhythmia, heart failure, and sudden death. The hallmark pathological findings are progressive myocyte loss and fibrofatty replacement, with a predilection for the right ventricle. A number of genetic studies have identified mutations in various components of the cardiac desmosome that have important roles in the pathogenesis of ARVC. Disruption of desmosomal function by defective proteins might lead to death of myocytes under mechanical stress. The myocardial injury may be accompanied by inflammation. Since regeneration of cardiac myocytes is limited, repair by fibrofatty replacement occurs. Several studies have implicated that desmosome dysfunction results in the delocalization and nuclear translocation of plakoglobin. As a result, competition between plakoglobin and beta-catenin will lead to the inhibition of Wnt/beta-catenin signaling, resulting in a shift from a myocyte fate towards an adipocyte fate of cells. The ryanodine receptor plays a crucial part in electromechanical coupling by control of release of calcium from the sarcoplasmic reticulum into the cytosol. Therefore, defects in this receptor could result in an imbalance of calcium homeostasis that might trigger cell death.",Cardiovascular disease,"JUP (mutation) [HSA:3728] [KO:K10056]
RYR2 (mutation) [HSA:6262] [KO:K04962]
DSP (mutation) [HSA:1832] [KO:K10381]
PKP2 (mutation) [HSA:5318] [KO:K12642]
TGF-beta 3 (mutation) [HSA:7043] [KO:K13377]
DSG2 (mutation) [HSA:1829] [KO:K07597]
DSC2 (mutation) [HSA:1824] [KO:K07601]
TMEM43 (mutation) [HSA:79188]",,,,,"Beta-blockers [ATC:C07A]
Sotalol [DG:DG00307]
Amiodarone [DG:DG00204]",,"ICD-10: I42
OMIM: 611528 600996 607450 609040 107970 610193 610476 604400","PMID:18001465 (gene, drug)
  AUTHORS   Thiene G, Corrado D, Basso C
  TITLE     Arrhythmogenic right ventricular cardiomyopathy/dysplasia.
  JOURNAL   Orphanet J Rare Dis 2:45 (2007)
DOI:10.1186/1750-1172-2-45

PMID:17413274 (gene)
  AUTHORS   van Tintelen JP, Hofstra RM, Wiesfeld AC, van den Berg MP, Hauer RN, Jongbloed JD
  TITLE     Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?
  JOURNAL   Curr Opin Cardiol 22:185-92 (2007)
DOI:10.1097/HCO.0b013e3280d942c4

PMID:18382419 (gene)
  AUTHORS   Awad MM, Calkins H, Judge DP
  TITLE     Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
  JOURNAL   Nat Clin Pract Cardiovasc Med 5:258-67 (2008)
DOI:10.1038/ncpcardio1182

PMID:22426942 (gene)
  AUTHORS   Murray B
  TITLE     Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Review of Molecular and Clinical Literature.
  JOURNAL   J Genet Couns 21:494-504 (2012)
DOI:10.1007/s10897-012-9497-7

PMID:19362677 (drug)
  AUTHORS   Basso C, Corrado D, Marcus FI, Nava A, Thiene G
  TITLE     Arrhythmogenic right ventricular cardiomyopathy.
  JOURNAL   Lancet 373:1289-300 (2009)
DOI:10.1016/S0140-6736(09)60256-7

PMID:19205777 (drug)
  AUTHORS   Herren T, Gerber PA, Duru F
  TITLE     Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare ""disease of the desmosome"" with multiple clinical presentations.
  JOURNAL   Clin Res Cardiol 98:141-58 (2009)
DOI:10.1007/s00392-009-0751-4",OMIM,611528,600996,607450,609040,107970,610193,610476,604400,,,,,,,,,,,,,,,,,,,,,,
H01216,Left ventricular noncompaction (LVNC),"Left ventricular noncompaction (LVNC) is a rare and potentially progressive cardiomyopathy, characterized by the presence of prominent trabeculations of the left ventricle, associated with progressive systolic failure, stroke and arrhythmia. It has been linked to mutations in several genes, including LIM domain binding protein 3 (ZASP), alpha-dystrobrevin (DTNA), tafazzin (TAZ/G4.5), lamin A/C (LMNA), and genes encoding the sarcomeric proteins, beta-myosin heavy chain (MYH7), alpha-cardiac actin (ACTC), and cardiac troponin T (TNNT2).",Cardiovascular disease,"ZASP (mutation) [HSA:11155] [KO:K19867]
DTNA (mutation) [HSA:1837]
TAZ (mutation) [HSA:6901] [KO:K13511]
LMNA (mutation) [HSA:4000] [KO:K12641]
MYH7 (mutation) [HSA:4625] [KO:K17751]
ACTC (mutation) [HSA:70] [KO:K12314]
TNNT2 (mutation) [HSA:7139] [KO:K12045]",,,,,,,"ICD-10: I42.8
OMIM: 604169 601493 300183","PMID:19057090 (gene, description)
  AUTHORS   Ichida F
  TITLE     Left ventricular noncompaction.
  JOURNAL   Circ J 73:19-26 (2009)
DOI:10.1253/circj.CJ-08-0995

PMID:19318934 (gene, description)
  AUTHORS   Pantazis AA, Elliott PM
  TITLE     Left ventricular noncompaction.
  JOURNAL   Curr Opin Cardiol 24:209-13 (2009)
DOI:10.1097/HCO.0b013e32832a11e7

PMID:21638988 (gene, description)
  AUTHORS   Antonio M, Costa C, Venancio M, Martins P, Dionisio T, Pires A, Sousa G, Santos I, Mota A, Duarte R, Costa H, Ribeiro L, Saraiva J, Castela E
  TITLE     Left ventricular noncompaction: analysis of a pediatric population.
  JOURNAL   Rev Port Cardiol 30:295-311 (2011)

PMID:21285074 (gene, description)
  AUTHORS   Oechslin E, Jenni R
  TITLE     Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?
  JOURNAL   Eur Heart J 32:1446-56 (2011)
DOI:10.1093/eurheartj/ehq508",OMIM,604169,601493,300183,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00534,Cerebral cavernous malformation,"Cerebral cavernous malformations are vascular malformations of the central nervous system comprising enlarged caverns with a single layer of endothelium, which easily lead to cerebral hemorrhages. The disease present as either sporadic or autosomal dominant conditions and is linked to three genes KRIT1, MGC4607, and PDCD10. Mutations in KRIT1 impair its interaction with ICAP-1 alpha, a beta 1 integrin binding protein, and influence beta 1 integrin-dependent angiogenesis.",Developmental disorder; Vascular disease,"CCM1 [HSA:889] [KO:K17705]
MGC4607 [HSA:83605]
PDCD10 [HSA:11235] [KO:K18269]",,,,,,,OMIM: 116860 603284 603285,"PMID:17670762 (description, gene)
  AUTHORS   Brouillard P, Vikkula M
  TITLE     Genetic causes of vascular malformations.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R140-9 (2007)
DOI:10.1093/hmg/ddm211

PMID:16379592 (description, gene)
  AUTHORS   Wang QK
  TITLE     Update on the molecular genetics of vascular anomalies.
  JOURNAL   Lymphat Res Biol 3:226-33 (2005)
DOI:10.1089/lrb.2005.3.226",OMIM,116860,603284,603285,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01795,"Blepharophimosis-mental retardation syndrome (BMRS);
Ohdo syndrome","Blepharophimosis-mental retardation syndromes (BMRS) include a group of clinically and etiologically heterogeneous conditions, which can occur as isolated features or as part of distinct disorders displaying multiple congenital anomalies. The majority of syndromic patients with blepharophimosis show a variable degree of mental retardation. In 1986, Ohdo et al. delineated a syndrome of blepharophimosis, ptosis, hypoplastic teeth, heart defect, and mental handicap, to which his name was attached. Subsequently, several cases have been reported as Ohdo/Ohdo-like syndrome, widening the spectrum of clinical findings of BMRS, which lately were classified into five subtypes by Verloes et al: (1) del(3p) syndrome; (2) BMRS, Ohdo type; (3) BMRS, SBBYS (Say-Barber/Biesecker/Young-Simpson) type [DS:H01793]; (4) BMRS, MKB (Maat-Kievit-Brunner) type; (5) BMRS, Verloes type. BMR may also be found in relatively nonspecific developmental anomalies and in unclassified individuals, further widening the etiology of BMR disorders.",Developmental disorder; Nervous system disease,"(SBBYS type) KAT6B [HSA:23522] [KO:K11306]
(MKB type) MED12 [HSA:9968] [KO:K15162]",,,,,,,"ICD-10: Q87.8
OMIM: 613792 603736 300895","PMID:16700052 (description)
  AUTHORS   Verloes A, Bremond-Gignac D, Isidor B, David A, Baumann C, Leroy MA, Stevens R, Gillerot Y, Heron D, Heron B, Benzacken B, Lacombe D, Brunner H, Bitoun P
  TITLE     Blepharophimosis-mental retardation (BMR) syndromes: A proposed clinical classification of the so-called Ohdo syndrome, and delineation of two new BMR syndromes, one X-linked and one autosomal recessive.
  JOURNAL   Am J Med Genet A 140:1285-96 (2006)
DOI:10.1002/ajmg.a.31270

PMID:21567902 (description)
  AUTHORS   Dentici ML, Mingarelli R, Dallapiccola B
  TITLE     The difficult nosology of blepharophimosis-mental retardation syndromes: report on two siblings.
  JOURNAL   Am J Med Genet A 155A:459-65 (2011)
DOI:10.1002/ajmg.a.33642

PMID:22077973 (gene)
  AUTHORS   Clayton-Smith J, O'Sullivan J, Daly S, Bhaskar S, Day R, Anderson B, Voss AK, Thomas T, Biesecker LG, Smith P, Fryer A, Chandler KE, Kerr B, Tassabehji M, Lynch SA, Krajewska-Walasek M, McKee S, Smith J, Sweeney E, Mansour S, Mohammed S, Donnai D, Black G
  TITLE     Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.
  JOURNAL   Am J Hum Genet 89:675-81 (2011)
DOI:10.1016/j.ajhg.2011.10.008

PMID:23395478 (gene)
  AUTHORS   Vulto-van Silfhout AT, de Vries BB, van Bon BW, Hoischen A, Ruiterkamp-Versteeg M, Gilissen C, Gao F, van Zwam M, Harteveld CL, van Essen AJ, Hamel BC, Kleefstra T, Willemsen MA, Yntema HG, van Bokhoven H, Brunner HG, Boyer TG, de Brouwer AP
  TITLE     Mutations in MED12 cause X-linked Ohdo syndrome.
  JOURNAL   Am J Hum Genet 92:401-6 (2013)
DOI:10.1016/j.ajhg.2013.01.007",OMIM,613792,603736,300895,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00108,"Autoimmune lymphoproliferative syndromes (ALPS), including the following five diseases:
CD95 (Fas) defect, ALPS type 1a;
CD95L (Fas ligand) defect, ALPS type 1b;
Caspase 10 defect, ALPS type 2a;
Caspase 8 defext, ALPS type 2b;
Activaing N-Ras defect, N-Ras ALPS","Autoimmune lymphoproliferative syndrome (ALPS) is an autosomal dominant disorder with clinical features of various autoimmune manifestations that predominantly involve polyclonal accumulation of lymphocytes in the spleen and lymph nodes with lymphadenopathy and/or splenomegaly, and expansion of double-negative (DN) T cells in the peripheral blood. Central to the cellular pathogenesis is defective FAS-induced apoptosis, which in turn leads to dysregulation of lymphocyte homeostasis. ALPS caused by heterozygous mutations in the Fas gene (ALPS Type Ia) make up the majority of identified cases. However, other mutations, namely of the FasL gene (ALPS Type Ib) and the caspase 8 and 10 gene (ALPS Type II) are occasionally detected, whereas some patients do not present any known mutations (ALPS-III). Recently, mutations of the NRAS gene have been suggested to cause ALPS Type IV.",Primary immunodeficiency,"TNFRSF6 (Fas) [HSA:8771] [KO:K05143]
TNFSF6 (Fas ligand) [HSA:356] [KO:K04389]
Caspase 10 [HSA:843] [KO:K04400]
Caspase 8 [HSA:841] [KO:K04398]
N-Ras [HSA:4893] [KO:K07828]
CTLA4 [HSA:1493] [KO:K06538]",,,,,,,OMIM: 601859 603909 614470 607271 616100,"PMID:17999750 (description, gene)
  AUTHORS   Cerutti E, Campagnoli MF, Ferretti M, Garelli E, Crescenzio N, Rosolen A, Chiocchetti A, Lenardo MJ, Ramenghi U, Dianzani U
  TITLE     Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
  JOURNAL   BMC Immunol 8:28 (2007)
DOI:10.1186/1471-2172-8-28

PMID:16611303 (gene)
  AUTHORS   Worth A, Thrasher AJ, Gaspar HB
  TITLE     Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
  JOURNAL   Br J Haematol 133:124-40 (2006)
DOI:10.1111/j.1365-2141.2006.05993.x

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:18424339 (gene)
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053

PMID:25213377 (gene)
  AUTHORS   Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, Schickel JN, Tran DQ, Stoddard J, Zhang Y, Frucht DM, Dumitriu B, Scheinberg P, Folio LR, Frein CA, Price S, Koh C, Heller T, Seroogy CM, Huttenlocher A, Rao VK, Su HC, Kleiner D, Notarangelo LD, Rampertaap Y, Olivier KN, McElwee J, Hughes J, Pittaluga S, Oliveira JB, Meffre E, Fleisher TA, Holland SM, Lenardo MJ, Tangye SG, Uzel G
  TITLE     Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.
  JOURNAL   Science 345:1623-1627 (2014)
DOI:10.1126/science.1255904",OMIM,601859,603909,614470,607271,616100,,,,,,,,,,,,,,,,,,,,,,,,,
H00228,"Thalassemia, including:
Alpha thalassemia;
Beta thalassemia;
Alpha thalassemia, X-linked (ATRX) [DS:H01752]",Thalassemia is the most common hereditary blood disease caused by mutation of genes encoding hemoglobin alpha and beta chains. The anemia that is associated with thalassemia is caused by ineffective erythropoiesis which results from apoptosis of erythroid precursors or hemolysis due to the chain imbalances.,Hematologic disease,"(Alpha) HBA1 [HSA:3039] [KO:K13822]
(Alpha) HBA2 [HSA:3040] [KO:K13822]
(Beta) HBB [HSA:3043] [KO:K13823]
(Beta) HBG1 [HSA:3047] [KO:K13824]
(Beta) HBG2 [HSA:3048] [KO:K13824]
(ATRX) ATRX [HSA:546] [KO:K10779]",,,,,"Deferoxamine [DR:D03670]
Deferasirox [DR:D03669]
Deferiprone [DR:D07416]","The X-linked mental retardation-hypotonic facies syndrome is also caused by mutation in the ATRX gene.
See also H01752 ATR-X syndrome.","ICD-10: D56.0 D56.1 D56.2 D56.4
OMIM: 141750 604131 603902 141800 141900 300448 301040 309580 141749","PMID:18406222
  AUTHORS   Leung WC, Leung KY, Lau ET, Tang MH, Chan V
  TITLE     Alpha-thalassaemia.
  JOURNAL   Semin Fetal Neonatal Med 13:215-22 (2008)
DOI:10.1016/j.siny.2008.02.006

PMID:16162884
  AUTHORS   Rund D, Rachmilewitz E
  TITLE     Beta-thalassemia.
  JOURNAL   N Engl J Med 353:1135-46 (2005)
DOI:10.1056/NEJMra050436

PMID:15660507
  AUTHORS   Schrier SL, Angelucci E
  TITLE     New strategies in the treatment of the thalassemias.
  JOURNAL   Annu Rev Med 56:157-71 (2005)
DOI:10.1146/annurev.med.56.082103.104718

PMID:15561674
  AUTHORS   Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E
  TITLE     Thalassemia.
  JOURNAL   Hematology Am Soc Hematol Educ Program 14-34 (2004)
DOI:10.1182/asheducation-2004.1.14

PMID:20439494
  AUTHORS   Miccio A, Blobel GA
  TITLE     Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes.
  JOURNAL   Mol Cell Biol 30:3460-70 (2010)
DOI:10.1128/MCB.00001-10",OMIM,141750,604131,603902,141800,141900,300448,301040,309580,141749,,,,,,,,,,,,,,,,,,,,,
H00294,Dilated cardiomyopathy (DCM),"Dilated cardiomyopathy (DCM) is a heart muscle disease characterised by dilation and impaired contraction of the left or both ventricles that results in progressive heart failure and sudden cardiac death from ventricular arrhythmia. Genetically inherited forms of DCM (""familial"" DCM) have been identified in 25-35% of patients presenting with this disease, and the inherited gene defects are an important cause of ""familial"" DCM. The pathophysiology may be separated into two categories: defects in force generation and defects in force transmission. In cases where an underlying pathology cannot be identified, the patient is diagnosed with an ""idiopathic"" DCM. Current hypotheses regarding causes of ""idiopathic"" DCM focus on myocarditis induced by enterovirus and subsequent autoimmune myocardium impairments. Antibodies to the beta1-adrenergic receptor (beta1AR), which are detected in a substantial number of patients with ""idiopathic"" DCM,  may increase the concentration of intracellular cAMP and intracellular Ca2+, a condition often leading to a transient hyper-performance of the heart followed by depressed heart function and heart failure.",Cardiovascular disease,"TNNT2 (mutation) [HSA:7139] [KO:K12045]
TTN (mutation) [HSA:7273] [KO:K12567]
DES (mutation) [HSA:1674] [KO:K07610]
SGCD (mutation) [HSA:6444] [KO:K12563]
MYBPC3 (mutation) [HSA:4607] [KO:K12568]
MYH7 (mutation) [HSA:4625] [KO:K17751]
ACTC1 (mutation) [HSA:70] [KO:K12314]
TPM1 (mutation) [HSA:7168] [KO:K10373]
LMNA (mutation) [HSA:4000] [KO:K12641]
DMD (mutation) [HSA:1756] [KO:K10366]
Tafazzin (mutation) [HSA:6901] [KO:K13511]
LDB3 (mutation) [HSA:11155] [KO:K19867]
ACTN2 (mutation) [HSA:88] [KO:K21073]
NEXN (mutation) [HSA:91624]
RBM20 (mutation) [HSA:282996]
SCN5A (mutation) [HSA:6331] [KO:K04838]
MYH6 (mutation) [HSA:4624] [KO:K17751]
TNNI3 (mutation) [HSA:7137] [KO:K12044]
SDHA (mutation) [HSA:6389] [KO:K00234]
EYA4 (mutation) [HSA:2070] [KO:K17622]
CSRP3 (mutation) [HSA:8048] [KO:K09377]
TCAP (mutation) [HSA:8557] [KO:K19879]
ABCC9 (mutation) [HSA:10060] [KO:K05033]
PLN (mutation) [HSA:5350] [KO:K05852]
TMPO (mutation) [HSA:7112]
PSEN1 (mutation) [HSA:5663] [KO:K04505]
PSEN2 (mutation) [HSA:5664] [KO:K04522]
VCL (mutation) [HSA:7414] [KO:K05700]
FKTN (mutation) [HSA:2218] [KO:K19872]
TNNC1 (mutation) [HSA:7134] [KO:K05865]
TNNI3 (mutation) [HSA:7137] [KO:K12044]
TAZ (mutation) [HSA:6901] [KO:K13511]
HLA-DRB1 (polymorphism) [HSA:3123] [KO:K06752]
HLA-DPA1 (polymorphism) [HSA:3113] [KO:K06752]
HLA-DPB1 (polymorphism) [HSA:3115] [KO:K06752]
HLA-DQA1 (polymorphism) [HSA:3117] [KO:K06752]
HLA-DQB1 (polymorphism) [HSA:3119] [KO:K06752]","  Coxsackievirus B3
Adenovirus
Cytomegalovirus
Parvovirus B19
Hepatitis C virus [GN:T40066]
Human immunodeficiency virus 1 (HIV-1) [GN:T40001]
Human immunodeficiency virus 2 (HIV-2) [GN:T40002]
Human herpesvirus 4 (Epstein-Barr virus) [GN:T40079]
Human herpesvirus 6B [GN:T40075]
Human herpes virus-6 (HHV6) [RS:NC_001664]
Trypanosoma cruzi [GN:tcr]
Chlamydia pneumoniae
Borrelia burgdorferi","LPS [CPD:C00338]
Ethanol [CPD:C00469]
Anthracycline
Low oxygen [CPD:C00007]",,Virus-specific IgM class antibodies,,,"ICD-10: I42
OMIM: 601494 604145 604765 606685 115200 613426 613424 611878 302045 601493 612158 613122 613172 601154 613252 613642 605362 607482 607487 608569 609909 613740 613694 613697 611407 611615 611879 611880 613286 300069","PMID:12270949 (gene)
  AUTHORS   Fatkin D, Graham RM
  TITLE     Molecular mechanisms of inherited cardiomyopathies.
  JOURNAL   Physiol Rev 82:945-80 (2002)
DOI:10.1152/physrev.00012.2002

PMID:12844200 (gene)
  AUTHORS   Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA
  TITLE     Molecular genetics of cardiomyopathy: changing times, shifting paradigms.
  JOURNAL   Cardiovasc J S Afr 14:145-55 (2003)

PMID:20864896 (gene)
  AUTHORS   Hershberger RE, Morales A, Siegfried JD
  TITLE     Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.
  JOURNAL   Genet Med 12:655-67 (2010)
DOI:10.1097/GIM.0b013e3181f2481f

PMID:20236114 (gene)
  AUTHORS   Franciosi S
  TITLE     Nexilin: a potential novel factor contributing to dilated cardiomyopathy.
  JOURNAL   Clin Genet 77:535-6 (2010)
DOI:10.1111/j.1399-0004.2010.01396_1.x

PMID:20551992 (gene)
  AUTHORS   Levitas A, Muhammad E, Harel G, Saada A, Caspi VC, Manor E, Beck JC, Sheffield V, Parvari R
  TITLE     Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase.
  JOURNAL   Eur J Hum Genet 18:1160-5 (2010)
DOI:10.1038/ejhg.2010.83

PMID:19015585 (gene)
  AUTHORS   Arimura T, Hayashi YK, Murakami T, Oya Y, Funabe S, Arikawa-Hirasawa E, Hattori N, Nishino I, Kimura A
  TITLE     Mutational analysis of fukutin gene in dilated cardiomyopathy and hypertrophic cardiomyopathy.
  JOURNAL   Circ J 73:158-61 (2009)
DOI:10.1253/circj.CJ-08-0722

(gene)
  AUTHORS   Richard P, Villard E, Charron P, Isnard R
  TITLE     The Genetic Bases of Cardiomyopathies
  JOURNAL   J Am Coll Cardiol 48:79-89 (2006)
DOI:10.1016/j.jacc.2006.09.014

PMID:19017683 (env_factor, marker, drug)
  AUTHORS   Luk A, Ahn E, Soor GS, Butany J
  TITLE     Dilated cardiomyopathy: a review.
  JOURNAL   J Clin Pathol 62:219-25 (2009)
DOI:10.1136/jcp.2008.060731

PMID:15246023 (env_factor, drug)
  AUTHORS   Mobini R, Maschke H, Waagstein F
  TITLE     New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
  JOURNAL   Autoimmun Rev 3:277-84 (2004)
DOI:10.1016/j.autrev.2003.10.005

PMID:15931504 (env_factor)
  AUTHORS   Poller W, Kuhl U, Tschoepe C, Pauschinger M, Fechner H, Schultheiss HP
  TITLE     Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
  JOURNAL   J Mol Med 83:579-86 (2005)
DOI:10.1007/s00109-005-0664-2

PMID:11716909 (drug)
  AUTHORS   Franz WM, Muller OJ, Katus HA
  TITLE     Cardiomyopathies: from genetics to the prospect of treatment.
  JOURNAL   Lancet 358:1627-37 (2001)
DOI:10.1016/S0140-6736(01)06657-0",OMIM,601494,604145,604765,606685,115200,613426,613424,611878,302045,601493,612158,613122,613172,601154,613252,613642,605362,607482,607487,608569,609909,613740,613694,613697,611407,611615,611879,611880,613286,300069
H01263,"Progressive cardiac conduction defect (PCCD);
Progressive familial heart block (PFHB);
Lenegre-Lev disease","Progressive cardiac conduction defect (PCCD) is a cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system. It leads to complete atrioventricular block causing syncope and sudden death. Mutations in the SCN5A gene encoding the cardiac sodium channel are responsible for Brugada syndrome (BS) and also for PCCD. Furthermore, another PCCD is caused by mutations in TRPM4.",Cardiovascular disease,"(type IA) SCN5A [HSA:6331] [KO:K04838]
(type IB) TRPM4 [HSA:54795] [KO:K04979]",,,,,,Brugada syndrome is described in H00728. [DS:H00728],"ICD-10: Q20.9
OMIM: 113900 604559","PMID:16643399
  AUTHORS   Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, Le Marec H
  TITLE     Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
  JOURNAL   J Cardiovasc Electrophysiol 17:270-5 (2006)
DOI:10.1111/j.1540-8167.2006.00349.x

PMID:19726882
  AUTHORS   Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Schulze-Bahr E, Brink P, Pongs O
  TITLE     Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.
  JOURNAL   J Clin Invest 119:2737-44 (2009)
DOI:10.1172/JCI38292",OMIM,113900,604559,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00805,"Vitreoretinal degeneration, including:
Stickler syndrome type I (STL1);
Stickler syndrome type II (STL2);
Snowflake vitreoretinal degeneration (SVD);
Wagner syndrome (WGN);
Knobloch syndrome (KNO);
Enhanced S-cone syndrome (ESCS);
Autosomal dominant vitreoretinochoroidopathy (ADVIRC)","The inherited vitreoretinal degenerations are disorders of the eye characterized by early onset cataract, anomalies of the vitreous manifesting as optically empty vitreous, course fibrils, and membranes, and retinal detachment. These diseases include Stickler syndrome types I (STL1) and II (STL2), caused by mutations in COL2A1 and COL11A1 respectively. Snowflake vitreoretinal degeneration (SVD) is associated with a mutation in a KCNJ13, and Wagner syndrome (WGN1) with mutations in CSPG2. Knobloch syndrome (KNO) may also be caused by mutations in a collagen gene, COL18A1. In addition to Stickler syndrome and other chondrodysplasias, enhanced S-cone syndrome (ESCS) and autosomal dominant vitreoretinochoroidopathy (ADVIRC) are associated with vitreoretinal degeneration.",Nervous system disease; Eye disease,"(STL1) COL2A1 [HSA:1280] [KO:K19719]
(STL2) COL11A1 [HSA:1301] [KO:K19721]
(SVD) KCNJ13 [HSA:3769] [KO:K05006]
(WGN1) CSPG2 [HSA:1462] [KO:K06793]
(KNO) COL18A1 [HSA:80781] [KO:K06823]
(ESCS) NR2E3 [HSA:10002] [KO:K08546]
(ADVIRC) BEST1 [HSA:7439] [KO:K13878]",,,,,,"STL1 and  STL2 are also included in Type II and XI collagenopathies, respectively. [DS:H00520] [DS:H00519]","ICD-10: H35.5
OMIM: 108300 604841 193230 143200 267750 268100 193220","PMID:18309337
  AUTHORS   Edwards AO
  TITLE     Clinical features of the congenital vitreoretinopathies.
  JOURNAL   Eye (Lond) 22:1233-42 (2008)
DOI:10.1038/eye.2008.38

PMID:18179896
  AUTHORS   Hejtmancik JF, Jiao X, Li A, Sergeev YV, Ding X, Sharma AK, Chan CC, Medina I, Edwards AO
  TITLE     Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration.
  JOURNAL   Am J Hum Genet 82:174-80 (2008)
DOI:10.1016/j.ajhg.2007.08.002

PMID:16043844
  AUTHORS   Miyamoto T, Inoue H, Sakamoto Y, Kudo E, Naito T, Mikawa T, Mikawa Y, Isashiki Y, Osabe D, Shinohara S, Shiota H, Itakura M
  TITLE     Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome.
  JOURNAL   Invest Ophthalmol Vis Sci 46:2726-35 (2005)
DOI:10.1167/iovs.05-0057

PMID:10942434
  AUTHORS   Sertie AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR
  TITLE     Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome).
  JOURNAL   Hum Mol Genet 9:2051-8 (2000)
DOI:10.1093/hmg/9.13.2051

PMID:12963616
  AUTHORS   Sharon D, Sandberg MA, Caruso RC, Berson EL, Dryja TP
  TITLE     Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.
  JOURNAL   Arch Ophthalmol 121:1316-23 (2003)
DOI:10.1001/archopht.121.9.1316

PMID:21072067
  AUTHORS   Vincent A, McAlister C, Vandenhoven C, Heon E
  TITLE     BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.
  JOURNAL   Eye (Lond) 25:113-8 (2011)
DOI:10.1038/eye.2010.165",OMIM,108300,604841,193230,143200,267750,268100,193220,,,,,,,,,,,,,,,,,,,,,,,
H00669,Naxos disease and Carvajal syndrome,"Naxos disease and Carvajal syndrome are disorders characterized by cardiomyopathy, palmoplantar keratoderma, and woolly hair. Cardiac manifestation in patients with Naxos disease is arrhythmogenic right ventricular cardiomyopathy that appears by adolescence with 100% penetrance. Carvajal syndrome is a variant of Naxos disease phenotype with left ventricular involvement that manifests in childhood and leads to early morbidity.",Congenital disorder; Skin and connective tissue disease; Cardiovascular disease,"(Naxos) JUP [HSA:3728] [KO:K10056]
(Carvajal) DSP [HSA:1832] [KO:K10381]",,,,,,,"ICD-10: Q87.8
OMIM: 601214 605676","PMID:15210133 (description, gene)
  AUTHORS   Protonotarios N, Tsatsopoulou A
  TITLE     Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy.
  JOURNAL   Cardiovasc Pathol 13:185-94 (2004)
DOI:10.1016/j.carpath.2004.03.609

PMID:10902626 (gene)
  AUTHORS   McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ
  TITLE     Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).
  JOURNAL   Lancet 355:2119-24 (2000)
DOI:10.1016/S0140-6736(00)02379-5

PMID:11063735 (gene)
  AUTHORS   Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell DP
  TITLE     Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma.
  JOURNAL   Hum Mol Genet 9:2761-6 (2000)
DOI:10.1093/hmg/9.18.2761

PMID:9738775 (description)
  AUTHORS   Carvajal-Huerta L
  TITLE     Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy.
  JOURNAL   J Am Acad Dermatol 39:418-21 (1998)
DOI:10.1016/S0190-9622(98)70317-2",OMIM,601214,605676,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00421,"Mucopolysaccharidosis (MPS), including:
Hurler-Scheie syndrome (type1) [DS:H00128];
Hunter syndrome (type2) [DS:H00129];
Sanfilippo syndrome (type3) [DS:H00130];
Morquio syndrome (type4) [DS:H00123];
Maroteaux-Lamy syndrome (type6) [DS:H00131];
Sly syndrome (type7) [DS:H00132];
Hyaluronidase deficiency (type9) [DS:H00133]","Mucopolysaccharidosis (MPS) is a group of lysosomal storage diseases caused by deficient activity of enzymes that play important roles in the degradation of glycosaminoglycans. MPS2/ Hunter syndrome is an X-linked disease and the others are autosomal recessive diseases. The enzyme defects result in the accumulation of glycosaminoglycans such as heparan sulfate, dermatan sulfate, and keratan sulfate in many organs, as well as elevated metabolite levels in urine. The MPS diseases share many clinical features that include organomegaly, dysostosis multiplex, decreased growth, and recurrent infections. Most of MPS diseases do not affect the nervous system, and are considered as potentially amenable to enzyme replacement therapy.",Inherited metabolic disease; Lysosomal storage disease,"(MPS1) IDUA; alpha-L-iduronidase [HSA:3425] [KO:K01217]
(MPS2) IDS; iduronate 2-sulfatase [HSA:3423] [KO:K01136]
(MPS3A) SGSH; N-sulfoglucosamine sulfohydrolase [HSA:6448] [KO:K01565]
(MPS3B) NAGLU; alpha-N-acetylglucosaminidase [HSA:4669] [KO:K01205]
(MPS3C) HGSNAT; heparan-alpha-glucosaminide N-acetyltransferase [HSA:138050] [KO:K10532]
(MPS3D) GNS; N-acetylglucosamine-6-sulfatase [HSA:2799] [KO:K01137]
(MPS4A) GALNS; N-acetylgalactosamine-6-sulfatase [HSA:2588] [KO:K01132]
(MPS4B) GLB1; beta-galactosidase [HSA:2720] [KO:K12309]
(MPS6) ARSB; arylsulfatase B [HSA:411] [KO:K01135]
(MPS7) GUSB; beta-glucuronidase [HSA:2990] [KO:K01195]
(MPS9) HYAL1; hyaluronoglucosaminidase [HSA:3373] [KO:K01197]",,,,"Urine glycosaminoglycans
(MPS1, MPS2, MPS3, MPS6, MPS7) Heparan sulfate [CPD:C00925]
(MPS1, MPS2, MPS7) Dermatan sulfate [CPD:C00426]
(MPS4A) keratan sulfate [CPD:C00573]
(MPS6) Chondroitin 4-sulfate [CPD:C00634]
(MPS4B, MPS7) Chondroitin sulfate [CPD:C00607]","Hematopoietic stem cell transplantation (MPS1, MPS4, MPS6, MPS7)
Enzyme-replacement therapy (MPS1, MPS2, MPS6)
(MPS1) Aldurazyme [DR:D04670]
(MPS2) Elaprase [DR:D04499]
(MPS6) Aryplase [DR:D06565]
Chemical chaperone therapy (MPS4, limited experience)
(MPS4) N-octyl-4-epi-beta-valienamine (NOEV)","The diagnosis is confirmed by measuring IDS activity in leukocytes or fibroblasts.
Morquio syndrome B (MPS4B) is allelic to the various forms of GM1-gangliosidosis (see, H00281). The latter disorders show central nervous system involvement.","ICD-10: E76.0 E76.1 E76.2
OMIM: 607015 607016 309900 252900 252920 252930 252940 253000 253010 253200 253220 601492","PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:16124866
  AUTHORS   Diez-Roux G, Ballabio A
  TITLE     Sulfatases and human disease.
  JOURNAL   Annu Rev Genomics Hum Genet 6:355-79 (2005)
DOI:10.1146/annurev.genom.6.080604.162334

PMID:15691212
  AUTHORS   Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA
  TITLE     Laronidase treatment of mucopolysaccharidosis I.
  JOURNAL   BioDrugs 19:1-7 (2005)

PMID:8680403 (MPS1)
  AUTHORS   Scott HS, Bunge S, Gal A, Clarke LA, Morris CP, Hopwood JJ
  TITLE     Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
  JOURNAL   Hum Mutat 6:288-302 (1995)
DOI:10.1002/humu.1380060403

PMID:18618289 (MPS2)
  AUTHORS   Al Sawaf S, Mayatepek E, Hoffmann B
  TITLE     Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed.
  JOURNAL   J Inherit Metab Dis 31:473-80 (2008)
DOI:10.1007/s10545-008-0878-x

PMID:18392742 (MPS3)
  AUTHORS   Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA
  TITLE     Sanfilippo syndrome: a mini-review.
  JOURNAL   J Inherit Metab Dis 31:240-52 (2008)
DOI:10.1007/s10545-008-0838-5

PMID:19472408 (MPS4B)
  AUTHORS   Hofer D, Paul K, Fantur K, Beck M, Burger F, Caillaud C, Fumic K, Ledvinova J, Lugowska A, Michelakakis H, Radeva B, Ramaswami U, Plecko B, Paschke E
  TITLE     GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.
  JOURNAL   Hum Mutat 30:1214-21 (2009)
DOI:10.1002/humu.21031

PMID:17671068 (MPS6)
  AUTHORS   Giugliani R, Harmatz P, Wraith JE
  TITLE     Management guidelines for mucopolysaccharidosis VI.
  JOURNAL   Pediatrics 120:405-18 (2007)
DOI:10.1542/peds.2006-2184

PMID:19224584 (MPS7)
  AUTHORS   Tomatsu S, Montano AM, Dung VC, Grubb JH, Sly WS
  TITLE     Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome).
  JOURNAL   Hum Mutat 30:511-9 (2009)
DOI:10.1002/humu.20828

PMID:10339581 (MPS9)
  AUTHORS   Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR
  TITLE     Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.
  JOURNAL   Proc Natl Acad Sci U S A 96:6296-300 (1999)
DOI:10.1073/pnas.96.11.6296",OMIM,607015,607016,309900,252900,252920,252930,252940,253000,253010,253200,253220,601492,,,,,,,,,,,,,,,,,,
H00801,"Familial thoracic aortic aneurysm and dissection (TAAD);
Aortic aneurysm familial thoracic type (AAT)","Thoracic aortic aneurysms leading to acute aortic dissections (TAAD) are the major diseases that affect the thoracic aorta. While majority of the cases are sporadic, more than 20% are inherited as a single gene disorder. Familial TAAD is diagnosed based on the presence of dilatation and/or dissection of the thoracic aorta, absence of clinical features of Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome, and presence of a positive family history of TAAD. TGFBR2, TGFBR1, MYH11, ACTA2, and two loci on other chromosomes, AAT1 and AAT2, are associated with familial TAAD.",Cardiovascular disease,"(AAT3) TGFBR2 [HSA:7048] [KO:K04388]
(AAT4) MYH11 [HSA:4629] [KO:K10352]
(AAT5) TGFBR1 [HSA:7046] [KO:K04674]
(AAT6) ACTA2 [HSA:59] [KO:K12313]
(AAT7) MYLK [HSA:4638] [KO:K00907]
(AAT8) PRKG1 [HSA:5592] [KO:K07376]
(AAT9) MFAP5 [HSA:8076]
(AAT10) LOX [HSA:4015] [KO:K00277]
(AAT11) FOXE3 [HSA:2301] [KO:K09398]",,,,"Echocardiography
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Angiography",,"Marfan syndrome, Loeys-Dietz syndrome, and Ehlers-Danlos syndrome are described in H00653, H00800, and H00802, respectively. [DS:H00653] [DS:H00800] [DS:H00802]","ICD-10: I71.2
OMIM: 607086 607087 610168 132900 608967 611788 613780 615436 616166 617168 617349","PMID:18544034
  AUTHORS   Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H
  TITLE     Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction.
  JOURNAL   Annu Rev Genomics Hum Genet 9:283-302 (2008)
DOI:10.1146/annurev.genom.8.080706.092303

PMID:20301299
  AUTHORS   Milewicz DM, Regalado E
  TITLE     Thoracic Aortic Aneurysms and Aortic Dissections
  JOURNAL   GeneReviews (1993)

PMID:21163914
  AUTHORS   Guo DC, Regalado ES, Minn C, Tran-Fadulu V, Coney J, Cao J, Wang M, Yu RK, Estrera AL, Safi HJ, Shete SS, Milewicz DM
  TITLE     Familial thoracic aortic aneurysms and dissections: identification of a novel locus for stable aneurysms with a low risk for progression to aortic dissection.
  JOURNAL   Circ Cardiovasc Genet 4:36-42 (2011)
DOI:10.1161/CIRCGENETICS.110.958066

PMID:11511117
  AUTHORS   Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, Rakowski H, Struyven J, Radegran K, Sechtem U, Taylor J, Zollikofer C, Klein WW, Mulder B, Providencia LA
  TITLE     Diagnosis and management of aortic dissection.
  JOURNAL   Eur Heart J 22:1642-81 (2001)
DOI:10.1053/euhj.2001.2782

PMID:23910461 (gene)
  AUTHORS   Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ, Dyack S, Horne SG, Chang G, Jondeau G, Boileau C, Coselli JS, Li Z, Leal SM, Shendure J, Rieder MJ, Bamshad MJ, Nickerson DA, Kim C, Milewicz DM
  TITLE     Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.
  JOURNAL   Am J Hum Genet 93:398-404 (2013)
DOI:10.1016/j.ajhg.2013.06.019

PMID:25434006 (gene)
  AUTHORS   Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC, Tosolini L, Ho-Tin-Noe B, Regalado E, Varret M, Abifadel M, Milleron O, Odent S, Dupuis-Girod S, Faivre L, Edouard T, Dulac Y, Busa T, Gouya L, Milewicz DM, Jondeau G, Boileau C
  TITLE     MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.
  JOURNAL   Am J Hum Genet 95:736-43 (2014)
DOI:10.1016/j.ajhg.2014.10.018

PMID:26838787 (gene)
  AUTHORS   Guo DC, Regalado ES, Gong L, Duan X, Santos-Cortez RL, Arnaud P, Ren Z, Cai B, Hostetler EM, Moran R, Liang D, Estrera A, Safi HJ, Leal SM, Bamshad MJ, Shendure J, Nickerson DA, Jondeau G, Boileau C, Milewicz DM
  TITLE     LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.
  JOURNAL   Circ Res 118:928-34 (2016)
DOI:10.1161/CIRCRESAHA.115.307130

PMID:26854927 (gene)
  AUTHORS   Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL, Boileau C, Jondeau G, Prakash SK, Kwartler CS, Zhu LY, Peters AM, Duan XY, Bamshad MJ, Shendure J, Nickerson DA, Santos-Cortez RL, Dong X, Leal SM, Majesky MW, Swindell EC, Jamrich M, Milewicz DM
  TITLE     FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.
  JOURNAL   J Clin Invest 126:948-61 (2016)
DOI:10.1172/JCI83778",OMIM,607086,607087,610168,132900,608967,611788,613780,615436,616166,617168,617349,,,,,,,,,,,,,,,,,,,
H00995,Combined deficiency of vitamin K-dependent clotting factors (VKCFD),"Combined vitamin K-dependent clotting factors deficiency (VKCFD) is a rare congenital bleeding disorder consisting of a deficiency of clotting factors II, VII, IX, and X , as well as the coagulation inhibitors protein C, protein S, and protein Z. VKCFD leads to a bleeding tendency with a variegate clinical picture. Two subtypes have been identified, deriving from mutations of two enzymes of the vitamin K cycle. VKCFD type1 is defined by defective GGCX activity, while VKCFD type 2 derives from functional deficiency of VKORC.",Inherited metabolic disease,"(VKCFD1) GGCX [HSA:2677] [KO:K10106]
(VKCFD2) VKORC1 [HSA:79001] [KO:K05357]",,,,,Vitamin K [DR:D00148],,"ICD-10: D68.4
OMIM: 277450 607473","PMID:20630065
  AUTHORS   Napolitano M, Mariani G, Lapecorella M
  TITLE     Hereditary combined deficiency of the vitamin K-dependent clotting factors.
  JOURNAL   Orphanet J Rare Dis 5:21 (2010)
DOI:10.1186/1750-1172-5-21",OMIM,277450,607473,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00731,Atrial fibrillation,"Atrial fibrillation (AF, ATFB) is the most common cardiac arrhythmia and is regarded generally as a sporadic, acquired disorder. Nevertheless, recent growing evidence points to an important heritable basis for AF. By linkage analysis, several loci have been mapped for monogenetic AF. Some of these loci encode for subunits of potassium channels.",Cardiovascular disease,"(ATFB3) KCNQ1 [HSA:3784] [KO:K04926]
(ATFB4) KCNE2 [HSA:9992] [KO:K04896]
(ATFB6) NPPA [HSA:4878] [KO:K12334]
(ATFB7) KCNA5 [HSA:3741] [KO:K04878]
(ATFB9) KCNJ2 [HSA:3759] [KO:K04996]
(ATFB10) SCN5A [HSA:6331] [KO:K04838]
(ATFB11) GJA5 [HSA:2702] [KO:K07614]
(ATFB12) ABCC9 [HSA:10060] [KO:K05033]
(ATFB13) SCN1B [HSA:6324] [KO:K04845]
(ATFB14) SCN2B [HSA:6327] [KO:K04846]
(ATFB15) NUP155 [HSA:9631] [KO:K14312]
(ATFB16) SCN3B [HSA:55800] [KO:K04847]
(ATFB17) SCN4B [HSA:6330] [KO:K04848]
(ATFB18) MYL4 [HSA:4635] [KO:K12750]",,,,,,,"ICD-10: I48
OMIM: 608583 607554 611493 612201 612240 613980 614022 614049 614050 615377 615378 615770 613120 611819 617280","PMID:18634977
  AUTHORS   Tsai CT, Lai LP, Hwang JJ, Lin JL, Chiang FT
  TITLE     Molecular genetics of atrial fibrillation.
  JOURNAL   J Am Coll Cardiol 52:241-50 (2008)
DOI:10.1016/j.jacc.2008.02.072

PMID:17768091
  AUTHORS   Otway R, Vandenberg JI, Fatkin D
  TITLE     Atrial fibrillation--a new cardiac channelopathy.
  JOURNAL   Heart Lung Circ 16:356-60 (2007)
DOI:10.1016/j.hlc.2007.07.003

PMID:19808477 (gene)
  AUTHORS   Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ, Roden DM
  TITLE     Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation.
  JOURNAL   Circ Arrhythm Electrophysiol 2:268-75 (2009)
DOI:10.1161/CIRCEP.108.779181

PMID:19070573 (gene)
  AUTHORS   Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, de la Fuente R, Wang L, Chen Q, Wang QK
  TITLE     Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death.
  JOURNAL   Cell 135:1017-27 (2008)
DOI:10.1016/j.cell.2008.10.022

PMID:21051419 (gene)
  AUTHORS   Olesen MS, Jespersen T, Nielsen JB, Liang B, Moller DV, Hedley P, Christiansen M, Varro A, Olesen SP, Haunso S, Schmitt N, Svendsen JH
  TITLE     Mutations in sodium channel beta-subunit SCN3B are associated with early-onset lone atrial fibrillation.
  JOURNAL   Cardiovasc Res 89:786-93 (2011)
DOI:10.1093/cvr/cvq348

PMID:27066836 (gene)
  AUTHORS   Orr N, Arnaout R, Gula LJ, Spears DA, Leong-Sit P, Li Q, Tarhuni W, Reischauer S, Chauhan VS, Borkovich M, Uppal S, Adler A, Coughlin SR, Stainier DY, Gollob MH
  TITLE     A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation.
  JOURNAL   Nat Commun 7:11303 (2016)
DOI:10.1038/ncomms11303",OMIM,608583,607554,611493,612201,612240,613980,614022,614049,614050,615377,615378,615770,613120,611819,617280,,,,,,,,,,,,,,,
H00424,"Defects in the degradation of sphingomyelin, including:
Niemann-Pick disease (NPD), type A/ B [DS:H00137];
Farber lipogranulomatosis [DS:H00138]","Defects in the degradation of sphingomyelin is a group of autosomal recessive lysosomal storage diseases including Niemann-Pick disease (NPD), type A/B and Farber lipogranulomatosis. NPD caused by deficient acid sphingomyelinase (ASM) activity, and Farber lipogranulomatosis is caused by acid ceramidase deficiency, resulting in accumulation of sphingomyelin, ceramide and cholesterol in many organs. ASM and acid ceramidase are key enzymes of the two steps degradation of sphingomyelin and play important roles in normal membrane turnover.",Inherited metabolic disease; Lysosomal storage disease; Nervous system disease,"(NPD) SMPD1, ASM; sphingomyelin phosphodiesterase [HSA:6609] [KO:K12350]
(Farber) ASAH1; acid ceramidase [HSA:427] [KO:K12348]",,,,"(NPD) Niemann-Pick cell: A rounded or polygonal mononuclear cell with indistinctly or palely staining, foamlike cytoplasm that contains numerous droplets of sphingomyelin. [CPD:C00550]
(Farber) Ceramide [CPD:C00195]","(NPD type B)
Enzyme-replacement therapy","NPD typeA is the infantile form characterized by a rapidly progressive neurodegenerative course that leads to early death. NPD typeB is the later-onset form in which patients exhibit little or no neurological symptoms, but may have severe and progressive visceral organ abnormalities, including hepatosplenomegaly and cardiovascular disease. The different clinical presentations of Types A and B NPD are likely due to small differences in the amount of residual, functional ASM activity.","ICD-10: E75.2
OMIM: 257200 607616 228000","PMID:18567738
  AUTHORS   Smith EL, Schuchman EH
  TITLE     The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.
  JOURNAL   FASEB J 22:3419-31 (2008)
DOI:10.1096/fj.08-108043

PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:17632693
  AUTHORS   Schuchman EH
  TITLE     The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
  JOURNAL   J Inherit Metab Dis 30:654-63 (2007)
DOI:10.1007/s10545-007-0632-9

PMID:10760463
  AUTHORS   Ridgway ND
  TITLE     Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin.
  JOURNAL   Biochim Biophys Acta 1484:129-41 (2000)
DOI:10.1016/S1388-1981(00)00006-8

PMID:19944693 (NPC)
  AUTHORS   Schuchman EH
  TITLE     Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
  JOURNAL   FEBS Lett 584:1895-900 (2010)
DOI:10.1016/j.febslet.2009.11.083

PMID:17064658 (Farber)
  AUTHORS   Park JH, Schuchman EH
  TITLE     Acid ceramidase and human disease.
  JOURNAL   Biochim Biophys Acta 1758:2133-8 (2006)
DOI:10.1016/j.bbamem.2006.08.019

PMID:11241842 (Farber)
  AUTHORS   Bar J, Linke T, Ferlinz K, Neumann U, Schuchman EH, Sandhoff K
  TITLE     Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
  JOURNAL   Hum Mutat 17:199-209 (2001)
DOI:10.1002/humu.5",OMIM,257200,607616,228000,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00532,"RASA1-related disorders, including:
Parkes-Weber slndrome;
Capillary malformation-arteriovenous malformation (CM-AVM);
Arteriovenous fistula (AVF)",These RASA1-related disorders are conditions with atypical cutaneous capillary malformations localized on the face and limbs. Some patients have fast-flow vascular lesion with directly connected arteries and veins.,Developmental disorder; Vascular disease,RASA1 [HSA:5921] [KO:K04352],,,,,,,OMIM: 608355 608354,"PMID:17670762 (description, gene)
  AUTHORS   Brouillard P, Vikkula M
  TITLE     Genetic causes of vascular malformations.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R140-9 (2007)
DOI:10.1093/hmg/ddm211

PMID:21348050 (description, gene)
  AUTHORS   Bayrak-Toydemir P, Stevenson D
  TITLE     RASA1-Related Disorders
  JOURNAL   GeneReviews (1993)",OMIM,608355,608354,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00725,Short QT syndrome,"Short QT syndrome (SQTS) is a cardiovascular disorder resulting from mutations in cardiac ion channels. The mutation of genes (KCNH2, KCNQ1, and KCNJ2) encoding for cardiac potassium channels plays a central role in SQTS. SQTS is characterized by constantly short QT interval associated with atrial fibrillation, syncopal episodes, and sudden cardiac death. The implantable cardioverter defibrillator (ICD) therapy in patients with a short QT syndrome has an increased risk due to possible T wave oversensing.",Cardiovascular disease,"(SQTS1) KCNH2 [HSA:3757] [KO:K04905]
(SQTS2) KCNQ1 [HSA:3784] [KO:K04926]
(SQTS3) KCNJ2 [HSA:3759] [KO:K04996]",,,,QT interval <300-320 msec,Quinidine [DG:DG00192] (still under evaluation),,OMIM: 609620 609621 609622,"PMID:15890322
  AUTHORS   Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M
  TITLE     Short QT syndrome.
  JOURNAL   Cardiovasc Res 67:357-66 (2005)
DOI:10.1016/j.cardiores.2005.03.026

PMID:19026859
  AUTHORS   Zareba W, Cygankiewicz I
  TITLE     Long QT syndrome and short QT syndrome.
  JOURNAL   Prog Cardiovasc Dis 51:264-78 (2008)
DOI:10.1016/j.pcad.2008.10.006

PMID:20126594
  AUTHORS   Crotti L, Taravelli E, Girardengo G, Schwartz PJ
  TITLE     Congenital short QT syndrome.
  JOURNAL   Indian Pacing Electrophysiol J 10:86-95 (2010)",OMIM,609620,609621,609622,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00104,"Alternative complement pathway component defects, including the following four diseases:
Factor B deficiency;
Factor D deficiency;
Factor H deficiency;
Properdin deficiency","The alternative pathway is antibody independent and relies on native C3 undergoing minimal spontaneous hydrolysis. Hydrolyzed C3 binds factor B. Factor B, when bound to hydrolyzed C3, is cleaved by factor D into Ba and Bb. Hydrolyzed C3Bb is responsible for a constant low level of C3 cleavage into C3b. If C3b binds to an appropriate surface, factor B will bind with C3b to form C3bBb, a highly efficient C3-cleaving enzyme. This overall series of successive proteolytic steps is enhanced by the serum protein properdin, which stabilizes protein:protein interactions during the process. Factor H is essential in controlling the function of the alternative pathway by inhibiting the formation of and degrading C3bBb. Deficiencies of alternative pathway-specific components are rare, and usually lead to an increased frequency of Neisseria infections.",Primary immunodeficiency,"BF [HSA:629] [KO:K01335]
DF [HSA:1675] [KO:K01334]
HF1 [HSA:3075] [KO:K04004]
PFC [HSA:5199] [KO:K15412]",,,,,,,OMIM: 613912 609814 312060,"PMID:19758139 (description, gene)
  AUTHORS   Pettigrew HD, Teuber SS, Gershwin ME
  TITLE     Clinical significance of complement deficiencies.
  JOURNAL   Ann N Y Acad Sci 1173:108-23 (2009)
DOI:10.1111/j.1749-6632.2009.04633.x

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,613912,609814,312060,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00756,"Pitt-Hopkins syndrome, including:
Pitt-Hopkins syndrome;
Pitt-Hopkins-like syndrome","Pitt-Hopkins Syndrome (PHS) is a rare disorder of severe mental retardation. Facial dysmorphism include a beaked nose, flared nostrils, and a wide mouth with a 'cupid's-bow' shaped upper lip. A particular breathing pattern is characteristic of PHS. The defective gene is TCF4 in PHS, and in patients who show severe mental retardation and other features resembling PHS have mutations in CNTNAP2 and Neurexin I.",Mental retardation,"(Pitt-Hopkins) TCF4 [HSA:6925] [KO:K15603]
(Pitt-Hopkins-like) CNTNAP2 [HSA:26047] [KO:K07380]
(Pitt-Hopkins-like) NRXN1 [HSA:9378] [KO:K07377]",,,,,,,"ICD-10: Q04.8
OMIM: 610954 610042 614325","PMID:20205897 (description, gene)
  AUTHORS   Taddeucci G, Bonuccelli A, Mantellassi I, Orsini A, Tarantino E
  TITLE     Pitt-Hopkins syndrome: report of a case with a TCF4 gene mutation.
  JOURNAL   Ital J Pediatr 36:12 (2010)
DOI:10.1186/1824-7288-36-12

PMID:9475596 (description, gene)
  AUTHORS   Van Balkom ID, Quartel S, Hennekam RC
  TITLE     Mental retardation, ""coarse"" face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome.
  JOURNAL   Am J Med Genet 75:273-6 (1998)
DOI:10.1002/(SICI)1096-8628(19980123)75:3<273:AID-AJMG9>3.0.CO;2-R",OMIM,610954,610042,614325,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00258,"Aldosterone synthase deficiency;
Corticosterone methyloxidase type I deficiency;
Corticosterone methyloxidase type II deficiency","Aldosterone synthase deficiency is an autosomal recessive disorder caused by a defect in the final biochemical step of aldosterone biosynthesis, the 18-hydroxylation of 18-hydroxycorticosterone to aldosterone. This disease is characterized by life-threatening salt-loss, failure to thrive, hyponatraemia and hyperkalaemia in early infancy. In type I deficiency, aldosterone is undetectable, whereas in type II aldosterone can be low or normal.",Endocrine disease,CYP11B2 [HSA:1585] [KO:K07433],,,,"Corticosterone [CPD:C02140]
11-deoxycorticosterone [CPD:C03205 ]","9alpha-fluorocortisol
Fludrocortisone acetate [DG:DG00506]",,"ICD-10: E27.4 I15.2
OMIM: 203400 610600","PMID:15134805
  AUTHORS   White PC
  TITLE     Aldosterone synthase deficiency and related disorders.
  JOURNAL   Mol Cell Endocrinol 217:81-7 (2004)
DOI:10.1016/j.mce.2003.10.013

PMID:11174838
  AUTHORS   Wasniewska M, De Luca F, Valenzise M, Lombardo F, De Luca F
  TITLE     Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene.
  JOURNAL   Eur J Endocrinol 144:59-62 (2001)
DOI:10.1530/eje.0.1440059

PMID:10559665
  AUTHORS   Peter M, Dubuis JM, Sippell WG
  TITLE     Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
  JOURNAL   Horm Res 51:211-22 (1999)
DOI:10.1159/000023374",OMIM,203400,610600,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00106,"Complement regulatory protein defects, including the following six diseases:
C1 inhibitor deficiency (hereditary angioedema);
C4 binding protein alpha deficiency;
C4 binding protein beta deficiency;
Factor I deficiency;
Decay-accelerating factor (CD55) deficiency;
CD59 deficiency","To prevent undesirable complement activation, host tissues express a number of complement regulatory proteins. They include C1 inhibitor (C1-INH, also termed SERPING1), C4 binding protein (C4BP), Factor I, decay accelerating factor (DAF), CD59, and so on. C1-INH (SERPING1) deficiency can be genetic or acquired, and this causes an episodic, local increase in vascular permeability in the subcutaneous and submucosal layers, identified as angioedema (hereditary or acquired). Genetic deficiency of C4BP has only been reported in one individual who developed an illness with similarities to Behcet's syndrome. Heterozygous mutations within the Factor I gene have been recently identified in individuals with atypical hemolytic uremic syndrome (aHUS), while homozygous deficiency of Factor I is an unusual feature. Factor I-deficient patients present high susceptibility to respiratory tract infections and meningitis. Kidney impairment and autoimmune disorders have also been observed. Only a single case of CD59 deficiency has been reported and this individual developed a paroxysmal nocturnal haemoglobinuria(PNH)-like illness. In contrast, deficiency of DAF is not associated with haemolytic anaemia.",Primary immunodeficiency,"SERPING1 [HSA:710] [KO:K04001]
C4BPA [HSA:722] [KO:K04002]
C4BPB [HSA:725] [KO:K04003]
IF [HSA:3426] [KO:K01333]
DAF [HSA:1604] [KO:K04006]
CD59 [HSA:966] [KO:K04008]",,,,,,,OMIM: 106100 610984 612300,"PMID:19481265 (description, gene)
  AUTHORS   Botto M, Kirschfink M, Macor P, Pickering MC, Wurzner R, Tedesco F
  TITLE     Complement in human diseases: Lessons from complement deficiencies.
  JOURNAL   Mol Immunol 46:2774-83 (2009)
DOI:10.1016/j.molimm.2009.04.029

PMID:19162547 (description, gene)
  AUTHORS   Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M
  TITLE     C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
  JOURNAL   Trends Mol Med 15:69-78 (2009)
DOI:10.1016/j.molmed.2008.12.001

PMID:18374984 (description, gene)
  AUTHORS   Ponce-Castro IM, Gonzalez-Rubio C, Delgado-Cervino EM, Abarrategui-Garrido C, Fontan G, Sanchez-Corral P, Lopez-Trascasa M
  TITLE     Molecular characterization of Complement Factor I deficiency in two Spanish families.
  JOURNAL   Mol Immunol 45:2764-71 (2008)
DOI:10.1016/j.molimm.2008.02.008

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,106100,610984,612300,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00728,Brugada syndrome (BRS),"The Brugada syndrome (BRS) is an autosomal dominant genetic disorder that is characterised by abnormal electrocardiogram (ECG) findings and an increased risk of sudden cardiac death. Diagnosis is based on clinical findings. Mutations in nine genes (SCN5A, GPD1L, CACNA1C, CACNB2, SCN1B, KCNE3, SCN3B, HCN4, and KCND3) are known to cause BRS. In approximately 20% of the cases BRS is caused by mutations in the SCN5A gene, encoding the cardiac sodium channel.",Cardiovascular disease,"(BRS1) SCN5A [HSA:6331] [KO:K04838]
(BRS2) GPD1L [HSA:23171] [KO:K00006]
(BRS3) CACNA1C [HSA:775] [KO:K04850]
(BRS4) CACNB2 [HSA:783] [KO:K04863]
(BRS5) SCN1B [HSA:6324] [KO:K04845]
(BRS6) KCNE3 [HSA:10008] [KO:K04897]
(BRS7) SCN3B [HSA:55800] [KO:K04847]
(BRS8) HCN4 [HSA:10021] [KO:K04957]
(BRS9) KCND3 [HSA:3752] [KO:K04893]",,,,"Presenting with a typical ECG pattern of ST segment elevation in leads V1 to V3, and incomplete or complete right bundle branch block.","Implantation of a cardioverter defibrillator
Quinidine [DG:DG00192]",,"ICD-10: I49.0
OMIM: 601144 611777 611875 611876 612838 613119 613120 613123 616399","PMID:16972995
  AUTHORS   Napolitano C, Priori SG
  TITLE     Brugada syndrome.
  JOURNAL   Orphanet J Rare Dis 1:35 (2006)
DOI:10.1186/1750-1172-1-35

PMID:20301690 (mutations and treatments)
  AUTHORS   Brugada R, Campuzano O, Brugada P, Brugada J, Hong K
  TITLE     Brugada Syndrome
  JOURNAL   GeneReviews (1993)

PMID:21209740
  AUTHORS   Kalavakunta JK, Bantu V, Tokala H, Kodenchery M
  TITLE     Sudden cause of cardiac death-be aware of me: a case report and short review on brugada syndrome.
  JOURNAL   Case Report Med 2010:823490 (2010)
DOI:10.1155/2010/823490

PMID:1309182
  AUTHORS   Brugada P, Brugada J
  TITLE     Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
  JOURNAL   J Am Coll Cardiol 20:1391-6 (1992)
DOI:10.1016/0735-1097(92)90253-J

PMID:22457051 (gene)
  AUTHORS   Giudicessi JR, Ye D, Kritzberger CJ, Nesterenko VV, Tester DJ, Antzelevitch C, Ackerman MJ
  TITLE     Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death.
  JOURNAL   Hum Mutat 33:989-97 (2012)
DOI:10.1002/humu.22058",OMIM,601144,611777,611875,611876,612838,613119,613120,613123,616399,,,,,,,,,,,,,,,,,,,,,
H01019,Catecholaminergic polymorphic ventricular tachycardia,Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a highly lethal form of inherited primary electrical myocardial disease characterized by exercise- and stress-related adrenergic ventricular tachycardia without structural cardiac abnormalities. It manifests as syncope and sudden death and can be caused by mutations in the cardiac ryanodine receptor gene (RYR2) accounting for an autosomal dominant form (CPVT1) or mutations in the cardiac calsequestrin gene CASQ2 accounting for an autosomal recessive form (CPVT2). It was also reported that absence of the inhibitory G-Protein Galphai2 predisposes to ventricular tachycardia.,Cardiovascular disease,"(CPVT1) RYR2 [HSA:6262] [KO:K04962]
(CPVT2) CASQ2 [HSA:845]
GNAI2 [HSA:2771] [KO:K04630]
(CPVT4) CALM1 [HSA:801] [KO:K02183]
(CPVT5) TRDN [HSA:10345]",,,,,"Beta-blockers (For primary manifestations)
Metoprolol (For secondary manifestations) [DG:DG00313]
Anticoagulant",,"ICD-10: I47.2
OMIM: 604772 611938 192605 614916 615441","PMID:22119737 (description, gene)
  AUTHORS   Pflaumer A, Davis AM
  TITLE     Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
  JOURNAL   Heart Lung Circ 21:96-100 (2012)
DOI:10.1016/j.hlc.2011.10.008

PMID:20301466 (description, gene, drug)
  AUTHORS   Napolitano C, Priori SG, Bloise R
  TITLE     Catecholaminergic Polymorphic Ventricular Tachycardia
  JOURNAL   GeneReviews (1993)

PMID:17497254 (description, gene)
  AUTHORS   Liu N, Colombi B, Raytcheva-Buono EV, Bloise R, Priori SG
  TITLE     Catecholaminergic polymorphic ventricular tachycardia.
  JOURNAL   Herz 32:212-7 (2007)
DOI:10.1007/s00059-007-2975-2

PMID:19068246 (description, gene)
  AUTHORS   Katz G, Arad M, Eldar M
  TITLE     Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
  JOURNAL   Curr Probl Cardiol 34:9-43 (2009)
DOI:10.1016/j.cpcardiol.2008.09.002

PMID:15176428 (description, gene)
  AUTHORS   Laitinen PJ, Swan H, Piippo K, Viitasalo M, Toivonen L, Kontula K
  TITLE     Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.
  JOURNAL   Ann Med 36 Suppl 1:81-6 (2004)
DOI:10.1080/17431380410032599

PMID:20495013
  AUTHORS   Zuberi Z, Nobles M, Sebastian S, Dyson A, Lim SY, Breckenridge R, Birnbaumer L, Tinker A
  TITLE     Absence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia.
  JOURNAL   Circ Arrhythm Electrophysiol 3:391-400 (2010)
DOI:10.1161/CIRCEP.109.894329

PMID:23040497 (gene)
  AUTHORS   Nyegaard M, Overgaard MT, Sondergaard MT, Vranas M, Behr ER, Hildebrandt LL, Lund J, Hedley PL, Camm AJ, Wettrell G, Fosdal I, Christiansen M, Borglum AD
  TITLE     Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
  JOURNAL   Am J Hum Genet 91:703-12 (2012)
DOI:10.1016/j.ajhg.2012.08.015

PMID:22422768 (gene)
  AUTHORS   Roux-Buisson N, Cacheux M, Fourest-Lieuvin A, Fauconnier J, Brocard J, Denjoy I, Durand P, Guicheney P, Kyndt F, Leenhardt A, Le Marec H, Lucet V, Mabo P, Probst V, Monnier N, Ray PF, Santoni E, Tremeaux P, Lacampagne A, Faure J, Lunardi J, Marty I
  TITLE     Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
  JOURNAL   Hum Mol Genet 21:2759-67 (2012)
DOI:10.1093/hmg/dds104",OMIM,604772,611938,192605,614916,615441,,,,,,,,,,,,,,,,,,,,,,,,,
H01219,Restrictive cardiomyopathy (RCM),"Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by impaired ventricular filling and increased stiffness of the myocardium with diastolic dysfunction, resulting in atrial enlargement and elevated systemic and pulmonary venous pressure. To date, mutations have been identified in the cardiac genes for desmin, alpha-actin, troponin I and troponin T.",Cardiovascular disease,"DES (mutation) [HSA:1674] [KO:K07610]
ACTC (mutation) [HSA:70] [KO:K12314]
TNNI3 (mutation) [HSA:7137] [KO:K12044]
TNNT2 (mutation) [HSA:7139] [KO:K12045]",,,,,,,"ICD-10: I42
OMIM: 115210 612422","PMID:20617149 (gene, description)
  AUTHORS   Parvatiyar MS, Pinto JR, Dweck D, Potter JD
  TITLE     Cardiac troponin mutations and restrictive cardiomyopathy.
  JOURNAL   J Biomed Biotechnol 2010:350706 (2010)
DOI:10.1155/2010/350706

PMID:18646564 (gene, description)
  AUTHORS   Arimura T, Hayashi T, Kimura A
  TITLE     Molecular etiology of idiopathic cardiomyopathy.
  JOURNAL   Acta Myol 26:153-8 (2007)

PMID:15201162 (gene, description)
  AUTHORS   Gomes AV, Potter JD
  TITLE     Molecular and cellular aspects of troponin cardiomyopathies.
  JOURNAL   Ann N Y Acad Sci 1015:214-24 (2004)
DOI:10.1196/annals.1302.018",OMIM,115210,612422,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00103,"Late complement pathway defects, including:
C5 deficiency;
C6 deficiency;
C7 deficiency;
C8 alpha-chain deficiency;
C8 beta-chain deficiency;
C8 gamma-chain deficiency;
C9 deficiency","Late complement component (the final common pathway C5b-C9 components) deficiencies are all inherited in an autosomal recessive manner. In all cases, homozygous recessive patients have greatly reduced levels of the respective complement component. Generally, patients with deficiencies of C5, C6, C7, or C8 are particularly susceptible to systemic infections with Neisseria meningitidies and N. gonorrhoeae. Infections are rarely fulminant but are often recurrent and frequently involve unusual serotypes of the organism.",Primary immunodeficiency,"C5 [HSA:727] [KO:K03994]
C6 [HSA:729] [KO:K03995]
C7 [HSA:730] [KO:K03996]
C8 alpha [HSA:731] [KO:K03997]
C8 beta [HSA:732] [KO:K03998]
C8 gamma [HSA:733] [KO:K03999]
C9 [HSA:735] [KO:K04000]",,,,,,,OMIM: 609536 612446 610102 608957 613790 613789 613825,"PMID:19758139 (description, gene)
  AUTHORS   Pettigrew HD, Teuber SS, Gershwin ME
  TITLE     Clinical significance of complement deficiencies.
  JOURNAL   Ann N Y Acad Sci 1173:108-23 (2009)
DOI:10.1111/j.1749-6632.2009.04633.x

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,609536,612446,610102,608957,613790,613789,613825,,,,,,,,,,,,,,,,,,,,,,,
H00730,Familial idiopathic ventricular fibrillation,"Idiopathic ventricular fibrillation (IVF) is a syndrome that causes sudden cardiac death in individuals with an apparently normal heart. It has been found a novel SCN5A missense mutation in one symptomatic IVF patient that did not exhibit the typical Brugada electrocardiogram (ECG). Recently, IVF linked to the DPP6 gene has been reported.",Cardiovascular disease,"(IVF1) SCN5A [HSA:6331] [KO:K04838]
(IVF2) DPP6 [HSA:1804]",,,,,,Brugada syndrome [DS:H00728],OMIM: 603829 612956,"PMID:10940383
  AUTHORS   Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, Nakazawa K, Kimura A, Hiraoka M
  TITLE     A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.
  JOURNAL   FEBS Lett 479:29-34 (2000)
DOI:10.1016/S0014-5793(00)01875-5

PMID:21512816
  AUTHORS   Postema PG, Christiaans I, Hofman N, Alders M, Koopmann TT, Bezzina CR, Loh P, Zeppenfeld K, Volders PG, Wilde AA
  TITLE     Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6.
  JOURNAL   Neth Heart J 19:290-6 (2011)
DOI:10.1007/s12471-011-0102-8",OMIM,603829,612956,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00100,"Neutropenic disorders, including the following three diseases:
Kostmann syndrome;
Cyclic neutropenia;
X-linked neutropenia/myelodysplasia","Neutropenias represent a series of potentially life-threatening disorders characterised by a reduction in circulating neutrophils. Since neutrophils play a major role in host defense against bacteria, neutropenia patients suffer from frequent episodes of opportunistic bacterial infections. Severe congenital neutropenia (SCN) is a rare neutropenia with a bone marrow maturation arrest of granulocytic differentiation. Kostmann syndrome is an autosomal recessive SCN. The characteristic maturation arrest and the lack of mature neutrophils in peripheral blood of patients with Kostmann syndrome can be explained by the deletion of an anti-apoptotic factor (HAX-1) in myeloid cells of these patients. Heterozygous mutations in the protooncogene growth factor-independent 1 (GFI1) gene are also associated with SCN. In patients with autosomal dominant cyclic neutropenia (CyN), a condition with oscillating neutrophil counts but less severe clinical symptoms, heterozygous mutations in ELA-2/ELANE were discovered. Patients with X-linked severe congenital neutropenia (SCN) have been reported with activating mutations in WASp leading to a constitutively-active form of the protein, and unregulated actin polymerization.",Primary immunodeficiency,"HAX1 [HSA:10456] [KO:K16220]
GFI1 [HSA:2672] [KO:K09223]
ELA2 [HSA:1991] [KO:K01327]
WAS [HSA:7454] [KO:K05747]",,,,,"Filgrastim [DR:D03235]
Lenograstim [DR:D03247]
Nartograstim [DR:D03245]",,"ICD-10: D70
OMIM: 610738 613107 202700 300299","PMID:17162365
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:15096561
  AUTHORS   Lim MS, Elenitoba-Johnson KS.
  TITLE     The molecular pathology of primary immunodeficiencies.
  JOURNAL   J Mol Diagn 6:59-83 (2004)
DOI:10.1016/S1525-1578(10)60493-X

PMID:18424339
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053

PMID:19811314
  AUTHORS   Rezaei N, Moazzami K, Aghamohammadi A, Klein C
  TITLE     Neutropenia and primary immunodeficiency diseases.
  JOURNAL   Int Rev Immunol 28:335-66 (2009)
DOI:10.1080/08830180902995645",OMIM,610738,613107,202700,300299,,,,,,,,,,,,,,,,,,,,,,,,,,
H00945,Factor XIII deficiency,"Factor XIII deficiency is a rare autosomal recessive disorder characterized by defective cross-linking of fibrin and poor resistance to fibrinolysis. The severity of the bleeding tendency varies from benign symptoms like excessive bruising to life threatening bleeding emergencies such as intracranial hemorrhages. In plasma, FXIII circulates as a pro-transglutaminase composed of two catalytic A subunits and two non-catalytic B subunits. Symptoms that are almost pathognomonic for A subunit deficiency are umbilical bleeding in the neonatal period and repeated fetal wastage in pregnant females.",Hematologic disease,"F13A1 [HSA:2162] [KO:K03917]
F13B [HSA:2165] [KO:K03906]",,,,,"Human blood-coagulation factor XIII fraction, dried [DR:D08802]",,"ICD-10: D68.2
OMIM: 613225 613235","PMID:19141159
  AUTHORS   Hsieh L, Nugent D
  TITLE     Factor XIII deficiency.
  JOURNAL   Haemophilia 14:1190-200 (2008)
DOI:10.1111/j.1365-2516.2008.01857.x

PMID:9028951
  AUTHORS   Mikkola H, Muszbek L, Laiho E, Syrjala M, Hamalainen E, Haramura G, Salmi T, Peltonen L, Palotie A
  TITLE     Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.
  JOURNAL   Blood 89:1279-87 (1997)",OMIM,613225,613235,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00898,"Myopathy with lactic acidosis and sideroblastic anaemia (MLASA);
Mitochondrial myopathy and sideroblastic anemia;
Hereditary myopathy with lactic acidosis (HML)","Myopathy with lactic acidosis and sideroblastic anaemia (MLASA) is a rare autosomal recessive oxidative phosphorylation disorder specific to skeletal muscle and bone marrow. MLASA has been associated with a missense mutation in pseudouridylate synthase 1 (PUS1), an enzyme located in both nucleus and mitochondria, which converts uridine into pseudouridine in several cytosolic and mitochondrial tRNA positions and increases the efficiency of protein synthesis in both compartments. Recentry, it has been reported that a mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, also causes MLASA. Myopathy with succinate dehydrogenase and aconitase deficiency has been found to be caused by mutations in the gene encoding the iron-sulphur cluster scaffold protein (ISCU). ISCU is essential for the activity mitochondrial iron-sulphur proteins such as succinate dehydrogenase and aconitase.",Inherited metabolic disease; Mitochondrial disease,"(MLASA1) PUS1 [HSA:80324] [KO:K06173]
(MLASA2) YARS2 [HSA:51067] [KO:K01866]
(HML) ISCU [HSA:23479] [KO:K22068]",,,,Lactic acidosis,,,"ICD-10: G71.3
OMIM: 600462 613561 255125","PMID:17056637
  AUTHORS   Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M
  TITLE     Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA).
  JOURNAL   J Med Genet 44:173-80 (2007)
DOI:10.1136/jmg.2006.045252

PMID:20598274
  AUTHORS   Riley LG, Cooper S, Hickey P, Rudinger-Thirion J, McKenzie M, Compton A, Lim SC, Thorburn D, Ryan MT, Giege R, Bahlo M, Christodoulou J
  TITLE     Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.
  JOURNAL   Am J Hum Genet 87:52-9 (2010)
DOI:10.1016/j.ajhg.2010.06.001

PMID:18304497
  AUTHORS   Mochel F, Knight MA, Tong WH, Hernandez D, Ayyad K, Taivassalo T, Andersen PM, Singleton A, Rouault TA, Fischbeck KH, Haller RG
  TITLE     Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance.
  JOURNAL   Am J Hum Genet 82:652-60 (2008)
DOI:10.1016/j.ajhg.2007.12.012",OMIM,600462,613561,255125,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00221,Combined deficiency of factors V and VIII (F5F8D),"Combined deficiency of factors V and VIII is caused by mutations in LMAN1 or MCFD2, which form a complex working as an cargo receptor for transport of coagulation factors V and VIII from ER to Golgi.",Hematologic disease,"LMAN1; mannose-binding lectin 1 [HSA:3998] [KO:K10080]
MCFD2 [HSA:90411] [KO:K20364]",,,,,"Desmopressin [DG:DG00497]
Coagulation factor VIII [DR:D08798]",,OMIM: 227300 613625,"PMID:19141160
  AUTHORS   Spreafico M, Peyvandi F
  TITLE     Combined FV and FVIII deficiency.
  JOURNAL   Haemophilia 14:1201-8 (2008)
DOI:10.1111/j.1365-2516.2008.01845.x

PMID:18391077
  AUTHORS   Zhang B, Spreafico M, Zheng C, Yang A, Platzer P, Callaghan MU, Avci Z, Ozbek N, Mahlangu J, Haw T, Kaufman RJ, Marchant K, Tuddenham EG, Seligsohn U, Peyvandi F, Ginsburg D
  TITLE     Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.
  JOURNAL   Blood 111:5592-600 (2008)
DOI:10.1182/blood-2007-10-113951

PMID:16304051
  AUTHORS   Zhang B, McGee B, Yamaoka JS, Guglielmone H, Downes KA, Minoldo S, Jarchum G, Peyvandi F, de Bosch NB, Ruiz-Saez A, Chatelain B, Olpinski M, Bockenstedt P, Sperl W, Kaufman RJ, Nichols WC, Tuddenham EG, Ginsburg D
  TITLE     Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.
  JOURNAL   Blood 107:1903-7 (2006)
DOI:10.1182/blood-2005-09-3620

PMID:12717434
  AUTHORS   Zhang B, Cunningham MA, Nichols WC, Bernat JA, Seligsohn U, Pipe SW, McVey JH, Schulte-Overberg U, de Bosch NB, Ruiz-Saez A, White GC, Tuddenham EG, Kaufman RJ, Ginsburg D
  TITLE     Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex.
  JOURNAL   Nat Genet 34:220-5 (2003)
DOI:10.1038/ng1153",OMIM,227300,613625,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00720,"Long QT syndrome, including:
Romano-Ward syndrome;
Jervell and Lange-Nielsen syndrome (JLNS)","Long QT syndrome (LQTS) is a cardiovascular disorder resulting from mutations in cardiac ion channels. LQTS is characterized by prolongation of the QT interval in the electrocardiogram (ECG) and a propensity to torsades de pointes ventricular tachycardia frequently leading to syncope, cardiac arrest, or sudden death usually in young otherwise healthy individuals. Anesthesia in a patient with LQTS can trigger malignant arrhythmias and is therefore a high-risk procedure. There are two well-known syndromes with a long QT interval. The Romano-Ward syndrome is characterized by an autosomal-dominant inheritance without familial deafness. The Jervell and Lange-Nielsen syndrome (JLNS) has an autosomal-recessive pattern of inheritance and is associated with deafness.",Cardiovascular disease,"(LQT1) KCNQ1 [HSA:3784] [KO:K04926]
(LQT2) KCNH2 [HSA:3757] [KO:K04905]
(LQT3) SCN5A [HSA:6331] [KO:K04838]
(LQT4) ANK2 [HSA:287] [KO:K10380]
(LQT5/JLNS2) KCNE1 [HSA:3753] [KO:K04894]
(LQT6) KCNE2 [HSA:9992] [KO:K04896]
(LQT7) KCNJ2 [HSA:3759] [KO:K04996]
(LQT8) CACNA1C [HSA:775] [KO:K04850]
(LQT9) CAV3 [HSA:859] [KO:K12959]
(LQT10) SCN4B [HSA:6330] [KO:K04848]
(LQT11) AKAP9 [HSA:10142] [KO:K16551]
(LQT12) SNTA1 [HSA:6640]
(LQT13) KCNJ5 [HSA:3762] [KO:K04999]
(LQT14) CALM1 [HSA:801] [KO:K02183]
(LQT15) CALM2 [HSA:805] [KO:K02183]
(JLNS1) KCNQ1 [HSA:3784] [KO:K04926]",,"Sevoflurane [DR:D00547]
Isoflurane [DR:D00545]
Desflurane [DR:D00546]",,,"(Generally) beta-Blockers
Implantation of a cardioverter defibrillator
(Torsades de pointes) Magnesium sulphate [DR:D01108]",Please refer to map07214 beta-Adrenergic receptor agonists/antagonists.,"ICD-10: I45.81
OMIM: 192500 613688 603830 600919 613695 613693 170390 601005 611818 611819 611820 612955 613485 220400 616247 616249 612347","PMID:21286418
  AUTHORS   Kim HT, Lee JH, Park IB, Heo HE, Kim TY, Lee MJ
  TITLE     Long QT syndrome provoked by induction of general anesthesia -A case report-.
  JOURNAL   Korean J Anesthesiol 59 Suppl:S114-8 (2010)
DOI:10.4097/kjae.2010.59.S.S114

PMID:19026859
  AUTHORS   Zareba W, Cygankiewicz I
  TITLE     Long QT syndrome and short QT syndrome.
  JOURNAL   Prog Cardiovasc Dis 51:264-78 (2008)
DOI:10.1016/j.pcad.2008.10.006

PMID:17498019 (environmental factor)
  AUTHORS   Aypar E, Karagoz AH, Ozer S, Celiker A, Ocal T
  TITLE     The effects of sevoflurane and desflurane anesthesia on QTc interval and cardiac rhythm in children.
  JOURNAL   Paediatr Anaesth 17:563-7 (2007)
DOI:10.1111/j.1460-9592.2006.02152.x

PMID:16409532
  AUTHORS   Saussine M, Massad I, Raczka F, Davy JM, Frapier JM
  TITLE     Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
  JOURNAL   Paediatr Anaesth 16:63-5 (2006)
DOI:10.1111/j.1460-9592.2005.01593.x

PMID:10593671
  AUTHORS   Ilhan A, Tuncer C, Komsuoglu SS, Kali S
  TITLE     Jervell and Lange-Nielsen syndrome: neurologic and cardiologic evaluation.
  JOURNAL   Pediatr Neurol 21:809-13 (1999)
DOI:10.1016/S0887-8994(99)00100-9

PMID:23388215 (gene)
  AUTHORS   Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kaab S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL Jr
  TITLE     Calmodulin mutations associated with recurrent cardiac arrest in infants.
  JOURNAL   Circulation 127:1009-17 (2013)
DOI:10.1161/CIRCULATIONAHA.112.001216",OMIM,192500,613688,603830,600919,613695,613693,170390,601005,611818,611819,611820,612955,613485,220400,616247,616249,612347,,,,,,,,,,,,,
H00102,"Classic complement pathway component defects, including the following eight diseases:
C1q alpha-chain deficiency;
C1q beta-chain deficiency;
C1q gamma-chain deficiency;
C1r deficiency;
C1s deficiency;
C2 deficiency;
C3 deficiency;
C4 deficiency","Complement disorders account for only 2 percent of all primary immunodeficiency disorders. They result from the disruption of one of the proteins involved in the classic or nonclassic activation pathways of the complement response. Defects in the classic pathway account for the more common type of complement deficiency, and are associated with increased risk to develop systemic lupus erythematosus (SLE) and SLE-like diseases. Homozygous C2 deficiency, which is the most frequent hereditary deficiency in complement classical pathway components, is associated with SLE in 10% of the cases. Complete C1q and C4 deficiencies are less frequent but associated with a higher prevalence of SLE.",Primary immunodeficiency,"C1QA [HSA:712] [KO:K03986]
C1QB [HSA:713] [KO:K03987]
C1QG [HSA:714] [KO:K03988]
C1R [HSA:715] [KO:K01330]
C1S [HSA:716] [KO:K01331]
C2 [HSA:717] [KO:K01332]
C3 [HSA:718] [KO:K03990]
C4A [HSA:720] [KO:K03989]
C4B [HSA:421]",,,,,,,OMIM: 613652 613783 217000 613779 614380 614379 120790,"PMID:19028607 (description, gene)
  AUTHORS   Bussone G, Mouthon L
  TITLE     Autoimmune manifestations in primary immune deficiencies.
  JOURNAL   Autoimmun Rev 8:332-6 (2009)
DOI:10.1016/j.autrev.2008.11.004

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,613652,613783,217000,613779,614380,614379,120790,,,,,,,,,,,,,,,,,,,,,,,
H00105,"Mannose-binding lectin pathway component defects, including the following two diseases:
Mannose-binding lectin deficiency;
Mannose-binding lectin-associated serine protease (MASP) 2 deficiency","There is an increasing number of clinical studies indicating that deficiency of the lectin pathway has been associated with an increased risk, severity, and frequency of infections but also autoimmune disorders. MBL deficiency is one of the most common human immunodeficiencies and arises primarily from three single point mutations in exon 1 of the MBL-2 gene. These mutations result in a failure to assemble fully functional multimeric protein. Inherited MASP-2 deficiency has been described as the result of a mutation causing the exchange of aspartic acid with a glycine at position 105, a position in the first domain, CUB1, involved in calcium binding. This mutation abolishes the binding to MBL and ficolins, and deprives MASP-2 of functional activity.",Primary immunodeficiency,"MBL2 [HSA:4153] [KO:K03991]
MASP2 [HSA:10747] [KO:K03993]",,,,,,,OMIM: 614372 613791,"PMID:19481265 (description, gene)
  AUTHORS   Botto M, Kirschfink M, Macor P, Pickering MC, Wurzner R, Tedesco F
  TITLE     Complement in human diseases: Lessons from complement deficiencies.
  JOURNAL   Mol Immunol 46:2774-83 (2009)
DOI:10.1016/j.molimm.2009.04.029

PMID:14568388 (description, gene)
  AUTHORS   Turner MW
  TITLE     The role of mannose-binding lectin in health and disease.
  JOURNAL   Mol Immunol 40:423-9 (2003)
DOI:10.1016/S0161-5890(03)00155-X

PMID:16189649 (description, gene)
  AUTHORS   Sorensen R, Thiel S, Jensenius JC
  TITLE     Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.
  JOURNAL   Springer Semin Immunopathol 27:299-319 (2005)
DOI:10.1007/s00281-005-0006-z

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",OMIM,614372,613791,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01208,"Globozoospermia;
Round-headed spermatozoa","Globozoospermia is a rare form of teratozoospermia, mainly characterized by round-headed spermatozoa that lack an acrosome. Acrosome plays an important role at the site of sperm-zonapellucida binding during the fertilization process. It was suggested that a homozygous mutation in SPATA16 was associated with male infertility in human globozoospermia. It has also been reported that a recurrent deletion of DPY19L2 causes infertility in man by blocking sperm head elongation and acrosome formation.",Developmental disorder,"SPATA16 [HSA:83893]
DPY19L2 [HSA:283417]",,,,,,"Disruption of several mouse genes, including GOPC, HRB, and CSNK2A2, results in a phenotype similar to globozoospermia in humans. However, no causative gene mutations have been identified in these orthologues. Recently, a newly discovered mutation in PICK1 in a human with globozoospermia was reported.",OMIM: 102530 613958,"PMID:17847006
  AUTHORS   Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, Tournaye H, Charlet N, Lagier-Tourenne C, van Bokhoven H, Viville S
  TITLE     Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia.
  JOURNAL   Am J Hum Genet 81:813-20 (2007)
DOI:10.1086/521314

PMID:21397064
  AUTHORS   Harbuz R, Zouari R, Pierre V, Ben Khelifa M, Kharouf M, Coutton C, Merdassi G, Abada F, Escoffier J, Nikas Y, Vialard F, Koscinski I, Triki C, Sermondade N, Schweitzer T, Zhioua A, Zhioua F, Latrous H, Halouani L, Ouafi M, Makni M, Jouk PS, Sele B, Hennebicq S, Satre V, Viville S, Arnoult C, Lunardi J, Ray PF
  TITLE     A recurrent deletion of DPY19L2 causes infertility in man by blocking sperm head elongation and acrosome formation.
  JOURNAL   Am J Hum Genet 88:351-61 (2011)
DOI:10.1016/j.ajhg.2011.02.007

PMID:20562896
  AUTHORS   Liu G, Shi QW, Lu GX
  TITLE     A newly discovered mutation in PICK1 in a human with globozoospermia.
  JOURNAL   Asian J Androl 12:556-60 (2010)
DOI:10.1038/aja.2010.47",OMIM,102530,613958,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01235,Bleeding disorder platelet-type,"Bleeding disorder platelet-type is a condition characterized by mild to moderate mucocutaneous bleeding. Patients are with platelet dysfunction but normal platelet number. It has been reported that these disorders are associated with mutations in key platelet activation receptors, namely those for ADP, collagen and thromboxane A2.",Hematologic disease,"P2RY12 [HSA:64805] [KO:K04298]
ITGA2 [HSA:3673] [KO:K06481]
GP6 [HSA:51206] [KO:K06264]
TBXA2R [HSA:6915] [KO:K04264]
RASGRP2 [HSA:10235] [KO:K12361]
SLFN14 [HSA:342618]
FLI1 [HSA:2313] [KO:K09436]",,,,,,See also H01740 Macrothrombocytopenia.,"ICD-10: D69.8
OMIM: 609821 614200 614201 614009 615888 616913 617443","PMID:12578987
  AUTHORS   Cattaneo M, Zighetti ML, Lombardi R, Martinez C, Lecchi A, Conley PB, Ware J, Ruggeri ZM
  TITLE     Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding.
  JOURNAL   Proc Natl Acad Sci U S A 100:1978-83 (2003)
DOI:10.1073/pnas.0437879100

PMID:19552682
  AUTHORS   Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K
  TITLE     A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
  JOURNAL   J Thromb Haemost 7:1356-63 (2009)
DOI:10.1111/j.1538-7836.2009.03520.x

PMID:20162250
  AUTHORS   Watson S, Daly M, Dawood B, Gissen P, Makris M, Mundell S, Wilde J, Mumford A
  TITLE     Phenotypic approaches to gene mapping in platelet function disorders - identification of new variant of P2Y12, TxA2 and GPVI receptors.
  JOURNAL   Hamostaseologie 30:29-38 (2010)

PMID:24958846 (gene)
  AUTHORS   Canault M, Ghalloussi D, Grosdidier C, Guinier M, Perret C, Chelghoum N, Germain M, Raslova H, Peiretti F, Morange PE, Saut N, Pillois X, Nurden AT, Cambien F, Pierres A, van den Berg TK, Kuijpers TW, Alessi MC, Tregouet DA
  TITLE     Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.
  JOURNAL   J Exp Med 211:1349-62 (2014)
DOI:10.1084/jem.20130477

PMID:26280575 (gene)
  AUTHORS   Fletcher SJ, Johnson B, Lowe GC, Bem D, Drake S, Lordkipanidze M, Guiu IS, Dawood B, Rivera J, Simpson MA, Daly ME, Motwani J, Collins PW, Watson SP, Morgan NV
  TITLE     SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
  JOURNAL   J Clin Invest 125:3600-5 (2015)
DOI:10.1172/JCI80347

PMID:28255014 (gene)
  AUTHORS   Saultier P, Vidal L, Canault M, Bernot D, Falaise C, Pouymayou C, Bordet JC, Saut N, Rostan A, Baccini V, Peiretti F, Favier M, Lucca P, Deleuze JF, Olaso R, Boland A, Morange PE, Gachet C, Malergue F, Faure S, Eckly A, Tregouet DA, Poggi M, Alessi MC
  TITLE     Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features.
  JOURNAL   Haematologica 102:1006-1016 (2017)
DOI:10.3324/haematol.2016.153577

PMID:22133774 (gene)
  AUTHORS   Kunicki TJ, Williams SA, Diaz D, Farndale RW, Nugent DJ
  TITLE     Platelet adhesion to decorin but not collagen I correlates with the integrin alpha2 dimorphism E534K, the basis of the human platelet alloantigen (HPA)-5 system.
  JOURNAL   Haematologica 97:692-5 (2012)
DOI:10.3324/haematol.2011.056556",OMIM,609821,614200,614201,614009,615888,616913,617443,,,,,,,,,,,,,,,,,,,,,,,
H01287,Congenital mirror movements (CMM),"Mirror movements are involuntary movements of one side of the body that mirror intentional movements on the opposite side. While mirror movements are occasionally found in young children, persistence beyond the age of 10 is abnormal. Congenital mirror movements (CMM) is a rare disorder that is mainly inherited in an autosomal-dominant fashion. Mutations in DCC, the gene encoding receptor for netrin 1 have been identified in CMM patients. It has also been reported that RAD51 haploinsufficiency causes the heterogeneous CMM.",Nervous system disease,"DCC [HSA:1630] [KO:K06765]
RAD51A [HSA:5888] [KO:K04482]",,,,,,,OMIM: 157600 614508,"PMID:20431009
  AUTHORS   Srour M, Riviere JB, Pham JM, Dube MP, Girard S, Morin S, Dion PA, Asselin G, Rochefort D, Hince P, Diab S, Sharafaddinzadeh N, Chouinard S, Theoret H, Charron F, Rouleau GA
  TITLE     Mutations in DCC cause congenital mirror movements.
  JOURNAL   Science 328:592 (2010)
DOI:10.1126/science.1186463

PMID:22305526
  AUTHORS   Depienne C, Bouteiller D, Meneret A, Billot S, Groppa S, Klebe S, Charbonnier-Beaupel F, Corvol JC, Saraiva JP, Brueggemann N, Bhatia K, Cincotta M, Brochard V, Flamand-Roze C, Carpentier W, Meunier S, Marie Y, Gaussen M, Stevanin G, Wehrle R, Vidailhet M, Klein C, Dusart I, Brice A, Roze E
  TITLE     RAD51 haploinsufficiency causes congenital mirror movements in humans.
  JOURNAL   Am J Hum Genet 90:301-7 (2012)
DOI:10.1016/j.ajhg.2011.12.002",OMIM,157600,614508,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01903,Brown-Vialetto-Van Laere syndrome,Brown-Vialetto-Van Laere Syndrome (BVVLS) is a rare neurological disorder characterized by bulbar palsies and sensorineural deafness. BVVLS is mainly associated with defective riboflavin transporters encoded by the SLC52A2 and SLC52A3 genes. It has been suggested that riboflavin supplementation can ameliorate the progression of this neurodegenerative condition.,Neurodegenerative disease,"(BVVLS1) SLC52A3 [HSA:113278] [KO:K14620]
(BVVLS2) SLC52A2 [HSA:79581] [KO:K22117]",,,,,Riboflavin [DR:D01622 D01913],See also H00841 Infantile progressive bulbar palsy.,"ICD-10: G12.1
OMIM: 211530 614707","PMID:27702554 (gene)
  AUTHORS   Udhayabanu T, Subramanian VS, Teafatiller T, Gowda VK, Raghavan VS, Varalakshmi P, Said HM, Ashokkumar B
  TITLE     SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.
  JOURNAL   Clin Chim Acta 462:210-214 (2016)
DOI:10.1016/j.cca.2016.09.022

PMID:22864630 (gene)
  AUTHORS   Haack TB, Makowski C, Yao Y, Graf E, Hempel M, Wieland T, Tauer U, Ahting U, Mayr JA, Freisinger P, Yoshimatsu H, Inui K, Strom TM, Meitinger T, Yonezawa A, Prokisch H
  TITLE     Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome.
  JOURNAL   J Inherit Metab Dis 35:943-8 (2012)
DOI:10.1007/s10545-012-9513-y

PMID:24253200 (gene)
  AUTHORS   Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Zuchner S, Muntoni F, Houlden H
  TITLE     Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
  JOURNAL   Brain 137:44-56 (2014)
DOI:10.1093/brain/awt315",OMIM,211530,614707,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01488,"Hyperphosphatasia with mental retardation syndrome (HPMPS);
Mabry syndrome","Hyperphosphatasia with mental retardation syndrome (HPMRS), also known as Mabry syndrome, is an autosomal recessive disorder comprising intellectual disability and elevated levels of serum alkaline phosphatase, often accompanied by seizures, facial dysmorphism, and various anomalies such as brachytelephalangy. Mutation in different genes result in phenotypic variation.",Inherited metabolic disease,"(HPMRS1) PIGV [HSA:55650] [KO:K07542]
(HPMRS2) PIGO [HSA:84720] [KO:K05288]
(HPMRS3) PGAP2 [HSA:27315]
(HPMRS4) PGAP3 [HSA:93210]
(HPMRS5) PIGW [HSA:284098] [KO:K05283]
(HPMRS6) PIGY [HSA:84992] [KO:K11001]",,,,,,,OMIM: 239300 614749 614207 615716 616025 616809,"PMID:26879448 (description and gene)
  AUTHORS   Jezela-Stanek A, Ciara E, Piekutowska-Abramczuk D, Trubicka J, Jurkiewicz E, Rokicki D, Mierzewska H, Spychalska J, Uhrynowska M, Szwarc-Bronikowska M, Buda P, Said AR, Jamroz E, Rydzanicz M, Ploski R, Krajewska-Walasek M, Pronicka E
  TITLE     Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis--The phenotype of two patients with novel mutations in the PIGN and  PGAP2 genes.
  JOURNAL   Eur J Paediatr Neurol 20:462-73 (2016)
DOI:10.1016/j.ejpn.2016.01.007

PMID:21739589 (gene)
  AUTHORS   Horn D, Krawitz P, Mannhardt A, Korenke GC, Meinecke P
  TITLE     Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum.
  JOURNAL   Am J Med Genet A 155A:1917-22 (2011)
DOI:10.1002/ajmg.a.34102

PMID:22683086 (gene)
  AUTHORS   Krawitz PM, Murakami Y, Hecht J, Kruger U, Holder SE, Mortier GR, Delle Chiaie B, De Baere E, Thompson MD, Roscioli T, Kielbasa S, Kinoshita T, Mundlos S, Robinson PN, Horn D
  TITLE     Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
  JOURNAL   Am J Hum Genet 91:146-51 (2012)
DOI:10.1016/j.ajhg.2012.05.004

PMID:23561847 (gene)
  AUTHORS   Krawitz PM, Murakami Y, Riess A, Hietala M, Kruger U, Zhu N, Kinoshita T, Mundlos S, Hecht J, Robinson PN, Horn D
  TITLE     PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
  JOURNAL   Am J Hum Genet 92:584-9 (2013)
DOI:10.1016/j.ajhg.2013.03.011

PMID:24439110 (gene)
  AUTHORS   Howard MF, Murakami Y, Pagnamenta AT, Daumer-Haas C, Fischer B, Hecht J, Keays DA, Knight SJ, Kolsch U, Kruger U, Leiz S, Maeda Y, Mitchell D, Mundlos S, Phillips JA 3rd, Robinson PN, Kini U, Taylor JC, Horn D, Kinoshita T, Krawitz PM
  TITLE     Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.
  JOURNAL   Am J Hum Genet 94:278-87 (2014)
DOI:10.1016/j.ajhg.2013.12.012

PMID:24367057 (gene)
  AUTHORS   Chiyonobu T, Inoue N, Morimoto M, Kinoshita T, Murakami Y
  TITLE     Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome.
  JOURNAL   J Med Genet 51:203-7 (2014)
DOI:10.1136/jmedgenet-2013-102156

PMID:26293662 (gene)
  AUTHORS   Ilkovski B, Pagnamenta AT, O'Grady GL, Kinoshita T, Howard MF, Lek M, Thomas B, Turner A, Christodoulou J, Sillence D, Knight SJ, Popitsch N, Keays DA, Anzilotti C, Goriely A, Waddell LB, Brilot F, North KN, Kanzawa N, Macarthur DG, Taylor JC, Kini U, Murakami Y, Clarke NF
  TITLE     Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies.
  JOURNAL   Hum Mol Genet 24:6146-59 (2015)
DOI:10.1093/hmg/ddv331",OMIM,239300,614749,614207,615716,616025,616809,,,,,,,,,,,,,,,,,,,,,,,,
H01815,Malignant migrating partial seizures in infancy,"Malignant migrating partial seizures in infancy (MMPSI) are rare, severe early infantile onset epileptic encephalopathy. The common clinical features are seizure onset within the first 6 months of life, occurrence of migrating polymorphic focal seizures, and progressive deterioration of psychomotor development. Seizures in MMPSI are refractory to conventional treatment with anti-epileptic drugs (AEDs). Early and multiple video/EEG recordings are critical to detect the characteristic multifocal and asynchronous long lasting ictal discharges and are essential for MMPSI diagnosis. MMPSI is a genetically heterogeneous disorder with few known etiologies. Recently, mutations of several genes have been reported in sporadic cases of MMPSI.",Nervous system disease; Epilepsy,"PLCB1 [HSA:23236] [KO:K05858]
TBC1D24 [HSA:57465] [KO:K21841]
KCNT1 [HSA:57582] [KO:K04946]
SLC12A5 [HSA:57468] [KO:K14427]
SCN1A [HSA:6323] [KO:K04833]",,,,,,,"ICD-10: G40.1
OMIM: 613722  614959  615338  616645","PMID:22690784 (gene)
  AUTHORS   Poduri A, Chopra SS, Neilan EG, Elhosary PC, Kurian MA, Meyer E, Barry BJ, Khwaja OS, Salih MA, Stodberg T, Scheffer IE, Maher ER, Sahin M, Wu BL, Berry GT, Walsh CA, Picker J, Kothare SV
  TITLE     Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy.
  JOURNAL   Epilepsia 53:e146-50 (2012)
DOI:10.1111/j.1528-1167.2012.03538.x

PMID:23086397 (gene)
  AUTHORS   Barcia G, Fleming MR, Deligniere A, Gazula VR, Brown MR, Langouet M, Chen H, Kronengold J, Abhyankar A, Cilio R, Nitschke P, Kaminska A, Boddaert N, Casanova JL, Desguerre I, Munnich A, Dulac O, Kaczmarek LK, Colleaux L, Nabbout R
  TITLE     De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.
  JOURNAL   Nat Genet 44:1255-9 (2012)
DOI:10.1038/ng.2441

PMID:23526554 (gene)
  AUTHORS   Milh M, Falace A, Villeneuve N, Vanni N, Cacciagli P, Assereto S, Nabbout R, Benfenati F, Zara F, Chabrol B, Villard L, Fassio A
  TITLE     Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy.
  JOURNAL   Hum Mutat 34:869-72 (2013)
DOI:10.1002/humu.22318

PMID:26333769 (gene)
  AUTHORS   Stodberg T, McTague A, Ruiz AJ, Hirata H, Zhen J, Long P, Farabella I, Meyer E, Kawahara A, Vassallo G, Stivaros SM, Bjursell MK, Stranneheim H, Tigerschiold S, Persson B, Bangash I, Das K, Hughes D, Lesko N, Lundeberg J, Scott RC, Poduri A, Scheffer IE, Smith H, Gissen P, Schorge S, Reith ME, Topf M, Kullmann DM, Harvey RJ, Wedell A, Kurian MA
  TITLE     Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures.
  JOURNAL   Nat Commun 6:8038 (2015)
DOI:10.1038/ncomms9038",OMIM,613722,614959,615338,616645,,,,,,,,,,,,,,,,,,,,,,,,,,
H01489,"Inherited glycosylphosphatidylinositol (GPI) deficiencies, including:
PIGM-congenital disorder of glycosylation (PIGM-CDG) [DS:H01127] ;
Autosomal recessive mental retardation-42 (MRT42) [DS:H01485];
Multiple congential anomalies-hypotonia-seizures (MCAHS) syndrom [DS:H01486];
CHIME syndrome [DS:H01487];
Hyperphosphatasia with mental retardation syndrome (HPMRS) [DS:H01488]","Inherited glycosylphosphatidylinositol (GPI) deficiencies (IGD) are a group of glycosylation disorders, which result from mutation in genes involved in the biosynthesis of GPI anchors. Mutation in at least twelve have been identified, mostly related to autosomal recessive. Clinical phenotypes are variable, often include developmental delay, hyperphosphatasia, (neonatal) seizures, hypotonia, and neurological symptoms, growth abnormalities, and congenital abnormalities.",Inherited metabolic disease,"(PIGM-CDG) PIGM [HSA:93183] [KO:K05284]
(MRT42) PGAP1 [HSA:80055] [KO:K05294]
(MCAHS 1) PIGN [HSA:23556] [KO:K05285]
(MCAHS 2) PIGA [HSA:5277] [KO:K03857]
(MCAHS 3) PIGT [HSA:51604] [KO:K05292]
(CHIME) PIGL [HSA:9487] [KO:K03434]
(HPMRS1) PIGV [HSA:55650] [KO:K07542]
(HPMRS2) PIGO [HSA:84720] [KO:K05288]
(HPMRS3) PGAP2 [HSA:27315]
(HPMRS4) PGAP3 [HSA:93210]
(HPMRS5) PIGW [HSA:284098] [KO:K05283]
(HPMRS6) PIGY [HSA:84992] [KO:K11001]",,,,,,,OMIM: 610293 615802 614080 300868 615398 280000 239300 614749 614207 615716 616025 616809,"PMID:26879448 (description and gene)
  AUTHORS   Jezela-Stanek A, Ciara E, Piekutowska-Abramczuk D, Trubicka J, Jurkiewicz E, Rokicki D, Mierzewska H, Spychalska J, Uhrynowska M, Szwarc-Bronikowska M, Buda P, Said AR, Jamroz E, Rydzanicz M, Ploski R, Krajewska-Walasek M, Pronicka E
  TITLE     Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis--The phenotype of two patients with novel mutations in the PIGN and  PGAP2 genes.
  JOURNAL   Eur J Paediatr Neurol 20:462-73 (2016)
DOI:10.1016/j.ejpn.2016.01.007

PMID:24727937 (description and gene)
  AUTHORS   Kinoshita T
  TITLE     Biosynthesis and deficiencies of glycosylphosphatidylinositol.
  JOURNAL   Proc Jpn Acad Ser B Phys Biol Sci 90:130-43 (2014)
DOI:10.2183/pjab.90.130

PMID:24784135 (description and gene)
  AUTHORS   Murakami Y, Tawamie H, Maeda Y, Buttner C, Buchert R, Radwan F, Schaffer S, Sticht H, Aigner M, Reis A, Kinoshita T, Jamra RA
  TITLE     Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy.
  JOURNAL   PLoS Genet 10:e1004320 (2014)
DOI:10.1371/journal.pgen.1004320",OMIM,610293,615802,614080,300868,615398,280000,239300,614749,614207,615716,616025,616809,,,,,,,,,,,,,,,,,,
H01880,Autosomal recessive microcephaly and chorioretinopathy,"Autosomal-recessive microcephaly and chorioretinopathy (MCCRP) is a rare developmental disorder characterized by primary microcephaly, delayed psychomotor development, growth retardation with dwarfism, and visual impairment. In MCCRP, microcephaly ranges from mild to severe and has variable impact on cognitive performance, ranging from moderate developmental delay to normal intelligence. The features of the visual impairment in MCCRP patients are variable, but the chorioretinopathy is a constant feature and includes typical punched-out lesions that can severely impair vision and occasional retinal folds that can progress to retinal detachment. To date, three responsible genes have been described.",Musculoskeletal disease; Nervous system disease; Eye disease; Developmental disorder,"(MCCRP1) TUBGCP6 [HSA:85378] [KO:K16573]
(MCCRP2) PLK4 [HSA:10733] [KO:K08863]
(MCCRP3) TUBGCP4 [HSA:27229] [KO:K16571]",,,,,,,"ICD-10: Q87.8
OMIM: 251270 616171 616335","PMID:5936364
  AUTHORS   McKusick VA, Stauffer M, Knox DL, Clark DB
  TITLE     Chorioretinopathy with hereditary microcephaly.
  JOURNAL   Arch Ophthalmol 75:597-600 (1966)
DOI:10.1001/archopht.1966.00970050599003

PMID:25817018 (description, gene)
  AUTHORS   Scheidecker S, Etard C, Haren L, Stoetzel C, Hull S, Arno G, Plagnol V, Drunat S, Passemard S, Toutain A, Obringer C, Koob M, Geoffroy V, Marion V, Strahle U, Ostergaard P, Verloes A, Merdes A, Moore AT, Dollfus H
  TITLE     Mutations in TUBGCP4 alter microtubule organization via the gamma-tubulin ring complex in autosomal-recessive microcephaly with chorioretinopathy.
  JOURNAL   Am J Hum Genet 96:666-74 (2015)
DOI:10.1016/j.ajhg.2015.02.011

PMID:27650967 (description)
  AUTHORS   Tsutsumi M, Yokoi S, Miya F, Miyata M, Kato M, Okamoto N, Tsunoda T, Yamasaki M, Kanemura Y, Kosaki K, Saitoh S, Kurahashi H
  TITLE     Novel compound heterozygous variants in PLK4 identified in a patient with autosomal recessive microcephaly and chorioretinopathy.
  JOURNAL   Eur J Hum Genet 24:1702-1706 (2016)
DOI:10.1038/ejhg.2016.119

PMID:22279524 (gene)
  AUTHORS   Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA
  TITLE     Genetic mapping and exome sequencing identify variants associated with five novel diseases.
  JOURNAL   PLoS One 7:e28936 (2012)
DOI:10.1371/journal.pone.0028936

PMID:25344692 (gene)
  AUTHORS   Martin CA, Ahmad I, Klingseisen A, Hussain MS, Bicknell LS, Leitch A, Nurnberg G, Toliat MR, Murray JE, Hunt D, Khan F, Ali Z, Tinschert S, Ding J, Keith C, Harley ME, Heyn P, Muller R, Hoffmann I, Daire VC, Dollfus H, Dupuis L, Bashamboo A, McElreavey K, Kariminejad A, Mendoza-Londono R, Moore AT, Saggar A, Schlechter C, Weleber R, Thiele H, Altmuller J, Hohne W, Hurles ME, Noegel AA, Baig SM, Nurnberg P, Jackson AP
  TITLE     Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy.
  JOURNAL   Nat Genet 46:1283-92 (2014)
DOI:10.1038/ng.3122

PMID:25320347 (gene)
  AUTHORS   Shaheen R, Al Tala S, Almoisheer A, Alkuraya FS
  TITLE     Mutation in PLK4, encoding a master regulator of centriole formation, defines a novel locus for primordial dwarfism.
  JOURNAL   J Med Genet 51:814-6 (2014)
DOI:10.1136/jmedgenet-2014-102790",OMIM,251270,616171,616335,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01923,"Microcephaly, short stature, and impaired glucose metabolism","Microcephaly, short stature, and impaired glucose metabolism (MSSGM) is a new syndrome of young onset diabetes, short stature and microcephaly with intellectual disability. The causal nonsense mutation in tRNA methyltransferase gene TRMT10A has been identified. TRMT10A is ubiquitously expressed but enriched in brain and pancreatic islets, consistent with the tissues affected in this syndrome. It has also been reported that mutation in the eukaryotic translation initiation factor 2 alpha (eIF2a) phosphatase gene, PPP1R15B, is associated with these symptoms.",Developmental disorder; Inherited metabolic disease,"(MSSGM1) TRMT10A [HSA:93587] [KO:K15445]
(MSSGM2) PPP1R15B [HSA:84919] [KO:K17558]",,,,,,"Wolcott-Rallison syndrome (H00766) is also characterized by microcephaly, short stature, and early-onset diabetes mellitus. 
See also H00269 Primary microcephaly (MCPH).","ICD-10: Q87.8
OMIM: 616033 616817","PMID:24204302 (gene)
  AUTHORS   Igoillo-Esteve M, Genin A, Lambert N, Desir J, Pirson I, Abdulkarim B, Simonis N, Drielsma A, Marselli L, Marchetti P, Vanderhaeghen P, Eizirik DL, Wuyts W, Julier C, Chakera AJ, Ellard S, Hattersley AT, Abramowicz M, Cnop M
  TITLE     tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans.
  JOURNAL   PLoS Genet 9:e1003888 (2013)
DOI:10.1371/journal.pgen.1003888

PMID:26307080 (gene)
  AUTHORS   Kernohan KD, Tetreault M, Liwak-Muir U, Geraghty MT, Qin W, Venkateswaran S, Davila J, Holcik M, Majewski J, Richer J, Boycott KM
  TITLE     Homozygous mutation in the eukaryotic translation initiation factor 2alpha phosphatase gene, PPP1R15B, is associated with severe microcephaly, short stature and intellectual disability.
  JOURNAL   Hum Mol Genet 24:6293-300 (2015)
DOI:10.1093/hmg/ddv337",OMIM,616033,616817,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01900,Encephalopathy due to defective mitochondrial and peroxisomal fission,"Encephalopathy due to defective mitochondrial and peroxisomal fission (EMPF) is a very rare lethal disorder characterized by cerebral dysgenesis, hypotonia, seizures, lactic acidosis, elevated very long chain fatty acids, and abnormally elongated mitochondria and peroxisomes. It has been described that patients have mutations in DNM1L gene, which has a critical role in regulating the fission of both mitochondria and peroxisomes. Recently, it has been reported that mutations in mitochondrial fission factor (MFF) also cause Leigh-like encephalopathy, optic atrophy and peripheral neuropathy.",Inherited metabolic disease; Nervous system disease; Mitochondrial disease,"DNM1L [HSA:10059] [KO:K17065]
MFF [HSA:56947] [KO:K22076]",,,,"Lactic acidosis
Elevated very long chain fatty acids",,See also H01354 Leigh syndrome.,"ICD-10: G31.8
OMIM: 614388 617086","PMID:26992161 (gene)
  AUTHORS   Sheffer R, Douiev L, Edvardson S, Shaag A, Tamimi K, Soiferman D, Meiner V, Saada A
  TITLE     Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1L mutation causing impaired mitochondrial fission and function.
  JOURNAL   Am J Med Genet A 170:1603-7 (2016)
DOI:10.1002/ajmg.a.37624

PMID:26825290 (gene)
  AUTHORS   Yoon G, Malam Z, Paton T, Marshall CR, Hyatt E, Ivakine Z, Scherer SW, Lee KS, Hawkins C, Cohn RD
  TITLE     Lethal Disorder of Mitochondrial Fission Caused by Mutations in DNM1L.
  JOURNAL   J Pediatr 171:313-6.e1-2 (2016)
DOI:10.1016/j.jpeds.2015.12.060

PMID:26783368 (gene)
  AUTHORS   Koch J, Feichtinger RG, Freisinger P, Pies M, Schrodl F, Iuso A, Sperl W, Mayr JA, Prokisch H, Haack TB
  TITLE     Disturbed mitochondrial and peroxisomal dynamics due to loss of MFF causes Leigh-like encephalopathy, optic atrophy and peripheral neuropathy.
  JOURNAL   J Med Genet 53:270-8 (2016)
DOI:10.1136/jmedgenet-2015-103500",OMIM,614388,617086,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01879,"Wiedemann-Steiner syndrome;
Alazami-Yuan syndrome","Wiedemann-Steiner Syndrome (WDSTS) is a rare autosomal dominant disorder characterized by hairy elbows, dysmorphic facial appearances (hypertelorism, thick eyebrows, downslanted and vertically narrow palpebral fissures), pre- and post-natal growth deficiency, and psychomotor delay. Sharing clinical features with Cornelia de Lange syndrome, WDSTS is another heterogeneous disease. WDSTS is caused by heterozygous mutations in KMT2A, also known as MLL. KMT2A encodes a histone methyltransferase that plays an important role in early development and hematopoiesis. Recently, an autosomal-recessive disorder with Cornelia de Lange syndrome-like features has been reported and termed Alazami-Yuan syndrome. It is caused by homozygous mutations in TAF6, which encodes a core transcriptional regulatory pathway component.",Developmental disorder; Skeletal dysplasia,"KMT2A [HSA:4297] [KO:K09186]
TAF6 [HSA:6878] [KO:K03131]",,,,,,,"ICD-10: Q87.1
OMIM: 605130 617126","PMID:25810209 (gene)
  AUTHORS   Miyake N, Tsurusaki Y, Koshimizu E, Okamoto N, Kosho T, Brown NJ, Tan TY, Yap PJ, Suzumura H, Tanaka T, Nagai T, Nakashima M, Saitsu H, Niikawa N, Matsumoto N
  TITLE     Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations.
  JOURNAL   Clin Genet 89:115-9 (2016)
DOI:10.1111/cge.12586

PMID:28359930
  AUTHORS   Aggarwal A, Rodriguez-Buritica DF, Northrup H
  TITLE     Wiedemann-Steiner syndrome: Novel pathogenic variant and review of literature.
  JOURNAL   Eur J Med Genet 60:285-288 (2017)
DOI:10.1016/j.ejmg.2017.03.006

PMID:25574841 (gene)
  AUTHORS   Yuan B, Pehlivan D, Karaca E, Patel N, Charng WL, Gambin T, Gonzaga-Jauregui C, Sutton VR, Yesil G, Bozdogan ST, Tos T, Koparir A, Koparir E, Beck CR, Gu S, Aslan H, Yuregir OO, Al Rubeaan K, Alnaqeb D, Alshammari MJ, Bayram Y, Atik MM, Aydin H, Geckinli BB, Seven M, Ulucan H, Fenercioglu E, Ozen M, Jhangiani S, Muzny DM, Boerwinkle E, Tuysuz B, Alkuraya FS, Gibbs RA, Lupski JR
  TITLE     Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes.
  JOURNAL   J Clin Invest 125:636-51 (2015)
DOI:10.1172/JCI77435",OMIM,605130,617126,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00340,Vancomycin-resistant enterococci infection,"Enterococci are gram-positive, facultative bacteria with low intrinsic virulence that constitute the normal colonizing flora of the human gastrointestinal tract. Vancomycin-resistant enterococci (VRE) have emerged as major hospital-acquired antimicrobial-resistant pathogens globally, causing bacteremia with or without endocarditis, and intra-abdominal, wound, and genitourinary infection in immunocompromised patients. The mortality rate is high.",Infectious disease,,"  Enterococcus faecalis [GN:efa]
Enterococcus faecium [GN:efc]
Enterococcus gallinarum",,,,"Ampicillin [DG:DG00517]
Ampicillin sodium-sulbactam sodium mixt [DR:D02065]
Teicoplanin [DR:D02142]
Doxycycline [DG:DG00008]
Novobiocin sodium [DR:D01209]
Bacitracin [DG:DG00400]
Nitrofurantoin [DR:D00439] (UTI)
Quinupristin-dalfopristin mixt [DR:D00854]
Linezolid [DR:D00947]",,ICD-10: A41.4A A49.8A J15.8A,"PMID:11827558 (drug)
  AUTHORS   Linden PK
  TITLE     Treatment options for vancomycin-resistant enterococcal infections.
  JOURNAL   Drugs 62:425-41 (2002)
DOI:10.2165/00003495-200262030-00002",ICD-10,A41.4A,A49.8A,J15.8A,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01454,Colonic spirochetosis,"Colonic spirochetosis (CS) is a disease caused by the Brachyspira genus, Brachyspira aalborgi and Brachyspira pilosicoli. B. pilosicoli induces disease in both humans and animals, whereas B. aalborgi affects only humans and higher primates. CS is a polymicrobial disease characterized by persistent intimate mucosal epithelial cell attachment of spirochetes alone or together with certain enterohepatic Helicobacter species. Symptoms in humans include diarrhea, rectal bleeding, and abdominal cramps.",Infectious disease,,  Brachyspira pilosicoli [GN:bpip],,,,,,ICD-10: A04.9 A69.9,"PMID:16013401 (description)
  AUTHORS   Smith JL
  TITLE     Colonic spirochetosis in animals and humans.
  JOURNAL   J Food Prot 68:1525-34 (2005)
DOI:10.4315/0362-028X-68.7.1525

PMID:23469345 (pathogen)
  AUTHORS   Lin C, den Bakker HC, Suzuki H, Lefebure T, Ponnala L, Sun Q, Stanhope MJ, Wiedmann M, Duhamel GE
  TITLE     Complete Genome Sequence of the Porcine Strain Brachyspira pilosicoli P43/6/78(T.).
  JOURNAL   Genome Announc 1:e00215-12 (2013)
DOI:10.1128/genomeA.00215-12",ICD-10,A04.9,A69.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00406,Acquired immunodeficiency syndrome (AIDS),"Since the discovery in 1980s, HIV/AIDS has become the most important infectious disease globally. Many of the clinical features of HIV/AIDS can be ascribed to the profound immune deficiency in patients. HIV infection also increases the risk of autoimmune diseases and malignancies such as non-Hodgkin's lymphoma and Kaposi's sarcoma.",Infectious disease; Immune system disease,,"  Human immunodeficiency virus 1 (HIV-1) [GN:T40001]
Human immunodeficiency virus 2 (HIV-2) [GN:T40002]",,,,,,ICD-10: B20 B21 B22 B23 B24,"PMID:22303636
  AUTHORS   Duesberg PH, Mandrioli D, McCormack A, Nicholson JM, Rasnick D, Fiala C, Koehnlein C, Bauer HH, Ruggiero M
  TITLE     AIDS since 1984: no evidence for a new, viral epidemic--not even in Africa.
  JOURNAL   Ital J Anat Embryol 116:73-92 (2011)
DOI:10.13128/IJAE-10336",ICD-10,B20,B21,B22,B23,B24,,,,,,,,,,,,,,,,,,,,,,,,,
H01410,Anaerobic infection,"Anaerobic infections are common and some are serious with a high mortality rate. The clinically important anaerobes are several genera of Gram-negative rods (Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Bilophila). Among the Gram-positive anaerobes, there are cocci (primarily Peptostreptococcus) and sporeforming (Clostridium) and non-sporeforming bacilli (especially Actinomyces and Propionibacterium). In terms of frequency, there are four major sites of anaerobic infection - pleuropulmonary, intra-abdominal, female genital tract, and skin and soft tissue infections (with or without involvement of underlying bone). Infectious diseases caused by these anaerobes include following symptoms, bacteremia, brain abscess, neck space infections and infections following head and neck surgery, chronic sinusitis and otitis media, dental and oral infections, pleuropulmonary infections, intra-abdominal infections, female genital tract infections, non-puerperal breast abscesses and diabetic foot ulcers.",Infectious disease,,"  Clostridium perfringens [GN:cpe cpf cpr]
Clostridium botulinum [GN:cbo cba cbh cby cbl cbk cbb cbi cbt cbf cbj ctc]
Peptoclostridium difficile [GN:cdf pdc cdc cdl cdg] 
Finegoldia magna [GN:fma]
Propionibacterium acnes [GN:pac paw pad]
Fusobacterium nucleatum [GN:fnu]
Bacteroides fragilis  [GN:bfr bfs]
Porphyromonas gingivalis [GN:pgi pgn pgt]
Parabacteroides distasonis [GN:pdi]
Eggerthella lenta [GN:ele]",,,,,"Infectious disease caused by Bacteroides spp., Prevotella spp., Porphyromonas spp., Porphyromonas spp., Fusobacterium spp., Peptostreptococcus spp., Clostridium spp., Bilophila spp. and Actinomyces spp..",ICD-10: A49 B96,"PMID:16887500 (description)
  AUTHORS   Finegold SM
  TITLE     Anaerobic infections in humans: an overview.
  JOURNAL   Anaerobe 1:3-9 (1995)
DOI:10.1016/S1075-9964(95)80340-8

PMID:18263572 (description)
  AUTHORS   Goto T, Yamashita A, Hirakawa H, Matsutani M, Todo K, Ohshima K, Toh H, Miyamoto K, Kuhara S, Hattori M, Shimizu T, Akimoto S.
  TITLE     Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen.
  JOURNAL   DNA Res 15:39-47 (2008)
DOI:10.1093/dnares/dsm030",ICD-10,A49,B96,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00752,Ankyloblepharon-ctodermal defects-cleft lip/palate (AEC) syndrome and Rapp-Hodgkin syndrome,"Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (also known as Hay-Wells syndrome) and Rapp-Hodgkin syndrome are rare ectodermal dysplasias characterized by ankyloblepharon filiforme adnatum and cleft lip/palate. Ectodermal findings include hair, nail, teeth and sweat gland dystrophies.",Developmental disorder,TP63 [HSA:8626] [KO:K10149],,,,,,,"ICD-10: Q87.8
MeSH: C535847 C535289
OMIM: 106260 129400","PMID:20556892 (descritpion, gene)
  AUTHORS   Sutton VR, Bree AF, van Bokhoven H
  TITLE     Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome
  JOURNAL   GeneReviews (1993)

PMID:20491771 (descritpion, gene)
  AUTHORS   Clements SE, Techanukul T, Holden ST, Mellerio JE, Dorkins H, Escande F, McGrath JA
  TITLE     Rapp-Hodgkin and Hay-Wells ectodermal dysplasia syndromes represent a variable spectrum of the same genetic disorder.
  JOURNAL   Br J Dermatol 163:624-9 (2010)
DOI:10.1111/j.1365-2133.2010.09859.x

PMID:19953814 (descritpion)
  AUTHORS   Tosun G, Elbay U
  TITLE     Rapp-Hodgkin syndrome: clinical and dental findings.
  JOURNAL   J Clin Pediatr Dent 34:71-5 (2009)
DOI:10.17796/jcpd.34.1.kr015833p1qg6873",MeSH,C535847,C535289,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00181,"3-Methylcrotonylglycinuria;
3-Methylcrotonyl-CoA carboxylase deficiency",3-Methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine catabolism with a variable phenotype.,Inherited metabolic disease,"MCCC1; 3-methylcrotonyl-CoA carboxylase alpha subunit [HSA:56922] [KO:K01968]
MCCC2; 3-methylcrotonyl-CoA carboxylase beta subunit [HSA:64087] [KO:K01969]",,,,"3-Methylcrotonylglycine [CPD:C20828]
3-Hydroxyisovaleric acid [CPD:C20827]",,,"ICD-10: E71.1
MeSH: C535308 C535309
OMIM: 210200 210210","PMID:16010683
  AUTHORS   Dantas MF, Suormala T, Randolph A, Coelho D, Fowler B, Valle D, Baumgartner MR
  TITLE     3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening.
  JOURNAL   Hum Mutat 26:164 (2005)
DOI:10.1002/humu.9352

PMID:15868465
  AUTHORS   Baumgartner MR
  TITLE     Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency.
  JOURNAL   J Inherit Metab Dis 28:301-9 (2005)
DOI:10.1007/s10545-005-7054-3

PMID:11181649
  AUTHORS   Baumgartner MR, Almashanu S, Suormala T, Obie C, Cole RN, Packman S, Baumgartner ER, Valle D
  TITLE     The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency.
  JOURNAL   J Clin Invest 107:495-504 (2001)
DOI:10.1172/JCI11948",MeSH,C535308,C535309,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01341,"Collagen VI myopathy, including:
Ullrich congenital muscular dystrophy (UCMD) [DS:H01778];
Bethlem myopathy [DS:H01340];
Myosclerosis [DS:H01338]","Collagen VI-related myopathy include severe Ullrich congenital muscular dystrophy (UCMD) and milder Bethlem myopathy. Mutations in each of the three collagen VI genes COL6A1, COL6A2, and COL6A3 cause these diseases. Recently, an additional phenotypes, autosomal recessive myosclerosis with mutations in COL6A2 have been reported. Collagen VI is an important component of the extracellular matrix which forms a microfibrillar network that is found in close association with the cell and surrounding basement membrane. Thus, collagen VI mutations result in disorders with combined muscle and connective tissue involvement, including weakness, joint and contractures, and abnormal skin findings.",Musculoskeletal disease; Nervous system disease,"COL6A1 [HSA:1291] [KO:K06238]
COL6A2 [HSA:1292] [KO:K06238]
COL6A3 [HSA:1293] [KO:K06238]",,,,,,,"ICD-10: G71.8
MeSH: C537521 C535436 C564968
OMIM: 254090 158810 255600","PMID:18852439
  AUTHORS   Merlini L, Martoni E, Grumati P, Sabatelli P, Squarzoni S, Urciuolo A, Ferlini A, Gualandi F, Bonaldo P
  TITLE     Autosomal recessive myosclerosis myopathy is a collagen VI disorder.
  JOURNAL   Neurology 71:1245-53 (2008)
DOI:10.1212/01.wnl.0000327611.01687.5e

PMID:20301676
  AUTHORS   Lampe AK, Flanigan KM, Bushby KM, Hicks D
  TITLE     Collagen Type VI-Related Disorders
  JOURNAL   GeneReviews (1993)",MeSH,C537521,C535436,C564968,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00628,"Congenital bile acid synthesis defect (CBAS), including:
3-beta-hydroxy-delta-5-C27-steroid oxidoreductase deficiency (CBAS1);
Delta(4)-3-oxosteroid 5-beta-reductase deficiency (CBAS2);
Oxysterol 7-alpha-hydroxylase deficiency (CBAS3);
Alpha-methylacyl-CoA racemase deficiency (CBAS4)","Congenital bile acid synthesis defects (CBAS) involve congenital deficiencies in enzymes responsible for catalyzing key reactions in bile acid synthesis. CBAS type 1, 2 ,3  and 4 are due to mutations in HSD3B7, AKR1D1, CYP7B1, and AMACR, respectively. Inherited mutations that impair bile acid synthesis cause a spectrum of human disease ranging from liver failure in early childhood to progressive neuropathy in adults.",Inherited metabolic disease; Liver disease,"(CBAS1) HSD3B7 [HSA:80270] [KO:K12408]
(CBAS2) AKR1D1 [HSA:6718] [KO:K00251]
(CBAS3) CYP7B1 [HSA:9420] [KO:K07430]
(CBAS4) AMACR [HSA:23600] [KO:K01796]
(CBAS5) ABCD3 [HSA:5825] [KO:K05677]",,,,"(Common) Low level or absence of primary bile acids [CPD:C02528] [CPD:C00695]
(CBAS1) Elevated monohydroxy bile acids
(CBAS2) Elevated 3-oxo-delta4 bile acids and allo bile acids
(CBAS3) Elevated dihydroxy and trihydroxy bile acids
(CBAS4) Elevated C27 trihydroxycholestanoic and pristanic acid",Chenodeoxycholic acid [DR:D00163],Cerebrotendinous xanthomatosis [DS:H00151] and Zellweger syndrome [DS:H00205] are also involved disorders in bile acid synthesis.,"ICD-10: K76.8
MeSH: C535442 C535443 C566340 C535444 C563673 C567703
OMIM: 607765 235555 613812 214950 213700 616278","PMID:18577977
  AUTHORS   Sundaram SS, Bove KE, Lovell MA, Sokol RJ
  TITLE     Mechanisms of disease: Inborn errors of bile acid synthesis.
  JOURNAL   Nat Clin Pract Gastroenterol Hepatol 5:456-68 (2008)
DOI:10.1038/ncpgasthep1179

PMID:15937079
  AUTHORS   van Mil SW, Houwen RH, Klomp LW
  TITLE     Genetics of familial intrahepatic cholestasis syndromes.
  JOURNAL   J Med Genet 42:449-63 (2005)
DOI:10.1136/jmg.2004.026187

PMID:25168382 (gene)
  AUTHORS   Ferdinandusse S, Jimenez-Sanchez G, Koster J, Denis S, Van Roermund CW, Silva-Zolezzi I, Moser AB, Visser WF, Gulluoglu M, Durmaz O, Demirkol M, Waterham HR, Gokcay G, Wanders RJ, Valle D
  TITLE     A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.
  JOURNAL   Hum Mol Genet 24:361-70 (2015)
DOI:10.1093/hmg/ddu448",MeSH,C535442,C535443,C566340,C535444,C563673,C567703,,,,,,,,,,,,,,,,,,,,,,,,
H00955,"Granular corneal dystrophies (GCD), including:
Corneal dystrophy Groenouw type I;
Avellino corneal dystrophy;
Granular-lattice dystrophy","Granular dystrophy (GCD), inherited in an autosomal dominant fasion, is one of the most common corneal dystrophies characterized by the deposition of gray-white crumb like opacities in the anterior stroma that slowly increase in number and progress into deeper parts of the cornea. The disease is typically asymptomatic, but can present with pain from recurrent erosions and decreased vision. Opacities in granular dystrophy are composed of eosinophilic hyaline deposits. Differences in the clinical appearance of the discrete corneal opacities permit to divide into types of GCD; Type I classic form of GCD, type II Avellino or granular-lattice type, and type III Reis-Bucklers type. GCD has been linked to several mutations in TGFBI gene.",Eye disease,TGFBI [HSA:7045] [KO:K19519],,,,,,"In regard to Granular corneal dystrophy (GCD) type III, see also [DS:H00951].","ICD-10: H18.5
MeSH: C537304 C535474
OMIM: 121900 607541 608470","PMID:19236704 (description, gene)
  AUTHORS   Klintworth GK
  TITLE     Corneal dystrophies.
  JOURNAL   Orphanet J Rare Dis 4:7 (2009)
DOI:10.1186/1750-1172-4-7

PMID:18214787 (description, gene)
  AUTHORS   Poulaki V, Colby K
  TITLE     Genetics of anterior and stromal corneal dystrophies.
  JOURNAL   Semin Ophthalmol 23:9-17 (2008)
DOI:10.1080/08820530701745173

PMID:16900028 (description, gene)
  AUTHORS   Pieramici SF, Afshari NA
  TITLE     Genetics of corneal dystrophies: the evolving landscape.
  JOURNAL   Curr Opin Ophthalmol 17:361-6 (2006)
DOI:10.1097/01.icu.0000233955.94347.84",MeSH,C537304,C535474,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00476,Multiple epiphyseal dysplasia (MED),"Multiple epiphyseal dysplasia (MED) is a genetically heterogeneous condition where ossification of epiphyses is delayed. Mutations causing MED have been identified in COMP, DTDST, MATN3, COL9A1, COL9A2, and COL9A3.",Skeletal dysplasia,"(EDM1) COMP [HSA:1311] [KO:K04659]
(EDM2) COL9A2 [HSA:1298] [KO:K08131]
(EDM3) COL9A3 [HSA:1299] [KO:K08131]
(EDM4) DTDST [HSA:1836] [KO:K14701]
(EDM5) MATN3 [HSA:4148] [KO:K19467]
(EDM6) COL9A1 [HSA:1297] [KO:K08131]",,,,,,,"MeSH: C535501 C535502 C535503 C535504 C535505
OMIM: 132400 600204 600969 226900 607078 614135","PMID:18328978 (description, gene)
  AUTHORS   Unger S, Bonafe L, Superti-Furga A
  TITLE     Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis.
  JOURNAL   Best Pract Res Clin Rheumatol 22:19-32 (2008)
DOI:10.1016/j.berh.2007.11.009

PMID:12687890 (description, gene)
  AUTHORS   Chapman KL, Briggs MD, Mortier GR
  TITLE     Review: clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia.
  JOURNAL   Pediatr Pathol Mol Med 22:53-75 (2003)

PMID:11891674 (description, gene)
  AUTHORS   Unger S, Hecht JT
  TITLE     Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments.
  JOURNAL   Am J Med Genet 106:244-50 (2001)
DOI:10.1002/ajmg.10234

PMID:11565064 (gene)
  AUTHORS   Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perala M, Carter L, Spector TD, Kolodziej L, Seppanen U, Glazar R, Krolewski J, Latos-Bielenska A, Ala-Kokko L
  TITLE     A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.
  JOURNAL   Am J Hum Genet 69:969-80 (2001)
DOI:10.1086/324023",MeSH,C535501,C535502,C535503,C535504,C535505,,,,,,,,,,,,,,,,,,,,,,,,,
H01868,"Mitral valve prolapse, including:
Familial mitral valve prolapse;
X-linked myxomatous valvular dystrophy","Mitral valve prolapse (MVP) is a very common clinical condition that refers to a systolic billowing of one or both mitral valve leaflets into the left atrium. MVP can be associated with significant mitral regurgitation (MR), bacterial endocarditis, congestive heart failure, and even sudden death. According to the presently used echocardiographic criteria, MVP is defined as an upward displacement of the mitral leaflets that exceeds 2 mm during diastole. In classical MVP, the leaflets' maximal thickness is >5 mm, whereas in non-classical MVP it remains <5 mm. MVP may or may not have associated mitral regurgitation. MVP can be distinguished into primary or nonsyndromic MVP and secondary or syndromic MVP. In the latter case, MVP occurs in the presence of connective tissue disorders such as Marfan syndrome (MFS) [DS:H00653], Loeys-Dietz syndrome [DS:H00800], Ehlers-Danlos syndrome [DS:H00802], and osteogenesis imperfecta [DS:H00506]. Nonsyndromic MVP can be sporadic or familial, demonstrating autosomal dominant and X-linked inheritance. Three different loci on chromosomes 16, 11 and 13 have been found to be linked to MVP. Another locus on chromosome X has been found to cosegregate with a rare form of MVP called X-linked myxomatous valvular dystrophy.",Cardiovascular disease,"(MVP2) DCHS1 [HSA:8642] [KO:K16507]
(XMVD) FLNA [HSA:2316] [KO:K04437]",,,,,,,"ICD-10: I34.1 Q24.8
MeSH: D008945 C535576
OMIM: 607829 314400","PMID:24867995 (description)
  AUTHORS   Delling FN, Vasan RS
  TITLE     Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.
  JOURNAL   Circulation 129:2158-70 (2014)
DOI:10.1161/CIRCULATIONAHA.113.006702

PMID:17850623 (description)
  AUTHORS   Grau JB, Pirelli L, Yu PJ, Galloway AC, Ostrer H
  TITLE     The genetics of mitral valve prolapse.
  JOURNAL   Clin Genet 72:288-95 (2007)
DOI:10.1111/j.1399-0004.2007.00865.x

PMID:10387935 (description)
  AUTHORS   Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ
  TITLE     Prevalence and clinical outcome of mitral-valve prolapse.
  JOURNAL   N Engl J Med 341:1-7 (1999)
DOI:10.1056/NEJM199907013410101

PMID:26258302 (gene)
  AUTHORS   Durst R, Sauls K, Peal DS, deVlaming A, Toomer K, Leyne M, Salani M, Talkowski ME, Brand H, Perrocheau M, Simpson C, Jett C, Stone MR, Charles F, Chiang C, Lynch SN, Bouatia-Naji N, Delling FN, Freed LA, Tribouilloy C, Le Tourneau T, LeMarec H, Fernandez-Friera L, Solis J, Trujillano D, Ossowski S, Estivill X, Dina C, Bruneval P, Chester A, Schott JJ, Irvine KD, Mao Y, Wessels A, Motiwala T, Puceat M, Tsukasaki Y, Menick DR, Kasiganesan H, Nie X, Broome AM, Williams K, Johnson A, Markwald RR, Jeunemaitre X, Hagege A, Levine RA, Milan DJ, Norris RA, Slaugenhaupt SA
  TITLE     Mutations in DCHS1 cause mitral valve prolapse.
  JOURNAL   Nature 525:109-13 (2015)
DOI:10.1038/nature14670

PMID:17190868 (gene)
  AUTHORS   Kyndt F, Gueffet JP, Probst V, Jaafar P, Legendre A, Le Bouffant F, Toquet C, Roy E, McGregor L, Lynch SA, Newbury-Ecob R, Tran V, Young I, Trochu JN, Le Marec H, Schott JJ
  TITLE     Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy.
  JOURNAL   Circulation 115:40-9 (2007)
DOI:10.1161/CIRCULATIONAHA.106.622621",MeSH,D008945,C535576,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01404,"Punctate palmoplantar keratoderma (PPKP), including:
Brauer-Buschke-Fischer disease;
Porokeratosis punctata palmaris et plantaris;
Acrokeratoelastoidosis","Punctate palmoplantar keratodermas (PPKPs) are rare autosomal-dominant inherited skin diseases that are characterized by multiple hyperkeratotic plaques distributed on the palms and soles. PPKPs are classified into 3 types; PPKP1 (Brauer-Buschke-Fischer disease), PPKP2 (porokeratosis punctata palmaris et plantaris), and PPKP3 (Acrokeratoelastoidosis lichenoides). PPKP has previously been mapped to chromosomal region 15q22-15q24 and region 8q24.13-8q24.21, but the molecular basis has not been identified yet. Recently, it has been reported that nonsense mutations in AAGAB gene cause PPKP1.",Skin and connective tissue disease,"(PPKP1A) AAGAB [HSA:79719]
(PPKP1B) COL14A1 [HSA:7373] [KO:K08133]",,,,,,,"ICD-10: Q82.8
MeSH: C536161 C535653
OMIM: 148600 614936 175860 101850","PMID:23000146
  AUTHORS   Giehl KA, Eckstein GN, Pasternack SM, Praetzel-Wunder S, Ruzicka T, Lichtner P, Seidl K, Rogers M, Graf E, Langbein L, Braun-Falco M, Betz RC, Strom TM
  TITLE     Nonsense mutations in AAGAB cause punctate palmoplantar keratoderma type Buschke-Fischer-Brauer.
  JOURNAL   Am J Hum Genet 91:754-9 (2012)
DOI:10.1016/j.ajhg.2012.08.024

PMID:23064416
  AUTHORS   Pohler E, Mamai O, Hirst J, Zamiri M, Horn H, Nomura T, Irvine AD, Moran B, Wilson NJ, Smith FJ, Goh CS, Sandilands A, Cole C, Barton GJ, Evans AT, Shimizu H, Akiyama M, Suehiro M, Konohana I, Shboul M, Teissier S, Boussofara L, Denguezli M, Saad A, Gribaa M, Dopping-Hepenstal PJ, McGrath JA, Brown SJ, Goudie DR, Reversade B, Munro CS, McLean WH
  TITLE     Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma.
  JOURNAL   Nat Genet 44:1272-6 (2012)
DOI:10.1038/ng.2444

PMID:22972947
  AUTHORS   Guo BR, Zhang X, Chen G, Zhang JG, Sun LD, Du WD, Zhang Q, Cui Y, Zhu J, Tang XF, Xiao R, Liu Y, Li M, Tang HY, Yang X, Cheng H, Li M, Gao M, Li P, Wang JB, Xu FP, Zuo XB, Zheng XD, Zhang XG, Yang L, Liu JJ, Wang J, Yang S, Zhang XJ
  TITLE     Exome sequencing identifies a COL14A1 mutation in a large Chinese pedigree with punctate palmoplantar keratoderma.
  JOURNAL   J Med Genet 49:563-8 (2012)
DOI:10.1136/jmedgenet-2012-100868",MeSH,C536161,C535653,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00466,"Grebe dysplasia;
Acromesomelic dysplasia Hunter-Thompson type","Acromesomelic dysplasia is a rare form of severe acromesomelic limb shortening inherited in autosomal recessive fashion. Lower limbs are more affected than the upper limbs, showing nonfunctional fingers. Homozygous mutations in GDF5 are the cause of the disease.",Skeletal dysplasia,GDF5 [HSA:8200] [KO:K04664],,,,,,,"ICD-10: Q77.8
MeSH: C537915 C535658
OMIM: 200700 201250","PMID:9288098 (description, gene)
  AUTHORS   Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP
  TITLE     Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.
  JOURNAL   Nat Genet 17:58-64 (1997)
DOI:10.1038/ng0997-58

PMID:12124730 (description, gene)
  AUTHORS   Faiyaz-Ul-Haque M, Ahmad W, Wahab A, Haque S, Azim AC, Zaidi SH, Teebi AS, Ahmad M, Cohn DH, Siddique T, Tsui LC
  TITLE     Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia.
  JOURNAL   Am J Med Genet 111:31-7 (2002)
DOI:10.1002/ajmg.10501

PMID:12567410 (description, gene)
  AUTHORS   Savarirayan R, White SM, Goodman FR, Graham JM Jr, Delatycki MB, Lachman RS, Rimoin DL, Everman DB, Warman ML
  TITLE     Broad phenotypic spectrum caused by an identical heterozygous CDMP-1 mutation in three unrelated families.
  JOURNAL   Am J Med Genet A 117A:136-42 (2003)
DOI:10.1002/ajmg.a.10924",MeSH,C537915,C535658,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00567,"Caveolinopathies, including:
Limb-girdle muscular dystrophy (LGMD) 1C;
Rippling muscle disease (RMD);
Idiopathic hyper CKemia;
Distal myopathy with decreased caveolin 3;
Hypertrophic cardiomyopathy (HCM)","Caveolinopathies are a group of muscle diseases and can lead to a broad spectrum of clinical phenotypes. The same mutation could lead to heterogeneous clinical phenotypes and muscle histopathological changes. They are usually inherited in an autosomal dominant pattern. Recently, an autosomal recessive inheritance was considered. The clinical findings that may suggest the diagnosis of a caveolinopathy are: onset usually in the first two decades, progressive, proximal, symmetrical muscle weakness, positive Gowers sign, calf hypertrophy, myalgia, cramps, and/or stiffness after exercise, muscle hyperirritability, etc.",Musculoskeletal disease; Nervous system disease,CAV3 [HSA:859] [KO:K12959],,,,,,,"ICD-10: G71.0 G71.1 I42.2
MeSH: C563362 C535686 D024741
OMIM: 607801 606072 123320 192600","PMID:21496630 (description, gene)
  AUTHORS   Gazzerro E, Bonetto A, Minetti C
  TITLE     Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
  JOURNAL   Handb Clin Neurol 101:135-42 (2011)
DOI:10.1016/B978-0-08-045031-5.00010-4

PMID:18583131 (description, gene)
  AUTHORS   Aboumousa A, Hoogendijk J, Charlton R, Barresi R, Herrmann R, Voit T, Hudson J, Roberts M, Hilton-Jones D, Eagle M, Bushby K, Straub V
  TITLE     Caveolinopathy--new mutations and additional symptoms.
  JOURNAL   Neuromuscul Disord 18:572-8 (2008)
DOI:10.1016/j.nmd.2008.05.003

PMID:15580566 (description, gene)
  AUTHORS   Fulizio L, Nascimbeni AC, Fanin M, Piluso G, Politano L, Nigro V, Angelini C
  TITLE     Molecular and muscle pathology in a series of caveolinopathy patients.
  JOURNAL   Hum Mutat 25:82-9 (2005)
DOI:10.1002/humu.20119",MeSH,C563362,C535686,D024741,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00665,Mandibuloacral dysplasia,"Mandibuloacral dysplasia (MAD) is an autosomal recessive disorder characterized by postnatal growth retardation, hypoplasia of the mandible and clavicles, acro-osteolysis, and partial lipodystrophy. Affected individuals have a normal appearance at birth, then progressively develop dysmorphic skeletal features. Mutations in LMNA or ZMPSTE24 are responsible for the disorder.",Skeletal dysplasia; Skin and connective tissue disease,"(type A) LMNA [HSA:4000] [KO:K12641]
(type B) ZMPSTE24 [HSA:10269] [KO:K06013]",,,,,,,"ICD-10: Q87.5
MeSH: C535705 C535706
OMIM: 248370 608612","PMID:20182615 (description, gene)
  AUTHORS   Worman HJ, Ostlund C, Wang Y
  TITLE     Diseases of the nuclear envelope.
  JOURNAL   Cold Spring Harb Perspect Biol 2:a000760 (2010)
DOI:10.1101/cshperspect.a000760

PMID:17467691 (description, gene)
  AUTHORS   Worman HJ, Bonne G
  TITLE     ""Laminopathies"": a wide spectrum of human diseases.
  JOURNAL   Exp Cell Res 313:2121-33 (2007)
DOI:10.1016/j.yexcr.2007.03.028

PMID:14615129 (description)
  AUTHORS   Bonne G, Levy N
  TITLE     LMNA mutations in atypical Werner's syndrome.
  JOURNAL   Lancet 362:1585-6; author reply 1586 (2003)
DOI:10.1016/S0140-6736(03)14761-7

PMID:16364671 (description, gene)
  AUTHORS   Jacob KN, Garg A
  TITLE     Laminopathies: multisystem dystrophy syndromes.
  JOURNAL   Mol Genet Metab 87:289-302 (2006)
DOI:10.1016/j.ymgme.2005.10.018

PMID:21267004 (gene)
  AUTHORS   Ben Yaou R, Navarro C, Quijano-Roy S, Bertrand AT, Massart C, De Sandre-Giovannoli A, Cadinanos J, Mamchaoui K, Butler-Browne G, Estournet B, Richard P, Barois A, Levy N, Bonne G
  TITLE     Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation.
  JOURNAL   Eur J Hum Genet 19:647-54 (2011)
DOI:10.1038/ejhg.2010.256

PMID:20814950 (gene)
  AUTHORS   Ahmad Z, Zackai E, Medne L, Garg A
  TITLE     Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24.
  JOURNAL   Am J Med Genet A 152A:2703-10 (2010)
DOI:10.1002/ajmg.a.33664",MeSH,C535705,C535706,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00099,"Leukocyte adhesion deficiency (LAD), including the following four diseases:
Leukocyte adhesion deficiency (I);
Leukocyte adhesion deficiency (II);
Leukocyte adhesion deficiency (III);
LAD with Rac2 deficiency","Leukocyte adhesion deficiency (LAD) is a rare, autosomal recessive genetic disorder in which neutrophils fail to mobilize and migrate to sites of injury. At least three genetically distinct forms of this group of disorders have been described: LAD I, II, and III. Defects in the expression of beta2-integrins and fucose- containing proteins account for LAD-I and LAD-II, respectively. In LAD-III integrin expression by leukocytes is normal, but the integrins fail to generate high avidity for their cognate endothelial-cell ligands. Mutations in the KINDLIN3 (official symbol FERMT3), a gene that encodes an intracellular protein that interacts with cytoplasmic tails of beta-integrins in hematopoietic cells, is the cause of LAD-III. Dominant-negative mutations resulting in deficiency of ras-related C3 botulinum toxin substrate (Rac2), the predominant hematopoeitic-specific Rho GTPase in neutrophils also leads to leukocyte adhesion deficiency.",Primary immunodeficiency,"ITGB2 [HSA:3689] [KO:K06464]
SLC35C1 [HSA:55343] [KO:K15279]
FERMT3 [HSA:83706] [KO:K17084]
RAC2 [HSA:5880] [KO:K07860]",,,,,,,"MeSH: C535887 C535755 C567555
OMIM: 116920 266265 612840 608203","PMID:17960151 (description, gene)
  AUTHORS   Marodi L, Notarangelo LD.
  TITLE     Immunological and genetic bases of new primary immunodeficiencies.
  JOURNAL   Nat Rev Immunol 7:851-61 (2007)
DOI:10.1038/nri2195

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:9737224 (gene)
  AUTHORS   Ten RM.
  TITLE     Primary immunodeficiencies.
  JOURNAL   Mayo Clin Proc 73:865-72 (1998)
DOI:10.4065/73.9.865

PMID:18424339 (gene)
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053

PMID:19423742 (gene)
  AUTHORS   Zimmerman GA
  TITLE     LAD syndromes: FERMT3 kindles the signal.
  JOURNAL   Blood 113:4485-6 (2009)
DOI:10.1182/blood-2009-01-198853

PMID:10758162
  AUTHORS   Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, Gonzalez-Aller C, Hiester A, deBoer M, Harbeck RJ, Oyer R, Johnson GL, Roos D
  TITLE     Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation.
  JOURNAL   Proc Natl Acad Sci U S A 97:4654-9 (2000)
DOI:10.1073/pnas.080074897",MeSH,C535887,C535755,C567555,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00522,"TRPV4-related skeletal dysplasias, including:
Autosomal dominant brachyolmia;
Spondylometaphyseal dysplasia, Kozlowski type (SMDK);
Metatropic dysplasia;
Spondyloepiphyseal dysplasia, Maroteaux type ;
Parastremmatic dysplasia","TRPV4-related skeletal dysplasias are a spectrum of disorders that share some clinical features. Mutations in the TRPV4, a calcium-permeable nonselective cation channel expressed in osteoblasts and osteoclasts, cause these bone dysplasias.",Skeletal dysplasia,TRPV4 [HSA:59341] [KO:K04973],,,,,,,"ICD-10: Q77.8 Q87.1
MeSH: C537098 C535797
OMIM: 113500 184252 156530 184095 168400","PMID:21658220 (description, gene)
  AUTHORS   Andreucci E, Aftimos S, Alcausin M, Haan E, Hunter W, Kannu P, Kerr B, McGillivray G, McKinlay Gardner RJ, Patricelli MG, Sillence D, Thompson E, Zacharin M, Zankl A, Lamande SR, Savarirayan R
  TITLE     TRPV4 related skeletal dysplasias: a phenotypic spectrum highlighted byclinical, radiographic, and molecular studies in 21 new families.
  JOURNAL   Orphanet J Rare Dis 6:37 (2011)
DOI:10.1186/1750-1172-6-37

PMID:20505684 (description, gene)
  AUTHORS   Dai J, Cho TJ, Unger S, Lausch E, Nishimura G, Kim OH, Superti-Furga A, Ikegawa S
  TITLE     TRPV4-pathy, a novel channelopathy affecting diverse systems.
  JOURNAL   J Hum Genet 55:400-2 (2010)
DOI:10.1038/jhg.2010.37

PMID:20503319 (gene)
  AUTHORS   Nishimura G, Dai J, Lausch E, Unger S, Megarbane A, Kitoh H, Kim OH, Cho TJ, Bedeschi F, Benedicenti F, Mendoza-Londono R, Silengo M, Schmidt-Rimpler M, Spranger J, Zabel B, Ikegawa S, Superti-Furga A
  TITLE     Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations.
  JOURNAL   Am J Med Genet A 152A:1443-9 (2010)
DOI:10.1002/ajmg.a.33414",MeSH,C537098,C535797,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00819,"Stargardt disease (STGD);
Fundus flavimaculatus","Stargardt disease (STGD) is the most common type of hereditary macular dystrophy. It is characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium (RPE), and frequent presence of prominent flecks in the posterior pole of the retina. Histopathologically, eyes with STGD reveal abnormal accumulations of lipofuscin in the RPE. To date, mutations in four genes have been identified as causing STGD, including ABCA4, ELOVL4, PROM1, and CNGB3.",Nervous system disease; Eye disease,"(STGD1) ABCA4 [HSA:24] [KO:K05644]
(STGD1) CNGB3 [HSA:54714] [KO:K04953]
(STGD3) ELOVL4 [HSA:6785] [KO:K10249]
(STGD4) PROM1 [HSA:8842] [KO:K06532]",,,,,,,"ICD-10: H35.5
MeSH: C535804 C535805 C535521
OMIM: 248200 600110 603786","PMID:12789571
  AUTHORS   Koenekoop RK
  TITLE     The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review.
  JOURNAL   Ophthalmic Genet 24:75-80 (2003)

PMID:19352439
  AUTHORS   Xi Q, Li L, Traboulsi EI, Wang QK
  TITLE     Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease.
  JOURNAL   Mol Vis 15:638-45 (2009)

PMID:20393116
  AUTHORS   Michaelides M, Gaillard MC, Escher P, Tiab L, Bedell M, Borruat FX, Barthelmes D, Carmona R, Zhang K, White E, McClements M, Robson AG, Holder GE, Bradshaw K, Hunt DM, Webster AR, Moore AT, Schorderet DF, Munier FL
  TITLE     The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy.
  JOURNAL   Invest Ophthalmol Vis Sci 51:4771-80 (2010)
DOI:10.1167/iovs.09-4561",MeSH,C535804,C535805,C535521,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01866,Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis,"Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare diseases that are classified as a subgroup of pulmonary arterial hypertension (PAH). PVOD is histologically characterized by intimal fibrosis that narrows and occludes pulmonary veins and it accounts for 5-10% of cases initially thought to be idiopathic PAH (IPAH). PCH is histologically characterized by localized capillary proliferation within the lung in which capillaries invade the pulmonary interstitium, vessels and, less commonly, airways. PCH has been reported to be much less frequent than PVOD. In recent years, PAH-targeted drugs including epoprostenol have improved the survival of patients with IPAH. PVOD/PCH has a very similar clinical presentation to PAH but is characterised by a worse prognosis and the possibility that severe pulmonary oedema can develop with specific PAH therapy. PVOD associated with a BMPR2 mutation has been reported. Recently, it has been suggested that EIF2AK4 mutations are the major cause of heritable PVOD.",Cardiovascular disease,"BMPR2 [HSA:659] [KO:K04671]
EIF2AK4 [HSA:440275] [KO:K16196]",,,,,,See also H01621 Pulmonary arterial hypertension.,"ICD-10: I27.0
MeSH: D011668 C535861
OMIM: 265450 234810","PMID:23312620
  AUTHORS   Miura A, Akagi S, Nakamura K, Ohta-Ogo K, Hashimoto K, Nagase S, Kohno K, Kusano K, Ogawa A, Matsubara H, Toyooka S, Oto T, Ohtsuka A, Ohe T, Ito H
  TITLE     Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
  JOURNAL   Cardiovasc Pathol 22:287-93 (2013)
DOI:10.1016/j.carpath.2012.12.002

PMID:19118230
  AUTHORS   Montani D, Price LC, Dorfmuller P, Achouh L, Jais X, Yaici A, Sitbon O, Musset D, Simonneau G, Humbert M
  TITLE     Pulmonary veno-occlusive disease.
  JOURNAL   Eur Respir J 33:189-200 (2009)
DOI:10.1183/09031936.00090608

PMID:24292273 (gene)
  AUTHORS   Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmuller P, Fadel E, Sitbon O, Simonneau G, Tregouet DA, Humbert M, Soubrier F
  TITLE     EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
  JOURNAL   Nat Genet 46:65-9 (2014)
DOI:10.1038/ng.2844

PMID:12446270 (gene)
  AUTHORS   Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA 3rd
  TITLE     Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.
  JOURNAL   Am J Respir Crit Care Med 167:889-94 (2003)
DOI:10.1164/rccm.200208-861OC",MeSH,D011668,C535861,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00485,Robinow syndrome,"Robinow syndrome (RS) is a rare genetically heterogeneous condition characterized by hypertelorism, nasal features (large nasal bridge, short upturned nose, and anteverted nares), midface hypoplasia, mesomelic limb shortening, brachydactyly, clinodactyly, micropenis, and short stature. Both autosomal recessive and autosomal dominant inheritance have been described. The phenotypic presentation in both types of RS overlaps; however, subtle variances in the severity of craniofacial, musculoskeletal, cardiovascular, and urogenital characteristics may be present. In general, autosomal recessive RS (RRS) patients have more severe dysmorphology than autosomal dominant RS (DRS), especially in the musculoskeletal system.",Skeletal dysplasia; Developmental disorder,"(RRS) ROR2 [HSA:4920] [KO:K05123]
(DRS1) WNT5A [HSA:7474] [KO:K00444]
(DRS2) DVL1 [HSA:1855] [KO:K02353]
(DRS3) DVL3 [HSA:1857] [KO:K02353]",,,,,,,"ICD-10: Q87.1
MeSH: C562492 C535863
OMIM: 268310 180700 616331 616894","PMID:19790289 (description, gene)
  AUTHORS   Mundlos S
  TITLE     The brachydactylies: a molecular disease family.
  JOURNAL   Clin Genet 76:123-36 (2009)
DOI:10.1111/j.1399-0004.2009.01238.x

PMID:12011143 (description, gene)
  AUTHORS   Patton MA, Afzal AR
  TITLE     Robinow syndrome.
  JOURNAL   J Med Genet 39:305-10 (2002)
DOI:10.1136/jmg.39.5.305

PMID:20301418 (description, gene)
  AUTHORS   Bacino C
  TITLE     ROR2-Related Robinow Syndrome
  JOURNAL   GeneReviews (1993)

PMID:21496006 (description)
  AUTHORS   Beiraghi S, Leon-Salazar V, Larson BE, John MT, Cunningham ML, Petryk A, Lohr JL
  TITLE     Craniofacial and intraoral phenotype of Robinow syndrome forms.
  JOURNAL   Clin Genet 80:15-24 (2011)
DOI:10.1111/j.1399-0004.2011.01683.x

PMID:17256787 (description)
  AUTHORS   Mazzeu JF, Pardono E, Vianna-Morgante AM, Richieri-Costa A, Ae Kim C, Brunoni D, Martelli L, de Andrade CE, Colin G, Otto PA
  TITLE     Clinical characterization of autosomal dominant and recessive variants of Robinow syndrome.
  JOURNAL   Am J Med Genet A 143:320-5 (2007)
DOI:10.1002/ajmg.a.31592

PMID:19918918 (gene)
  AUTHORS   Person AD, Beiraghi S, Sieben CM, Hermanson S, Neumann AN, Robu ME, Schleiffarth JR, Billington CJ Jr, van Bokhoven H, Hoogeboom JM, Mazzeu JF, Petryk A, Schimmenti LA, Brunner HG, Ekker SC, Lohr JL
  TITLE     WNT5A mutations in patients with autosomal dominant Robinow syndrome.
  JOURNAL   Dev Dyn 239:327-37 (2010)
DOI:10.1002/dvdy.22156

PMID:25817016 (gene)
  AUTHORS   White J, Mazzeu JF, Hoischen A, Jhangiani SN, Gambin T, Alcino MC, Penney S, Saraiva JM, Hove H, Skovby F, Kayserili H, Estrella E, Vulto-van Silfhout AT, Steehouwer M, Muzny DM, Sutton VR, Gibbs RA, Lupski JR, Brunner HG, van Bon BW, Carvalho CM
  TITLE     DVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome.
  JOURNAL   Am J Hum Genet 96:612-22 (2015)
DOI:10.1016/j.ajhg.2015.02.015

PMID:26924530 (gene)
  AUTHORS   White JJ, Mazzeu JF, Hoischen A, Bayram Y, Withers M, Gezdirici A, Kimonis V, Steehouwer M, Jhangiani SN, Muzny DM, Gibbs RA, van Bon BW, Sutton VR, Lupski JR, Brunner HG, Carvalho CM
  TITLE     DVL3 Alleles Resulting in a -1 Frameshift of the Last Exon Mediate Autosomal-Dominant Robinow Syndrome.
  JOURNAL   Am J Hum Genet 98:553-61 (2016)
DOI:10.1016/j.ajhg.2016.01.005",MeSH,C562492,C535863,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00566,"Dysferlinopathies, including:
Miyoshi myopathy (MM);
Limb-girdle muscular dystrophy (LGMD) 2B;
Distal myopathy with anterior tibial onset (DMAT)","Dysferlinopathies encompass a large variety of neuromuscular diseases characterized by the absence of dysferlin in skeletal muscle and an autosomal recessive mode of inheritance. Dysferlin is a sarcolemmal protein involved in an important role in repairing defects in skeletal membrane. The clinical phenotype is quite variable. Dysferlinopathies present two main phenotypes: Miyoshi myopathy with primarily distal weakness and limb-girdle muscular dystrophy type 2B (LGMD2B) with primarily proximal weakness. Less commonly, it can be with anterior tibial weakness.",Musculoskeletal disease; Nervous system disease,DYSF [HSA:8291] [KO:K18261],,,,,,,"ICD-10: G71.0
MeSH: C537480 C535899
OMIM: 254130 253601 606768","PMID:21496627 (description, gene)
  AUTHORS   Amato AA, Brown RH Jr
  TITLE     Dysferlinopathies.
  JOURNAL   Handb Clin Neurol 101:111-8 (2011)
DOI:10.1016/B978-0-08-045031-5.00007-4

PMID:18974555 (description, gene)
  AUTHORS   Urtizberea JA, Bassez G, Leturcq F, Nguyen K, Krahn M, Levy N
  TITLE     Dysferlinopathies.
  JOURNAL   Neurol India 56:289-97 (2008)
DOI:10.4103/0028-3886.43447

PMID:25574751
  AUTHORS   Szymanska S, Rokicki D, Karkucinska-Wieckowska A, Szymanska-Debinska T, Ciara E, Ploski R, Grajkowska W, Pronicki M
  TITLE     Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
  JOURNAL   Folia Neuropathol 52:452-6 (2014)
DOI:10.5114/fn.2014.47847",MeSH,C537480,C535899,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00518,"RMRP related disorders, including:
Anauxetic dysplasia (AD) [DS:H01967];
Cartilage-hair hypoplasia (CHH) [DS:H01966];
Metaphyseal dysplasia without hypotrichosis (MDWH)","RNase MRP RNA is the RNA subunit of the RNase mitochondrial RNA processing (MRP) enzyme complex. In addition to its mitochondrial function, mutations on RNase MRP RNA gene (RMRP) cause a recessively inherited developmental disorder, cartilage-hair hypoplasia (CHH). CHH is a skeletal dysplasia inherited as an autosomal recessive trait. Beyond CHH, RNase MRP RNA mutations have been implicated in a variety of other inherited skeletal dysplasias, including anauxetic dysplasia (AD) and metaphyseal dysplasia without hypotrichosis (MDWH).",Congenital disorder of development; Ribosomopathy,RMRP [HSA:6023] [KO:K14576],,,,,,,"ICD-10: Q78.8 Q78.5
MeSH: C538256 C535916 C563574
OMIM: 607095 250250 250460","PMID:17189938
  AUTHORS   Martin AN, Li Y
  TITLE     RNase MRP RNA and human genetic diseases.
  JOURNAL   Cell Res 17:219-26 (2007)
DOI:10.1038/sj.cr.7310120",MeSH,C538256,C535916,C563574,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01782,Eosinophilic gastrointestinal disorder,"Eosinophilic gastrointestinal disorder (EGID) is a disorder characterised by eosinophilic infiltration of the gastrointestinal tract. The most common form of EGID is Eosinophilic Esophagitis (EoE). Other forms of EGID include eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis and eosinophilic gastroenteritis (EGE). While these disorders are less frequent than EoE, their pathogenesis and treatment are probably similar. Clinically, patients with EGID often present with dysphagia, vomiting or abdominal pain. While the etiology remains unclear, there is a well documented association of atopy with EGID. Clinical studies in children and adults have demonstrated an association with food allergy.",Immune system disease; Digestive system disease,,,,,,Glucocorticoid,See also H01361 Eosinophilic esophagitis.,"ICD-10: K20 K52.8
MeSH: D057765 C535952
OMIM: 610247 613412","PMID:24813518
  AUTHORS   Prussin C
  TITLE     Eosinophilic gastroenteritis and related eosinophilic disorders.
  JOURNAL   Gastroenterol Clin North Am 43:317-27 (2014)
DOI:10.1016/j.gtc.2014.02.013

PMID:22792476
  AUTHORS   Jawairia M, Shahzad G, Mustacchia P
  TITLE     Eosinophilic gastrointestinal diseases: review and update.
  JOURNAL   ISRN Gastroenterol 2012:463689 (2012)
DOI:10.5402/2012/463689

PMID:23346427
  AUTHORS   Lim DN, Wilkins A, Horton LE, Ahmad I, Lo Polito C, Phillips C
  TITLE     Eosinophilic gastrointestinal disorder in coeliac disease: a case report and review.
  JOURNAL   Case Rep Gastrointest Med 2012:124275 (2012)
DOI:10.1155/2012/124275",MeSH,D057765,C535952,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00515,"The DTDST-related disorders, including:
Achondrogenesis IB (ACG IB);
Atelosteogenesis II (AO II);
Diastrophic dysplasia (DTD)",The DTDST-related disorders are severe autosomal recessive chondrodysplasias including two lethal disorders ACG IB and AO II; and a non-lethal disorder DTD. Patients with these disorders suffer from impaired proteoglycan sulfation due to mutations in DTDST.,Skeletal dysplasia,DTDST [HSA:1836] [KO:K14701],,,,,,,"ICD-10: Q77.0 Q77.5
MeSH: C536016 C536017 C536170
OMIM: 600972 256050 222600","PMID:11448940 (description, gene)
  AUTHORS   Karniski LP
  TITLE     Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
  JOURNAL   Hum Mol Genet 10:1485-90 (2001)
DOI:10.1093/hmg/10.14.1485

PMID:8791509 (description, gene)
  AUTHORS   Francomano CA, McIntosh I, Wilkin DJ
  TITLE     Bone dysplasias in man: molecular insights.
  JOURNAL   Curr Opin Genet Dev 6:301-8 (1996)
DOI:10.1016/S0959-437X(96)80006-2",MeSH,C536016,C536017,C536170,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00456,"Fronto-Otopalatodigital Osteodysplasia, including:
Otopalatodigital syndrome, type I;
Otopalatodigital syndrome, type II;
Melnick-Needles syndrome;
Frontometaphyseal dysplasia",Fronto-Otopalatodigital Osteodysplasia comprises four disorders that arise from missense mutations in FLNA encoding the actin-binding cytoskeletal protein filamin A. The disorders are inherited in X-linked fashion and characterized by a typical facial appearance and generalized osteodysplasia.,Developmental disorder; Skeletal dysplasia,FLNA [HSA:2316] [KO:K04437],,,,,,,"ICD-10: Q77.8 Q78.5
MeSH: C538064 C536065 C538089
OMIM: 311300 304120 309350 305620","PMID:10706363 (description)
  AUTHORS   Verloes A, Lesenfants S, Barr M, Grange DK, Journel H, Lombet J, Mortier G, Roeder E
  TITLE     Fronto-otopalatodigital osteodysplasia: clinical evidence for a single entity encompassing Melnick-Needles syndrome, otopalatodigital syndrome types 1 and 2, and frontometaphyseal dysplasia.
  JOURNAL   Am J Med Genet 90:407-22 (2000)
DOI:10.1002/(SICI)1096-8628(20000228)90:5<407:AID-AJMG11>3.0.CO;2-D

PMID:21031081 (gene)
  AUTHORS   Foley C, Roberts K, Tchrakian N, Morgan T, Fryer A, Robertson SP, Tubridy N
  TITLE     Expansion of the Spectrum of FLNA Mutations Associated with Melnick-Needles Syndrome.
  JOURNAL   Mol Syndromol 1:121-126 (2010)
DOI:10.1159/000320184",MeSH,C538064,C536065,C538089,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00261,"Meckel syndrome (MKS);
Meckel-Gruber syndrome","Meckel syndrome (MKS) is a lethal, autosomal recessive disorder characterized by anomalies of the central nervous system, cystic dysplasia of the kidneys, and malformations of the hands and feet.",Nervous system disease; Kidney disease,"(MKS1) MKS1 [HSA:54903] [KO:K19332]
(MKS3) TMEM67 [HSA:91147] [KO:K19348]
(MKS4) CEP290 [HSA:80184] [KO:K16533]
(MKS5) RPGRIP1L [HSA:23322] [KO:K16550]
(MKS6) CC2D2A [HSA:57545] [KO:K19352]
(MKS7) NPHP3 [HSA:27031] [KO:K19360]
(MKS8) TCTN2 [HSA:79867] [KO:K19361]
(MKS9) B9D1 [HSA:27077] [KO:K16744]
(MKS10) B9D2 [HSA:80776] [KO:K16745]
(MKS11) TMEM231 [HSA:79583] [KO:K19362]",,,,,,,"ICD-10: Q61.9
MeSH: C536133 C536131 C536132
OMIM: 249000 603194 607361 611134 611561 612284 267010 613885 614209 614175 615397","PMID:17389183
  AUTHORS   Chen CP
  TITLE     Meckel syndrome: genetics, perinatal findings, and differential diagnosis.
  JOURNAL   Taiwan J Obstet Gynecol 46:9-14 (2007)
DOI:10.1016/S1028-4559(08)60100-X

PMID:16879033
  AUTHORS   Alexiev BA, Lin X, Sun CC, Brenner DS
  TITLE     Meckel-Gruber syndrome: pathologic manifestations, minimal diagnostic criteria, and differential diagnosis.
  JOURNAL   Arch Pathol Lab Med 130:1236-8 (2006)
DOI:10.1043/1543-2165(2006)130[1236:MS]2.0.CO;2

PMID:9643292
  AUTHORS   Salonen R, Paavola P
  TITLE     Meckel syndrome.
  JOURNAL   J Med Genet 35:497-501 (1998)
DOI:10.1136/jmg.35.6.497

PMID:21898032
  AUTHORS   Bergmann C
  TITLE     Educational paper: ciliopathies.
  JOURNAL   Eur J Pediatr 171:1285-300 (2012)
DOI:10.1007/s00431-011-1553-z

PMID:18371931
  AUTHORS   Bergmann C, Fliegauf M, Bruchle NO, Frank V, Olbrich H, Kirschner J, Schermer B, Schmedding I, Kispert A, Kranzlin B, Nurnberg G, Becker C, Grimm T, Girschick G, Lynch SA, Kelehan P, Senderek J, Neuhaus TJ, Stallmach T, Zentgraf H, Nurnberg P, Gretz N, Lo C, Lienkamp S, Schafer T, Walz G, Benzing T, Zerres K, Omran H
  TITLE     Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia.
  JOURNAL   Am J Hum Genet 82:959-70 (2008)
DOI:10.1016/j.ajhg.2008.02.017

PMID:21462283
  AUTHORS   Shaheen R, Faqeih E, Seidahmed MZ, Sunker A, Alali FE, AlQahtani K, Alkuraya FS
  TITLE     A TCTN2 mutation defines a novel Meckel Gruber syndrome locus.
  JOURNAL   Hum Mutat 32:573-8 (2011)
DOI:10.1002/humu.21507

PMID:21763481
  AUTHORS   Dowdle WE, Robinson JF, Kneist A, Sirerol-Piquer MS, Frints SG, Corbit KC, Zaghloul NA, van Lijnschoten G, Mulders L, Verver DE, Zerres K, Reed RR, Attie-Bitach T, Johnson CA, Garcia-Verdugo JM, Katsanis N, Bergmann C, Reiter JF
  TITLE     Disruption of a ciliary B9 protein complex causes Meckel syndrome.
  JOURNAL   Am J Hum Genet 89:94-110 (2011)
DOI:10.1016/j.ajhg.2011.06.003

PMID:23349226
  AUTHORS   Shaheen R, Ansari S, Mardawi EA, Alshammari MJ, Alkuraya FS
  TITLE     Mutations in TMEM231 cause Meckel-Gruber syndrome.
  JOURNAL   J Med Genet 50:160-2 (2013)
DOI:10.1136/jmedgenet-2012-101431",MeSH,C536133,C536131,C536132,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01885,"Megalencephaly-capillary malformation syndrome (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH);
MCAP syndrome;
MPPH syndrome","Megalencephaly-capillary malformation syndrome (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH) are rare overgrowth disorders. MCAP and MPPH show very similar symptoms; the main symptoms are progressive megalencephaly, polymicrogyria, capillary malformations, syndactyly, and connective tissue dysplasia in the former, and progressive megalencephaly, polymicrogyria, and polydactyly in the latter. Polydactyly in MPPH seems to be a variable feature presenting with varied severity in both upper and lower limbs. MCAP and MPPH have been shown to result from gain-of-function mutations in the mTOR-pathway.",Developmental disorder; Nervous system disease,"(MPPH1) PIK3R2 [HSA:5296] [KO:K02649]
(MPPH2) AKT3 [HSA:10000] [KO:K04456]
(MPPH3) CCND2 [HSA:894] [KO:K10151]
(MCAP) PIK3CA [HSA:5290] [KO:K00922]",,,,,,,"ICD-10: Q87.3
MeSH: C566381 C536142
OMIM: 603387 615937 615938 602501","PMID:9129744 (description)
  AUTHORS   Moore CA, Toriello HV, Abuelo DN, Bull MJ, Curry CJ, Hall BD, Higgins JV, Stevens CA, Twersky S, Weksberg R, Dobyns WB
  TITLE     Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities.
  JOURNAL   Am J Med Genet 70:67-73 (1997)
DOI:10.1002/(SICI)1096-8628(19970502)70:1<67:AID-AJMG13>3.0.CO;2-V

PMID:15627943 (description)
  AUTHORS   Mirzaa G, Dodge NN, Glass I, Day C, Gripp K, Nicholson L, Straub V, Voit T, Dobyns WB
  TITLE     Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures.
  JOURNAL   Neuropediatrics 35:353-9 (2004)
DOI:10.1055/s-2004-830497

PMID:28502730 (description)
  AUTHORS   Akgumus G, Chang F, Li MM
  TITLE     Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
  JOURNAL   J Mol Diagn 19:487-497 (2017)
DOI:10.1016/j.jmoldx.2017.04.001

PMID:24092603 (description)
  AUTHORS   Zamora TG, Roberts KD
  TITLE     Four-year follow-up of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephalus (MPPH) syndrome.
  JOURNAL   BMJ Case Rep 2013:bcr2012007826 (2013)
DOI:10.1136/bcr-2012-007826

PMID:28086757 (description)
  AUTHORS   Negishi Y, Miya F, Hattori A, Johmura Y, Nakagawa M, Ando N, Hori I, Togawa T, Aoyama K, Ohashi K, Fukumura S, Mizuno S, Umemura A, Kishimoto Y, Okamoto N, Kato M, Tsunoda T, Yamasaki M, Kanemura Y, Kosaki K, Nakanishi M, Saitoh S
  TITLE     A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
  JOURNAL   BMC Med Genet 18:4 (2017)
DOI:10.1186/s12881-016-0363-6

PMID:22228622 (description)
  AUTHORS   Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, Lev D, Kramer N, Hopkins E, Graham JM Jr, Dobyns WB
  TITLE     Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.
  JOURNAL   Am J Med Genet A 158A:269-91 (2012)
DOI:10.1002/ajmg.a.34402

PMID:22729224 (gene)
  AUTHORS   Riviere JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluseriu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GM, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, Weksberg R, Zirn B, Beaulieu CL, Majewski J, Bulman DE, O'Driscoll M, Shendure J, Graham JM Jr, Boycott KM, Dobyns WB
  TITLE     De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
  JOURNAL   Nat Genet 44:934-40 (2012)
DOI:10.1038/ng.2331

PMID:24705253 (gene)
  AUTHORS   Mirzaa GM, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S, Kholmanskikh SS, Adams C, Hodge RD, Hevner RF, Bonthron DT, Braun KP, Faivre L, Riviere JB, St-Onge J, Gripp KW, Mancini GM, Pang K, Sweeney E, van Esch H, Verbeek N, Wieczorek D, Steinraths M, Majewski J, Boycott KM, Pilz DT, Ross ME, Dobyns WB, Sheridan EG
  TITLE     De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
  JOURNAL   Nat Genet 46:510-5 (2014)
DOI:10.1038/ng.2948",MeSH,C566381,C536142,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00095,"Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases:
NF-kappa-B essential modulator (NEMO) defect;
Inhibitor of kappa-B (I-kappa-B) defect","Ectodermal dysplasia (ED) refers to a group of inherited disorders involving absence or dysplasia of the ectodermal appendages. Clinically, it is characterized by absence, abnormality, or deficient function of ectodermal derivatives, including skin, teeth, hair, eccrine glands, or nails. In the hypohidrotic/ anhidrotic form of ED (HED/EDA) the patient has no sweat glands, sparse scalp hair and rare conical teeth. Patients with EDA and immunodeficiency (EDA-ID) present some or all of these features, together with severe infectious diseases. EDA-ID principally affects boys, suggesting X-linked recessive inheritance (XL-EDA-ID). This was confirmed in 2000 and beyond with the identification of disease-causing hypomorphic mutations in NEMO, which is located on the X chromosome and encodes IKK-gamma. A novel autosomal dominant of EDA-ID, recently identified in one child, was found to be caused by a hypermorphic mutation of the gene encoding I{kappa}B{alpha}. Similar to XL-EDA-ID patients, from the age of two months he suffered from multiple and severe infections with several Gram-positive and Gram-negative bacteria, leading to chronic bronchopneumonitis and gastroenteritis, with failure to thrive.",Primary immunodeficiency,"IKBKG [HSA:8517] [KO:K07210]
IKBA [HSA:4792] [KO:K04734]",,,,,,,"MeSH: C567411 C536181
OMIM: 612132 300291","PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:18424339
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",MeSH,C567411,C536181,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00530,Joubert syndrome,"Joubert syndrome and related disorders are a group of multiple congenital anomaly syndromes characterized by 'molar tooth sign', a specific midbrain-hindbrain malformation seen in brain images. Joubert syndrome is associated with retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Most of the causative genes encode cilium-related proteins.",Developmental disorder,"(JBTS1) INPP5E [HSA:56623] [KO:K20278]
(JBTS2) TMEM216 [HSA:51259] [KO:K19385]
(JBTS3) AHI1 [HSA:54806] [KO:K16740]
(JBTS4) NPHP1 (deletion) [HSA:4867] [KO:K19657]
(JBTS5) CEP290 [HSA:80184] [KO:K16533]
(JBTS6) TMEM67 [HSA:91147] [KO:K19348]
(JBTS7) RPGRIP1L [HSA:23322] [KO:K16550]
(JBTS8) ARL13B [HSA:200894] [KO:K07962]
(JBTS9) CC2D2A [HSA:57545] [KO:K19352]
(JBTS10) OFD1 [HSA:8481] [KO:K16480]
(JBTS11) TTC21B [HSA:79809] [KO:K19673]
(JBTS12) KIF7 [HSA:374654] [KO:K18806]
(JBTS13) TECT1 [HSA:79600] [KO:K19382]
(JBTS14) TMEM237 [HSA:65062]
(JBTS15) CEP41 [HSA:95681] [KO:K16455]
(JBTS16) TMEM138 [HSA:51524]
(JBTS17) C5orf42 [HSA:65250]
(JBTS18) TCTN3 [HSA:26123] [KO:K19382]
(JBTS19) ZNF423 [HSA:23090]
(JBTS20) TMEM231 [HSA:79583] [KO:K19362]
(JBTS21) CSPP1 [HSA:79848] [KO:K16771]
(JBTS22) PDE6D [HSA:5147] [KO:K13758]
(JBTS23) JBTS23 [HSA:9786]
(JBTS24) TCTN2 [HSA:79867] [KO:K19361]
(JBTS25) CEP104 [HSA:9731] [KO:K16458]
(JBTS26) JBTS26 [HSA:23247]",,,,,,,"ICD-10: Q04.3 Q87.8 Q87.0
MeSH: C536293 C536294 C536295 C536296 C537688 C537689 C566916 C567358 C567364 C567582
OMIM: 213300 608091 608629 609583 610188 610688 611560 612291 612285 300804 613820 200990 614173 614424 614464 614465 614615 614815 614844 614970 615636 615665 616490 616654 616781 616784","PMID:21108387 (description, gene)
  AUTHORS   Brugmann SA, Cordero DR, Helms JA
  TITLE     Craniofacial ciliopathies: A new classification for craniofacial disorders.
  JOURNAL   Am J Med Genet A 152A:2995-3006 (2010)
DOI:10.1002/ajmg.a.33727

PMID:20615230 (description, gene)
  AUTHORS   Brancati F, Dallapiccola B, Valente EM
  TITLE     Joubert Syndrome and related disorders.
  JOURNAL   Orphanet J Rare Dis 5:20 (2010)
DOI:10.1186/1750-1172-5-20

PMID:19668216 (gene)
  AUTHORS   Bielas SL, Silhavy JL, Brancati F, Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS, Abdel-Aleem A, Rosti RO, Kayserili H, Swistun D, Scott LC, Bertini E, Boltshauser E, Fazzi E, Travaglini L, Field SJ, Gayral S, Jacoby M, Schurmans S, Dallapiccola B, Majerus PW, Valente EM, Gleeson JG
  TITLE     Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.
  JOURNAL   Nat Genet 41:1032-6 (2009)
DOI:10.1038/ng.423

PMID:21258341
  AUTHORS   Davis EE, Zhang Q, Liu Q, Diplas BH, Davey LM, Hartley J, Stoetzel C, Szymanska K, Ramaswami G, Logan CV, Muzny DM, Young AC, Wheeler DA, Cruz P, Morgan M, Lewis LR, Cherukuri P, Maskeri B, Hansen NF, Mullikin JC, Blakesley RW, Bouffard GG, Gyapay G, Rieger S, Tonshoff B, Kern I, Soliman NA, Neuhaus TJ, Swoboda KJ, Kayserili H, Gallagher TE, Lewis RA, Bergmann C, Otto EA, Saunier S, Scambler PJ, Beales PL, Gleeson JG, Maher ER, Attie-Bitach T, Dollfus H, Johnson CA, Green ED, Gibbs RA, Hildebrandt F, Pierce EA, Katsanis N
  TITLE     TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum.
  JOURNAL   Nat Genet 43:189-96 (2011)
DOI:10.1038/ng.756

PMID:21633164
  AUTHORS   Dafinger C, Liebau MC, Elsayed SM, Hellenbroich Y, Boltshauser E, Korenke GC, Fabretti F, Janecke AR, Ebermann I, Nurnberg G, Nurnberg P, Zentgraf H, Koerber F, Addicks K, Elsobky E, Benzing T, Schermer B, Bolz HJ
  TITLE     Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics.
  JOURNAL   J Clin Invest 121:2662-7 (2011)
DOI:10.1172/JCI43639

PMID:21725307
  AUTHORS   Garcia-Gonzalo FR, Corbit KC, Sirerol-Piquer MS, Ramaswami G, Otto EA, Noriega TR, Seol AD, Robinson JF, Bennett CL, Josifova DJ, Garcia-Verdugo JM, Katsanis N, Hildebrandt F, Reiter JF
  TITLE     A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition.
  JOURNAL   Nat Genet 43:776-84 (2011)
DOI:10.1038/ng.891

PMID:22152675
  AUTHORS   Huang L, Szymanska K, Jensen VL, Janecke AR, Innes AM, Davis EE, Frosk P, Li C, Willer JR, Chodirker BN, Greenberg CR, McLeod DR, Bernier FP, Chudley AE, Muller T, Shboul M, Logan CV, Loucks CM, Beaulieu CL, Bowie RV, Bell SM, Adkins J, Zuniga FI, Ross KD, Wang J, Ban MR, Becker C, Nurnberg P, Douglas S, Craft CM, Akimenko MA, Hegele RA, Ober C, Utermann G, Bolz HJ, Bulman DE, Katsanis N, Blacque OE, Doherty D, Parboosingh JS, Leroux MR, Johnson CA, Boycott KM
  TITLE     TMEM237 is mutated in individuals with a Joubert syndrome related disorder and expands the role of the TMEM family at the ciliary transition zone.
  JOURNAL   Am J Hum Genet 89:713-30 (2011)
DOI:10.1016/j.ajhg.2011.11.005

PMID:22246503
  AUTHORS   Lee JE, Silhavy JL, Zaki MS, Schroth J, Bielas SL, Marsh SE, Olvera J, Brancati F, Iannicelli M, Ikegami K, Schlossman AM, Merriman B, Attie-Bitach T, Logan CV, Glass IA, Cluckey A, Louie CM, Lee JH, Raynes HR, Rapin I, Castroviejo IP, Setou M, Barbot C, Boltshauser E, Nelson SF, Hildebrandt F, Johnson CA, Doherty DA, Valente EM, Gleeson JG
  TITLE     CEP41 is mutated in Joubert syndrome and is required for tubulin glutamylation at the cilium.
  JOURNAL   Nat Genet 44:193-9 (2012)
DOI:10.1038/ng.1078

PMID:22282472
  AUTHORS   Lee JH, Silhavy JL, Lee JE, Al-Gazali L, Thomas S, Davis EE, Bielas SL, Hill KJ, Iannicelli M, Brancati F, Gabriel SB, Russ C, Logan CV, Sharif SM, Bennett CP, Abe M, Hildebrandt F, Diplas BH, Attie-Bitach T, Katsanis N, Rajab A, Koul R, Sztriha L, Waters ER, Ferro-Novick S, Woods CG, Johnson CA, Valente EM, Zaki MS, Gleeson JG
  TITLE     Evolutionarily assembled cis-regulatory module at a human ciliopathy locus.
  JOURNAL   Science 335:966-9 (2012)
DOI:10.1126/science.1213506

PMID:22425360
  AUTHORS   Srour M, Schwartzentruber J, Hamdan FF, Ospina LH, Patry L, Labuda D, Massicotte C, Dobrzeniecka S, Capo-Chichi JM, Papillon-Cavanagh S, Samuels ME, Boycott KM, Shevell MI, Laframboise R, Desilets V, Maranda B, Rouleau GA, Majewski J, Michaud JL
  TITLE     Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population.
  JOURNAL   Am J Hum Genet 90:693-700 (2012)
DOI:10.1016/j.ajhg.2012.02.011

PMID:22883145
  AUTHORS   Thomas S, Legendre M, Saunier S, Bessieres B, Alby C, Bonniere M, Toutain A, Loeuillet L, Szymanska K, Jossic F, Gaillard D, Yacoubi MT, Mougou-Zerelli S, David A, Barthez MA, Ville Y, Bole-Feysot C, Nitschke P, Lyonnet S, Munnich A, Johnson CA, Encha-Razavi F, Cormier-Daire V, Thauvin-Robinet C, Vekemans M, Attie-Bitach T
  TITLE     TCTN3 mutations cause Mohr-Majewski syndrome.
  JOURNAL   Am J Hum Genet 91:372-8 (2012)
DOI:10.1016/j.ajhg.2012.06.017

PMID:22863007
  AUTHORS   Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang H, Hurd TW, Zhou W, Cluckey A, Gee HY, Ramaswami G, Hong CJ, Hamilton BA, Cervenka I, Ganji RS, Bryja V, Arts HH, van Reeuwijk J, Oud MM, Letteboer SJ, Roepman R, Husson H, Ibraghimov-Beskrovnaya O, Yasunaga T, Walz G, Eley L, Sayer JA, Schermer B, Liebau MC, Benzing T, Le Corre S, Drummond I, Janssen S, Allen SJ, Natarajan S, O'Toole JF, Attanasio M, Saunier S, Antignac C, Koenekoop RK, Ren H, Lopez I, Nayir A, Stoetzel C, Dollfus H, Massoudi R, Gleeson JG, Andreoli SP, Doherty DG, Lindstrad A, Golzio C, Katsanis N, Pape L, Abboud EB, Al-Rajhi AA, Lewis RA, Omran H, Lee EY, Wang S, Sekiguchi JM, Saunders R, Johnson CA, Garner E, Vanselow K, Andersen JS, Shlomai J, Nurnberg G, Nurnberg P, Levy S, Smogorzewska A, Otto EA, Hildebrandt F
  TITLE     Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.
  JOURNAL   Cell 150:533-48 (2012)
DOI:10.1016/j.cell.2012.06.028

PMID:23012439
  AUTHORS   Srour M, Hamdan FF, Schwartzentruber JA, Patry L, Ospina LH, Shevell MI, Desilets V, Dobrzeniecka S, Mathonnet G, Lemyre E, Massicotte C, Labuda D, Amrom D, Andermann E, Sebire G, Maranda B, Rouleau GA, Majewski J, Michaud JL
  TITLE     Mutations in TMEM231 cause Joubert syndrome in French Canadians.
  JOURNAL   J Med Genet 49:636-41 (2012)
DOI:10.1136/jmedgenet-2012-101132

PMID:24360807
  AUTHORS   Akizu N, Silhavy JL, Rosti RO, Scott E, Fenstermaker AG, Schroth J, Zaki MS, Sanchez H, Gupta N, Kabra M, Kara M, Ben-Omran T, Rosti B, Guemez-Gamboa A, Spencer E, Pan R, Cai N, Abdellateef M, Gabriel S, Halbritter J, Hildebrandt F, van Bokhoven H, Gunel M, Gleeson JG
  TITLE     Mutations in CSPP1 lead to classical Joubert syndrome.
  JOURNAL   Am J Hum Genet 94:80-6 (2014)
DOI:10.1016/j.ajhg.2013.11.015

PMID:24166846
  AUTHORS   Thomas S, Wright KJ, Le Corre S, Micalizzi A, Romani M, Abhyankar A, Saada J, Perrault I, Amiel J, Litzler J, Filhol E, Elkhartoufi N, Kwong M, Casanova JL, Boddaert N, Baehr W, Lyonnet S, Munnich A, Burglen L, Chassaing N, Encha-Ravazi F, Vekemans M, Gleeson JG, Valente EM, Jackson PK, Drummond IA, Saunier S, Attie-Bitach T
  TITLE     A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to the primary cilium.
  JOURNAL   Hum Mutat 35:137-46 (2014)
DOI:10.1002/humu.22470

PMID:26096313 (gene)
  AUTHORS   Bachmann-Gagescu R, Phelps IG, Dempsey JC, Sharma VA, Ishak GE, Boyle EA, Wilson M, Marques Lourenco C, Arslan M, Shendure J, Doherty D
  TITLE     KIAA0586 is Mutated in Joubert Syndrome.
  JOURNAL   Hum Mutat 36:831-5 (2015)
DOI:10.1002/humu.22821

PMID:25118024 (gene)
  AUTHORS   Huppke P, Wegener E, Bohrer-Rabel H, Bolz HJ, Zoll B, Gartner J, Bergmann C
  TITLE     Tectonic gene mutations in patients with Joubert syndrome.
  JOURNAL   Eur J Hum Genet 23:616-20 (2015)
DOI:10.1038/ejhg.2014.160

PMID:26477546 (gene)
  AUTHORS   Srour M, Hamdan FF, McKnight D, Davis E, Mandel H, Schwartzentruber J, Martin B, Patry L, Nassif C, Dionne-Laporte A, Ospina LH, Lemyre E, Massicotte C, Laframboise R, Maranda B, Labuda D, Decarie JC, Rypens F, Goldsher D, Fallet-Bianco C, Soucy JF, Laberge AM, Maftei C, Boycott K, Brais B, Boucher RM, Rouleau GA, Katsanis N, Majewski J, Elpeleg O, Kukolich MK, Shalev S, Michaud JL
  TITLE     Joubert Syndrome in French Canadians and Identification of Mutations in CEP104.
  JOURNAL   Am J Hum Genet 97:744-53 (2015)
DOI:10.1016/j.ajhg.2015.09.009

PMID:26714646 (gene)
  AUTHORS   Sanders AA, de Vrieze E, Alazami AM, Alzahrani F, Malarkey EB, Sorusch N, Tebbe L, Kuhns S, van Dam TJ, Alhashem A, Tabarki B, Lu Q, Lambacher NJ, Kennedy JE, Bowie RV, Hetterschijt L, van Beersum S, van Reeuwijk J, Boldt K, Kremer H, Kesterson RA, Monies D, Abouelhoda M, Roepman R, Huynen MH, Ueffing M, Russell RB, Wolfrum U, Yoder BK, van Wijk E, Alkuraya FS, Blacque OE
  TITLE     KIAA0556 is a novel ciliary basal body component mutated in Joubert syndrome.
  JOURNAL   Genome Biol 16:293 (2015)
DOI:10.1186/s13059-015-0858-z",MeSH,C536293,C536294,C536295,C536296,C537688,C537689,C566916,C567358,C567364,C567582,,,,,,,,,,,,,,,,,,,,
H00737,Peeling skin syndrome,"Peeling skin syndrome (PSS) is a group of rare autosomal recessive disorders characterized by superficial detachment of the epidermal corneal layers. PSS can be divided into two main types, acral PSS (APSS) and generalized PSS. APSS involves the palmar, plantar and dorsal surfaces of hands and feet and is caused by mutations in the transglutaminase 5 gene (TGM5). Generalized PSS can be further divided into the non-inflammatory (type A) and the inflammatory (type B) forms. Recently, it was found that mutations in the corneodesmosin gene (CDSN) underlie PSS type B.",Skin and connective tissue disease,"CDSN [HSA:1041]
TGM5 [HSA:9333] [KO:K05622]
CHST8 [HSA:64377] [KO:K09672]
CSTA [HSA:1475] [KO:K13907]
SERPINB8 [HSA:5271] [KO:K13965]",,,,,,,"ICD-10: Q80.8
MeSH: C564818 C536316
OMIM: 270300 609796 616265 607936 617115","PMID:16935789 (description, gene)
  AUTHORS   Oji V, Traupe H
  TITLE     Ichthyoses: differential diagnosis and molecular genetics.
  JOURNAL   Eur J Dermatol 16:349-59 (2006)

PMID:22066523 (description, gene)
  AUTHORS   Pavlovic S, Krunic AL, Bulj TK, Medenica MM, Fong K, Arita K, McGrath JA
  TITLE     Acral peeling skin syndrome: a clinically and genetically heterogeneous disorder.
  JOURNAL   Pediatr Dermatol 29:258-63 (2012)
DOI:10.1111/j.1525-1470.2011.01563.x

PMID:11100033 (description)
  AUTHORS   Hashimoto K, Hamzavi I, Tanaka K, Shwayder T
  TITLE     Acral peeling skin syndrome.
  JOURNAL   J Am Acad Dermatol 43:1112-9 (2000)
DOI:10.1067/mjd.2000.103645

PMID:21191406 (gene)
  AUTHORS   Israeli S, Zamir H, Sarig O, Bergman R, Sprecher E
  TITLE     Inflammatory peeling skin syndrome caused by a mutation in CDSN encoding corneodesmosin.
  JOURNAL   J Invest Dermatol 131:779-81 (2011)
DOI:10.1038/jid.2010.363

PMID:22289416 (gene)
  AUTHORS   Cabral RM, Kurban M, Wajid M, Shimomura Y, Petukhova L, Christiano AM
  TITLE     Whole-exome sequencing in a single proband reveals a mutation in the CHST8 gene in autosomal recessive peeling skin syndrome.
  JOURNAL   Genomics 99:202-8 (2012)
DOI:10.1016/j.ygeno.2012.01.005

PMID:23534700 (gene)
  AUTHORS   Krunic AL, Stone KL, Simpson MA, McGrath JA
  TITLE     Acral peeling skin syndrome resulting from a homozygous nonsense mutation in the CSTA gene encoding cystatin A.
  JOURNAL   Pediatr Dermatol 30:e87-8 (2013)
DOI:10.1111/pde.12092

PMID:27476651 (gene)
  AUTHORS   Pigors M, Sarig O, Heinz L, Plagnol V, Fischer J, Mohamad J, Malchin N, Rajpopat S, Kharfi M, Lestringant GG, Sprecher E, Kelsell DP, Blaydon DC
  TITLE     Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions.
  JOURNAL   Am J Hum Genet 99:430-6 (2016)
DOI:10.1016/j.ajhg.2016.06.004",MeSH,C564818,C536316,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00483,"Brachydactyly type C, including:
Angel shaped phalangoepiphyseal dysplasia (ASPED)",Brachydactyly represents hereditary limb malformation characterised by apparent shortening of digits. Type C characterized by shortening of multiple phalanges and hyperphalangy. Digit 4 is relatively normal in brachydactyly type C. Transformed middle phalanges with angel-like shape have been observed.,Developmental disorder; Skeletal dysplasia,GDF5 [HSA:8200] [KO:K04664],,,,,,,"MeSH: C537093 C536361
OMIM: 113100 105835","PMID:19790289 (description, gene)
  AUTHORS   Mundlos S
  TITLE     The brachydactylies: a molecular disease family.
  JOURNAL   Clin Genet 76:123-36 (2009)
DOI:10.1111/j.1399-0004.2009.01238.x

PMID:18554391 (description, gene)
  AUTHORS   Temtamy SA, Aglan MS
  TITLE     Brachydactyly.
  JOURNAL   Orphanet J Rare Dis 3:15 (2008)
DOI:10.1186/1750-1172-3-15

PMID:15173244 (description)
  AUTHORS   Holder-Espinasse M, Escande F, Mayrargue E, Dieux-Coeslier A, Fron D, Doual-Bisser A, Boute-Benejean O, Robert Y, Porchet N, Manouvrier-Hanu S
  TITLE     Angel shaped phalangeal dysplasia, hip dysplasia, and positional teeth abnormalities are part of the brachydactyly C spectrum associated with CDMP-1 mutations.
  JOURNAL   J Med Genet 41:e78 (2004)
DOI:10.1136/jmg.2003.013904

PMID:15565340 (description)
  AUTHORS   Castriota-Scanderbeg A, Garaci FG, Beluffi G
  TITLE     Angel-shaped phalanges in brachydactyly C: a case report, and speculation on pathogenesis.
  JOURNAL   Pediatr Radiol 35:535-8 (2005)
DOI:10.1007/s00247-004-1362-x

PMID:12580536 (description)
  AUTHORS   Warashina H, Sakano S, Kitamura S, Yamauchi K, Kito H, Hasegawa Y
  TITLE     Total hip arthroplasty for a patient with angel-shaped phalango-epiphyseal dysplasia (ASPED). A case report.
  JOURNAL   Nagoya J Med Sci 65:103-7 (2002)

PMID:8267010 (description)
  AUTHORS   Giedion A, Prader A, Fliegel C, Krasikov N, Langer L, Poznanski A
  TITLE     Angel-shaped phalango-epiphyseal dysplasia (ASPED): identification of a new genetic bone marker.
  JOURNAL   Am J Med Genet 47:765-71 (1993)
DOI:10.1002/ajmg.1320470534",MeSH,C537093,C536361,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01209,"Deafness, X-linked","Hereditary deafness is divided into syndromic forms (in which hearing loss is associated with a variety of other anomalies) and non-syndromic forms. Non-syndromic forms are responsible for 70% of the cases of hereditary etiology and syndromic cases represent 30% of them. Among the forms of heritage, autosomal-recessive inheritance is the most frequent one (75%-85%), followed by autosomal-dominant inheritance (12-13%) and X-linked or mitochondrial, with 2-3% of the cases of non-syndromic hearing loss. X-linked deafness is clinically and genetically heterogeneous disorder. PRPS1 and POU3F4 have been identified as the genes to be implicated in X-linked non-syndromic hearing loss.",Nervous system disease; Nervous system disease,"PRPS1 [HSA:5631] [KO:K00948]
POU3F4 [HSA:5456] [KO:K09365]",,,,,,,"ICD-10: H91.9
MeSH: C564433 C536424 C564727 C564723 C564472
OMIM: 304500 304400","PMID:16446920 (description, gene)
  AUTHORS   Piatto VB, Nascimento EC, Alexandrino F, Oliveira CA, Lopes AC, Sartorato EL, Maniglia JV
  TITLE     Molecular genetics of non-syndromic deafness.
  JOURNAL   Braz J Otorhinolaryngol 71:216-23 (2005)
DOI:10.1590/S0034-72992005000200016

PMID:20021999 (description, gene)
  AUTHORS   Liu X, Han D, Li J, Han B, Ouyang X, Cheng J, Li X, Jin Z, Wang Y, Bitner-Glindzicz M, Kong X, Xu H, Kantardzhieva A, Eavey RD, Seidman CE, Seidman JG, Du LL, Chen ZY, Dai P, Teng M, Yan D, Yuan H
  TITLE     Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.
  JOURNAL   Am J Hum Genet 86:65-71 (2010)
DOI:10.1016/j.ajhg.2009.11.015

PMID:19671658 (gene)
  AUTHORS   Lee HK, Song MH, Kang M, Lee JT, Kong KA, Choi SJ, Lee KY, Venselaar H, Vriend G, Lee WS, Park HJ, Kwon TK, Bok J, Kim UK
  TITLE     Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein.
  JOURNAL   Physiol Genomics 39:195-201 (2009)
DOI:10.1152/physiolgenomics.00100.2009",MeSH,C564433,C536424,C564727,C564723,C564472,,,,,,,,,,,,,,,,,,,,,,,,,
H00450,"Sclerosing bone dysplasias, including:
Endosteal hyperostosis;
Van Buchem disease type 2","These are a heterogeneous group of genetic disorders characterized by high bone density. These diseases are caused by missense mutations in the LRP5, a co-receptor for Wnt.",Skeletal dysplasia,LRP5 [HSA:4041] [KO:K03068],,,,,,,"ICD-10: Q78.8 Q78.2
MeSH: C536748 C536527
OMIM: 144750 607636","PMID:12579474
  AUTHORS   Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W
  TITLE     Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.
  JOURNAL   Am J Hum Genet 72:763-71 (2003)
DOI:10.1086/368277",MeSH,C536748,C536527,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00611,"IRF6-related disorders, including:
Popliteal pterygium syndrome (PPS);
Van der Woude syndrome (VWS)","Popliteal pterygium syndrome (PPS) and Van der Woude syndrome (VWS) are autosomal dominant orofacial cleft syndromes caused by IRF6 mutations. Clinical manifestations of PPS include cleft lip and/or palate in association with webcausing popliteal connective tissue, syndactyly, and genital abnormalities. VWS shows milder phenotype in which individials with this disorder are born with a cleft lip and cleft palate.",Developmental disorder,IRF6 [HSA:3664] [KO:K10154],,,,,,Isolated orofacial clefts are described in H00516.,"ICD-10: Q38.0 Q68.2 Q87.2
MeSH: C562509 C536528
OMIM: 119500 119300","PMID:20803643 (description, gene)
  AUTHORS   Matsuzawa N, Kondo S, Shimozato K, Nagao T, Nakano M, Tsuda M, Hirano A, Niikawa N, Yoshiura K
  TITLE     Two missense mutations of the IRF6 gene in two Japanese families with popliteal pterygium syndrome.
  JOURNAL   Am J Med Genet A 152A:2262-7 (2010)
DOI:10.1002/ajmg.a.33338

PMID:20301581 (description, gene)
  AUTHORS   Durda KM, Schutte BC, Murray JC
  TITLE     IRF6-Related Disorders
  JOURNAL   GeneReviews (1993)",MeSH,C562509,C536528,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01898,"PNPLA6-related disorders, including:
Boucher-Neuhauser syndrome;
Oliver-McFarlane syndrome;
Laurence-Moon syndrome;
Autosomal recessive spastic paraplegia 39","PNPLA6-related disorders have been implicated in a broad spectrum of neurodegenerative disorders. The phenotypic spectrum includes at least four clinical key features: ataxia, motor neuron disease (upper motor neuron disease with or without additional lower motor neuropathy), hypogonadism, and chorioretinal dystrophy. Although these clinical features appear to be frequent in PNPLA6 disease none of them is an obligate feature of the disease. The majority of the PNPLA6 mutations affect a phospholipid esterase domain in neuropathy target esterase (NTE), which has been shown to de-esterify phosphatidylcholine, a major component of biological membranes, into its constituent fatty acids and glycerophosphocholine. Other phenotypes caused by NTE dysfunction due to PNPLA6 mutations include anterior hypopituitarism, trichomegaly, alopecia, and facial dysmorphisms.",Nervous system disease,PNPLA6 [HSA:10908] [KO:K14676],,,,,,,"ICD-10: Q87.8 G11.8 G11.4
MeSH: C565850 C536554 D007849 C567433
OMIM: 245800 215470 275400 612020","PMID:24355708 (description, gene)
  AUTHORS   Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, Hannequin D, Strom TM, Prokisch H, Kernstock C, Durr A, Schols L, Lima-Martinez MM, Farooq A, Schule R, Stevanin G, Marques W Jr, Zuchner S
  TITLE     PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.
  JOURNAL   Brain 137:69-77 (2014)
DOI:10.1093/brain/awt326

PMID:27866050 (description)
  AUTHORS   Langdahl JH, Frederiksen AL, Nguyen N, Brusgaard K, Juhl CB
  TITLE     Boucher Neuhauser Syndrome - A rare cause of inherited hypogonadotropic hypogonadism. A case of two adult siblings with two novel mutations in PNPLA6.
  JOURNAL   Eur J Med Genet 60:105-109 (2017)
DOI:10.1016/j.ejmg.2016.11.003

PMID:25480986 (description, gene)
  AUTHORS   Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, Krueger LA, Gregory LC, Stoetzel C, Jaworek TJ, Hull S, Li A, Plagnol V, Willen CM, Morgan TM, Prows CA, Hegde RS, Riazuddin S, Grabowski GA, Richardson RJ, Dieterich K, Huang T, Revesz T, Martinez-Barbera JP, Sisk RA, Jefferies C, Houlden H, Dattani MT, Fink JK, Dollfus H, Moore AT, Ahmed ZM
  TITLE     Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.
  JOURNAL   J Med Genet 52:85-94 (2015)
DOI:10.1136/jmedgenet-2014-102856",MeSH,C565850,C536554,D007849,C567433,,,,,,,,,,,,,,,,,,,,,,,,,,
H00609,"46,XY disorders of sex development (Other), including:
Persistent Mullerian duct syndrome;
Hypospadias;
Cryptorchidism","46,XY disorders of sex development (46,XY DSD) with other various causes includes persistent Mullerian duct syndrome, hypospadias, and cryptorchidism. During embryogenesis, regression of the Mullerian duct is induced by anti-Mullerian hormone (AMH) in normal 46,XY individuals. In perisitent Mullerian duct syndrome, mutations of the AMH and AMH receptor produce persistence of the uterus and Fallopian tubes in males. Hypospadias is a congenital malformation with ectopic opening of the urethral meatus. Compromised androgen effects can cause this malformation. Cryptorchidism, or undescended testes, is a condition controlled by AMH and insulin-like hormone 3.",Reproductive system disease,"(Mullerian) AMH [HSA:268] [KO:K04665]
(Mullerian) AMHR2 [HSA:269] [KO:K04672]
(Hypospadias) AR [HSA:367] [KO:K08557]
(Hypospadias) MAMLD1 [HSA:10046] [KO:K19512]
(Cryptorchidism) INSL3 [HSA:3640] [KO:K21999]
(Cryptorchidism) GREAT [HSA:122042] [KO:K04307]",,,,,,,"ICD-10: Q55.8 Q54.8
MeSH: D058490 C536665
OMIM: 261550 300633 300758 219050","PMID:18279784 (description, gene)
  AUTHORS   Hughes IA
  TITLE     Disorders of sex development: a new definition and classification.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 22:119-34 (2008)
DOI:10.1016/j.beem.2007.11.001

PMID:18811725 (description, gene)
  AUTHORS   Mendonca BB, Domenice S, Arnhold IJ, Costa EM
  TITLE     46,XY disorders of sex development (DSD).
  JOURNAL   Clin Endocrinol (Oxf) 70:173-87 (2009)
DOI:10.1111/j.1365-2265.2008.03392.x

PMID:15878900 (description, gene)
  AUTHORS   Josso N, Belville C, di Clemente N, Picard JY
  TITLE     AMH and AMH receptor defects in persistent Mullerian duct syndrome.
  JOURNAL   Hum Reprod Update 11:351-6 (2005)
DOI:10.1093/humupd/dmi014

PMID:21256920 (description, gene)
  AUTHORS   Kalfa N, Philibert P, Baskin LS, Sultan C
  TITLE     Hypospadias: interactions between environment and genetics.
  JOURNAL   Mol Cell Endocrinol 335:89-95 (2011)
DOI:10.1016/j.mce.2011.01.006

PMID:20920735 (description, gene)
  AUTHORS   Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, Southwell BR, Hutson JM
  TITLE     What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis.
  JOURNAL   J Pediatr Surg 45:2074-86 (2010)
DOI:10.1016/j.jpedsurg.2010.07.030",MeSH,D058490,C536665,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00718,Sotos syndrome,"Overgrowth syndromes are a heterogeneous group of disorders resulting from the dysfunction of various processes involving cell proliferation, cell growth, or apoptosis. Within this group, Sotos syndrome is characterised  by overgrowth, multiple congenital anomalies, and developmental delay.  It has been reported that the majority of patients with typical Sotos and Weaver syndrome have intragenic mutations or deletions of NSD1, and thus, represent allelic disorders.",Developmental disorder,NSD1 [HSA:64324] [KO:K15588],,,,,,"Beckwith-Wiedemann syndrome [DS:H00713] is a distinct overgrowth condition, and a few cases could be related to NSD1 deletions or mutations.
See also H01751 Weaver syndrome.","ICD-10: Q87.3
MeSH: D058495 C536687
OMIM: 117550 277590","PMID:12807965
  AUTHORS   Rio M, Clech L, Amiel J, Faivre L, Lyonnet S, Le Merrer M, Odent S, Lacombe D, Edery P, Brauner R, Raoul O, Gosset P, Prieur M, Vekemans M, Munnich A, Colleaux L, Cormier-Daire V
  TITLE     Spectrum of NSD1 mutations in Sotos and Weaver syndromes.
  JOURNAL   J Med Genet 40:436-40 (2003)
DOI:10.1136/jmg.40.6.436

PMID:12464997
  AUTHORS   Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N
  TITLE     NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.
  JOURNAL   Am J Hum Genet 72:132-43 (2003)
DOI:10.1086/345647

PMID:14997421
  AUTHORS   Baujat G, Rio M, Rossignol S, Sanlaville D, Lyonnet S, Le Merrer M, Munnich A, Gicquel C, Cormier-Daire V, Colleaux L
  TITLE     Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome.
  JOURNAL   Am J Hum Genet 74:715-20 (2004)
DOI:10.1086/383093",MeSH,D058495,C536687,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01203,Primary congenital glaucoma (PCG),"Primary congenital glaucoma (PCG) is a severe form of glaucoma that presents early in life. PCG results from developmental abnormalities that affect the aqueous humor outflow pathway. PCG clinical features include elevated IOP, corneal edema, enlargement of the globe (buphthalmos), corneal enlargement, rupture of Descemet's membrane, and optic nerve damage. Two genes have been reported to cause PCG, CYP1B1 and LTBP2. Both genes cause a recessive form of this disease.",Developmental disorder; Eye disease,"(GLC3A) CYP1B1 [HSA:1545] [KO:K07410]
(GLC3D) LTBP2 [HSA:4053] [KO:K08023]",,,,,"Surgery for glaucoma: goniotomy, goniopuncture, trabeculotomy, and trabeculectomy.",,"ICD-10: Q15.0
MeSH: C565547 C536824 C567765
OMIM: 231300 613086","PMID:22128238
  AUTHORS   Abu-Amero KK, Osman EA, Mousa A, Wheeler J, Whigham B, Allingham RR, Hauser MA, Al-Obeidan SA
  TITLE     Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation.
  JOURNAL   Mol Vis 17:2911-9 (2011)

PMID:21081970
  AUTHORS   Azmanov DN, Dimitrova S, Florez L, Cherninkova S, Draganov D, Morar B, Saat R, Juan M, Arostegui JI, Ganguly S, Soodyall H, Chakrabarti S, Padh H, Lopez-Nevot MA, Chernodrinska V, Anguelov B, Majumder P, Angelova L, Kaneva R, Mackey DA, Tournev I, Kalaydjieva L
  TITLE     LTBP2 and CYP1B1 mutations and associated ocular phenotypes in the Roma/Gypsy founder population.
  JOURNAL   Eur J Hum Genet 19:326-33 (2011)
DOI:10.1038/ejhg.2010.181

PMID:21150024
  AUTHORS   Sharaawy T, Bhartiya S
  TITLE     Surgical management of glaucoma: evolving paradigms.
  JOURNAL   Indian J Ophthalmol 59 Suppl:S123-30 (2011)
DOI:10.4103/0301-4738.73692",MeSH,C565547,C536824,C567765,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00531,"Venous malformations, including:
Sporadic venous malformation;
Cutaneomucosal venous malformation;
Glomuvenous malformation","Venous malformations are vascular anomalies that present with congenital blue-colored birthmarks resulted from dilated veins. Venous malformations are low-flow vascular malformations. Majority of them occur in the head and neck region. Birthmarks in cutaneomucosal venous malformation appear mainly on skin and mucosa, whereas plaques in glomuvenous malformation are located on the extremities, usually nodular and associated with abnormal smooth muscle-like 'glomus cells'. Most cases are unifocal, with extensive venous malformations accounting for only one percent of cases and more commonly manifesting as rare, inherited forms. Venous malformations will grow with age, infiltrating normal structures. They can give rise to functional disabilities, including obstruction to airway and swallowing difficulties. Also, they can cause visual or auditory disturbance and delayed speech development. In addition, bleeding, pain, infection, skeletal deformity, and cosmetic disfigurement may occur. Active treatment of venous malformations is indicated especially in head and neck region. Surgery can cause damage to normal surrounding structures, resulting in significant disfigurement and loss of function. Complete excision is often impossible for infiltrative lesions. Sclerotherapy has gained popularity recently and become the first-line treatment for venous malformations in head and neck region.",Developmental disorder; Vascular disease,"(sporadic, cutaneomucosal) TIE2 [HSA:7010] [KO:K05121]
(glomuvenous) GLMN [HSA:11146]",,,,,,,"ICD-10: Q27.3
MeSH: C563977 C536827
OMIM: 600195 138000","PMID:26483982
  AUTHORS   Amato MV, Patel NA, Hu S, Pantelides H
  TITLE     Sporadic Multifocal Venous Malformations of the Head and Neck.
  JOURNAL   Case Rep Otolaryngol 2015:508149 (2015)
DOI:10.1155/2015/508149

PMID:24008546
  AUTHORS   Leung M, Leung L, Fung D, Poon WL, Liu C, Chung K, Tang P, Tse S, Fan TW, Chao N, Liu K
  TITLE     Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
  JOURNAL   Eur J Pediatr Surg 24:97-101 (2014)
DOI:10.1055/s-0033-1354585

PMID:17670762 (description, gene)
  AUTHORS   Brouillard P, Vikkula M
  TITLE     Genetic causes of vascular malformations.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R140-9 (2007)
DOI:10.1093/hmg/ddm211

PMID:16379592 (description, gene)
  AUTHORS   Wang QK
  TITLE     Update on the molecular genetics of vascular anomalies.
  JOURNAL   Lymphat Res Biol 3:226-33 (2005)
DOI:10.1089/lrb.2005.3.226

PMID:19079259 (gene)
  AUTHORS   Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, Eklund L, Boon LM, Vikkula M
  TITLE     Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.
  JOURNAL   Nat Genet 41:118-24 (2009)
DOI:10.1038/ng.272",MeSH,C563977,C536827,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00178,"Glutaric acidemia, including:
Glutaric acidemia, type I (GA1);
Glutaric acidemia, type II (GA2);
Multiple acyl coenzyme A dehydrogenase deficiency",Glutaric aciduria type I is an autosomal recessive disorder resulting from a deficiency of glutaryl-CoA dehydrogenase leading to an accumulation of glutaric and 3-hydroxyglutaric acids and secondary carnitine deficiency. Glutaric aciduria type II is caused by a deficiency of either electron transport flavoprotein or of electron transport flavoprotein oxoreductase.,Inherited metabolic disease,"(GA1) GCDH; glutaryl-CoA dehydrogenase [HSA:2639] [KO:K00252]
(GA2) ETFA; electron transfer flavoprotein alpha subunit [HSA:2108] [KO:K03522]
(GA2) ETFB; electron transfer flavoprotein beta subunit [HSA:2109] [KO:K03521]
(GA2) ETFDH; electron-transferring-flavoprotein dehydrogenase [HSA:2110] [KO:K00311]
(GA3) SUGCT; succinate--hydroxymethylglutarate CoA-transferase [HSA:79783] [KO:K18703]",,,,"(GA1) 3-hydroxyglutarate
(GA2) 2-hydroxyglutarate [CPD:C02630]
(GA2) Methylmalonate [CPD:C02170]
(GA2) Hippurate [CPD:C01586]
(GA2) adipic acid","Baclofen [DR:D00241]
Riboflavin [DG:DG00130]
Carnitine [DR:D02030]
Sodium-D,L-3-hydroxybutyrate",,"ICD-10: E71.3 E72.3
MeSH: D054069 C536833
OMIM: 231670 231680 231690","PMID:16368216
  AUTHORS   Gordon N
  TITLE     Glutaric aciduria types I and II.
  JOURNAL   Brain Dev 28:136-40 (2006)
DOI:10.1016/j.braindev.2005.06.010

PMID:23893049
  AUTHORS   Marlaire S, Van Schaftingen E, Veiga-da-Cunha M
  TITLE     C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA.
  JOURNAL   J Inherit Metab Dis 37:13-9 (2014)
DOI:10.1007/s10545-013-9632-0",MeSH,D054069,C536833,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00890,"Azoospermia, including:
Azoospermia;
Azoospermia due to perturbations of meiosis",Azoospermia is a disorder in which there is a complete absence of sperm in the semen. It is classified as obstructive azoospermia caused by problems with sperm transport and nonobstructive azoospermia caused by failure of spermatogenesis. Y-linked gene USP9Y has been implicated in moderate oligoasthenoteratozoospermia and azoospermia. SYCP3 mutations lead to complete infertility due to meiotic arrest.,Reproductive system disease,"USP9Y [HSA:8287] [KO:K11840]
(meiosis) SYCP3 [HSA:50511] [KO:K19528]",,,,,,,"ICD-10: N46
MeSH: D053713 C536875
OMIM: 415000 270960","PMID:21195467 (description)
  AUTHORS   Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A
  TITLE     Role of genetics in azoospermia.
  JOURNAL   Urology 77:598-601 (2011)
DOI:10.1016/j.urology.2010.10.001

PMID:19246366 (description, gene)
  AUTHORS   Tyler-Smith C, Krausz C
  TITLE     The will-o'-the-wisp of genetics--hunting for the azoospermia factor gene.
  JOURNAL   N Engl J Med 360:925-7 (2009)
DOI:10.1056/NEJMe0900301

PMID:19246359 (description, gene)
  AUTHORS   Luddi A, Margollicci M, Gambera L, Serafini F, Cioni M, De Leo V, Balestri P, Piomboni P
  TITLE     Spermatogenesis in a man with complete deletion of USP9Y.
  JOURNAL   N Engl J Med 360:881-5 (2009)
DOI:10.1056/NEJMoa0806218

PMID:14643120 (description, gene)
  AUTHORS   Miyamoto T, Hasuike S, Yogev L, Maduro MR, Ishikawa M, Westphal H, Lamb DJ
  TITLE     Azoospermia in patients heterozygous for a mutation in SYCP3.
  JOURNAL   Lancet 362:1714-9 (2003)
DOI:10.1016/S0140-6736(03)14845-3

PMID:19110213 (description)
  AUTHORS   Bolor H, Mori T, Nishiyama S, Ito Y, Hosoba E, Inagaki H, Kogo H, Ohye T, Tsutsumi M, Kato T, Tong M, Nishizawa H, Pryor-Koishi K, Kitaoka E, Sawada T, Nishiyama Y, Udagawa Y, Kurahashi H
  TITLE     Mutations of the SYCP3 gene in women with recurrent pregnancy loss.
  JOURNAL   Am J Hum Genet 84:14-20 (2009)
DOI:10.1016/j.ajhg.2008.12.002",MeSH,D053713,C536875,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00484,"Other brachydactylies, including:
Proximal symphalangism;
Multiple synostosis syndrome","Proximal symphalangism is an autosomal-dominant condition characterized by variable fusion of the proximal interphalangeal joints. Multiple synostosis syndrome is a more severe form of proximal symphalangism with additional bone fusions involving carpal, tarsal, and other joints.",Skeletal dysplasia; Developmental disorder,"GDF5 [HSA:8200] [KO:K04664]
NOG [HSA:9241] [KO:K04658]
FGF9 [HSA:2254] [KO:K04358]",,,,,,,"ICD-10: Q70.9 Q87.8
MeSH: C536223 C536943 C537380 C567839
OMIM: 185800 186500 610017 612961","PMID:19790289 (description, gene)
  AUTHORS   Mundlos S
  TITLE     The brachydactylies: a molecular disease family.
  JOURNAL   Clin Genet 76:123-36 (2009)
DOI:10.1111/j.1399-0004.2009.01238.x

PMID:18283415 (description, gene)
  AUTHORS   Yang W, Cao L, Liu W, Jiang L, Sun M, Zhang D, Wang S, Lo WH, Luo Y, Zhang X
  TITLE     Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism.
  JOURNAL   J Hum Genet 53:368-74 (2008)
DOI:10.1007/s10038-008-0253-7

PMID:17994231 (description, gene)
  AUTHORS   Plett SK, Berdon WE, Cowles RA, Oklu R, Campbell JB
  TITLE     Cushing proximal symphalangism and the NOG and GDF5 genes.
  JOURNAL   Pediatr Radiol 38:209-15 (2008)
DOI:10.1007/s00247-007-0675-y

PMID:7428777 (description)
  AUTHORS   Pedersen JC, Fryns JP, Carpentier G, Heremans G, Van den Berghe H
  TITLE     Multiple synostosis syndrome.
  JOURNAL   Eur J Pediatr 134:273-5 (1980)
DOI:10.1007/BF00441486

PMID:16532400
  AUTHORS   Dawson K, Seeman P, Sebald E, King L, Edwards M, Williams J 3rd, Mundlos S, Krakow D
  TITLE     GDF5 is a second locus for multiple-synostosis syndrome.
  JOURNAL   Am J Hum Genet 78:708-12 (2006)
DOI:10.1086/503204

PMID:19589401
  AUTHORS   Wu XL, Gu MM, Huang L, Liu XS, Zhang HX, Ding XY, Xu JQ, Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, Fei J, Chen Z, Yuan ZM, Wang ZG
  TITLE     Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.
  JOURNAL   Am J Hum Genet 85:53-63 (2009)
DOI:10.1016/j.ajhg.2009.06.007",MeSH,C536223,C536943,C537380,C567839,,,,,,,,,,,,,,,,,,,,,,,,,,
H00784,Localized autosomal recessive hypotrichosis,"Localized autosomal recessive hypotrichosis is a rare non-syndromic human alopecia/hypotrichosis that is inherited as an autosomal recessive trait. Affected individuals display short, sparse hairs on the scalp, trunk, and extremities. Facial hair including the eye-brows, eye-lashes and beard show a broad range of hypotrichosis from almost normal to less dense condition. Patients' skin is normal.",Skin and connective tissue disease,"HR [HSA:55806] [KO:K00478]
DSG4 [HSA:147409] [KO:K07599]
P2Y5 [HSA:10161] [KO:K04273]
VDR [HSA:7421] [KO:K08539]
LIPH [HSA:200879] [KO:K19404]",,,,,,,"MeSH: C564312 C536973 C566950
OMIM: 607903 611452 604379","PMID:12705872 (description, gene)
  AUTHORS   Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaughnessy R, Mahoney MG, Levy M, Montagutelli X, Ahmad W, Aita VM, Gordon D, Uitto J, Whiting D, Ott J, Fischer S, Gilliam TC, Jahoda CA, Morris RJ, Panteleyev AA, Nguyen VT, Christiano AM
  TITLE     Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris.
  JOURNAL   Cell 113:249-60 (2003)
DOI:10.1016/S0092-8674(03)00273-3

PMID:17392831 (description, gene)
  AUTHORS   Wajid M, Bazzi H, Rockey J, Lubetkin J, Zlotogorski A, Christiano AM
  TITLE     Localized autosomal recessive hypotrichosis due to a frameshift mutation in the desmoglein 4 gene exhibits extensive phenotypic variability within a Pakistani family.
  JOURNAL   J Invest Dermatol 127:1779-82 (2007)
DOI:10.1038/sj.jid.5700791

PMID:18297070 (description, gene)
  AUTHORS   Pasternack SM, von Kugelgen I, Aboud KA, Lee YA, Ruschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, Ramirez A, Nurnberg P, Nothen MM, Betz RC
  TITLE     G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth.
  JOURNAL   Nat Genet 40:329-34 (2008)
DOI:10.1038/ng.84

PMID:17095700 (description, gene)
  AUTHORS   Kazantseva A, Goltsov A, Zinchenko R, Grigorenko AP, Abrukova AV, Moliaka YK, Kirillov AG, Guo Z, Lyle S, Ginter EK, Rogaev EI
  TITLE     Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH.
  JOURNAL   Science 314:982-5 (2006)
DOI:10.1126/science.1133276

PMID:11564167 (description, gene)
  AUTHORS   Miller J, Djabali K, Chen T, Liu Y, Ioffreda M, Lyle S, Christiano AM, Holick M, Cotsarelis G
  TITLE     Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene.
  JOURNAL   J Invest Dermatol 117:612-7 (2001)
DOI:10.1046/j.0022-202x.2001.01438.x

PMID:17609203 (description)
  AUTHORS   Wang J, Malloy PJ, Feldman D
  TITLE     Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions.
  JOURNAL   J Biol Chem 282:25231-9 (2007)
DOI:10.1074/jbc.M702939200

PMID:21919222 (description)
  AUTHORS   Azeem Z, Wasif N, Basit S, Razak S, Waheed RA, Islam A, Ayub M, Kafaitullah, Kamran-ul-hassan Naqvi S, Ali G, Ahmad W
  TITLE     Congenital atrichia with papular lesions resulting from novel mutations in human hairless gene in four consanguineous families.
  JOURNAL   J Dermatol 38:755-60 (2011)
DOI:10.1111/j.1346-8138.2010.01151.x",MeSH,C564312,C536973,C566950,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01210,Hypomagnesemia,"Hypomagnesemia is defined as a serum magnesium level less than 1.8 mg/dl. Hypomagnesemia may result from inadequate magnesium intake, increased gastrointestinal or renal losses, or redistribution from extracellular to intracellular space.",Inherited metabolic disease,"TRPM6 [HSA:140803] [KO:K04981]
FXYD2 [HSA:486] [KO:K01538]
CLDN16 [HSA:10686] [KO:K06087]
EGF [HSA:1950] [KO:K04357]
CLDN19 [HSA:149461] [KO:K06087]",,Furosemide [DR:D00331],,,"Magnesium oxide [DR:D01167]
Magnesium sulfate heptahydrate [DR:D01108]",Gitelman syndrome is described in H00240. [DS:H00240],"ICD-10: E83.4
MeSH: C566593 C537152 C537153 C564024 C567127
OMIM: 602014 154020 248250 248190 611718","PMID:20081299
  AUTHORS   Assadi F
  TITLE     Hypomagnesemia: an evidence-based approach to clinical cases.
  JOURNAL   Iran J Kidney Dis 4:13-9 (2010)

PMID:24699222 (gene)
  AUTHORS   Arjona FJ, de Baaij JH, Schlingmann KP, Lameris AL, van Wijk E, Flik G, Regele S, Korenke GC, Neophytou B, Rust S, Reintjes N, Konrad M, Bindels RJ, Hoenderop JG
  TITLE     CNNM2 mutations cause impaired brain development and seizures in patients with hypomagnesemia.
  JOURNAL   PLoS Genet 10:e1004267 (2014)
DOI:10.1371/journal.pgen.1004267",MeSH,C566593,C537152,C537153,C564024,C567127,,,,,,,,,,,,,,,,,,,,,,,,,
H00492,"SHOX-related haploinsufficiency disorders, including:
Isolated short stature;
Langer syndrome;
Leri-Weill syndrome","Isolated short stature, Leri-Weill and Langer syndromes are conditions with growth retardation. Patients also exhibit mesomelic shortening in Leri-Weill and Langer syndromes. These conditions are due to mutations in SHOX gene within the pseudoautosomal regions of sex chromosomes.",Skeletal dysplasia,SHOX [HSA:6473] [KO:K09331],,,,,,,"ICD-10: E34.3 Q87.1 Q77.8
MeSH: C564479 C537267 C537119
OMIM: 300582 249700 127300","PMID:16650979 (gene)
  AUTHORS   Blaschke RJ, Rappold G
  TITLE     The pseudoautosomal regions, SHOX and disease.
  JOURNAL   Curr Opin Genet Dev 16:233-9 (2006)
DOI:10.1016/j.gde.2006.04.004

PMID:16807223 (description, gene)
  AUTHORS   Leka SK, Kitsiou-Tzeli S, Kalpini-Mavrou A, Kanavakis E
  TITLE     Short stature and dysmorphology associated with defects in the SHOX gene.
  JOURNAL   Hormones (Athens) 5:107-18 (2006)
DOI:10.14310/horm.2002.11174

PMID:11408757 (description, gene)
  AUTHORS   Blaschke RJ, Rappold GA
  TITLE     SHOX in short stature syndromes.
  JOURNAL   Horm Res 55 Suppl 1:21-3 (2001)
DOI:10.1159/000063458",MeSH,C564479,C537267,C537119,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00407,"Peroxisomal beta-oxidation enzyme deficiency, including:
Acyl-CoA oxidase (ACOX) deficiency;
D-bifunctional protein (DBP) deficiency;
Perrault syndrome;
Sterol carrier protein X (SCPx) deficiency;
2-Methylacyl-CoA racemase (AMCR) deficiency;
Hypercholanemia [DS:H01935]","Peroxisomal beta-oxidation enzyme deficiency is a group of inherited peroxisomal diseases caused by mutation of one of genes that encode peroxisomal fatty acid beta-oxidation system enzymes. The system includes straight-chain acyl-CoA oxidase (ACOX1), 2-methylacyl CoA racemase (AMACR), D-bifunctional protein (DBP) and sterol carrier protein X (SCPx). It is known that some types of fatty acids including very-long-chain fatty acids (VLCFA), branched-chain fatty acid, and the bile acid synthesis intermediates, rely fully on peroxisomes for beta-oxidation. The enzyme defects result in the accumulation of these fatty acids in many organs. The clinical manifestations mimic those of the Zellweger syndrome spectrum. [DS:H00205]",Inherited metabolic disease; Peroxisomal disease,"ACOX1; acyl-CoA oxidase 1 [HSA:51] [KO:K00232]
AMACR; alpha-methylacyl-CoA racemase [HSA:23600] [KO:K01796]
SCL2; sterol carrier protein 2 [HSA:6342] [KO:K08764]
HSD17B4; D-bifunctional protein [HSA:3295] [KO:K12405]
BAAT; bile acid-CoA:amino acid N-acyltransferase [HSA:570] [KO:K00659]",,,,"(ACOX1, DBP) increased VLCFA
(SCPx, AMACR) increased phytanic acid [CPD:C01607] and pristanic acid",,,"ICD-10: E71.3
MeSH: C536662 C537286 C565768 C535444 C564336
OMIM: 264470 261515 614307 214950 607748 233400","PMID:17347916
  AUTHORS   Shimozawa N
  TITLE     Molecular and clinical aspects of peroxisomal diseases.
  JOURNAL   J Inherit Metab Dis 30:193-7 (2007)
DOI:10.1007/s10545-007-0516-z

PMID:16376506
  AUTHORS   Funato M, Shimozawa N, Nagase T, Takemoto Y, Suzuki Y, Imamura Y, Matsumoto T, Tsukamoto T, Kojidani T, Osumi T, Fukao T, Kondo N
  TITLE     Aberrant peroxisome morphology in peroxisomal beta-oxidation enzyme deficiencies.
  JOURNAL   Brain Dev 28:287-92 (2006)
DOI:10.1016/j.braindev.2005.10.010

PMID:20064629
  AUTHORS   Wanders RJ, Ferdinandusse S, Brites P, Kemp S
  TITLE     Peroxisomes, lipid metabolism and lipotoxicity.
  JOURNAL   Biochim Biophys Acta 1801:272-80 (2010)
DOI:10.1016/j.bbalip.2010.01.001",MeSH,C536662,C537286,C565768,C535444,C564336,,,,,,,,,,,,,,,,,,,,,,,,,
H00263,"Acrocallosal syndrome;
Greig cephalopolysyndactyly syndrome","Acrocallosal syndrome is an autosomal recessive condition, characterized by agenesis of the corpus callosum, polydactyly, minor craniofacial anomalies and psychomotor retardation.",Nervous system disease; Skeletal dysplasia,GLI3 [HSA:2737] [KO:K06230],,,,,,,"ICD-10: Q04.0
MeSH: D055673 C537300
OMIM: 200990 175700","PMID:18435847
  AUTHORS   Biesecker LG
  TITLE     The Greig cephalopolysyndactyly syndrome.
  JOURNAL   Orphanet J Rare Dis 3:10 (2008)
DOI:10.1186/1750-1172-3-10

PMID:12414818
  AUTHORS   Elson E, Perveen R, Donnai D, Wall S, Black GC
  TITLE     De novo GLI3 mutation in acrocallosal syndrome: broadening the phenotypic spectrum of GLI3 defects and overlap with murine models.
  JOURNAL   J Med Genet 39:804-6 (2002)
DOI:10.1136/jmg.39.11.804

PMID:11857542
  AUTHORS   Koenig R, Bach A, Woelki U, Grzeschik KH, Fuchs S
  TITLE     Spectrum of the acrocallosal syndrome.
  JOURNAL   Am J Med Genet 108:7-11 (2002)
DOI:10.1002/ajmg.10236

PMID:15739154
  AUTHORS   Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG
  TITLE     Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.
  JOURNAL   Am J Hum Genet 76:609-22 (2005)
DOI:10.1086/429346",MeSH,D055673,C537300,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01226,"GLI3 morphopathies, including:
Greig cephalopolysyndactyly syndrome [DS:H00263];
Pallister-Hall syndrome [DS:H00502];
Preaxial polydactyly type-IV;
Postaxial polydactyly types A1 and B","GLI3 morphopathies are autosomal dominant developmental defect syndromes, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV, and postaxial polydactyly. All GLI3 morphopathies show malformations of the autopod, such as polydactylies or syndactylies. Heterozygous mutations in human GLI3, a zinc-finger transcription factor, are associated with these syndromes. GLI3 is regarded as a mediator of sonic hedgehog signaling regulating development at multiple sites such as the limbs, the lungs, and the brain.",Developmental disorder; Skeletal dysplasia,GLI3 [HSA:2737] [KO:K06230],,,,,,,"ICD-10: Q69.1
MeSH: D054975 C537300
OMIM: 175700 146510 174700 174200","PMID:15811011
  AUTHORS   Fujioka H, Ariga T, Horiuchi K, Otsu M, Igawa H, Kawashima K, Yamamoto Y, Sugihara T, Sakiyama Y
  TITLE     Molecular analysis of non-syndromic preaxial polydactyly: preaxial polydactyly type-IV and preaxial polydactyly type-I.
  JOURNAL   Clin Genet 67:429-33 (2005)
DOI:10.1111/j.1399-0004.2005.00431.x

PMID:10441570
  AUTHORS   Radhakrishna U, Bornholdt D, Scott HS, Patel UC, Rossier C, Engel H, Bottani A, Chandal D, Blouin JL, Solanki JV, Grzeschik KH, Antonarakis SE
  TITLE     The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; No phenotype prediction from the position of GLI3 mutations.
  JOURNAL   Am J Hum Genet 65:645-55 (1999)
DOI:10.1086/302557

PMID:17661744
  AUTHORS   Paparidis Z, Abbasi AA, Malik S, Goode DK, Callaway H, Elgar G, deGraaff E, Lopez-Rios J, Zeller R, Grzeschik KH
  TITLE     Ultraconserved non-coding sequence element controls a subset of spatiotemporal GLI3 expression.
  JOURNAL   Dev Growth Differ 49:543-53 (2007)
DOI:10.1111/j.1440-169X.2007.00954.x",MeSH,D054975,C537300,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00493,"Heparan sulfate proteoglycan gene defects, including:
Dyssegmental dysplasia, Silverman-Handmaker type;
Schwartz-Jampel syndrome;
Simpson-Golabi-Behmel syndrome, type 1;
Omodysplasia 1;
Multiple exostoses","Defects in heparan sulfate proteoglycans (HSPGs), which present in cartilage, are associated with skeletal growth disorders. Mutations in either HS biosynthetic enzymes or HS proteoglycan core proteins have been reported so far.",Skeletal dysplasia,"(Silverman-Handmaker, Schwartz-Jampel) HSPG2 [HSA:3339] [KO:K06255]
(Simpson-Golabi-Behmel) GPC3 [HSA:2719] [KO:K08109]
(Omodysplasia 1) GPC6 [HSA:10082] [KO:K08112]
(Multiple exostoses) EXT1 [HSA:2131] [KO:K02366]
(Multiple exostoses) EXT2 [HSA:2132] [KO:K02367]",,,,,,,"ICD-10: Q87.1 G71.1 Q87.8 Q78.6
MeSH: C537998 C537340 C537746 D005097
OMIM: 224410 255800 312870 258315 133700 133701","PMID:12042245 (description, gene)
  AUTHORS   Schwartz NB, Domowicz M
  TITLE     Chondrodysplasias due to proteoglycan defects.
  JOURNAL   Glycobiology 12:57R-68R (2002)
DOI:10.1093/glycob/12.4.57R

PMID:12975604 (description, gene)
  AUTHORS   Hassell J, Yamada Y, Arikawa-Hirasawa E
  TITLE     Role of perlecan in skeletal development and diseases.
  JOURNAL   Glycoconj J 19:263-7 (2002)
DOI:10.1023/A:1025340215261

PMID:15831077 (description)
  AUTHORS   Farach-Carson MC, Hecht JT, Carson DD
  TITLE     Heparan sulfate proteoglycans: key players in cartilage biology.
  JOURNAL   Crit Rev Eukaryot Gene Expr 15:29-48 (2005)

PMID:14566439 (description)
  AUTHORS   Elcioglu NH, Gustavson KH, Wilkie AO, Yuksel-Apak M, Spranger JW
  TITLE     Recessive omodysplasia: five new cases and review of the literature.
  JOURNAL   Pediatr Radiol 34:75-82 (2004)
DOI:10.1007/s00247-003-1064-9

PMID:19481194 (gene)
  AUTHORS   Campos-Xavier AB, Martinet D, Bateman J, Belluoccio D, Rowley L, Tan TY, Baxova A, Gustavson KH, Borochowitz ZU, Innes AM, Unger S, Beckmann JS, Mittaz L, Ballhausen D, Superti-Furga A, Savarirayan R, Bonafe L
  TITLE     Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.
  JOURNAL   Am J Hum Genet 84:760-70 (2009)
DOI:10.1016/j.ajhg.2009.05.002",MeSH,C537998,C537340,C537746,D005097,,,,,,,,,,,,,,,,,,,,,,,,,,
H00174,"Methylmalonic aciduria (MMA);
Methylmalonic acidemia","Methylmalonic aciduria (MMA) is caused by a deficiency of methylmalonyl-CoA mutase, which is a vitamin B12-dependent enzyme. Defects of adenosylcobalamin metabolism lead to variant forms of MMA.",Inherited metabolic disease; Nervous system disease,"MUT; methylmalonyl-CoA mutase [HSA:4594] [KO:K01847]
MMAA [HSA:166785] [KO:K07588]
MMAB [HSA:326625] [KO:K00798]
LMBRD1 [HSA:55788] [KO:K14617]
MMACHC [HSA:25974] [KO:K14618]
MMADHC [HSA:27249]
MCEE [HSA:84693] [KO:K05606]
ABCD4 [HSA:5826] [KO:K05678]",,,,"(blood and urine) Methylmalonic acid [CPD:C02170]
(urine) Propanoic acid [CPD:C00163], 3-Hydroxypropionic acid [CPD:C01013]
(blood) Propionylcarnitine [CPD:C03017]
Acylcarnitine [CPD:C02301]",Vitamin B12 [DR:D00191],,"ICD-10: E71.1
MeSH: C537358 C537359 C564743 C564747
OMIM: 251000 251100 251110 277380 277400 277410 251120 614857","PMID:16602092
  AUTHORS   Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C
  TITLE     Methylmalonic and propionic aciduria.
  JOURNAL   Am J Med Genet C Semin Med Genet 142C:104-12 (2006)
DOI:10.1002/ajmg.c.30090

PMID:12069539
  AUTHORS   Ogier de Baulny H, Saudubray JM
  TITLE     Branched-chain organic acidurias.
  JOURNAL   Semin Neonatol 7:65-74 (2002)
DOI:10.1053/siny.2001.0087

PMID:16752391
  AUTHORS   Bikker H, Bakker HD, Abeling NG, Poll-The BT, Kleijer WJ, Rosenblatt DS, Waterham HR, Wanders RJ, Duran M
  TITLE     A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria.
  JOURNAL   Hum Mutat 27:640-3 (2006)
DOI:10.1002/humu.20373

PMID:22922874
  AUTHORS   Coelho D, Kim JC, Miousse IR, Fung S, du Moulin M, Buers I, Suormala T, Burda P, Frapolli M, Stucki M, Nurnberg P, Thiele H, Robenek H, Hohne W, Longo N, Pasquali M, Mengel E, Watkins D, Shoubridge EA, Majewski J, Rosenblatt DS, Fowler B, Rutsch F, Baumgartner MR
  TITLE     Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism.
  JOURNAL   Nat Genet 44:1152-5 (2012)
DOI:10.1038/ng.2386",MeSH,C537358,C537359,C564743,C564747,,,,,,,,,,,,,,,,,,,,,,,,,,
H00514,Bruck syndrome,"Bruck syndrome is a recessively-inherited form of osteogenesis imperfecta in combination with pterygium formation across large joints. In Bruck syndrome, joint mobility is significantly reduced, showing arthrogryposis multiplex congenita.",Skeletal dysplasia,"PLOD2 [HSA:5352] [KO:K13645]
FKBP10 [HSA:60681] [KO:K09575]",,,,,,,"ICD-10: Q78.0
MeSH: C537406 C537407
OMIM: 609220","PMID:15523624 (description, gene)
  AUTHORS   Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, Bonafe L
  TITLE     Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2.
  JOURNAL   Am J Med Genet A 131:115-20 (2004)
DOI:10.1002/ajmg.a.30231

PMID:21567934 (description, gene)
  AUTHORS   Shaheen R, Al-Owain M, Faqeih E, Al-Hashmi N, Awaji A, Al-Zayed Z, Alkuraya FS
  TITLE     Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans.
  JOURNAL   Am J Med Genet A 155A:1448-52 (2011)
DOI:10.1002/ajmg.a.34025",MeSH,C537406,C537407,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01008,"C syndrome, including:
Opitz trigonocephaly syndrome;
Bohring-Opitz syndrome (BOPS)","The C syndrome/ Opitz trigonocephaly syndrome is characterized by trigonocephaly and associated anomalies, such as unusual facies, psychomotor retardation, redundant skin, joint and limb abnormalities, and visceral anomalies. The C syndrome is caused by mutations in CD96, a member of the immunoglobulin superfamily. Because of close similarity between both syndromes, Bohring-Opitz syndrome (BOPS) is considered the more severe form of the C syndrome, therefore known as C-like syndrome. Recently, It has been reported that de novo nonsense mutations in ASXL1 cause BOPS.",Developmental disorder,"CD96 [HSA:10225] [KO:K06517]
(BOPS) ASXL1 [HSA:171023] [KO:K11471]",,,,,,,"ICD-10: Q87.8
MeSH: C537418 C537419
OMIM: 211750 605039","PMID:17847009
  AUTHORS   Kaname T, Yanagi K, Chinen Y, Makita Y, Okamoto N, Maehara H, Owan I, Kanaya F, Kubota Y, Oike Y, Yamamoto T, Kurosawa K, Fukushima Y, Bohring A, Opitz JM, Yoshiura K, Niikawa N, Naritomi K
  TITLE     Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome.
  JOURNAL   Am J Hum Genet 81:835-41 (2007)
DOI:10.1086/522014

PMID:16691589
  AUTHORS   Bohring A, Oudesluijs GG, Grange DK, Zampino G, Thierry P
  TITLE     New cases of Bohring-Opitz syndrome, update, and critical review of the literature.
  JOURNAL   Am J Med Genet A 140:1257-63 (2006)
DOI:10.1002/ajmg.a.31265

PMID:21706002
  AUTHORS   Hoischen A, van Bon BW, Rodriguez-Santiago B, Gilissen C, Vissers LE, de Vries P, Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S, Goodship J, McGowan R, Bartholdi D, Rauch A, Peippo M, Cobben JM, Wieczorek D, Gillessen-Kaesbach G, Veltman JA, Brunner HG, de Vries BB
  TITLE     De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
  JOURNAL   Nat Genet 43:729-31 (2011)
DOI:10.1038/ng.868",MeSH,C537418,C537419,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01752,"ATR-X syndrome;
X-linked alpha-thalassemia/mental retardation syndrome","X-linked alpha-thalassemia/mental retardation syndrome (ATR-X syndrome) is a rare syndromic form of X-linked mental retardation. It is characterized by severe mental retardation in males, characteristic facial appearance, alpha thalassaemia, genital anomalies, skeletal abnormalities, and characteristic posture and/or behavior. ATR-X syndrome is caused by a mutation in the ATRX gene, a critical factor involved in heterochromatin formation at mammalian centromeres and telomeres.",Developmental disorder; Hematologic disease; Mental retardation,ATRX [HSA:546] [KO:K10779],,,,,,"The X-linked mental retardation-hypotonic facies syndrome (MRXHF1) is also caused by mutation in the ATRX gene. MRXHF1 comprises several syndromes previously reported separately. These include Juberg-Marsidi, Carpenter-Waziri, Holmes-Gang, and Smith-Fineman-Myers syndromes. See also H00228 Thalassemia and H00577 Syndromic X-linked mental retardation.","ICD-10: Q87.0
MeSH: C538258 C537457
OMIM: 301040 309580","PMID:16100724
  AUTHORS   Wada T, Sugie H, Fukushima Y, Saitoh S
  TITLE     Non-skewed X-inactivation may cause mental retardation in a female carrier of X-linked alpha-thalassemia/mental retardation syndrome (ATR-X): X-inactivation study of nine female carriers of ATR-X.
  JOURNAL   Am J Med Genet A 138:18-20 (2005)
DOI:10.1002/ajmg.a.30901

PMID:17579672 (gene)
  AUTHORS   Thienpont B, de Ravel T, Van Esch H, Van Schoubroeck D, Moerman P, Vermeesch JR, Fryns JP, Froyen G, Lacoste C, Badens C, Devriendt K
  TITLE     Partial duplications of the ATRX gene cause the ATR-X syndrome.
  JOURNAL   Eur J Hum Genet 15:1094-7 (2007)
DOI:10.1038/sj.ejhg.5201878

PMID:21653732 (gene)
  AUTHORS   De La Fuente R, Baumann C, Viveiros MM
  TITLE     Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.
  JOURNAL   Reproduction 142:221-34 (2011)
DOI:10.1530/REP-10-0380",MeSH,C538258,C537457,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01174,"Congenital diarrhea, including:
Congenital chloride diarrhea (DIAR1);
Microvillus inclusion disease (DIAR2);
Congenital sodium diarrhea (DIAR3);
Congenital malabsorptive diarrhea (DIAR4);
Congenital tufting enteropathy (DIAR5)","Congenital diarrheas are a group of rare chronic enteropathies characterized by a heterogeneous etiology. In the first weeks of life, patients usually present with severe diarrhea that within a few hours leads to a life-threatening condition secondary to massive dehydration and metabolic acidosis.",Gastrointestinal disease,"(DIAR1) SLC26A3 [HSA:1811] [KO:K14078]
(DIAR2) MYO5B [HSA:4645] [KO:K10357]
(DIAR3) SPINT2 [HSA:10653]
(DIAR4) NEUROG3 [HSA:50674] [KO:K08028]
(DIAR5) EPCAM [HSA:4072] [KO:K06737]
(DIAR6) GUCY2C [HSA:2984] [KO:K12320]
(DIAR7) DGAT1 [HSA:8694] [KO:K11155]
(DIAR8) SLC9A3 [HSA:6550] [KO:K12040]",,,,,,,"ICD-10: P78.3
MeSH: C536210 C537470 C562576
OMIM: 214700 251850 270420 610370 613217 614616 615863 616868","PMID:20216094
  AUTHORS   Berni Canani R, Terrin G, Cardillo G, Tomaiuolo R, Castaldo G
  TITLE     Congenital diarrheal disorders: improved understanding of gene defects is leading to advances in intestinal physiology and clinical management.
  JOURNAL   J Pediatr Gastroenterol Nutr 50:360-6 (2010)
DOI:10.1097/MPG.0b013e3181d135ef

PMID:21199752
  AUTHORS   Chen CP, Chiang MC, Wang TH, Hsueh C, Chang SD, Tsai FJ, Wang CN, Chern SR, Wang W
  TITLE     Microvillus inclusion disease: prenatal ultrasound findings, molecular diagnosis and genetic counseling of congenital diarrhea.
  JOURNAL   Taiwan J Obstet Gynecol 49:487-94 (2010)
DOI:10.1016/S1028-4559(10)60102-7

PMID:22436048 (gene)
  AUTHORS   Fiskerstrand T, Arshad N, Haukanes BI, Tronstad RR, Pham KD, Johansson S, Havik B, Tonder SL, Levy SE, Brackman D, Boman H, Biswas KH, Apold J, Hovdenak N, Visweswariah SS, Knappskog PM
  TITLE     Familial diarrhea syndrome caused by an activating GUCY2C mutation.
  JOURNAL   N Engl J Med 366:1586-95 (2012)
DOI:10.1056/NEJMoa1110132

PMID:23114594 (gene)
  AUTHORS   Haas JT, Winter HS, Lim E, Kirby A, Blumenstiel B, DeFelice M, Gabriel S, Jalas C, Branski D, Grueter CA, Toporovski MS, Walther TC, Daly MJ, Farese RV Jr
  TITLE     DGAT1 mutation is linked to a congenital diarrheal disorder.
  JOURNAL   J Clin Invest 122:4680-4 (2012)
DOI:10.1172/JCI64873

PMID:26358773 (gene)
  AUTHORS   Janecke AR, Heinz-Erian P, Yin J, Petersen BS, Franke A, Lechner S, Fuchs I, Melancon S, Uhlig HH, Travis S, Marinier E, Perisic V, Ristic N, Gerner P, Booth IW, Wedenoja S, Baumgartner N, Vodopiutz J, Frechette-Duval MC, De Lafollie J, Persad R, Warner N, Tse CM, Sud K, Zachos NC, Sarker R, Zhu X, Muise AM, Zimmer KP, Witt H, Zoller H, Donowitz M, Muller T
  TITLE     Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea.
  JOURNAL   Hum Mol Genet 24:6614-23 (2015)
DOI:10.1093/hmg/ddv367",MeSH,C536210,C537470,C562576,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00519,"Type XI collagenopathies, including:
Stickler syndrome type 2;
Stickler syndrome type 3;
Otospondylomegaepiphyseal dysplasia (OSMED);
Marshall syndrome;
Weissenbacher-Zweymuller syndrome","Type XI collagenopathies are a group of osteochondrodysplasias that arise from mutations in the COL11A1 and COL11A2 genes. These diseases are characterized by midfacial hypoplasia, early-onset arthropathy, and sensorineuronal hearing loss.",Skeletal dysplasia,"(Stickler 2, Marshall) COL11A1 [HSA:1301] [KO:K19721]
(Stickler 3, OSMED, Weissenbacher-Zweymuller) COL11A2 [HSA:1302] [KO:K19721]",,,,,,,"ICD-10: Q87.8 Q77.7 Q87.0 Q87.2
MeSH: C537493 C537494 C536025
OMIM: 604841 184840 215150 154780 277610","PMID:9799295 (description, gene)
  AUTHORS   Spranger J
  TITLE     The type XI collagenopathies.
  JOURNAL   Pediatr Radiol 28:745-50 (1998)
DOI:10.1007/s002470050459

PMID:12453309 (description, gene)
  AUTHORS   Reginato AM, Olsen BR
  TITLE     The role of structural genes in the pathogenesis of osteoarthritic disorders.
  JOURNAL   Arthritis Res 4:337-45 (2002)
DOI:10.1186/ar595",MeSH,C537493,C537494,C536025,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00992,Seckel syndrome,"Seckel syndrome is a recessively inherited dwarfism characterized by intrauterine growth retardation, proportionate postnatal dwarfism, severe microcephaly, micrognathia, and 'bird-headed' profile. Mental retardation also occurs. Genes that control cellular responses to DNA damage are linked to the syndrome.",Developmental disorder,"ATR [HSA:545] [KO:K06640]
CENPJ [HSA:55835] [KO:K11502]
CTIP [HSA:5932] [KO:K20773]
PCNT [HSA:5116] [KO:K16481]
CEP152 [HSA:22995] [KO:K16728]
CEP63 [HSA:80254] [KO:K16763]
NIN [HSA:51199] [KO:K16476]
DNA2 [HSA:1763] [KO:K10742]
TRAIP [HSA:10293] [KO:K11985]",,,,,,,"ICD-10: Q87.1
MeSH: C537533 C537534
OMIM: 210600 606744 613676 613823 614728 614851 615807 616777","PMID:17921644 (description)
  AUTHORS   Harsha Vardhan BG, Muthu MS, Saraswathi K, Koteeswaran D
  TITLE     Bird-headed dwarf of Seckel.
  JOURNAL   J Indian Soc Pedod Prev Dent 25 Suppl:S8-9 (2007)

PMID:3300331 (description)
  AUTHORS   Majoor-Krakauer DF, Wladimiroff JW, Stewart PA, van de Harten JJ, Niermeijer MF
  TITLE     Microcephaly, micrognathia, and bird-headed dwarfism: prenatal diagnosis of a Seckel-like syndrome.
  JOURNAL   Am J Med Genet 27:183-8 (1987)
DOI:10.1002/ajmg.1320270119

PMID:12640452 (description, gene)
  AUTHORS   O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA
  TITLE     A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.
  JOURNAL   Nat Genet 33:497-501 (2003)
DOI:10.1038/ng1129

PMID:20522431 (description, gene)
  AUTHORS   Al-Dosari MS, Shaheen R, Colak D, Alkuraya FS
  TITLE     Novel CENPJ mutation causes Seckel syndrome.
  JOURNAL   J Med Genet 47:411-4 (2010)
DOI:10.1136/jmg.2009.076646

PMID:21998596 (description, gene)
  AUTHORS   Qvist P, Huertas P, Jimeno S, Nyegaard M, Hassan MJ, Jackson SP, Borglum AD
  TITLE     CtIP Mutations Cause Seckel and Jawad Syndromes.
  JOURNAL   PLoS Genet 7:e1002310 (2011)
DOI:10.1371/journal.pgen.1002310

PMID:21131973 (description, gene)
  AUTHORS   Kalay E, Yigit G, Aslan Y, Brown KE, Pohl E, Bicknell LS, Kayserili H, Li Y, Tuysuz B, Nurnberg G, Kiess W, Koegl M, Baessmann I, Buruk K, Toraman B, Kayipmaz S, Kul S, Ikbal M, Turner DJ, Taylor MS, Aerts J, Scott C, Milstein K, Dollfus H, Wieczorek D, Brunner HG, Hurles M, Jackson AP, Rauch A, Nurnberg P, Karaguzel A, Wollnik B
  TITLE     CEP152 is a genome maintenance protein disrupted in Seckel syndrome.
  JOURNAL   Nat Genet 43:23-6 (2011)
DOI:10.1038/ng.725

PMID:18157127 (description, gene)
  AUTHORS   Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, Jeggo PA, Jackson AP, O'Driscoll M
  TITLE     Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling.
  JOURNAL   Nat Genet 40:232-6 (2008)
DOI:10.1038/ng.2007.80

PMID:21983783
  AUTHORS   Sir JH, Barr AR, Nicholas AK, Carvalho OP, Khurshid M, Sossick A, Reichelt S, D'Santos C, Woods CG, Gergely F
  TITLE     A primary microcephaly protein complex forms a ring around parental centrioles.
  JOURNAL   Nat Genet 43:1147-53 (2011)
DOI:10.1038/ng.971

PMID:22933543
  AUTHORS   Dauber A, Lafranchi SH, Maliga Z, Lui JC, Moon JE, McDeed C, Henke K, Zonana J, Kingman GA, Pers TH, Baron J, Rosenfeld RG, Hirschhorn JN, Harris MP, Hwa V
  TITLE     Novel microcephalic primordial dwarfism disorder associated with variants in the centrosomal protein ninein.
  JOURNAL   J Clin Endocrinol Metab 97:E2140-51 (2012)
DOI:10.1210/jc.2012-2150

PMID:24389050 (gene)
  AUTHORS   Shaheen R, Faqeih E, Ansari S, Abdel-Salam G, Al-Hassnan ZN, Al-Shidi T, Alomar R, Sogaty S, Alkuraya FS
  TITLE     Genomic analysis of primordial dwarfism reveals novel disease genes.
  JOURNAL   Genome Res 24:291-9 (2014)
DOI:10.1101/gr.160572.113

PMID:26595769 (gene)
  AUTHORS   Harley ME, Murina O, Leitch A, Higgs MR, Bicknell LS, Yigit G, Blackford AN, Zlatanou A, Mackenzie KJ, Reddy K, Halachev M, McGlasson S, Reijns MA, Fluteau A, Martin CA, Sabbioneda S, Elcioglu NH, Altmuller J, Thiele H, Greenhalgh L, Chessa L, Maghnie M, Salim M, Bober MB, Nurnberg P, Jackson SP, Hurles ME, Wollnik B, Stewart GS, Jackson AP
  TITLE     TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism.
  JOURNAL   Nat Genet 48:36-43 (2016)
DOI:10.1038/ng.3451",MeSH,C537533,C537534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01384,"The ataxia neuropathy spectrum (ANS), including:
Mitochondrial recessive ataxia syndrome (MIRAS);
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO)","The ataxia neuropathy spectrum (ANS) is the mitochondrial disease, that is caused by mutations of the POLG1 gene encoding the mitochondrial DNA polymerase gamma enzyme. ANS includes the phenotypes previously referred to as mitochondrial recessive ataxia syndrome (MIRAS) and sensory ataxia neuropathy dysarthria and ophthalmoplegia (SANDO). MIRAS is a common cause of autosomal recessive juvenile- or adult-onset ataxia, at least in Scandinavia. Most cases of SANDO present with an initial stage of sensory neuropathy, a second stage of progressive external ophahlmoplegia and dysarthria, which is then followed by other symptoms, often with epilepsia or myoclonus.",Inherited metabolic disease; Mitochondrial disease,POLG [HSA:5428] [KO:K02332],,,,,,"(MIRAS)
W748S, E1143G
(early onset SANDO)
A467T, W748S
(late onset SANDO)
T251I, P587L, G848S","ICD-10: G71.3
MeSH: C579922 C537583
OMIM: 607459","PMID:12210792
  AUTHORS   Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S, Papadimitriou A, Spelbrink H, Silvestri L, Casari G, Comi GP, Zeviani M
  TITLE     Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia.
  JOURNAL   Ann Neurol 52:211-9 (2002)
DOI:10.1002/ana.10278

PMID:20513108
  AUTHORS   Weiss MD, Saneto RP
  TITLE     Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations.
  JOURNAL   Muscle Nerve 41:882-5 (2010)
DOI:10.1002/mus.21636

PMID:22616202
  AUTHORS   Gati I, Danielsson O, Jonasson J, Landtblom AM
  TITLE     Sensory ataxic neuropathy with dysarthria/dysphagia and ophthalmoplegia (SANDO). Two case reports.
  JOURNAL   Acta Myol 30:188-90 (2011)

PMID:16080118
  AUTHORS   Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, Goethem GV, Lofgren A, Hackman P, Paetau A, Kaakkola S, Majamaa K, Varilo T, Udd B, Kaariainen H, Bindoff LA, Suomalainen A
  TITLE     Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin.
  JOURNAL   Am J Hum Genet 77:430-41 (2005)
DOI:10.1086/444548",MeSH,C579922,C537583,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01574,"Familial idiopathic basal ganglia calcification;
Bilateral striopallidodentate calcinosis (BSPDC);
Fahr's disease","Familial idiopathic basal ganglia calcification (IBGC), also known as Fahr disease, is an inherited neurological disorder characterized by symmetric calcification in the basal ganglia and other brain regions, a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures and chronic headache, and normal serum levels of calcium, phosphate, alkaline phosphatase and parathyroid hormone. The typical age at clinical onset is between 30 and 50 years, and most individuals affected with IBGC are asymptomatic during childhood and young adulthood. The diagnosis of IBGC generally relies on the visualization of bilateral calcification mainly in the basal ganglia by neuroimaging and the absence of metabolic, infectious, toxic, or traumatic causes. Familial IBGC is genetically heterogeneous and typically transmitted in an autosomal dominant fashion. The mutations in SLC20A2 encoding type III sodium-dependent phosphate transporter 2 (PiT-2) are a major cause of familial IBGC. Recently the mutations of PDGFRB encoding platelet-derived growth factor (PDGF) receptor-beta, PDGFB encoding the PDGFR receptor-beta main ligand and XRP1 encoding a retroviral receptor have been reported to cause calcification in the brain.",Nervous system disease,"SLC20A2 [HSA:6575] [KO:K14640]
PDGFRB [HSA:5159] [KO:K05089]
PDGFB [HSA:5155] [KO:K17386]
XPR1 [HSA:9213]",,,,,,,"ICD-10: G23.8
MeSH: C536275 C537657 C536276
OMIM: 213600 615007 615483 616413","PMID:22327515 (description, gene)
  AUTHORS   Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, de Oliveira JR, Sobrido MJ, Quintans B, Baquero M, Cui X, Zhang XY, Wang L, Xu H, Wang J, Yao J, Dai X, Liu J, Zhang L, Ma H, Gao Y, Ma X, Feng S, Liu M, Wang QK, Forster IC, Zhang X, Liu JY
  TITLE     Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis.
  JOURNAL   Nat Genet 44:254-6 (2012)
DOI:10.1038/ng.1077

PMID:23334463 (description)
  AUTHORS   Hsu SC, Sears RL, Lemos RR, Quintans B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, Carmona O, Dobricic V, Fogel BL, Garcia-Estevez D, Goldman J, Goudreau JL, Hopfer S, Jankovic M, Jauma S, Jen JC, Kirdlarp S, Klepper J, Kostic V, Lang AE, Linglart A, Maisenbacher MK, Manyam BV, Mazzoni P, Miedzybrodzka Z, Mitarnun W, Mitchell PB, Mueller J, Novakovic I, Paucar M, Paulson H, Simpson SA, Svenningsson P, Tuite P, Vitek J, Wetchaphanphesat S, Williams C, Yang M, Schofield PR, de Oliveira JR, Sobrido MJ, Geschwind DH, Coppola G
  TITLE     Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.
  JOURNAL   Neurogenetics 14:11-22 (2013)
DOI:10.1007/s10048-012-0349-2

PMID:24463626 (description)
  AUTHORS   Yamada M, Tanaka M, Takagi M, Kobayashi S, Taguchi Y, Takashima S, Tanaka K, Touge T, Hatsuta H, Murayama S, Hayashi Y, Kaneko M, Ishiura H, Mitsui J, Atsuta N, Sobue G, Shimozawa N, Inuzuka T, Tsuji S, Hozumi I
  TITLE     Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan.
  JOURNAL   Neurology 82:705-12 (2014)
DOI:10.1212/WNL.0000000000000143

PMID:23255827 (gene)
  AUTHORS   Nicolas G, Pottier C, Maltete D, Coutant S, Rovelet-Lecrux A, Legallic S, Rousseau S, Vaschalde Y, Guyant-Marechal L, Augustin J, Martinaud O, Defebvre L, Krystkowiak P, Pariente J, Clanet M, Labauge P, Ayrignac X, Lefaucheur R, Le Ber I, Frebourg T, Hannequin D, Campion D
  TITLE     Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
  JOURNAL   Neurology 80:181-7 (2013)
DOI:10.1212/WNL.0b013e31827ccf34

PMID:23913003 (gene)
  AUTHORS   Keller A, Westenberger A, Sobrido MJ, Garcia-Murias M, Domingo A, Sears RL, Lemos RR, Ordonez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, Lohmann K, Dobricic V, Carracedo A, Petrovic I, Miyasaki JM, Abakumova I, Mae MA, Raschperger E, Zatz M, Zschiedrich K, Klepper J, Spiteri E, Prieto JM, Navas I, Preuss M, Dering C, Jankovic M, Paucar M, Svenningsson P, Saliminejad K, Khorshid HR, Novakovic I, Aguzzi A, Boss A, Le Ber I, Defer G, Hannequin D, Kostic VS, Campion D, Geschwind DH, Coppola G, Betsholtz C, Klein C, Oliveira JR
  TITLE     Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.
  JOURNAL   Nat Genet 45:1077-82 (2013)
DOI:10.1038/ng.2723

PMID:25938945 (gene)
  AUTHORS   Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JR, Sears RL, Ramos EM, Spiteri E, Sobrido MJ, Carracedo A, Castro-Fernandez C, Cubizolle S, Fogel BL, Goizet C, Jen JC, Kirdlarp S, Lang AE, Miedzybrodzka Z, Mitarnun W, Paucar M, Paulson H, Pariente J, Richard AC, Salins NS, Simpson SA, Striano P, Svenningsson P, Tison F, Unni VK, Vanakker O, Wessels MW, Wetchaphanphesat S, Yang M, Boller F, Campion D, Hannequin D, Sitbon M, Geschwind DH, Battini JL, Coppola G
  TITLE     Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
  JOURNAL   Nat Genet 47:579-81 (2015)
DOI:10.1038/ng.3289",MeSH,C536275,C537657,C536276,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01887,"3MC syndrome;
Malpuech-Michels-Mingarelli-Carnevale syndrome","3MC syndrome is an autosomal recessive heterogeneous disorder with features linked to developmental abnormalities. Patients with 3MC syndrome may exhibit a spectrum of developmental features, including developmental delay, growth and mental retardation, and characteristic facial dysmorphism, such as hypertelorism, telecanthus, blepharophimosis, blepharoptosis, and epicanthus inversus. 3MC syndrome was originally described as four separate disorders: Malpuech syndrome, Carnevale syndrome, Michels syndrome, and Mingarelli syndrome. There is considerable overlap between them, which have similarities in facial appearance, leading to the suggestion that they should all be considered part of the same phenotypic spectrum known as 3MC syndrome. Mutations in lectin complement pathway genes have been reported to cause 3MC syndrome.",Developmental disorder,"(3MC1) MASP1 [HSA:5648] [KO:K03992]
(3MC2) COLEC11 [HSA:78989] [KO:K10066]
(3MC3) COLEC10 [HSA:10584] [KO:K10065]",,,,,,,"ICD-10: Q87.8
MeSH: C535704 C537738 C535586
OMIM: 257920 265050 248340","PMID:690758 (description)
  AUTHORS   Michels VV, Hittner HM, Beaudet AL
  TITLE     A clefting syndrome with ocular anterior chamber defect and lid anomalies.
  JOURNAL   J Pediatr 93:444-6 (1978)
DOI:10.1016/S0022-3476(78)81154-8

PMID:6660246 (description)
  AUTHORS   Malpuech G, Demeocq F, Palcoux JB, Vanlieferinghen P
  TITLE     A previously undescribed autosomal recessive multiple congenital anomalies/mental retardation (MCA/MR) syndrome with growth failure, lip/palate cleft(s), and urogenital anomalies.
  JOURNAL   Am J Med Genet 16:475-80 (1983)
DOI:10.1002/ajmg.1320160405

PMID:2569826 (description)
  AUTHORS   Carnevale F, Krajewska G, Fischetto R, Greco MG, Bonvino A
  TITLE     Ptosis of eyelids, strabismus, diastasis recti, hip defect, cryptorchidism, and developmental delay in two sibs.
  JOURNAL   Am J Med Genet 33:186-9 (1989)
DOI:10.1002/ajmg.1320330210

PMID:8933348 (description)
  AUTHORS   Mingarelli R, Castriota Scanderbeg A, Dallapiccola B
  TITLE     Two sisters with a syndrome of ocular, skeletal, and abdominal abnormalities (OSA syndrome).
  JOURNAL   J Med Genet 33:884-6 (1996)
DOI:10.1136/jmg.33.10.884

PMID:28301481 (description, gene)
  AUTHORS   Munye MM, Diaz-Font A, Ocaka L, Henriksen ML, Lees M, Brady A, Jenkins D, Morton J, Hansen SW, Bacchelli C, Beales PL, Hernandez-Hernandez V
  TITLE     COLEC10 is mutated in 3MC patients and regulates early craniofacial development.
  JOURNAL   PLoS Genet 13:e1006679 (2017)
DOI:10.1371/journal.pgen.1006679

PMID:26789649 (description)
  AUTHORS   Urquhart J, Roberts R, de Silva D, Shalev S, Chervinsky E, Nampoothiri S, Sznajer Y, Revencu N, Gunasekera R, Suri M, Ellingford J, Williams S, Bhaskar S, Clayton-Smith J
  TITLE     Exploring the genetic basis of 3MC syndrome: Findings in 12 further families.
  JOURNAL   Am J Med Genet A 170A:1216-24 (2016)
DOI:10.1002/ajmg.a.37564

PMID:21664996 (description)
  AUTHORS   Degn SE, Jensenius JC, Thiel S
  TITLE     Disease-causing mutations in genes of the complement system.
  JOURNAL   Am J Hum Genet 88:689-705 (2011)
DOI:10.1016/j.ajhg.2011.05.011

PMID:16096999 (description)
  AUTHORS   Titomanlio L, Bennaceur S, Bremond-Gignac D, Baumann C, Dupuy O, Verloes A
  TITLE     Michels syndrome, Carnevale syndrome, OSA syndrome, and Malpuech syndrome: variable expression of a single disorder (3MC syndrome)?
  JOURNAL   Am J Med Genet A 137A:332-5 (2005)
DOI:10.1002/ajmg.a.30878

PMID:21258343 (gene)
  AUTHORS   Rooryck C, Diaz-Font A, Osborn DP, Chabchoub E, Hernandez-Hernandez V, Shamseldin H, Kenny J, Waters A, Jenkins D, Kaissi AA, Leal GF, Dallapiccola B, Carnevale F, Bitner-Glindzicz M, Lees M, Hennekam R, Stanier P, Burns AJ, Peeters H, Alkuraya FS, Beales PL
  TITLE     Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome.
  JOURNAL   Nat Genet 43:197-203 (2011)
DOI:10.1038/ng.757",MeSH,C535704,C537738,C535586,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00787,"Congenital stationary night blindness (CSNB), including:
CSNB type 1 (CSNB1);
CSNB type 2 (CSNB2);
CSNB autosomal dominant (CSNBAD);
Oguchi disease/ CSNB Oguchi type (CSNBO)","Congenital stationary night blindness (CSNB) is a group of nonprogressive retinal disorders characterized by impaired night vision. CSNB is currently associated with X-linked genes (NYX, CACNA1F), autosomal recessive genes (CABP4, GRK1, GRM6, SAG, TRPM1), and autosomal dominant genes (GNAT1, PDE6B, RHO). Two types of CSNB can be distinguished by use of the standard flash electroretinogram (ERG). CSNB type 1 (CSNB1) is characterized by the complete absence of rod pathway function, whereas CSNB type 2 (CSNB2) is caused by impaired rod and cone pathway function. Oguchi disease is a form of CSNB. Patients with the Oguchi disease have a unique yellowish-gold fundus that regains its normal color after prolonged dark adaptation. That is called the Mizuo-Nakamura phenomenon.",Nervous system disease; Eye disease,"(CSNB1A) NYX [HSA:60506] [KO:K08129]
(CSNB1B) GRM6 [HSA:2916] [KO:K04608]
(CSNB1C) TRPM1 [HSA:4308] [KO:K04976]
(CSNB1D) SLC24A1 [HSA:9187] [KO:K13749]
(CSNB1E) GPR179 [HSA:440435]
(CSNB1F) LRIT3 [HSA:345193]
(CSNB2A) CACNA1F [HSA:778] [KO:K04853]
(CSNB2B) CABP4 [HSA:57010]
(CSNBAD1) RHO [HSA:6010] [KO:K04250]
(CSNBAD2) PDE6B [HSA:5158] [KO:K13756]
(CSNBAD3) GNAT1 [HSA:2779] [KO:K04631]
(CSNBO1) SAG [HSA:6295] [KO:K19627]
(CSNBO2) GRK1 [HSA:6011] [KO:K00909]",,,,Electroretinogram (ERG),,,"ICD-10: H53.6
MeSH: C536122 C537743
OMIM: 310500 257270 613216 613830 614565 615058 300071 610427 610445 163500 610444 258100 613411","PMID:20301423
  AUTHORS   Boycott KM, Bech-Hansen NT, Sauve Y, MacDonald IM
  TITLE     X-Linked Congenital Stationary Night Blindness
  JOURNAL   GeneReviews (1993)

PMID:19896109
  AUTHORS   van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M
  TITLE     Mutations in TRPM1 are a common cause of complete congenital stationary night blindness.
  JOURNAL   Am J Hum Genet 85:730-6 (2009)
DOI:10.1016/j.ajhg.2009.10.012

PMID:21920492
  AUTHORS   Chen RW, Greenberg JP, Lazow MA, Ramachandran R, Lima LH, Hwang JC, Schubert C, Braunstein A, Allikmets R, Tsang SH
  TITLE     Autofluorescence imaging and spectral-domain optical coherence tomography in incomplete congenital stationary night blindness and comparison with retinitis pigmentosa.
  JOURNAL   Am J Ophthalmol 153:143-54.e2 (2012)
DOI:10.1016/j.ajo.2011.06.018

PMID:17765441
  AUTHORS   Oishi A, Akimoto M, Kawagoe N, Mandai M, Takahashi M, Yoshimura N
  TITLE     Novel mutations in the GRK1 gene in Japanese patients With Oguchi disease.
  JOURNAL   Am J Ophthalmol 144:475-7 (2007)
DOI:10.1016/j.ajo.2007.03.025

PMID:20850105
  AUTHORS   Riazuddin SA, Shahzadi A, Zeitz C, Ahmed ZM, Ayyagari R, Chavali VR, Ponferrada VG, Audo I, Michiels C, Lancelot ME, Nasir IA, Zafar AU, Khan SN, Husnain T, Jiao X, MacDonald IM, Riazuddin S, Sieving PA, Katsanis N, Hejtmancik JF
  TITLE     A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness.
  JOURNAL   Am J Hum Genet 87:523-31 (2010)
DOI:10.1016/j.ajhg.2010.08.013

PMID:22325361 (gene)
  AUTHORS   Audo I, Bujakowska K, Orhan E, Poloschek CM, Defoort-Dhellemmes S, Drumare I, Kohl S, Luu TD, Lecompte O, Zrenner E, Lancelot ME, Antonio A, Germain A, Michiels C, Audier C, Letexier M, Saraiva JP, Leroy BP, Munier FL, Mohand-Said S, Lorenz B, Friedburg C, Preising M, Kellner U, Renner AB, Moskova-Doumanova V, Berger W, Wissinger B, Hamel CP, Schorderet DF, De Baere E, Sharon D, Banin E, Jacobson SG, Bonneau D, Zanlonghi X, Le Meur G, Casteels I, Koenekoop R, Long VW, Meire F, Prescott K, de Ravel T, Simmons I, Nguyen H, Dollfus H, Poch O, Leveillard T, Nguyen-Ba-Charvet K, Sahel JA, Bhattacharya SS, Zeitz C
  TITLE     Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness.
  JOURNAL   Am J Hum Genet 90:321-30 (2012)
DOI:10.1016/j.ajhg.2011.12.007

PMID:23246293 (gene)
  AUTHORS   Zeitz C, Jacobson SG, Hamel CP, Bujakowska K, Neuille M, Orhan E, Zanlonghi X, Lancelot ME, Michiels C, Schwartz SB, Bocquet B, Antonio A, Audier C, Letexier M, Saraiva JP, Luu TD, Sennlaub F, Nguyen H, Poch O, Dollfus H, Lecompte O, Kohl S, Sahel JA, Bhattacharya SS, Audo I
  TITLE     Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness.
  JOURNAL   Am J Hum Genet 92:67-75 (2013)
DOI:10.1016/j.ajhg.2012.10.023",MeSH,C536122,C537743,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00889,"MED12-related disorders, including:
Lujan-Fryns syndrome (LFS);
Lujan syndrome;
X-linked mental retardation with Marfanoid habitus;
FG syndrome type 1 (FGS1);
Opitz-Kaveggia syndrome","Lujan-Fryns syndrome (LFS) and FG syndrome type 1 (FGS1) are X-linked mental retardation (XLMR) syndromes. These two syndromes are allelic, with different mutations in the MED12 gene. LFS and FGS1 share certain clinical findings (dysgenesis of the corpus callosum, macrocephaly, a tall forehead, a high palate, hypotonia, mental retardation, and behavioural disturbances). Anal anomalies/constipation are common in FGS1, and tall stature, long hands and fingers, and hypernasal speech are common in families with LFS.",Skeletal dysplasia; Nervous system disease,MED12 [HSA:9968] [KO:K15162],,,,,,"A recurrent mutation (c.2881C->T, p.R961W) in exon 21 of MED12 gene has been found in the family with FGS. A separate sequence alteration (c.3020A->G, p.N1007S) in exon 22 of the MED12 gene has been found in the family with LFS.","ICD-10: F79 Q87.8
MeSH: C537724 C537923
OMIM: 309520 305450","PMID:17369503 (description, gene, comment)
  AUTHORS   Schwartz CE, Tarpey PS, Lubs HA, Verloes A, May MM, Risheg H, Friez MJ, Futreal PA, Edkins S, Teague J, Briault S, Skinner C, Bauer-Carlin A, Simensen RJ, Joseph SM, Jones JR, Gecz J, Stratton MR, Raymond FL, Stevenson RE
  TITLE     The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene.
  JOURNAL   J Med Genet 44:472-7 (2007)
DOI:10.1136/jmg.2006.048637

PMID:20301719 (description, gene)
  AUTHORS   Lyons MJ
  TITLE     MED12-Related Disorders
  JOURNAL   GeneReviews (1993)",MeSH,C537724,C537923,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00524,"TRPV4-related peripheral neuropathies, including:
Congenital distal spinal muscular atrophy (CDSMA) [DS:H00856];
Scapuloperoneal spinal muscle atrophy (SPSMA);
Hereditary motor and sensory neuropathy type IIC (HMSN IIC) [DS:H00264]",These are a heterogeneous group of dominantly inherited disorders with muscle weakness. Mutations in TRPV4 have been linked to these disorders.,Nervous system disease,TRPV4 [HSA:59341] [KO:K04973],,,,,,,"ICD-10: G12.2 G12.1 G60.0
MeSH: C563981 C537992
OMIM: 600175 181405 606071","PMID:20505684 (gene)
  AUTHORS   Dai J, Cho TJ, Unger S, Lausch E, Nishimura G, Kim OH, Superti-Furga A, Ikegawa S
  TITLE     TRPV4-pathy, a novel channelopathy affecting diverse systems.
  JOURNAL   J Hum Genet 55:400-2 (2010)
DOI:10.1038/jhg.2010.37

PMID:21454511 (gene)
  AUTHORS   Fecto F, Shi Y, Huda R, Martina M, Siddique T, Deng HX
  TITLE     Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies.
  JOURNAL   J Biol Chem 286:17281-91 (2011)
DOI:10.1074/jbc.M111.237685

PMID:20460441 (gene, description)
  AUTHORS   Zimon M, Baets J, Auer-Grumbach M, Berciano J, Garcia A, Lopez-Laso E, Merlini L, Hilton-Jones D, McEntagart M, Crosby AH, Barisic N, Boltshauser E, Shaw CE, Landoure G, Ludlow CL, Gaudet R, Houlden H, Reilly MM, Fischbeck KH, Sumner CJ, Timmerman V, Jordanova A, Jonghe PD
  TITLE     Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.
  JOURNAL   Brain 133:1798-809 (2010)
DOI:10.1093/brain/awq109",MeSH,C563981,C537992,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01376,"Acrofacial dysostosis, including:
Nager syndrome;
Miller (Genee-Wiedemann) syndrome;
Weyers acrofacial dysostosis;
Acrofacial dysostosis, Cincinnati type","Acrofacial dysostosis (AFD) is a heterogeneous group of disorders combining mandibulofacial dysostosis (micrognathia and ear anomalies) with limb defects. The predominantly preaxial form is called Nager AFD, the predominantly postaxial form of AFD (POADS) is also known as the Genee-Wiedemann or Miller syndrome. Among several AFDs, causative mutations have recently been identified in an enzyme involved in pyrimidine biosynthesis in association with Miller syndrome, and in a component of the pre-mRNA spliceosomal complex with respect to Nager syndrome.",Skeletal dysplasia; Developmental disorder,"DHODH [HSA:1723] [KO:K00254]
SF3B4 [HSA:10262] [KO:K12831]
EVC2 [HSA:132884] [KO:K19608]
POLR1A [HSA:25885] [KO:K02999]",,,,,,,"ICD-10: Q75.4
MeSH: C537680 C538182 C538183 C538184 C538185
OMIM: 154400 263750 193530 616462","PMID:8266994
  AUTHORS   Opitz JM, Mollica F, Sorge G, Milana G, Cimino G, Caltabiano M
  TITLE     Acrofacial dysostoses: review and report of a previously undescribed condition: the autosomal or X-linked dominant Catania form of acrofacial dysostosis.
  JOURNAL   Am J Med Genet 47:660-78 (1993)
DOI:10.1002/ajmg.1320470517

PMID:24123981
  AUTHORS   Trainor PA, Andrews BT
  TITLE     Facial dysostoses: Etiology, pathogenesis and management.
  JOURNAL   Am J Med Genet C Semin Med Genet 163:283-94 (2013)
DOI:10.1002/ajmg.c.31375

PMID:17674260
  AUTHORS   Verrotti C, Benassi G, Piantelli G, Magnani C, Giordano G, Gramellini D
  TITLE     Acrofacial dysostosis syndromes: a relevant prenatal dilemma. A case report and brief literature review.
  JOURNAL   J Matern Fetal Neonatal Med 20:487-90 (2007)
DOI:10.1080/14767050701398447

PMID:23565775
  AUTHORS   Wieczorek D
  TITLE     Human facial dysostoses.
  JOURNAL   Clin Genet 83:499-510 (2013)
DOI:10.1111/cge.12123

PMID:16404586 (gene)
  AUTHORS   Ye X, Song G, Fan M, Shi L, Jabs EW, Huang S, Guo R, Bian Z
  TITLE     A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial dysostosis.
  JOURNAL   Hum Genet 119:199-205 (2006)
DOI:10.1007/s00439-005-0129-2

PMID:25913037 (gene)
  AUTHORS   Weaver KN, Watt KE, Hufnagel RB, Navajas Acedo J, Linscott LL, Sund KL, Bender PL, Konig R, Lourenco CM, Hehr U, Hopkin RJ, Lohmann DR, Trainor PA, Wieczorek D, Saal HM
  TITLE     Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
  JOURNAL   Am J Hum Genet 96:765-74 (2015)
DOI:10.1016/j.ajhg.2015.03.011",MeSH,C537680,C538182,C538183,C538184,C538185,,,,,,,,,,,,,,,,,,,,,,,,,
H00190,Hyperprolinemia (HP),"Hyperprolinemia is a phenotype present in two distinct, autosomal recessive metabolic disorders caused by defects in the l-proline catabolic pathway. Hyperprolinemia type I (HPI) and type II (HPII) are caused by deficiencies in proline dehydrogenase (PRODH) and P5C dehydrogenase (P5CDH; also known as ALDH4A1), respectively. Patients with HPI may exhibit an increase in plasma proline level in absence of urinary pyrroline-5-carboxylate (P5C) while those with HPII have elevated levels of P5C and proline in plasma, urine, and cerebrospinal fluid. Some patients have neurological, renal, and/or auditory defects.",Inherited metabolic disease; Nervous system disease,"(HP1) PRODH; proline dehydrogenase [HSA:5625] [KO:K00318]
(HP2) ALDH4A1; 1-pyrroline-5-carboxylate dehydrogenase [HSA:8659] [KO:K00294]",,,,Proline [CPD:C00148],,,"ICD-10: E72.5
MeSH: C538384 C538385
OMIM: 239500 239510","PMID:18806117
  AUTHORS   Mitsubuchi H, Nakamura K, Matsumoto S, Endo F
  TITLE     Inborn errors of proline metabolism.
  JOURNAL   J Nutr 138:2016S-2020S (2008)

PMID:15214748 (gene)
  AUTHORS   Onenli-Mungan N, Yuksel B, Elkay M, Topaloglu AK, Baykal T, Ozer G
  TITLE     Type II hyperprolinemia: a case report.
  JOURNAL   Turk J Pediatr 46:167-9 (2004)

PMID:12217952 (gene)
  AUTHORS   Jacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, Demilly C, Haouzir S, Allio G, Fouldrin G, Drouin V, Bou J, Petit M, Campion D, Frebourg T
  TITLE     PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.
  JOURNAL   Hum Mol Genet 11:2243-9 (2002)
DOI:10.1093/hmg/11.19.2243

PMID:20524212 (description, gene)
  AUTHORS   Guilmatre A, Legallic S, Steel G, Willis A, Di Rosa G, Goldenberg A, Drouin-Garraud V, Guet A, Mignot C, Des Portes V, Valayannopoulos V, Van Maldergem L, Hoffman JD, Izzi C, Espil-Taris C, Orcesi S, Bonafe L, Le Galloudec E, Maurey H, Ioos C, Afenjar A, Blanchet P, Echenne B, Roubertie A, Frebourg T, Valle D, Campion D
  TITLE     Type I hyperprolinemia: genotype/phenotype correlations.
  JOURNAL   Hum Mutat 31:961-5 (2010)
DOI:10.1002/humu.21296

PMID:22516612 (description, gene)
  AUTHORS   Srivastava D, Singh RK, Moxley MA, Henzl MT, Becker DF, Tanner JJ
  TITLE     The Three-Dimensional Structural Basis of Type II Hyperprolinemia.
  JOURNAL   J Mol Biol 420:176-89 (2012)
DOI:10.1016/j.jmb.2012.04.010

PMID:21882227 (description, gene)
  AUTHORS   Ferreira AG, da Cunha AA, Machado FR, Pederzolli CD, Dalazen GR, de Assis AM, Lamers ML, dos Santos MF, Dutra-Filho CS, Wyse AT
  TITLE     Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver.
  JOURNAL   J Cell Biochem 113:174-83 (2012)
DOI:10.1002/jcb.23342",MeSH,C538384,C538385,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00583,Opitz-GBBB syndrome,"Opitz GBBB syndrome is a pleiotropic genetic disorder characterized by hypertelorism, hypospadias, and additional midline defects. This syndrome was originally described as two distinct entities, the BBB syndrome with cleft lip, palate and mental retardation, and the G-syndrome characterized by gastrointestinal anomalies. Subsequently, both syndromes were merged and reclassified as Opitz GBBB syndrome. There are two forms of Opitz GBBB syndrome, which are distinguished by their genetic causes and patterns of inheritance. The X-linked form is caused by a mutation in the gene MID1 that encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Autosomal dominant form results from a deletion at chromosome 22q11.2.",Congenital disorder of development,MID1 [HSA:4281] [KO:K08285],,,,,,,"MeSH: C567932 C538387
OMIM: 300000 145410","PMID:12655643
  AUTHORS   Schweiger S, Schneider R
  TITLE     The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.
  JOURNAL   Bioessays 25:356-66 (2003)
DOI:10.1002/bies.10256

PMID:12833403
  AUTHORS   De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, Rodriguez Criado G, Rittinger O, Dennis N, Odent S, Rastogi A, Liebelt J, Chitayat D, Winter R, Jawanda H, Ballabio A, Franco B, Meroni G
  TITLE     X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.
  JOURNAL   Am J Med Genet A 120A:222-8 (2003)
DOI:10.1002/ajmg.a.10265

PMID:18197188
  AUTHORS   Chiurazzi P, Schwartz CE, Gecz J, Neri G
  TITLE     XLMR genes: update 2007.
  JOURNAL   Eur J Hum Genet 16:422-34 (2008)
DOI:10.1038/sj.ejhg.5201994",MeSH,C567932,C538387,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01194,"X-linked chondrodysplasia punctata, including:
X-linked recessive chondrodysplasia punctata (CDPX1);
X-linked dominant chondrodysplasia punctata (CDPX2)","Chondrodysplasia punctata (CDP) is a congenital disorder characterized by a skeletal abnormality, characterized by punctate calcification of the cartilage of the epiphyses, larynx and trachea. Different forms of CDP exist, the most common of which is inherited as an autosomal recessive trait (Rhizomelic CDP). CDP may also be inherited in a recessive and dominant X-linked fashion. The X-linked recessive CDP (CDPX1) characterized by facial anomalies with severe nasal hypoplasia, short stature, and distal phalangeal hypoplasia. Mutations in ARSE which encodes arylsulfatase E, showing a high sequence homology to steroid sulfatase. In X-linked dominant CDP (CDPX2), aberrant punctate calcification in cartilage is most prominent around the vertebral column, pelvis, and long bones. Additionally, CDPX2 patients may have asymmetric rhizomesomelia, sectorial cataracts, patchy alopecia, ichthyosis, and atrophoderma. It has been found that defects in D8-D7 sterol isomerase (EBP) cause CDPX2 and suggest a role for sterols in bone development.",Inherited metabolic disease; Musculoskeletal disease,"(CDPX1) ARSE [HSA:415] [KO:K18222]
(CDPX2) EBP [HSA:10682] [KO:K01824]",,,,,,Rhizomelic chondrodysplasia punctata is described in H00207. [DS:H00207],"ICD-10: Q77.3
MeSH: C580533 C538416
OMIM: 302950 302960","PMID:12567415
  AUTHORS   Brunetti-Pierri N, Andreucci MV, Tuzzi R, Vega GR, Gray G, McKeown C, Ballabio A, Andria G, Meroni G, Parenti G
  TITLE     X-linked recessive chondrodysplasia punctata: spectrum of arylsulfatase E gene mutations and expanded clinical variability.
  JOURNAL   Am J Med Genet A 117A:164-8 (2003)
DOI:10.1002/ajmg.a.10950

PMID:10391219
  AUTHORS   Braverman N, Lin P, Moebius FF, Obie C, Moser A, Glossmann H, Wilcox WR, Rimoin DL, Smith M, Kratz L, Kelley RI, Valle D
  TITLE     Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome.
  JOURNAL   Nat Genet 22:291-4 (1999)
DOI:10.1038/10357",MeSH,C580533,C538416,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00198,Orotic aciduria,Orotic aciduria is characterized by megaloblastic anemia that is unresponsive to vitamin B12 and folic acid.,Inherited metabolic disease; Hematologic disease,UMPS; uridine monophosphate synthetase [HSA:7372] [KO:K13421],,,,Orotic acid [CPD:C00295],Uridine [CPD:C00299],,"ICD-10: D53.0
MeSH: C537136 C562589
OMIM: 258900","PMID:16176880
  AUTHORS   Nyhan WL
  TITLE     Disorders of purine and pyrimidine metabolism.
  JOURNAL   Mol Genet Metab 86:25-33 (2005)
DOI:10.1016/j.ymgme.2005.07.027

PMID:9042911
  AUTHORS   Suchi M, Mizuno H, Kawai Y, Tsuboi T, Sumi S, Okajima K, Hodgson ME, Ogawa H, Wada Y
  TITLE     Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.
  JOURNAL   Am J Hum Genet 60:525-39 (1997)",MeSH,C537136,C562589,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00937,"Precocious puberty, including:
Central precocious puberty (CEPREPU);
Familial male precocious puberty (FMPP)","Precocious puberty has been classically defined as the onset of secondary sexual characteristics in girls younger than 8 years old and in boys younger than 9 and a half years old. Central precocious puberty (CEPREPU) refers to a gonadotropin-dependent type which results from premature activation of the hypothalamic-pituitary-gonadal axis (HPG). CEPREPU is much more frequent in girls than in boys (up to 20:1 ratio). Recently, kisspeptin receptor (KISS1R) and its ligand, kisspeptin, were revealed as major gatekeepers of puberty onset. Mutations of the KISS1R gene were described in patients with impaired pubertal development. On the other hand, it has been reported that heterozygous mutations of the LHCGR gene cause gonadotropin-independent precocious puberty in males, but have no detectable effects on prepubertal or postpubertal females.",Endocrine disease,"(CEPREPU) KISS1R [HSA:84634] [KO:K08374]
(FMPP) LHCGR [HSA:3973] [KO:K04248]",,,,,"Leuprorelin [DR:D00989]
Nafarelin [DR:D00990]
Buserelin [DR:D01831]",,"ICD-10: E22.8 E30.1
MeSH: D011629 C562787 C536961
OMIM: 176400 176410","PMID:21664234
  AUTHORS   Teles MG, Silveira LF, Tusset C, Latronico AC
  TITLE     New genetic factors implicated in human GnRH-dependent precocious puberty: the role of kisspeptin system.
  JOURNAL   Mol Cell Endocrinol 346:84-90 (2011)
DOI:10.1016/j.mce.2011.05.019

PMID:20374734
  AUTHORS   Segaloff DL
  TITLE     Diseases associated with mutations of the human lutropin receptor.
  JOURNAL   Prog Mol Biol Transl Sci 89:97-114 (2009)
DOI:10.1016/S1877-1173(09)89004-2

PMID:18478155 (drug)
  AUTHORS   Bertelloni S, Mul D
  TITLE     Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
  JOURNAL   Asian J Androl 10:525-34 (2008)
DOI:10.1111/j.1745-7262.2008.00409.x",MeSH,D011629,C562787,C536961,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00700,Centronuclear myopathy,"Centronuclear myopathy (CNM) is an inherited neuromuscular disorder defined by numerous centrally placed nuclei on muscle biopsy and clinical features of a congenital myopathy. CNM exists in the genetic bases of the three main forms: the X-linked recessive form or myotubular myopathy (XLMTM) with severe neonatal phenotype, caused by mutations in the MTM1 gene; the classical autosomal dominant (AD) forms with mild, moderate or severe phenotypes caused by mutations in the DNM2 gene; and an autosomal recessive (AR)  form presenting severe and moderate phenotypes caused by mutations in the BIN1 gene. Recently, heterozygous MYF6 mutation is reported to be associated with CNM.",Musculoskeletal disease; Nervous system disease,"(XLMTM) MTM1 [HSA:4534] [KO:K01108]
(CNM1) DNM2 [HSA:1785] [KO:K01528]
(CNM2) BIN1 [HSA:274] [KO:K12562]
(CNM3) MYF6 [HSA:4618] [KO:K18485]",,,,,,,"ICD-10: G71.2
MeSH: C538647 C562934 C563544
OMIM: 310400 160150 255200 614408","PMID:20181480 (description, gene)
  AUTHORS   Romero NB
  TITLE     Centronuclear myopathies: a widening concept.
  JOURNAL   Neuromuscul Disord 20:223-8 (2010)
DOI:10.1016/j.nmd.2010.01.014

PMID:18817572 (description, gene)
  AUTHORS   Jungbluth H, Wallgren-Pettersson C, Laporte J
  TITLE     Centronuclear (myotubular) myopathy.
  JOURNAL   Orphanet J Rare Dis 3:26 (2008)
DOI:10.1186/1750-1172-3-26

PMID:11053684 (gene)
  AUTHORS   Kerst B, Mennerich D, Schuelke M, Stoltenburg-Didinger G, von Moers A, Gossrau R, van Landeghem FK, Speer A, Braun T, Hubner C
  TITLE     Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy.
  JOURNAL   Neuromuscul Disord 10:572-7 (2000)
DOI:10.1016/S0960-8966(00)00150-4",MeSH,C538647,C562934,C563544,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00251,"Thyroid dyshormonogenesis;
Dyshormogenetic goiter",Thyroid dyshormonogenesis is a genetically heterogeneous group of inherited disorders in the enzymatic cascade of thyroid hormone synthesis that result in congenital hypothyroidism due to genetic defects in the synthesis of thyroid hormones.,Endocrine disease,"(Type 1) SLC5A5 [HSA:6528] [KO:K14385]
(Type 2A) TPO [HSA:7173] [KO:K00431]
(Type 2B) SLC26A4 [HSA:5172] [KO:K14702]
(Type 2B) FOXI1 [HSA:2299] [KO:K09401]
(Type 4) IYD [HSA:389434] [KO:K17231]
(Type 5) DUOXA2 [HSA:405753] [KO:K17232]
TG [HSA:7038] [KO:K10809]
(Type 6) DUOX2 [HSA:50506] [KO:K13411]",,,,Thyroglobulin [HSA:7038] [KO:K10809],"Thyroid [DR:D06482]
Levothroid [DG:DG00510]",,"ICD-10: E07.1
MeSH: C564766 C563206 C536648 C562769 C562770 C562771 C564608
OMIM: 274400 274500 274600 274800 274900 607200 188450","PMID:17551472
  AUTHORS   Topaloglu AK
  TITLE     Athyreosis, dysgenesis, and dyshormonogenesis in congenital hypothyroidism.
  JOURNAL   Pediatr Endocrinol Rev 3  Suppl 3:498-502 (2006)

PMID:17684392
  AUTHORS   Moreno JC, Visser TJ
  TITLE     New phenotypes in thyroid dyshormonogenesis: hypothyroidism due to DUOX2 mutations.
  JOURNAL   Endocr Dev 10:99-117 (2007)
DOI:10.1159/0000106822

PMID:17468186
  AUTHORS   Avbelj M, Tahirovic H, Debeljak M, Kusekova M, Toromanovic A, Krzisnik C, Battelino T
  TITLE     High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis.
  JOURNAL   Eur J Endocrinol 156:511-9 (2007)
DOI:10.1530/EJE-07-0037

PMID:16424561
  AUTHORS   Kumar PG, Anand SS, Sood V, Kotwal N
  TITLE     Thyroid dyshormonogenesis.
  JOURNAL   Indian Pediatr 42:1233-5 (2005)

PMID:15863666
  AUTHORS   Park SM, Chatterjee VK
  TITLE     Genetics of congenital hypothyroidism.
  JOURNAL   J Med Genet 42:379-89 (2005)
DOI:10.1136/jmg.2004.024158

PMID:18042646
  AUTHORS   Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, Onigata K, Fugazzola L, Refetoff S, Persani L, Weber G
  TITLE     Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism.
  JOURNAL   J Clin Endocrinol Metab 93:605-10 (2008)
DOI:10.1210/jc.2007-2020",MeSH,C564766,C563206,C536648,C562769,C562770,C562771,C564608,,,,,,,,,,,,,,,,,,,,,,,
H00822,Renal agenesis and Renal adysplasia,Renal agenesis and renal adysplasia are congenital defects of kidney development. Renal agenesis can be unilateral/bilateral with no kidneys or very little kidney present. Renal adysplasia is a condition in which kidneys begin to form but contain undifferentiated tissues. Sometimes the hypoplastic tissues regress. These diseases can lead to childhood end-stage renal failure.,Kidney disease,"UPK3A [HSA:7380] [KO:K19520]
RET [HSA:5979] [KO:K05126]",,,,,,,"ICD-10: Q60.1
MeSH: C536482 C563261
OMIM: 191830","PMID:15888565 (description, gene)
  AUTHORS   Jenkins D, Bitner-Glindzicz M, Malcolm S, Hu CC, Allison J, Winyard PJ, Gullett AM, Thomas DF, Belk RA, Feather SA, Sun TT, Woolf AS
  TITLE     De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure.
  JOURNAL   J Am Soc Nephrol 16:2141-9 (2005)
DOI:10.1681/ASN.2004090776

PMID:16731295 (description, gene)
  AUTHORS   Schonfelder EM, Knuppel T, Tasic V, Miljkovic P, Konrad M, Wuhl E, Antignac C, Bakkaloglu A, Schaefer F, Weber S
  TITLE     Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans.
  JOURNAL   Am J Kidney Dis 47:1004-12 (2006)
DOI:10.1053/j.ajkd.2006.02.177

PMID:20539737 (description, gene)
  AUTHORS   Jain S
  TITLE     The many faces of RET dysfunction in kidney.
  JOURNAL   Organogenesis 5:177-90 (2009)

PMID:18252215 (description, gene)
  AUTHORS   Skinner MA, Safford SD, Reeves JG, Jackson ME, Freemerman AJ
  TITLE     Renal aplasia in humans is associated with RET mutations.
  JOURNAL   Am J Hum Genet 82:344-51 (2008)
DOI:10.1016/j.ajhg.2007.10.008",MeSH,C536482,C563261,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00595,"Myofibrillar myopathies (MFM), including:
Desminopathy (MFM1);
alpha-B Crystallinopathy (MFM2);
Myotilinopathy (MFM3);
Zaspopathy (MFM4);
Filaminopathy (MFM5);
BAG3-related myofibrillar myopathy","Myofibrillar myopathy (MFM) is a group of genetically distinct disorders linked by common morphologic features observed on muscle histology. MFM is characterized by slowly progressive weakness that can involve both proximal and distal muscles. Distal muscle weakness is more pronounced than proximal weakness. All disease proteins identified to date are involved in maintaining the structural integrity of the Z-disk. The pathology includes accumulations of these proteins irrespective of primary gene defect, suggesting that these share molecular pathways involved in actin dynamics organized by the Z-disk. Besides accumulations of these proteins, congophilic amyloid products of myofibrillar degradation and ectopic aggregation of dystrophin and gelsolin appear in abnormal myofibers.",Musculoskeletal disease; Nervous system disease,"(MFM1) DES [HSA:1674] [KO:K07610]
(MFM2) CRYAB [HSA:1410] [KO:K09542]
(MFM3) TTID [HSA:9499] [KO:K19875]
(MFM4) ZASP [HSA:11155] [KO:K19867]
(MFM5) FLNC [HSA:2318] [KO:K04437]
(BAG3-related MFM) BAG3 [HSA:9531] [KO:K09557]",,,,,,,"ICD-10: G71.8
MeSH: C580316 C563319 C563848 C563775 C563718 C537932 C567843
OMIM: 601419 608810 609200 609452 609524 612954","PMID:20301672 (gene, description)
  AUTHORS   Selcen D, Engel AG
  TITLE     Myofibrillar Myopathy
  JOURNAL   GeneReviews (1993)

PMID:17029922 (gene, description)
  AUTHORS   Udd B
  TITLE     Molecular biology of distal muscular dystrophies--sarcomeric proteins on top.
  JOURNAL   Biochim Biophys Acta 1772:145-58 (2007)
DOI:10.1016/j.bbadis.2006.08.005",MeSH,C580316,C563319,C563848,C563775,C563718,C537932,C567843,,,,,,,,,,,,,,,,,,,,,,,
H00245,"Calcium sensing receptor (CASR) related disease, including:
Familial hypocalciuric hypercalcemia (FHH1);
Neonatal severe hyperparathyroidism (NSHPT);
Autosomal dominant hypocalcemia (ADH);
Familial hypercalciuric hypocalcemia","The mutations in the CASR gene which expresses in the parathyroid hormone producing chief cells of the parathyroid gland and the cells lining the kidney tubule affect calcium homeostasis. Loss-of-function mutations in the CASR gene are responsible for familial hypocalciuric hypercalcemia (FHH1) and for neonatal severe hyperparathyroidism (NSHPT). FHH1 is caused by homozygous mutations and characterized by benign symptoms with mild hypercalcaemia, whereas NSHPT is caused by homozygous mutations and characterized by more severe ones with severe hypercalcaemia and hyperparathyroid bone disease. Gain-of-function mutations are responsible for autosomal dominant hypocalcemia (ADH) that characterized by seizures in infancy, moderate hypocalcaemia and, absolute hypercalciuria.",Endocrine disease; Urinary system disease,CASR [HSA:846] [KO:K04612],,,,,,,"ICD-10: E83.5
MeSH: C537145 C563375 C562783
OMIM: 145980 239200 146200 601198","PMID:18328986
  AUTHORS   Egbuna OI, Brown EM
  TITLE     Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
  JOURNAL   Best Pract Res Clin Rheumatol 22:129-48 (2008)
DOI:10.1016/j.berh.2007.11.006

PMID:11706743
  AUTHORS   Heath DA
  TITLE     Familial hypocalciuric hypercalcemia.
  JOURNAL   Rev Endocr Metab Disord 1:291-6 (2000)
DOI:10.1023/A:1026566418011

PMID:11033758
  AUTHORS   Brown EM
  TITLE     Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium.
  JOURNAL   Endocrinol Metab Clin North Am 29:503-22 (2000)
DOI:10.1016/S0889-8529(05)70148-1

PMID:11013439
  AUTHORS   Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE
  TITLE     Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
  JOURNAL   Hum Mutat 16:281-96 (2000)
DOI:10.1002/1098-1004(200010)16:4<281:AID-HUMU1>3.0.CO;2-A",MeSH,C537145,C563375,C562783,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00512,Permanent neonatal diabetes mellitus (PNDM),"Neonatal diabetes mellitus (NDM), which is a monogenic form of diabetes, is a heterogeneous group of disorders characterized by hyperglycemia in the first 6 months of life. NDM is categorized into transient (TNDM) and permanent (PNDM). In the case of PNDM, the condition does not resolve over time. The most frequent causes of PNDM are heterozygous mutations in the KCNJ11, INS and ABCC8 genes that play a critical role in insulin secretion from pancreatic beta-cells. The responsible genes remain unknown in up to 40% of patients.",Metabolic disease; Endocrine disease,"KCNJ11 [HSA:3767] [KO:K05004]
ABCC8 [HSA:6833] [KO:K05032]
GCK [HSA:2645] [KO:K12407]
INS [HSA:3630] [KO:K04526]
IPF1 [HSA:3651] [KO:K07594]
PTF1A [HSA:256297] [KO:K09073]
FOXP3 [HSA:50943] [KO:K10163]
EIF2AK3 [HSA:9451] [KO:K08860]
GLIS3 [HSA:169792] [KO:K09232]",,,,,Insulin [DR:D00085],,"ICD-10: P70.2
MeSH: C563424 C563425 C563796
OMIM: 606176 609069 610199","PMID:17349054 (gene)
  AUTHORS   Polak M, Cave H
  TITLE     Neonatal diabetes mellitus: a disease linked to multiple mechanisms.
  JOURNAL   Orphanet J Rare Dis 2:12 (2007)
DOI:10.1186/1750-1172-2-12

PMID:21054355 (gene)
  AUTHORS   Rubio-Cabezas O, Klupa T, Malecki MT
  TITLE     Permanent neonatal diabetes mellitus--the importance of diabetes differential diagnosis in neonates and infants.
  JOURNAL   Eur J Clin Invest 41:323-33 (2011)
DOI:10.1111/j.1365-2362.2010.02409.x",MeSH,C563424,C563425,C563796,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01982,Carnitine palmitoyltransferase II deficiency,"Carnitine palmitoyltransferase II (CPT2) deficiency is an inherited disorder of mitochondrial long-chain fatty-acid oxidation. Three distinct clinical manifestations of CPT2 deficiency have been defined including a mild adult onset myopathy, a severe infantile disorder and a lethal neonatal form.",Inherited metabolic disease; Mitochondrial disease,CPT2 [HSA:1376] [KO:K08766],,,,,,,"ICD-10: E71.4
MeSH: C563462 C563463
OMIM: 600649 608836 255110","PMID:8651281 (gene)
  AUTHORS   Bonnefont JP, Taroni F, Cavadini P, Cepanec C, Brivet M, Saudubray JM, Leroux JP, Demaugre F
  TITLE     Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.
  JOURNAL   Am J Hum Genet 58:971-8 (1996)

PMID:18550408 (gene)
  AUTHORS   Isackson PJ, Bennett MJ, Lichter-Konecki U, Willis M, Nyhan WL, Sutton VR, Tein I, Vladutiu GD
  TITLE     CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
  JOURNAL   Mol Genet Metab 94:422-7 (2008)
DOI:10.1016/j.ymgme.2008.05.002",MeSH,C563462,C563463,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00513,Transient neonatal diabetes mellitus (TNDM),"Neonatal diabetes mellitus (NDM), which is a monogenic form of diabetes, is a heterogeneous group of disorders characterized by hyperglycemia in the first 6 months of life. NDM is categorized into transient (TNDM) and permanent (PNDM). TNDM is a developmental disorder of insulin production that resolves by age 18 months but can reappear later in life. TNDM is different from type 1 diabetes since no islet cell antibodies or autoimmune phenomenon were found in these patients. 6q24-related TNDM is an imprinting disorder resulting from overexpression of at least two imprinted genes, PLAGL1 and HYMAI, on chromosome 6q24. Hypomethylation of multiple imprinted loci is associated with mutations in ZFP57. Mutations in ABCC8 and KCNJ11 encoding Kir6.2 and SUR1 are other genetic causes of TNDM.",Metabolic disease; Endocrine disease,"ZFP57 [HSA:346171] [KO:K09228]
PLAGL1 [HSA:5325] [KO:K19485]
HYMAI [HSA:57061]
ABCC8 [HSA:6833] [KO:K05032]
KCNJ11 [HSA:3767] [KO:K05004]",,,,,Insulin [DR:D00085],,"ICD-10: P70.2
MeSH: C563322 C563672 C566432
OMIM: 601410 610374 610582","PMID:21034612 (gene)
  AUTHORS   Xu XF, Du LZ
  TITLE     Epigenetics in neonatal diseases.
  JOURNAL   Chin Med J (Engl) 123:2948-54 (2010)
DOI:10.3760/cma.j.issn.0366-6999.2010.20.036

PMID:20922569 (gene)
  AUTHORS   Temple IK, Shield JP
  TITLE     6q24 transient neonatal diabetes.
  JOURNAL   Rev Endocr Metab Disord 11:199-204 (2010)
DOI:10.1007/s11154-010-9150-4

PMID:17349054 (gene)
  AUTHORS   Polak M, Cave H
  TITLE     Neonatal diabetes mellitus: a disease linked to multiple mechanisms.
  JOURNAL   Orphanet J Rare Dis 2:12 (2007)
DOI:10.1186/1750-1172-2-12",MeSH,C563322,C563672,C566432,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01171,Poor drug metabolism (PM),"Many administered drugs are first activated by phase I drug-metabolizing enzymes, such as cytochrome P450 (CYP). There are some defective activity mutants due to CYP polymorphisms. In these cases, drugs are not metabolized, the high drug levels in blood are maintained, and toxic effects appear in the patients.",Inherited metabolic disease,"CYP2C19 [HSA:1557] [KO:K17721]
CYP2D6 [HSA:1565] [KO:K17712]",,,,,,"In Caucasians and Asians, PM and allele frequency levels of CYPs (CYP2A6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) are summarized from previous findings.","MeSH: C563703 C563835
OMIM: 609535 608902","PMID:12959412
  AUTHORS   Mizutani T
  TITLE     PM frequencies of major CYPs in Asians and Caucasians.
  JOURNAL   Drug Metab Rev 35:99-106 (2003)
DOI:10.1081/DMR-120023681

PMID:12879168
  AUTHORS   Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmoller J, Frotschl R, Kopke K, Gerloff T, Chernov JN, Roots I
  TITLE     Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
  JOURNAL   Eur J Clin Pharmacol 59:303-12 (2003)
DOI:10.1007/s00228-003-0606-2

PMID:9093256
  AUTHORS   Kaneko A, Kaneko O, Taleo G, Bjorkman A, Kobayakawa T
  TITLE     High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
  JOURNAL   Lancet 349:921-2 (1997)
DOI:10.1016/S0140-6736(05)62696-7",MeSH,C563703,C563835,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01143,Vitamin D-dependent rickets,"Rickets is the failure of growing bone to mineralize. Many skeletal and radiographic changes can occur because of the lack of calcified osteoid and the buildup of unossified cartilage. Vitamin D-dependent rickets type I results from abnormalities in the gene coding for 25(OH)D3-1-alpha-hydroxylase and vitamin D 25-hydroxylase, and type II results from defective vitamin D receptors. Both diseases are rare autosomal recessive disorders characterized by hypocalcemia, secondary hyperparathyroidism and early onset severe rickets.",Musculoskeletal disease; Inherited metabolic disease,"(VDDR1A) CYP27B1 [HSA:1594] [KO:K07438]
(VDDR1B) CYP2R1 [HSA:120227] [KO:K07419]
(VDDR2A) VDR [HSA:7421] [KO:K08539]",,,,,"Calcitriol [DR:D00129]
Calcium [ATC:A12A]",,"ICD-10: E55.0
MeSH: C562688 C564005 C562794
OMIM: 264700 277440 600081","PMID:16939184 (description, gene, drug)
  AUTHORS   Nield LS, Mahajan P, Joshi A, Kamat D
  TITLE     Rickets: not a disease of the past.
  JOURNAL   Am Fam Physician 74:619-26 (2006)

PMID:20675935 (description, gene)
  AUTHORS   Kitanaka S
  TITLE     [Genetic basis for skeletal disease. Hereditary rickets].
  JOURNAL   Clin Calcium 20:1238-44 (2010)

PMID:20511055 (description, gene)
  AUTHORS   Malloy PJ, Feldman D
  TITLE     Genetic disorders and defects in vitamin d action.
  JOURNAL   Endocrinol Metab Clin North Am 39:333-46, table of contents (2010)
DOI:10.1016/j.ecl.2010.02.004

PMID:8201479 (gene)
  AUTHORS   Casella SJ, Reiner BJ, Chen TC, Holick MF, Harrison HE
  TITLE     A possible genetic defect in 25-hydroxylation as a cause of rickets.
  JOURNAL   J Pediatr 124:929-32 (1994)
DOI:10.1016/S0022-3476(05)83184-1

PMID:15128933 (gene)
  AUTHORS   Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW
  TITLE     Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.
  JOURNAL   Proc Natl Acad Sci U S A 101:7711-5 (2004)
DOI:10.1073/pnas.0402490101",MeSH,C562688,C564005,C562794,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01282,Spermatogenic failure,"Spermatogenic failure is reflected in a lower or absent production of spermatozoa and is described by routine semen analysis using terms such as azoospermia, oligozoospermia, teratozoospermia or asthenozoospermia. The genetic causes of spermatogenetic failure still remain largely unknown. It has been estimated that more than 2300 genes play a role in spermatogenesis. But only a few of these genes have been investigated in humans.",Developmental disorder,"(SPGF3) SLC26A8 [HSA:116369] [KO:K14705]
(SPGF4) SYCP3 [HSA:50511] [KO:K19528]
(SPGF5) AURKC [HSA:6795] [KO:K11480]
(SPGF6) SPATA16 [HSA:83893]
(SPGF7) CATSPER1 [HSA:117144] [KO:K16889]
(SPGF8) NR5A1 [HSA:2516] [KO:K08560]
(SPGF9) DPY19L2 [HSA:283417]
(SPGF10) SEPT12 [HSA:124404] [KO:K16938]
(SPGF11) KLHL10 [HSA:317719] [KO:K10448]
(SPGF12) NANOS1 [HSA:340719] [KO:K18741]
(SPGF13) TAF4B [HSA:6875] [KO:K03129]
(SPGF14) ZMYND15 [HSA:84225]
(SPGF15) SYCE1 [HSA:93426] [KO:K19534]
(SPGF16) SUN5 [HSA:140732] [KO:K21876]
(SPGF17) PLCZ1 [HSA:89869] [KO:K05861]
(SPGF18) DNAH1 [HSA:25981] [KO:K10408]
(SPGF19) CFAP43 [HSA:80217]
(SPGF20) CFAP44 [HSA:55779]
(SPGF21) BRDT [HSA:676] [KO:K11724]
(SPGF22) MEIOB [HSA:254528]
(SPGF23) TEX14 [HSA:56155] [KO:K17540]
(X-linked) TEX11 [HSA:56159]
(Y-linked) USP9Y [HSA:8287] [KO:K11840]",,,,,,"Globozoospermia and Azoospermia is described in H01208 and H00890, respectively. [DS:H01208] [DS:H00890]","ICD-10: N46
MeSH: C567832 C564030
OMIM: 258150 606766 270960 243060 102530 612997 613957 613958 614822 615081 615413 615841 615842 616950 617187 617214 617576 617592 617593 617644 617706 617707 415000 309120","PMID:22138898
  AUTHORS   Massart A, Lissens W, Tournaye H, Stouffs K
  TITLE     Genetic causes of spermatogenic failure.
  JOURNAL   Asian J Androl 14:40-8 (2012)
DOI:10.1038/aja.2011.67

PMID:23582645 (gene)
  AUTHORS   Dirami T, Rode B, Jollivet M, Da Silva N, Escalier D, Gaitch N, Norez C, Tuffery P, Wolf JP, Becq F, Ray PF, Dulioust E, Gacon G, Bienvenu T, Toure A
  TITLE     Missense mutations in SLC26A8, encoding a sperm-specific activator of CFTR, are associated with human asthenozoospermia.
  JOURNAL   Am J Hum Genet 92:760-6 (2013)
DOI:10.1016/j.ajhg.2013.03.016

PMID:21733974
  AUTHORS   Ben Khelifa M, Zouari R, Harbuz R, Halouani L, Arnoult C, Lunardi J, Ray PF
  TITLE     A new AURKC mutation causing macrozoospermia: implications for human spermatogenesis and clinical diagnosis.
  JOURNAL   Mol Hum Reprod 17:762-8 (2011)
DOI:10.1093/molehr/gar050

PMID:19344877
  AUTHORS   Avenarius MR, Hildebrand MS, Zhang Y, Meyer NC, Smith LL, Kahrizi K, Najmabadi H, Smith RJ
  TITLE     Human male infertility caused by mutations in the CATSPER1 channel protein.
  JOURNAL   Am J Hum Genet 84:505-10 (2009)
DOI:10.1016/j.ajhg.2009.03.004

PMID:20887963
  AUTHORS   Bashamboo A, Ferraz-de-Souza B, Lourenco D, Lin L, Sebire NJ, Montjean D, Bignon-Topalovic J, Mandelbaum J, Siffroi JP, Christin-Maitre S, Radhakrishna U, Rouba H, Ravel C, Seeler J, Achermann JC, McElreavey K
  TITLE     Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1.
  JOURNAL   Am J Hum Genet 87:505-12 (2010)
DOI:10.1016/j.ajhg.2010.09.009

PMID:22275165 (gene)
  AUTHORS   Kuo YC, Lin YH, Chen HI, Wang YY, Chiou YW, Lin HH, Pan HA, Wu CM, Su SM, Hsu CC, Kuo PL
  TITLE     SEPT12 mutations cause male infertility with defective sperm annulus.
  JOURNAL   Hum Mutat 33:710-9 (2012)
DOI:10.1002/humu.22028

PMID:17047026
  AUTHORS   Yatsenko AN, Roy A, Chen R, Ma L, Murthy LJ, Yan W, Lamb DJ, Matzuk MM
  TITLE     Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization.
  JOURNAL   Hum Mol Genet 15:3411-9 (2006)
DOI:10.1093/hmg/ddl417

PMID:23315541 (gene)
  AUTHORS   Kusz-Zamelczyk K, Sajek M, Spik A, Glazar R, Jedrzejczak P, Latos-Bielenska A, Kotecki M, Pawelczyk L, Jaruzelska J
  TITLE     Mutations of NANOS1, a human homologue of the Drosophila morphogen, are associated with a lack of germ cells in testes or severe oligo-astheno-teratozoospermia.
  JOURNAL   J Med Genet 50:187-93 (2013)
DOI:10.1136/jmedgenet-2012-101230

PMID:24431330 (gene)
  AUTHORS   Ayhan O, Balkan M, Guven A, Hazan R, Atar M, Tok A, Tolun A
  TITLE     Truncating mutations in TAF4B and ZMYND15 causing recessive azoospermia.
  JOURNAL   J Med Genet 51:239-44 (2014)
DOI:10.1136/jmedgenet-2013-102102

PMID:25899990 (gene)
  AUTHORS   Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S, Laufer N, Richler C, Frumkin A
  TITLE     Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia.
  JOURNAL   J Assist Reprod Genet 32:887-91 (2015)
DOI:10.1007/s10815-015-0445-y

PMID:27640305 (gene)
  AUTHORS   Zhu F, Wang F, Yang X, Zhang J, Wu H, Zhang Z, Zhang Z, He X, Zhou P, Wei Z, Gecz J, Cao Y
  TITLE     Biallelic SUN5 Mutations Cause Autosomal-Recessive Acephalic Spermatozoa Syndrome.
  JOURNAL   Am J Hum Genet 99:942-949 (2016)
DOI:10.1016/j.ajhg.2016.08.004

PMID:26721930 (gene)
  AUTHORS   Escoffier J, Lee HC, Yassine S, Zouari R, Martinez G, Karaouzene T, Coutton C, Kherraf ZE, Halouani L, Triki C, Nef S, Thierry-Mieg N, Savinov SN, Fissore R, Ray PF, Arnoult C
  TITLE     Homozygous mutation of PLCZ1 leads to defective human oocyte activation and infertility that is not rescued by the WW-binding protein PAWP.
  JOURNAL   Hum Mol Genet 25:878-91 (2016)
DOI:10.1093/hmg/ddv617

PMID:27798045 (gene)
  AUTHORS   Amiri-Yekta A, Coutton C, Kherraf ZE, Karaouzene T, Le Tanno P, Sanati MH, Sabbaghian M, Almadani N, Sadighi Gilani MA, Hosseini SH, Bahrami S, Daneshipour A, Bini M, Arnoult C, Colombo R, Gourabi H, Ray PF
  TITLE     Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations.
  JOURNAL   Hum Reprod 31:2872-2880 (2016)
DOI:10.1093/humrep/dew262

PMID:28552195 (gene)
  AUTHORS   Tang S, Wang X, Li W, Yang X, Li Z, Liu W, Li C, Zhu Z, Wang L, Wang J, Zhang L, Sun X, Zhi E, Wang H, Li H, Jin L, Luo Y, Wang J, Yang S, Zhang F
  TITLE     Biallelic Mutations in CFAP43 and CFAP44 Cause Male Infertility with Multiple Morphological Abnormalities of the Sperm Flagella.
  JOURNAL   Am J Hum Genet 100:854-864 (2017)
DOI:10.1016/j.ajhg.2017.04.012

PMID:28199965 (gene)
  AUTHORS   Li L, Sha Y, Wang X, Li P, Wang J, Kee K, Wang B
  TITLE     Whole-exome sequencing identified a homozygous BRDT mutation in a patient with acephalic spermatozoa.
  JOURNAL   Oncotarget 8:19914-19922 (2017)
DOI:10.18632/oncotarget.15251

PMID:28206990 (gene)
  AUTHORS   Gershoni M, Hauser R, Yogev L, Lehavi O, Azem F, Yavetz H, Pietrokovski S, Kleiman SE
  TITLE     A familial study of azoospermic men identifies three novel causative mutations in three new human azoospermia genes.
  JOURNAL   Genet Med 19:998-1006 (2017)
DOI:10.1038/gim.2016.225

PMID:25970010 (gene)
  AUTHORS   Yatsenko AN, Georgiadis AP, Ropke A, Berman AJ, Jaffe T, Olszewska M, Westernstroer B, Sanfilippo J, Kurpisz M, Rajkovic A, Yatsenko SA, Kliesch S, Schlatt S, Tuttelmann F
  TITLE     X-linked TEX11 mutations, meiotic arrest, and azoospermia in infertile men.
  JOURNAL   N Engl J Med 372:2097-107 (2015)
DOI:10.1056/NEJMoa1406192",MeSH,C567832,C564030,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00471,Split-hand/foot malformation (SHFM),Split hand/foot malformation (SHFM) is a congenital limb malformation characterized by median clefts of hands and foot. Disrupted formation of the apical ectodermal ridge during development results in central ray deficiency in SHFM patients.,Skeletal dysplasia; Developmental disorder,"(SHFM4) TP63 [HSA:8626] [KO:K10149]
(SHFM6) WNT10B [HSA:7480] [KO:K01357]
(SHFM1D) DLX5 [HSA:1749] [KO:K18489]
(SFMMP) MAP3K20 [HSA:51776] [KO:K04424]",,,,,,"SHFM1D refers to split-hand/foot malformation 1 with sensorineural hearing loss.
SFMMP refers to split-foot malformation with mesoaxial polydactyly.","CD-10: Q71.6  Q72.7
MeSH: C567893 C564056 C565437 C565344 C564674 C567616
OMIM: 183600 605289 225300 220600 616890","PMID:16283879 (description, gene)
  AUTHORS   Elliott AM, Evans JA, Chudley AE
  TITLE     Split hand foot malformation (SHFM).
  JOURNAL   Clin Genet 68:501-5 (2005)
DOI:10.1111/j.1399-0004.2005.00530.x

PMID:16763964 (description, gene)
  AUTHORS   Basel D, Kilpatrick MW, Tsipouras P
  TITLE     The expanding panorama of split hand foot malformation.
  JOURNAL   Am J Med Genet A 140:1359-65 (2006)
DOI:10.1002/ajmg.a.31304

PMID:12668597 (description, gene)
  AUTHORS   Duijf PH, van Bokhoven H, Brunner HG
  TITLE     Pathogenesis of split-hand/split-foot malformation.
  JOURNAL   Hum Mol Genet 12 Spec No 1:R51-60 (2003)
DOI:10.1093/hmg/ddg090

PMID:21554266 (gene)
  AUTHORS   Khan S, Basit S, Zimri FK, Ali N, Ali G, Ansar M, Ahmad W
  TITLE     A novel homozygous missense mutation in WNT10B in familial split-hand/foot malformation.
  JOURNAL   Clin Genet 82:48-55 (2012)
DOI:10.1111/j.1399-0004.2011.01698.x

PMID:22121204 (gene)
  AUTHORS   Shamseldin HE, Faden MA, Alashram W, Alkuraya FS
  TITLE     Identification of a novel DLX5 mutation in a family with autosomal recessive split hand and foot malformation.
  JOURNAL   J Med Genet 49:16-20 (2012)
DOI:10.1136/jmedgenet-2011-100556

PMID:26755636 (gene)
  AUTHORS   Spielmann M, Kakar N, Tayebi N, Leettola C, Nurnberg G, Sowada N, Lupianez DG, Harabula I, Flottmann R, Horn D, Chan WL, Wittler L, Yilmaz R, Altmuller J, Thiele H, van Bokhoven H, Schwartz CE, Nurnberg P, Bowie JU, Ahmad J, Kubisch C, Mundlos S, Borck G
  TITLE     Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice.
  JOURNAL   Genome Res 26:183-91 (2016)
DOI:10.1101/gr.199430.115",MeSH,C567893,C564056,C565437,C565344,C564674,C567616,,,,,,,,,,,,,,,,,,,,,,,,
H01781,Autophagic vacuolar myopathy,"Autophagic vacuolar myopathies (AVM) are a group of disorders united by shared histopathological features on muscle biopsy that include the aberrant accumulation of autophagic vacuoles. They are characterized by autophagic vacuoles in which the vacuolar membranes have sarcolemmal features, and include four entities: Danon disease, X-linked myopathy with excessive autophagy (XMEA), infantile AVM, and adult onset AVM with multiorgan involvement. Danon disease has been shown to be associated with mutations in the LAMP2 gene located on the X chromosome. XMEA is characterized by weakness and wasting primarily of the proximal muscles of the lower extremities. Mutations in the VMA21 gene at Xq28 cause XMEA by reducing the activity of lysosomal hydrolases.",Musculoskeletal disease,"LAMP2 [HSA:3920] [KO:K06528]
VMA21 [HSA:203547]",,,,,,See also H00150 Danon disease.,"ICD-10: G71.8
MeSH: D052120 C564093 C536522
OMIM: 300257 310440 609500","PMID:16640643
  AUTHORS   Holton JL, Beesley C, Jackson M, Venner K, Bhardwaj N, Winchester B, Al-Memar A
  TITLE     Autophagic vacuolar myopathy in twin girls.
  JOURNAL   Neuropathol Appl Neurobiol 32:253-9 (2006)
DOI:10.1111/j.1365-2990.2006.00691.x

PMID:25644398
  AUTHORS   Dowling JJ, Moore SA, Kalimo H, Minassian BA
  TITLE     X-linked myopathy with excessive autophagy: a failure of self-eating.
  JOURNAL   Acta Neuropathol 129:383-90 (2015)
DOI:10.1007/s00401-015-1393-4

PMID:25817839 (gene)
  AUTHORS   Munteanu I, Ramachandran N, Ruggieri A, Awaya T, Nishino I, Minassian BA
  TITLE     Congenital autophagic vacuolar myopathy is allelic to X-linked myopathy with excessive autophagy.
  JOURNAL   Neurology 84:1714-6 (2015)
DOI:10.1212/WNL.0000000000001499",MeSH,D052120,C564093,C536522,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00249,"Thyroid hormone resistance syndrome, including:
Generalized thyroid hormone resistance;
Refetoff syndrome;
Selective pituitary thyroid hormone resistance","Thyroid hormone resistance syndrome, which inherits in either autosomal dominant or recessive manner, is characterized by reduced end-organ responsiveness to thyroid hormone. It is caused by mutations in the gene of thyroid hormone receptor and the locations of the mutations in the gene are associated with the phenotypes, such as generalized resistance, pituitary selective resistance.",Endocrine disease,THRB [HSA:7068] [KO:K08362],,,,thyroid hormone [HSA:5741] [KO:K05261],,,"ICD-10: E07.8
MeSH: D018382 C564154
OMIM: 188570 274300 145650","PMID:17132274
  AUTHORS   Olateju TO, Vanderpump MP
  TITLE     Thyroid hormone resistance.
  JOURNAL   Ann Clin Biochem 43:431-40 (2006)
DOI:10.1258/000456306778904678

PMID:15860414
  AUTHORS   Cheng SY
  TITLE     Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.
  JOURNAL   Trends Endocrinol Metab 16:176-82 (2005)
DOI:10.1016/j.tem.2005.03.008",MeSH,D018382,C564154,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00668,"Anemia due to disorders of glutathione metabolism, including:
Glucose-6-phosphate dehydrogenase deficiency [DS:H01375];
Glutathione peroxidase deficiency;
Gamma-glutamylcysteine synthetase deficiency;
Glutathione synthetase deficiency;
5-oxoprolinase deficiency","Anemia due to disorders of glutathione metabolism is a group of red cell disorders caused by inherited abnormality of enzymes of glutathione metabolism. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic disorder of red blood cells in humans. It is estimated that about 400 million people are affected by this deficiency. A G6PD-deficient patient lacks the ability to protect red blood cells against oxidative stresses from certain drugs, infections, metabolic conditions, and ingestion of fava beans. GCLC catalyzes the initial and the rate-limiting step of glutathione synthesis. Deficiency of GCLC is extremely rare. GSS deficiency is a more frequent cause of glutathione deficiency.",Inherited metabolic disease; Hematologic disease,"G6PD [HSA:2539] [KO:K00036]
GPX1 [HSA:2876] [KO:K00432]
GCLC [HSA:2729] [KO:K11204]
GSS [HSA:2937] [KO:K21456]
OPLAH [HSA:26873] [KO:K01469]",,,,,,,"ICD-10: D55.0 D55.1
MeSH: D005955 C564217 C565557 C536835
OMIM: 300908 614164 230450 231900 266130 260005","PMID:8634459
  AUTHORS   Hirono A, Iyori H, Sekine I, Ueyama J, Chiba H, Kanno H, Fujii H, Miwa S
  TITLE     Three cases of hereditary nonspherocytic hemolytic anemia associated with red blood cell glutathione deficiency.
  JOURNAL   Blood 87:2071-4 (1996)

PMID:5766310
  AUTHORS   Necheles TF, Maldonado N, Barquet-Chediak A, Allen DM
  TITLE     Homozygous erythrocyte glutathione-peroxidase deficiency: clinical and biochemical studies.
  JOURNAL   Blood 33:164-9 (1969)

PMID:21852236
  AUTHORS   Lubos E, Kelly NJ, Oldebeken SR, Leopold JA, Zhang YY, Loscalzo J, Handy DE
  TITLE     Glutathione Peroxidase-1 Deficiency Augments Proinflammatory Cytokine-induced Redox Signaling and Human Endothelial Cell Activation.
  JOURNAL   J Biol Chem 286:35407-17 (2011)
DOI:10.1074/jbc.M110.205708

PMID:10515893
  AUTHORS   Beutler E, Gelbart T, Kondo T, Matsunaga AT
  TITLE     The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency.
  JOURNAL   Blood 94:2890-4 (1999)

PMID:21651516 (gene)
  AUTHORS   Almaghlouth IA, Mohamed JY, Al-Amoudi M, Al-Ahaidib L, Al-Odaib A, Alkuraya FS
  TITLE     5-Oxoprolinase deficiency: report of the first human OPLAH mutation.
  JOURNAL   Clin Genet 82:193-6 (2012)
DOI:10.1111/j.1399-0004.2011.01728.x",MeSH,D005955,C564217,C565557,C536835,,,,,,,,,,,,,,,,,,,,,,,,,,
H00410,Maturity onset diabetes of the young (MODY),"Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous subtype of familial diabetes mellitus characterized by autosomal dominant inheritance, early onset before 25 years of age and primary insulin secretion defects. Mutations in six genes, encoding the glucose sensor enzyme glucokinase and five transcription factors that participate in a regulatory network essential for adult beta cell function, cause most of the MODY cases.",Metabolic disease; Endocrine disease,"(MODY1) HNF4A [HSA:3172] [KO:K07292]
(MODY2) GCK [HSA:2645] [KO:K12407]
(MODY3) TCF1 [HSA:6927] [KO:K08036]
(MODY4) PDX1 [HSA:3651] [KO:K07594]
(MODY5) TCF2 [HSA:6928] [KO:K08034]
(MODY6) NEUROD1 [HSA:4760] [KO:K08033]
(MODY7) KLF11 [HSA:8462] [KO:K09209]
(MODY8) CEL [HSA:1056] [KO:K12298]
(MODY9) PAX4 [HSA:5078] [KO:K08032]
(MODY10) INS [HSA:3630] [KO:K04526]
(MODY11) BLK [HSA:640] [KO:K08890]
(MODY13) KCNJ11 [HSA:3767] [KO:K05004]
(MODY14) APPL1 [HSA:26060] [KO:K08733]",,,,,Insulin [DR:D00085],,"ICD-10: E13
MeSH: C565101 C564219 C563933 C563451 C535520 C565231 C566466 C565225 C567393
OMIM: 606391 125850 138079 600496 606392 137920 606394 610508 609812 612225 613370 613375 616329 616511","PMID:18436708 (gene)
  AUTHORS   Vaxillaire M, Froguel P
  TITLE     Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes.
  JOURNAL   Endocr Rev 29:254-64 (2008)
DOI:10.1210/er.2007-0024

PMID:11979019 (gene)
  AUTHORS   Velho G, Robert JJ
  TITLE     Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics.
  JOURNAL   Horm Res 57 Suppl 1:29-33 (2002)
DOI:10.1159/000053309

PMID:15774581 (MODY7)
  AUTHORS   Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, Vaillant E, Benmezroua Y, Durand E, Bakaher N, Delannoy V, Vaxillaire M, Cook T, Dallinga-Thie GM, Jansen H, Charles MA, Clement K, Galan P, Hercberg S, Helbecque N, Charpentier G, Prentki M, Hansen T, Pedersen O, Urrutia R, Melloul D, Froguel P
  TITLE     Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.
  JOURNAL   Proc Natl Acad Sci U S A 102:4807-12 (2005)
DOI:10.1073/pnas.0409177102

PMID:16369531 (MODY8)
  AUTHORS   Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bjorkhaug L, Sagen JV, Aksnes L, Sovik O, Lombardo D, Molven A, Njolstad PR
  TITLE     Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction.
  JOURNAL   Nat Genet 38:54-62 (2006)
DOI:10.1038/ng1708

PMID:17426099 (MODY9)
  AUTHORS   Plengvidhya N, Kooptiwut S, Songtawee N, Doi A, Furuta H, Nishi M, Nanjo K, Tantibhedhyangkul W, Boonyasrisawat W, Yenchitsomanus PT, Doria A, Banchuin N
  TITLE     PAX4 mutations in Thais with maturity onset diabetes of the young.
  JOURNAL   J Clin Endocrinol Metab 92:2821-6 (2007)
DOI:10.1210/jc.2006-1927

PMID:20226046 (MODY10)
  AUTHORS   Boesgaard TW, Pruhova S, Andersson EA, Cinek O, Obermannova B, Lauenborg J, Damm P, Bergholdt R, Pociot F, Pisinger C, Barbetti F, Lebl J, Pedersen O, Hansen T
  TITLE     Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY).
  JOURNAL   BMC Med Genet 11:42 (2010)
DOI:10.1186/1471-2350-11-42

PMID:19667185 (MODY11)
  AUTHORS   Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS, Krolewski AS, Bonner-Weir S, Sharma A, Sale M, Mychaleckyj JC, Kulkarni RN, Doria A
  TITLE     Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction.
  JOURNAL   Proc Natl Acad Sci U S A 106:14460-5 (2009)
DOI:10.1073/pnas.0906474106

PMID:22701567 (MODY13)
  AUTHORS   Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A, Vatin V, Delplanque J, Le Guilcher D, De Graeve F, Lecoeur C, Sand O, Vaxillaire M, Froguel P
  TITLE     Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.
  JOURNAL   PLoS One 7:e37423 (2012)
DOI:10.1371/journal.pone.0037423

PMID:26073777 (MODY14)
  AUTHORS   Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, Pascarella S, Marchetti P, Trischitta V, Di Paola R, Doria A
  TITLE     Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus.
  JOURNAL   Am J Hum Genet 97:177-85 (2015)
DOI:10.1016/j.ajhg.2015.05.011",MeSH,C565101,C564219,C563933,C563451,C535520,C565231,C566466,C565225,C567393,,,,,,,,,,,,,,,,,,,,,
H00865,Lethal congenital contractural syndrome (LCCS),"Lethal congenital contractural syndrome (LCCS) is a heterogeneous group of disorders characterized by congenital nonprogressive joint contractures with a severe form of arthrogryposis. LCCS is inherited in an autosomal recessive manner. It has a worldwide incidence, but it is more common in isolated populations, such as Finland and the Bedouin community in Israel. Several mutations associated with LCCS have been reported.",Musculoskeletal disease,"(LCCS1) GLE1 [HSA:2733] [KO:K18723]
(LCCS2) ERBB3 [HSA:2065] [KO:K05084]
(LCCS3) PIP5K1C [HSA:23396] [KO:K00889]
(LCCS4) MYBPC1 [HSA:4604] [KO:K12557]
(LCCS5) DNM2 [HSA:1785] [KO:K01528]
(LCCS6) ZBTB42 [HSA:100128927]
(LCCS7) CNTNAP1 [HSA:8506] [KO:K07379]
(LCCS8) ADCY6 [HSA:112] [KO:K08046]
(LCCS9) ADGRG6 [HSA:57211] [KO:K08463]",,,,,,,"ICD-10: Q68.8
MeSH: C537194 C564369 C566961
OMIM: 253310 607598 611369 614915 615368 616248 616286 616287 616503","PMID:18204449 (gene)
  AUTHORS   Nousiainen HO, Kestila M, Pakkasjarvi N, Honkala H, Kuure S, Tallila J, Vuopala K, Ignatius J, Herva R, Peltonen L
  TITLE     Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease.
  JOURNAL   Nat Genet 40:155-7 (2008)
DOI:10.1038/ng.2007.65

PMID:17701904 (gene)
  AUTHORS   Narkis G, Ofir R, Manor E, Landau D, Elbedour K, Birk OS
  TITLE     Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway.
  JOURNAL   Am J Hum Genet 81:589-95 (2007)
DOI:10.1086/520770

PMID:17701898 (description, gene)
  AUTHORS   Narkis G, Ofir R, Landau D, Manor E, Volokita M, Hershkowitz R, Elbedour K, Birk OS
  TITLE     Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.
  JOURNAL   Am J Hum Genet 81:530-9 (2007)
DOI:10.1086/520771

PMID:22610851 (gene)
  AUTHORS   Markus B, Narkis G, Landau D, Birk RZ, Cohen I, Birk OS
  TITLE     Autosomal recessive lethal congenital contractural syndrome type 4 (LCCS4) caused by a mutation in MYBPC1.
  JOURNAL   Hum Mutat 33:1435-8 (2012)
DOI:10.1002/humu.22122

PMID:23092955 (gene)
  AUTHORS   Koutsopoulos OS, Kretz C, Weller CM, Roux A, Mojzisova H, Bohm J, Koch C, Toussaint A, Heckel E, Stemkens D, Ter Horst SA, Thibault C, Koch M, Mehdi SQ, Bijlsma EK, Mandel JL, Vermot J, Laporte J
  TITLE     Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome.
  JOURNAL   Eur J Hum Genet 21:637-42 (2013)
DOI:10.1038/ejhg.2012.226

PMID:25055871 (gene)
  AUTHORS   Patel N, Smith LL, Faqeih E, Mohamed J, Gupta VA, Alkuraya FS
  TITLE     ZBTB42 mutation defines a novel lethal congenital contracture syndrome (LCCS6).
  JOURNAL   Hum Mol Genet 23:6584-93 (2014)
DOI:10.1093/hmg/ddu384

PMID:24319099 (gene)
  AUTHORS   Laquerriere A, Maluenda J, Camus A, Fontenas L, Dieterich K, Nolent F, Zhou J, Monnier N, Latour P, Gentil D, Heron D, Desguerres I, Landrieu P, Beneteau C, Delaporte B, Bellesme C, Baumann C, Capri Y, Goldenberg A, Lyonnet S, Bonneau D, Estournet B, Quijano-Roy S, Francannet C, Odent S, Saint-Frison MH, Sigaudy S, Figarella-Branger D, Gelot A, Mussini JM, Lacroix C, Drouin-Garraud V, Malinge MC, Attie-Bitach T, Bessieres B, Bonniere M, Encha-Razavi F, Beaufrere AM, Khung-Savatovsky S, Perez MJ, Vasiljevic A, Mercier S, Roume J, Trestard L, Saugier-Veber P, Cordier MP, Layet V, Legendre M, Vigouroux-Castera A, Lunardi J, Bayes M, Jouk PS, Rigonnot L, Granier M, Sternberg D, Warszawski J, Gut I, Gonzales M, Tawk M, Melki J
  TITLE     Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.
  JOURNAL   Hum Mol Genet 23:2279-89 (2014)
DOI:10.1093/hmg/ddt618

PMID:26004201 (gene)
  AUTHORS   Ravenscroft G, Nolent F, Rajagopalan S, Meireles AM, Paavola KJ, Gaillard D, Alanio E, Buckland M, Arbuckle S, Krivanek M, Maluenda J, Pannell S, Gooding R, Ong RW, Allcock RJ, Carvalho ED, Carvalho MD, Kok F, Talbot WS, Melki J, Laing NG
  TITLE     Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita.
  JOURNAL   Am J Hum Genet 96:955-61 (2015)
DOI:10.1016/j.ajhg.2015.04.014",MeSH,C537194,C564369,C566961,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01772,"Adrenal hypoplasia congenita, ingluding:;
X-linked adrenal hypoplasia congenita;
Autosomal recessive adrenal hypoplasia congenita;
IMAGe syndrome","Adrenal hypoplasia congenita (AHC) is an inherited disorder of the adrenal cortex commonly manifested as an early onset adrenal insufficiency syndrome. AHC includes X-linked form, a rare autosomal recessive form, and IMAGe syndrome. If untreated with glucocorticoids and mineralocorticoids, adrenal insufficiency is rapidly lethal as a result of hyperkalemia, acidosis, hypoglycemia, and shock. A constant feature of the X-linked AHC is the association with hypogonadotropic hypogonadism (HHG). Affected males typically have delayed puberty or arrested puberty caused by HHG. Mutations in the DAX-1 (NR0B1) gene are responsible for X-linked AHC. Autosomal recessive AHC is caused by mutations in SF-1 (NR5A1) gene. However, disruption of SF-1 only rarely causes adrenal insufficiency, usually in combination with testicular dysgenesis. IMAGe syndrome (intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita and genital anomalies) is an autosomal dominant undergrowth developmental disorder with life-threatening consequences and caused by mutations in CDKN1C.",Endocrine System Disease,"DAX1 [HSA:190] [KO:K08562]
NR5A1 [HSA:2516] [KO:K08560]
CDKN1C [HSA:1028] [KO:K09993]",,,,,"Saline, glucose, and hydrocortisone (acute adrenal insufficiency)
Glucocorticoids and mineralocorticoids (lifelong follow-up)",See also H01598 Addison's disease.,"ICD-10: E27.4
MeSH: C536757 C564543
OMIM:300200 614732","PMID:12034880
  AUTHORS   Lehmann SG, Lalli E, Sassone-Corsi P
  TITLE     X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein.
  JOURNAL   Proc Natl Acad Sci U S A 99:8225-30 (2002)
DOI:10.1073/pnas.122044099

PMID:26303087 (gene)
  AUTHORS   Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC
  TITLE     DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 29:607-19 (2015)
DOI:10.1016/j.beem.2015.07.004

PMID:22634751 (gene)
  AUTHORS   Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, Delot EC, Rodriguez-Fernandez IA, Braslavsky D, Bergada I, Dell'Angelica EC, Nelson SF, Martinez-Agosto JA, Achermann JC, Vilain E
  TITLE     Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome.
  JOURNAL   Nat Genet 44:788-92 (2012)
DOI:10.1038/ng.2275

PMID:20301604 (drug)
  AUTHORS   Achermann JC, Vilain EJ
  TITLE     X-Linked Adrenal Hypoplasia Congenita
  JOURNAL   GeneReviews (1993)",MeSH,C536757,C564543,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00256,Familial glucocorticoid deficiency (FGD),"Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterized by glucocorticoid deficiency despite high levels of plasma ACTH. Affected individuals typically present within the first few months of life with symptoms related to cortisol deficiency, including recurrent illnesses or infections, hypoglycemia, convulsions, failure to thrive and shock. The disease is life threatening if untreated. Glucocorticoid replacement is the recommended treatment. It has been reported that FGD is caused by mutation of the ACTH receptor (MC2R) and the accessory protein (MRAP).",Endocrine disease,"(FGD1) MC2R [HSA:4158] [KO:K04200]
(FGD2) MRAP [HSA:56246]
(FGD4) NNT [HSA:23530] [KO:K00323]",,,,"Low levels of serum cortisol [CPD:C00735], plasma androstenedione [CPD:C00280], dehydroepiandrosterone (DHEA)[CPD:C01227], and DHEA sulfate (DHEA-S) [CPD:C04555].","Hydrocortisone [DR:D00088]
Dexamethasone [DR:D00292]",See also H00257 Achalasia-Addisonianism-Alacrima syndrome.,"ICD-10: E27
MeSH: C565974 C564577
OMIM: 202200 607398 609197 614736","PMID:18059087
  AUTHORS   Chan LF, Clark AJ, Metherell LA
  TITLE     Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action.
  JOURNAL   Horm Res 69:75-82 (2008)
DOI:10.1159/000111810

PMID:18493136
  AUTHORS   Cooray SN, Chan L, Metherell L, Storr H, Clark AJ
  TITLE     Adrenocorticotropin resistance syndromes.
  JOURNAL   Endocr Dev 13:99-116 (2008)
DOI:10.1159/000134828

PMID:17161331
  AUTHORS   Metherell LA, Chan LF, Clark AJ
  TITLE     The genetics of ACTH resistance syndromes.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 20:547-60 (2006)
DOI:10.1016/j.beem.2006.09.002

PMID:22634753 (gene)
  AUTHORS   Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, Nurnberg P, Mann NP, Banerjee R, Saka HN, Chapple JP, King PJ, Clark AJ, Metherell LA
  TITLE     Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.
  JOURNAL   Nat Genet 44:740-2 (2012)
DOI:10.1038/ng.2299

PMID:17893271 (drug , marker)
  AUTHORS   Rumie H, Metherell LA, Clark AJ, Beauloye V, Maes M
  TITLE     Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein.
  JOURNAL   Eur J Endocrinol 157:539-42 (2007)
DOI:10.1530/EJE-07-0242

PMID:9196605 (marker)
  AUTHORS   Weber A, Clark AJ, Perry LA, Honour JW, Savage MO
  TITLE     Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche.
  JOURNAL   Clin Endocrinol (Oxf) 46:431-7 (1997)
DOI:10.1046/j.1365-2265.1997.1580969.x",MeSH,C565974,C564577,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00757,Dyggve-Melchior-Clausen disease and Smith-McCort dysplasia,"Dyggve-Melchior-Clausen (DMC) syndrome is a rare autosomal recessive disorder characterized by the association of spondylo-epi-metaphyseal dysplasia and mental retardation. The patients have a shortened trunk, striking barrel-shaped thorax, rhizomelic limb shortening, and distal deformities. A clinical entity similar to DMC but without mental retardation is called Smith McCort dysplasia.",Skeletal dysplasia,DYM [HSA:54808],,,,,,,"ICD-10: Q87.1
MeSH: C535726 C564589
OMIM: 223800 607326","PMID:15464420 (description, gene)
  AUTHORS   Paupe V, Gilbert T, Le Merrer M, Munnich A, Cormier-Daire V, El Ghouzzi V
  TITLE     Recent advances in Dyggve-Melchior-Clausen syndrome.
  JOURNAL   Mol Genet Metab 83:51-9 (2004)
DOI:10.1016/j.ymgme.2004.08.012

PMID:16470731 (description, gene)
  AUTHORS   Neumann LM, El Ghouzzi V, Paupe V, Weber HP, Fastnacht E, Leenen A, Lyding S, Klusmann A, Mayatepek E, Pelz J, Cormier-Daire V
  TITLE     Dyggve-Melchior-Clausen syndrome and Smith-McCort dysplasia: clinical and molecular findings in three families supporting genetic heterogeneity in Smith-McCort dysplasia.
  JOURNAL   Am J Med Genet A 140:421-6 (2006)
DOI:10.1002/ajmg.a.31090

PMID:12499951 (description)
  AUTHORS   Burns C, Powell BR, Hsia YE, Reinker K
  TITLE     Dyggve-Melchior-Clausen syndrome: report of seven patients with the Smith-McCort variant and review of the literature.
  JOURNAL   J Pediatr Orthop 23:88-93 (2003)

PMID:16206059 (description)
  AUTHORS   Bayrak IK, Nural MS, Diren HB
  TITLE     Dyggve-Melchior-Clausen syndrome without mental retardation (Smith-McCort dysplasia).
  JOURNAL   Diagn Interv Radiol 11:163-5 (2005)",MeSH,C535726,C564589,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00717,Striate palmoplantar keratoderma,"Striate palmoplantar keratoderma (SPPK) is an autosomal dominant genodermatosis characterized by linear hyperkeratosis of volar aspects of the fingers and on the palm as well as by focal hyperkeratosis on the soles. SPPK is a heterogenous group of disorders caused by mutations in either desmoglein 1 (DSG1), desmoplakin (DSP), or keratin 1 (KRT1).",Skin and connective tissue disease,"(type I) DSG1 [HSA:1828] [KO:K07596]
(type II) DSP [HSA:1832] [KO:K10381]
(type III) KRT1 [HSA:3848] [KO:K07605]",,,,,,,"MeSH: C536162 C565102 C536163
OMIM: 148700 612908 607654","PMID:20883380 (description, gene)
  AUTHORS   Kawai K, Fukushige T, Sakanoue M, Kanekura T
  TITLE     Striate palmoplantar keratoderma.
  JOURNAL   J Dermatol 37:854-6 (2010)
DOI:10.1111/j.1346-8138.2010.00874.x

PMID:18627762 (description)
  AUTHORS   Bragg J, Rizzo C, Mengden S
  TITLE     Striate palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome).
  JOURNAL   Dermatol Online J 14:26 (2008)

PMID:19558595 (gene)
  AUTHORS   Zamiri M, Smith FJ, Campbell LE, Tetley L, Eady RA, Hodgins MB, McLean WH, Munro CS
  TITLE     Mutation in DSG1 causing autosomal dominant striate palmoplantar keratoderma.
  JOURNAL   Br J Dermatol 161:692-4 (2009)
DOI:10.1111/j.1365-2133.2009.09316.x

PMID:17194569 (gene)
  AUTHORS   Barber AG, Wajid M, Columbo M, Lubetkin J, Christiano AM
  TITLE     Striate palmoplantar keratoderma resulting from a frameshift mutation in the desmoglein 1 gene.
  JOURNAL   J Dermatol Sci 45:161-6 (2007)
DOI:10.1016/j.jdermsci.2006.11.013

PMID:11982762 (gene)
  AUTHORS   Whittock NV, Smith FJ, Wan H, Mallipeddi R, Griffiths WA, Dopping-Hepenstal P, Ashton GH, Eady RA, McLean WH, McGrath JA
  TITLE     Frameshift mutation in the V2 domain of human keratin 1 results in striate palmoplantar keratoderma.
  JOURNAL   J Invest Dermatol 118:838-44 (2002)
DOI:10.1046/j.1523-1747.2002.01750.x",MeSH,C536162,C565102,C536163,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00473,"Mitochondrial respiratory chain deficiencies (MRCD), including:
Mitochondrial complex I deficiency (MT-C1D);
Complex II deficiency (MT-C2D);
Complex III deficiency (MT-C3D);
Leigh syndrome (LS) [DS:H01354];
Leber Hereditary Optic Neuropathy (LHON) [DS:H00068];
Leber Optic Atrophy and Dystonia (LDYT) [DS:H01365];
MELAS syndrome [DS:H01347];
Kearns-Sayre syndrome (KSS) [DS:H01355];
GRACILE syndrome","Mitochondrial respiratory chain deficiencies (MRCD) are a group of disorders of adults and children, with highly variable phenotypes that include macrocephaly with progressive leukodystrophy, encephalopathy (including MELAS), cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease and Alzheimer's disease.",Inherited metabolic disease; Mitochondrial disease,"(MT-C1D) NDUFS1 [HSA:4719] [KO:K03934]
(MT-C1D) NDUFS2 [HSA:4720] [KO:K03935]
(MT-C1D/LS) NDUFS3 [HSA:4722] [KO:K03936]
(MT-C1D/LS) NDUFS4 [HSA:4724] [KO:K03937]
(MT-C1D) NDUFS6 [HSA:4726] [KO:K03939]
(MT-C1D/LS) NDUFS7 [HSA:374291] [KO:K03940]
(MT-C1D/LS) NDUFS8 [HSA:4728] [KO:K03941]
(MT-C1D) NDUFA1 [HSA:4694] [KO:K03945]
(MT-C1D) NDUFA11 [HSA:126328] [KO:K03956]
(MT-C1D) NDUFAF1 [HSA:51103] [KO:K18159]
(MT-C1D/LS) NDUFAF2 [HSA:91942] [KO:K18160]
(MT-C1D) NDUFAF3 [HSA:25915] [KO:K09008]
(MT-C1D) NDUFAF4 [HSA:29078] [KO:K18161]
(MT-C1D/LS) NDUFV1 [HSA:4723] [KO:K03942]
(MT-C1D) NDUFV2 [HSA:4729] [KO:K03943]
(MT-C1D) NUBPL [HSA:80224] [KO:K03593]
(MT-C1D/LS) FOXRED1 [HSA:55572] [KO:K18166]
(MT-C1D) NDUFAF5 [HSA:79133] [KO:K18162]
(MT-C1D/LS) NDUFAF6 [HSA:137682] [KO:K18163]
(MT-C1D) NDUFB3 [HSA:4709] [KO:K03959]
(MT-C1D) NDUFB9 [HSA:4715] [KO:K03965]
(MT-C1D) ACAD9 [HSA:28976] [KO:K15980]
(MT-C1D) TIMMDC1 [HSA:51300]
(MT-C1D) TMEM126B [HSA:55863] [KO:K18165]
(MT-C1D/LHON/LDYT/MELAS) MT-ND1 [HSA:4535] [KO:K03878]
(MT-C1D/LHON) MT-ND2 [HSA:4536] [KO:K03879]
(MT-C1D/LS/LDYT/KSS) MT-ND3 [HSA:4537] [KO:K03880]
(MT-C1D/LHON/LDYT/KSS) MT-ND4 [HSA:4538] [KO:K03881]
(MT-C1D/LHON) MT-ND4L [HSA:4539] [KO:K03882]
(MT-C1D/LHON/LS/MELAS/KSS) MT-ND5 [HSA:4540] [KO:K03883]
(MT-C1D/LHON/LDYT/KSS) MT-ND6 [HSA:4541] [KO:K03884]
(MT-C2D) SDHAF1 [HSA:644096] [KO:K18167]
(MT-C2D/LS) SDHA [HSA:6389] [KO:K00234]
(MT-C3D/LS/GRACILE) BCS1L [HSA:617] [KO:K08900]
(MT-C3D) UQCRQ [HSA:27089] [KO:K00418]
(MT-C3D) UQCRB [HSA:7381] [KO:K00417]
(MT-C3D/LHON/KSS) MT-CYB [HSA:4519] [KO:K00412]
(MT-C3D) TTC19 [HSA:54902] [KO:K18169]
(MT-C3D) UQCRC2 [HSA:7385] [KO:K00415]
(MT-C3D) CYC1 [HSA:1537] [KO:K00413]
(MT-C3D) UQCC2 [HSA:84300] [KO:K17682]
(MT-C3D) LYRM7 [HSA:90624] [KO:K18170]
(MT-C3D) UQCC3 [HSA:790955]",,,,,,"KSS, LHON, MELAS, and MERRF can be caused by mutation in multiple genes encoded by the mitochondrial genome mtDNA.","ICD-10: E88.8
MeSH: C537475 C565375 C565128
OMIM: 252010 252011 124000 611126 256000 220111 535000 500001 540000 530000 603358 615160 615453 615824 615838 616111","PMID:19336460
  AUTHORS   Distelmaier F, Koopman WJ, van den Heuvel LP, Rodenburg RJ, Mayatepek E, Willems PH, Smeitink JA
  TITLE     Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease.
  JOURNAL   Brain 132:833-42 (2009)
DOI:10.1093/brain/awp058

PMID:16288654
  AUTHORS   Bayley JP, Devilee P, Taschner PE
  TITLE     The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
  JOURNAL   BMC Med Genet 6:39 (2005)
DOI:10.1186/1471-2350-6-39

PMID:18601960
  AUTHORS   Benit P, Lebon S, Rustin P
  TITLE     Respiratory-chain diseases related to complex III deficiency.
  JOURNAL   Biochim Biophys Acta 1793:181-5 (2009)
DOI:10.1016/j.bbamcr.2008.06.004

PMID:18590986
  AUTHORS   Saneto RP, Friedman SD, Shaw DW
  TITLE     Neuroimaging of mitochondrial disease.
  JOURNAL   Mitochondrion 8:396-413 (2008)
DOI:10.1016/j.mito.2008.05.003

PMID:21412973
  AUTHORS   Alfadhel M, Lillquist YP, Waters PJ, Sinclair G, Struys E, McFadden D, Hendson G, Hyams L, Shoffner J, Vallance HD
  TITLE     Infantile cardioencephalopathy due to a COX15 gene defect: report and review.
  JOURNAL   Am J Med Genet A 155A:840-4 (2011)
DOI:10.1002/ajmg.a.33881

PMID:20973690
  AUTHORS   Santa KM
  TITLE     Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
  JOURNAL   Pharmacotherapy 30:1179-96 (2010)
DOI:10.1592/phco.30.11.1179

PMID:20649546
  AUTHORS   Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T
  TITLE     MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
  JOURNAL   Ann N Y Acad Sci 1201:104-10 (2010)
DOI:10.1111/j.1749-6632.2010.05624.x

PMID:21871538
  AUTHORS   Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC
  TITLE     A mitochondrial etiology of Alzheimer and Parkinson disease.
  JOURNAL   Biochim Biophys Acta 1820:553-64 (2012)
DOI:10.1016/j.bbagen.2011.08.008

PMID:17564966
  AUTHORS   He M, Rutledge SL, Kelly DR, Palmer CA, Murdoch G, Majumder N, Nicholls RD, Pei Z, Watkins PA, Vockley J
  TITLE     A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
  JOURNAL   Am J Hum Genet 81:87-103 (2007)
DOI:10.1086/519219

PMID:19162478
  AUTHORS   Blazquez A, Gil-Borlado MC, Moran M, Verdu A, Cazorla-Calleja MR, Martin MA, Arenas J, Ugalde C
  TITLE     Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient.
  JOURNAL   Neuromuscul Disord 19:143-6 (2009)
DOI:10.1016/j.nmd.2008.11.016

PMID:23281071
  AUTHORS   Miyake N, Yano S, Sakai C, Hatakeyama H, Matsushima Y, Shiina M, Watanabe Y, Bartley J, Abdenur JE, Wang RY, Chang R, Tsurusaki Y, Doi H, Nakashima M, Saitsu H, Ogata K, Goto Y, Matsumoto N
  TITLE     Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation.
  JOURNAL   Hum Mutat 34:446-52 (2013)
DOI:10.1002/humu.22257

PMID:23910460
  AUTHORS   Gaignard P, Menezes M, Schiff M, Bayot A, Rak M, Ogier de Baulny H, Su CH, Gilleron M, Lombes A, Abida H, Tzagoloff A, Riley L, Cooper ST, Mina K, Sivadorai P, Davis MR, Allcock RJ, Kresoje N, Laing NG, Thorburn DR, Slama A, Christodoulou J, Rustin P
  TITLE     Mutations in CYC1, encoding cytochrome c1 subunit of respiratory chain complex III, cause insulin-responsive hyperglycemia.
  JOURNAL   Am J Hum Genet 93:384-9 (2013)
DOI:10.1016/j.ajhg.2013.06.015

PMID:24385928
  AUTHORS   Tucker EJ, Wanschers BF, Szklarczyk R, Mountford HS, Wijeyeratne XW, van den Brand MA, Leenders AM, Rodenburg RJ, Reljic B, Compton AG, Frazier AE, Bruno DL, Christodoulou J, Endo H, Ryan MT, Nijtmans LG, Huynen MA, Thorburn DR
  TITLE     Mutations in the UQCC1-interacting protein, UQCC2, cause human complex III deficiency associated with perturbed cytochrome b protein expression.
  JOURNAL   PLoS Genet 9:e1004034 (2013)
DOI:10.1371/journal.pgen.1004034

PMID:26912632
  AUTHORS   Dallabona C, Abbink TE, Carrozzo R, Torraco A, Legati A, van Berkel CG, Niceta M, Langella T, Verrigni D, Rizza T, Diodato D, Piemonte F, Lamantea E, Fang M, Zhang J, Martinelli D, Bevivino E, Dionisi-Vici C, Vanderver A, Philip SG, Kurian MA, Verma IC, Bijarnia-Mahay S, Jacinto S, Furtado F, Accorsi P, Ardissone A, Moroni I, Ferrero I, Tartaglia M, Goffrini P, Ghezzi D, van der Knaap MS, Bertini E
  TITLE     LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance.
  JOURNAL   Brain 139:782-94 (2016)
DOI:10.1093/brain/awv392

PMID:25008109
  AUTHORS   Wanschers BF, Szklarczyk R, van den Brand MA, Jonckheere A, Suijskens J, Smeets R, Rodenburg RJ, Stephan K, Helland IB, Elkamil A, Rootwelt T, Ott M, van den Heuvel L, Nijtmans LG, Huynen MA
  TITLE     A mutation in the human CBP4 ortholog UQCC3 impairs complex III assembly, activity and cytochrome b stability.
  JOURNAL   Hum Mol Genet 23:6356-65 (2014)
DOI:10.1093/hmg/ddu357

PMID:21931170
  AUTHORS   Fassone E, Taanman JW, Hargreaves IP, Sebire NJ, Cleary MA, Burch M, Rahman S
  TITLE     Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy.
  JOURNAL   J Med Genet 48:691-7 (2011)
DOI:10.1136/jmedgenet-2011-100340

PMID:22277967
  AUTHORS   Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, Laskowski A, Garone C, Liu S, Jaffe DB, Christodoulou J, Fletcher JM, Bruno DL, Goldblatt J, Dimauro S, Thorburn DR, Mootha VK
  TITLE     Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.
  JOURNAL   Sci Transl Med 4:118ra10 (2012)
DOI:10.1126/scitranslmed.3003310

PMID:22499348
  AUTHORS   Haack TB, Haberberger B, Frisch EM, Wieland T, Iuso A, Gorza M, Strecker V, Graf E, Mayr JA, Herberg U, Hennermann JB, Klopstock T, Kuhn KA, Ahting U, Sperl W, Wilichowski E, Hoffmann GF, Tesarova M, Hansikova H, Zeman J, Plecko B, Zeviani M, Wittig I, Strom TM, Schuelke M, Freisinger P, Meitinger T, Prokisch H
  TITLE     Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing.
  JOURNAL   J Med Genet 49:277-83 (2012)
DOI:10.1136/jmedgenet-2012-100846",MeSH,C537475,C565375,C565128,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01022,"Diseases of the tricarboxylic acid cycle, including:
Fumarase (FH) deficiency;
Succinate dehydrogenase (SDH) deficiency;
Alpha-ketoglutarate dehydrogenase (AKGDH) deficiency","Diseases of the tricarboxylic acid cycle (TCA cycle) constitute a group of rare human diseases that affect core mitochondrial metabolism. The Fumarase deficiency is caused by impairment of the fumarate hydratase enzyme. The symptoms of the disorder include developmental delay, severe mental retardation, language impairment, seizures and dysmorphic facial features. The succinate dehydrogenase deficiency affects mitochondrial complex II, which links the TCA cycle with the electron transport chain. The phenotype is highly variable and can include Leigh syndrome, leukodystrophy, cardiomyopathy and mental and motor skill deterioration. The alpha-ketoglutarate dehydrogenase deficiency is extremely rare and characterised by encephalopathy and hyperlactatemia resulting in death in early childhood.",Metabolic disease,"(FH) FH [HSA:2271] [KO:K01679]
(SDH) SDHA [HSA:6389] [KO:K00234]
(AKGDH) OGDH [HSA:4967] [KO:K00164]",,,,"(FH) Fumarate [CPD:C00122] , 2-Oxoglutarate [CPD:C00026] (urine) Lactate [CPD:C00186] (cerebrospinal fluid)
(SDH) Lactate (blood plasma) 2-Oxoglutarate and Succinate [CPD:C00042] (urine in some cases) Succinate accumulation (brain)
(AKGDH) Oxoglutarate [CPD:C00026] Lactate",,Succinate dehydrogenase deficiency is also included in mitochondrial respiratory chain deficiencies. [DS:H00473],"ICD-10: E88.8
MeSH: C538191 C565375 C536582
OMIM: 606812 252011 203740","PMID:21714867
  AUTHORS   Smith AC, Robinson AJ
  TITLE     A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle.
  JOURNAL   BMC Syst Biol 5:102 (2011)
DOI:10.1186/1752-0509-5-102

PMID:9300800
  AUTHORS   Rustin P, Bourgeron T, Parfait B, Chretien D, Munnich A, Rotig A
  TITLE     Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human.
  JOURNAL   Biochim Biophys Acta 1361:185-97 (1997)
DOI:10.1016/S0925-4439(97)00035-5",MeSH,C538191,C565375,C536582,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00638,Ectrodactyly-ectodermal dysplasia cleft-palate syndrome (EEC syndrome),"Ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome is a rare autosomal dominant genetic disorder. This condition is a combination of ectrodactyly, the lobster claw-like deformities of the hands and feet, ectodermal dysplasia affecting skin, hair, and nails, and cleft lip with or without cleft palate. Other symptoms include anomalies of eyes and urinary tract.",Skeletal dysplasia,TP63 [HSA:8626] [KO:K10149],,,,,,Isolated ectrodactyly is described in split-hand/foot malformation (H00471).,"ICD-10: Q82.4
MeSH: C565062 C565799
OMIM: 604292","PMID:20944926 (description)
  AUTHORS   Trope BM, Salomao JN, Costa VD, Verde RB, Barros DS
  TITLE     Do you know this syndrome? Ectrodactyly - ectodermal dysplasia - cleft lip/palate(EEC) syndrome.
  JOURNAL   An Bras Dermatol 85:573-5 (2010)
DOI:10.1590/S0365-05962010000400027

PMID:1261073 (description)
  AUTHORS   Rosenmann A, Shapira T, Cohen MM
  TITLE     Ectrodactyly, ectodermal dysplasia and cleft palate (EEC syndrome). Report of a family and review of the literature.
  JOURNAL   Clin Genet 9:347-53 (1976)
DOI:10.1111/j.1399-0004.1976.tb01585.x

PMID:10535733 (gene)
  AUTHORS   Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H
  TITLE     Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.
  JOURNAL   Cell 99:143-53 (1999)
DOI:10.1016/S0092-8674(00)81646-3",MeSH,C565062,C565799,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00192,Xanthinuria,"Xanthinuria is characterized by excretion of large amounts of xanthine in the urine and caused by deficiency of xanthine dehydrogenase and molybdenum cofactors, which are essential to the function of xanthine dehydrogenase.",Inherited metabolic disease; Urologic disease,"XDH; xanthine dehydrogenase [HSA:7498] [KO:K00106]
AOX1 [HSA:316] [KO:K00157]
MOCS1 [HSA:4337] [KO:K20967]
MOCS2 [HSA:4338] [KO:K03635]
GEPH [HSA:10243] [KO:K15376]
MOCOS [HSA:55034] [KO:K15631]",,,,,,,"ICD-10: E79.9
MeSH: C562584 C566358
OMIM: 278300 252150 603592","PMID:14624414
  AUTHORS   Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Tuneyoshi K, Matsui K, Cheng J, Hada T
  TITLE     Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II.
  JOURNAL   Metabolism 52:1501-4 (2003)
DOI:10.1016/S0026-0495(03)00272-5

PMID:11379872
  AUTHORS   Sakamoto N, Yamamoto T, Moriwaki Y, Teranishi T, Toyoda M, Onishi Y, Kuroda S, Sakaguchi K, Fujisawa T, Maeda M, Hada T
  TITLE     Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria.
  JOURNAL   Hum Genet 108:279-83 (2001)
DOI:10.1007/s004390100477

PMID:11302742 (gene)
  AUTHORS   Ichida K, Matsumura T, Sakuma R, Hosoya T, Nishino T
  TITLE     Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.
  JOURNAL   Biochem Biophys Res Commun 282:1194-200 (2001)
DOI:10.1006/bbrc.2001.4719

PMID:10844591
  AUTHORS   Levartovsky D, Lagziel A, Sperling O, Liberman U, Yaron M, Hosoya T, Ichida K, Peretz H
  TITLE     XDH gene mutation is the underlying cause of classical xanthinuria: a second report.
  JOURNAL   Kidney Int 57:2215-20 (2000)
DOI:10.1046/j.1523-1755.2000.00082.x

PMID:9153281
  AUTHORS   Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O
  TITLE     Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.
  JOURNAL   J Clin Invest 99:2391-7 (1997)
DOI:10.1172/JCI119421

PMID:12754701
  AUTHORS   Reiss J, Johnson JL
  TITLE     Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH.
  JOURNAL   Hum Mutat 21:569-76 (2003)
DOI:10.1002/humu.10223",MeSH,C562584,C566358,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01269,"Congenital hyperthyroidism, including:
Familial gestational hyperthyroidism (HTFG);
Hyperthyroidism non-autoimmune (HTNA)","Congenital hyperthyroidism is a rare clinical condition, and in most cases, it is a transient disorder caused by maternal Graves disease associated with the transplacental passage of maternal thyroid-stimulating antibodies. Germline mutations of thyrotropin receptor (TSHR) gene determining a constitutive activation of the receptor were identified as a molecular cause of congenital nonautoimmune hyperthyroidism. TSHR gene mutations also causes the familial gestational hyperthyroidism, that is characterized by thyrotoxicosis and hyperemesis gravidarum.",Endocrine disease,TSHR [HSA:7253] [KO:K04249],,,,,"Propylthiouracil [DR:D00562]
Sodium iodide [DR:D02259]",,"ICD-10: E05.8
MeSH: C563786 C566384
OMIM: 603373 609152","PMID:22371259
  AUTHORS   Agretti P, De Marco G, Biagioni M, Iannilli A, Marigliano M, Pinchera A, Vitti P, Cherubini V, Tonacchera M
  TITLE     Sporadic congenital nonautoimmune hyperthyroidism caused by P639S mutation in thyrotropin receptor gene.
  JOURNAL   Eur J Pediatr 171:1133-7 (2012)
DOI:10.1007/s00431-012-1702-z

PMID:10427147
  AUTHORS   Asteria C
  TITLE     TSH receptor gene mutations and familial gestational hyperthyroidism.
  JOURNAL   Eur J Endocrinol 141:93-4 (1999)
DOI:10.1530/eje.0.1410093

PMID:20172477 (drug)
  AUTHORS   Leung AM, Pearce EN, Braverman LE
  TITLE     Perchlorate, iodine and the thyroid.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 24:133-41 (2010)
DOI:10.1016/j.beem.2009.08.009",MeSH,C563786,C566384,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01024,Hereditary mixed polyposis syndrome,"Hereditary mixed polyposis syndrome (HMPS) is a rare condition characterized by mixed hyperplastic, adenomatous and juvenile polyps and is associated with an increased risk of colorectal carcinoma. HMPS is linked to mutations in the BMPR1A gene.",Gastrointestinal disease,BMPR1A [HSA:657] [KO:K04673],,,,,,,"MeSH: C563365 C566451
OMIM: 610069","PMID:19438883 (description, gene)
  AUTHORS   O'Riordan JM, O'Donoghue D, Green A, Keegan D, Hawkes LA, Payne SJ, Sheahan K, Winter DC
  TITLE     Hereditary mixed polyposis syndrome due to a BMPR1A mutation.
  JOURNAL   Colorectal Dis 12:570-3 (2010)
DOI:10.1111/j.1463-1318.2009.01931.x

PMID:16525031 (description, gene)
  AUTHORS   Cao X, Eu KW, Kumarasinghe MP, Li HH, Loi C, Cheah PY
  TITLE     Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function.
  JOURNAL   J Med Genet 43:e13 (2006)
DOI:10.1136/jmg.2005.034827",MeSH,C563365,C566451,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00891,Combined oxidative phosphorylation deficiency (COXPD),"Combined oxidative phosphorylation deficiency (COXPD) is a group of multisystem disorders with variable manifestations resulting from a defect in the mitochondrial oxidative phosphorylation system. It has been reported that the mutations in the ribosomal protein gene (MRPS16 and MRPS22) cause severe antenatal-onset infantile disease. The patients with COXPD caused by mutations in mitochondrial translation elongation factor genes (GFM1, TUFM, TSFM and C12orf65) have also been reported.",Inherited metabolic disease; Mitochondrial disease,"(COXPD1) GFM1 [HSA:85476] [KO:K02355]
(COXPD2) MRPS16 [HSA:51021] [KO:K02959]
(COXPD3) TSFM [HSA:10102] [KO:K02357]
(COXPD4) TUFM [HSA:7284] [KO:K02358]
(COXPD5) MRPS22 [HSA:56945] [KO:K17401]
(COXPD6) AIFM1 [HSA:9131] [KO:K04727]
(COXPD7) C12orf65 [HSA:91574]
(COXPD8) AARS2 [HSA:57505] [KO:K01872]
(COXPD9) MRPL3 [HSA:11222] [KO:K02906]
(COXPD10) MTO1 [HSA:25821] [KO:K03495]
(COXPD11) RMND1 [HSA:55005]
(COXPD12) EARS2 [HSA:124454] [KO:K01885]
(COXPD13) PNPT1 [HSA:87178] [KO:K00962]
(COXPD14) FARS2 [HSA:10667] [KO:K01889]
(COXPD15) MTFMT [HSA:123263] [KO:K00604]
(COXPD16) MRPL44 [HSA:65080] [KO:K17425]
(COXPD17) ELAC2 [HSA:60528] [KO:K00784]
(COXPD18) SFXN4 [HSA:119559]
(COXPD19) LYRM4 [HSA:57128] [KO:K22069]
(COXPD20) VARS2 [HSA:57176] [KO:K01873]
(COXPD21) TARS2 [HSA:80222] [KO:K01868]
(COXPD22) ATP5A1 [HSA:498] [KO:K02132]
(COXPD23) GTPBP3 [HSA:84705] [KO:K03650]
(COXPD24) NARS2 [HSA:79731] [KO:K01893]
(COXPD25) MARS2 [HSA:92935] [KO:K01874]
(COXPD26) TRMT5 [HSA:57570] [KO:K15429]
(COXPD27) CARS2 [HSA:79587] [KO:K01883]
(COXPD28) SLC25A26 [HSA:115286] [KO:K15111]
(COXPD29) TXN2 [HSA:25828] [KO:K03671]
(COXPD30) TRMT10C [HSA:54931] [KO:K17654]
(COXPD31) MIPEP [HSA:4285] [KO:K01410]",,,,,,,"ICD-10: E88.8
MeSH: C563797 C566468 C566467 C565690 C567126
OMIM: 609060 610498 610505 610678 611719 300816 613559 614096 614582 614702 614922 614924 614932 614946 614947 615395 615440 615578 615595 615917 615918 616045 616198 616239 616430 616539 616672 616794 616811 616974 617228","PMID:21169334
  AUTHORS   Kemp JP, Smith PM, Pyle A, Neeve VC, Tuppen HA, Schara U, Talim B, Topaloglu H, Holinski-Feder E, Abicht A, Czermin B, Lochmuller H, McFarland R, Chinnery PF, Chrzanowska-Lightowlers ZM, Lightowlers RN, Taylor RW, Horvath R
  TITLE     Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency.
  JOURNAL   Brain 134:183-95 (2011)
DOI:10.1093/brain/awq320

PMID:15505824
  AUTHORS   Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag A, Hershkovitz E, Elpeleg O
  TITLE     Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation.
  JOURNAL   Ann Neurol 56:734-8 (2004)
DOI:10.1002/ana.20282

PMID:17033963
  AUTHORS   Smeitink JA, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P, Sasarman F, Vriend G, Jacob-Hirsch J, Shaag A, Rechavi G, Welling B, Horst J, Rodenburg RJ, van den Heuvel B, Shoubridge EA
  TITLE     Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.
  JOURNAL   Am J Hum Genet 79:869-77 (2006)
DOI:10.1086/508434

PMID:17160893
  AUTHORS   Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C, Mereghetti P, De Gioia L, Burlina A, Castellan C, Comi GP, Savasta S, Ferrero I, Zeviani M
  TITLE     Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu.
  JOURNAL   Am J Hum Genet 80:44-58 (2007)
DOI:10.1086/510559

PMID:17873122
  AUTHORS   Saada A, Shaag A, Arnon S, Dolfin T, Miller C, Fuchs-Telem D, Lombes A, Elpeleg O
  TITLE     Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation.
  JOURNAL   J Med Genet 44:784-6 (2007)
DOI:10.1136/jmg.2007.053116

PMID:20362274
  AUTHORS   Ghezzi D, Sevrioukova I, Invernizzi F, Lamperti C, Mora M, D'Adamo P, Novara F, Zuffardi O, Uziel G, Zeviani M
  TITLE     Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor.
  JOURNAL   Am J Hum Genet 86:639-49 (2010)
DOI:10.1016/j.ajhg.2010.03.002

PMID:20598281 (gene)
  AUTHORS   Antonicka H, Ostergaard E, Sasarman F, Weraarpachai W, Wibrand F, Pedersen AM, Rodenburg RJ, van der Knaap MS, Smeitink JA, Chrzanowska-Lightowlers ZM, Shoubridge EA
  TITLE     Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect.
  JOURNAL   Am J Hum Genet 87:115-22 (2010)
DOI:10.1016/j.ajhg.2010.06.004

PMID:22492562 (gene)
  AUTHORS   Steenweg ME, Ghezzi D, Haack T, Abbink TE, Martinelli D, van Berkel CG, Bley A, Diogo L, Grillo E, Te Water Naude J, Strom TM, Bertini E, Prokisch H, van der Knaap MS, Zeviani M
  TITLE     Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.
  JOURNAL   Brain 135:1387-94 (2012)
DOI:10.1093/brain/aws070

PMID:23084291 (gene)
  AUTHORS   Vedrenne V, Gowher A, De Lonlay P, Nitschke P, Serre V, Boddaert N, Altuzarra C, Mager-Heckel AM, Chretien F, Entelis N, Munnich A, Tarassov I, Rotig A
  TITLE     Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency.
  JOURNAL   Am J Hum Genet 91:912-8 (2012)
DOI:10.1016/j.ajhg.2012.09.001

PMID:24161539 (gene)
  AUTHORS   Almalki A, Alston CL, Parker A, Simonic I, Mehta SG, He L, Reza M, Oliveira JM, Lightowlers RN, McFarland R, Taylor RW, Chrzanowska-Lightowlers ZM
  TITLE     Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency.
  JOURNAL   Biochim Biophys Acta 1842:56-64 (2014)
DOI:10.1016/j.bbadis.2013.10.008

PMID:23499752 (gene)
  AUTHORS   Neeve VC, Pyle A, Boczonadi V, Gomez-Duran A, Griffin H, Santibanez-Koref M, Gaiser U, Bauer P, Tzschach A, Chinnery PF, Horvath R
  TITLE     Clinical and functional characterisation of the combined respiratory chain defect in two sisters due to autosomal recessive mutations in MTFMT.
  JOURNAL   Mitochondrion 13:743-8 (2013)
DOI:10.1016/j.mito.2013.03.002

PMID:25058219 (gene)
  AUTHORS   Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A, Yarham JW, Kirschner J, Schara U, Talim B, Topaloglu H, Baric I, Holinski-Feder E, Abicht A, Czermin B, Kleinle S, Morris AA, Vassallo G, Gorman GS, Ramesh V, Turnbull DM, Santibanez-Koref M, McFarland R, Horvath R, Chinnery PF
  TITLE     Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.
  JOURNAL   JAMA 312:68-77 (2014)
DOI:10.1001/jama.2014.7184

PMID:23315540 (gene)
  AUTHORS   Carroll CJ, Isohanni P, Poyhonen R, Euro L, Richter U, Brilhante V, Gotz A, Lahtinen T, Paetau A, Pihko H, Battersby BJ, Tyynismaa H, Suomalainen A
  TITLE     Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.
  JOURNAL   J Med Genet 50:151-9 (2013)
DOI:10.1136/jmedgenet-2012-101375

PMID:23849775 (gene)
  AUTHORS   Haack TB, Kopajtich R, Freisinger P, Wieland T, Rorbach J, Nicholls TJ, Baruffini E, Walther A, Danhauser K, Zimmermann FA, Husain RA, Schum J, Mundy H, Ferrero I, Strom TM, Meitinger T, Taylor RW, Minczuk M, Mayr JA, Prokisch H
  TITLE     ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy.
  JOURNAL   Am J Hum Genet 93:211-23 (2013)
DOI:10.1016/j.ajhg.2013.06.006

PMID:24119684 (gene)
  AUTHORS   Hildick-Smith GJ, Cooney JD, Garone C, Kremer LS, Haack TB, Thon JN, Miyata N, Lieber DS, Calvo SE, Akman HO, Yien YY, Huston NC, Branco DS, Shah DI, Freedman ML, Koehler CM, Italiano JE Jr, Merkenschlager A, Beblo S, Strom TM, Meitinger T, Freisinger P, Donati MA, Prokisch H, Mootha VK, DiMauro S, Paw BH
  TITLE     Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4.
  JOURNAL   Am J Hum Genet 93:906-14 (2013)
DOI:10.1016/j.ajhg.2013.09.011

PMID:21786366 (gene)
  AUTHORS   Galmiche L, Serre V, Beinat M, Assouline Z, Lebre AS, Chretien D, Nietschke P, Benes V, Boddaert N, Sidi D, Brunelle F, Rio M, Munnich A, Rotig A
  TITLE     Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy.
  JOURNAL   Hum Mutat 32:1225-31 (2011)
DOI:10.1002/humu.21562

PMID:23814038 (gene)
  AUTHORS   Lim SC, Friemel M, Marum JE, Tucker EJ, Bruno DL, Riley LG, Christodoulou J, Kirk EP, Boneh A, DeGennaro CM, Springer M, Mootha VK, Rouault TA, Leimkuhler S, Thorburn DR, Compton AG
  TITLE     Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes.
  JOURNAL   Hum Mol Genet 22:4460-73 (2013)
DOI:10.1093/hmg/ddt295

PMID:24827421 (gene)
  AUTHORS   Diodato D, Melchionda L, Haack TB, Dallabona C, Baruffini E, Donnini C, Granata T, Ragona F, Balestri P, Margollicci M, Lamantea E, Nasca A, Powell CA, Minczuk M, Strom TM, Meitinger T, Prokisch H, Lamperti C, Zeviani M, Ghezzi D
  TITLE     VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies.
  JOURNAL   Hum Mutat 35:983-9 (2014)
DOI:10.1002/humu.22590

PMID:23596069 (gene)
  AUTHORS   Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, Hershman SG, Gold NB, Chapman BA, Thorburn DR, Berry GT, Schmahmann JD, Borowsky ML, Mueller DM, Sims KB, Mootha VK
  TITLE     Targeted exome sequencing of suspected mitochondrial disorders.
  JOURNAL   Neurology 80:1762-70 (2013)
DOI:10.1212/WNL.0b013e3182918c40

PMID:25434004 (gene)
  AUTHORS   Kopajtich R, Nicholls TJ, Rorbach J, Metodiev MD, Freisinger P, Mandel H, Vanlander A, Ghezzi D, Carrozzo R, Taylor RW, Marquard K, Murayama K, Wieland T, Schwarzmayr T, Mayr JA, Pearce SF, Powell CA, Saada A, Ohtake A, Invernizzi F, Lamantea E, Sommerville EW, Pyle A, Chinnery PF, Crushell E, Okazaki Y, Kohda M, Kishita Y, Tokuzawa Y, Assouline Z, Rio M, Feillet F, Mousson de Camaret B, Chretien D, Munnich A, Menten B, Sante T, Smet J, Regal L, Lorber A, Khoury A, Zeviani M, Strom TM, Meitinger T, Bertini ES, Van Coster R, Klopstock T, Rotig A, Haack TB, Minczuk M, Prokisch H
  TITLE     Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.
  JOURNAL   Am J Hum Genet 95:708-20 (2014)
DOI:10.1016/j.ajhg.2014.10.017

PMID:25629079 (gene)
  AUTHORS   Sofou K, Kollberg G, Holmstrom M, Davila M, Darin N, Gustafsson CM, Holme E, Oldfors A, Tulinius M, Asin-Cayuela J
  TITLE     Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome.
  JOURNAL   Mol Genet Genomic Med 3:59-68 (2015)
DOI:10.1002/mgg3.115

PMID:25754315 (gene)
  AUTHORS   Webb BD, Wheeler PG, Hagen JJ, Cohen N, Linderman MD, Diaz GA, Naidich TP, Rodenburg RJ, Houten SM, Schadt EE
  TITLE     Novel, compound heterozygous, single-nucleotide variants in MARS2 associated with developmental delay, poor growth, and sensorineural hearing loss.
  JOURNAL   Hum Mutat 36:587-92 (2015)
DOI:10.1002/humu.22781

PMID:26189817 (gene)
  AUTHORS   Powell CA, Kopajtich R, D'Souza AR, Rorbach J, Kremer LS, Husain RA, Dallabona C, Donnini C, Alston CL, Griffin H, Pyle A, Chinnery PF, Strom TM, Meitinger T, Rodenburg RJ, Schottmann G, Schuelke M, Romain N, Haller RG, Ferrero I, Haack TB, Taylor RW, Prokisch H, Minczuk M
  TITLE     TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies.
  JOURNAL   Am J Hum Genet 97:319-28 (2015)
DOI:10.1016/j.ajhg.2015.06.011

PMID:25787132 (gene)
  AUTHORS   Coughlin CR 2nd, Scharer GH, Friederich MW, Yu HC, Geiger EA, Creadon-Swindell G, Collins AE, Vanlander AV, Coster RV, Powell CA, Swanson MA, Minczuk M, Van Hove JL, Shaikh TH
  TITLE     Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder.
  JOURNAL   J Med Genet 52:532-40 (2015)
DOI:10.1136/jmedgenet-2015-103049

PMID:26522469 (gene)
  AUTHORS   Kishita Y, Pajak A, Bolar NA, Marobbio CM, Maffezzini C, Miniero DV, Monne M, Kohda M, Stranneheim H, Murayama K, Naess K, Lesko N, Bruhn H, Mourier A, Wibom R, Nennesmo I, Jespers A, Govaert P, Ohtake A, Van Laer L, Loeys BL, Freyer C, Palmieri F, Wredenberg A, Okazaki Y, Wedell A
  TITLE     Intra-mitochondrial Methylation Deficiency Due to Mutations in SLC25A26.
  JOURNAL   Am J Hum Genet 97:761-8 (2015)
DOI:10.1016/j.ajhg.2015.09.013

PMID:26626369 (gene)
  AUTHORS   Holzerova E, Danhauser K, Haack TB, Kremer LS, Melcher M, Ingold I, Kobayashi S, Terrile C, Wolf P, Schaper J, Mayatepek E, Baertling F, Friedmann Angeli JP, Conrad M, Strom TM, Meitinger T, Prokisch H, Distelmaier F
  TITLE     Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration.
  JOURNAL   Brain 139:346-54 (2016)
DOI:10.1093/brain/awv350

PMID:27132592 (gene)
  AUTHORS   Metodiev MD, Thompson K, Alston CL, Morris AA, He L, Assouline Z, Rio M, Bahi-Buisson N, Pyle A, Griffin H, Siira S, Filipovska A, Munnich A, Chinnery PF, McFarland R, Rotig A, Taylor RW
  TITLE     Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.
  JOURNAL   Am J Hum Genet 98:993-1000 (2016)
DOI:10.1016/j.ajhg.2016.03.010

PMID:27799064 (gene)
  AUTHORS   Eldomery MK, Akdemir ZC, Vogtle FN, Charng WL, Mulica P, Rosenfeld JA, Gambin T, Gu S, Burrage LC, Al Shamsi A, Penney S, Jhangiani SN, Zimmerman HH, Muzny DM, Wang X, Tang J, Medikonda R, Ramachandran PV, Wong LJ, Boerwinkle E, Gibbs RA, Eng CM, Lalani SR, Hertecant J, Rodenburg RJ, Abdul-Rahman OA, Yang Y, Xia F, Wang MC, Lupski JR, Meisinger C, Sutton VR
  TITLE     MIPEP recessive variants cause a syndrome of left ventricular non-compaction, hypotonia, and infantile death.
  JOURNAL   Genome Med 8:106 (2016)
DOI:10.1186/s13073-016-0360-6",MeSH,C563797,C566468,C566467,C565690,C567126,,,,,,,,,,,,,,,,,,,,,,,,,
H00260,Pigmented micronodular adrenocortical disease (PPNAD),Primary pigmented micronodular adrenocortical disease is a form of ACTH-independent adrenal hyperplasia resulting in endogenous Cushing's syndrome.,Endocrine disease,"(PPNAD1) PRKAR1A [HSA:5573] [KO:K04739]
(PPNAD2) PDE11A [HSA:50940] [KO:K13298]
(PPNAD3) PDE8B [HSA:8622] [KO:K18437]",,,,,,,"ICD-10: E27.5
MeSH: C566469 C566472
OMIM: 610489 610475 603390","PMID:18549891
  AUTHORS   Powell AC, Stratakis CA, Patronas NJ, Steinberg SM, Batista D, Alexander HR, Pingpank JF, Keil M, Bartlett DL, Libutti SK
  TITLE     Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia.
  JOURNAL   Surgery 143:750-8 (2008)
DOI:10.1016/j.surg.2008.03.022

PMID:18493137
  AUTHORS   Stratakis CA
  TITLE     Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).
  JOURNAL   Endocr Dev 13:117-32 (2008)
DOI:10.1159/000134829

PMID:12119280
  AUTHORS   Bourdeau I, Stratakis CA
  TITLE     Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease.
  JOURNAL   Ann N Y Acad Sci 968:240-55 (2002)
DOI:10.1111/j.1749-6632.2002.tb04339.x",MeSH,C566469,C566472,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01193,Familial tumoral calcinosis (FTC),"Familial tumoral calcinosis (FTC) refers to a group of disorders inherited in an autosomal recessive fashion, distinguished by the development of ectopic and vascular calcified masses that occur in settings of hyperphosphatemia (hFTC) and normophosphatemia (nFTC). hFTC is characterized by increased re-absorption of phosphate through the renal proximal tubule, resulting in elevated phosphate concentration and deposition of calcified deposits in cutaneous and subcutaneous tissues, occasionally, in visceral organs. hFTC has been shown to result from mutations in three genes: fibroblast growth factor-23 (FGF23), KL encoding Klotho, and GALNT3, which encodes a glycosyltransferase responsible for FGF23 O-glycosylation; defective function of any one of these three proteins results in hyperphosphatemia and ectopic calcification. nFTC is characterized by absence of metabolic abnormalities. nFTC has been found to be associated with absence of functional SAMD9, a putative tumor suppressor and anti-inflammatory protein.",Inherited metabolic disease,"(hFTC) GALNT3 [HSA:2591] [KO:K00710]
(hFTC) FGF23 [HSA:8074] [KO:K04358]
(hFTC) KL [HSA:9365] [KO:K14756]
(nFTC) SAMD9 [HSA:54809]",,,,,,,"ICD-10: M11.2
MeSH: C566870 C566473
OMIM: 211900 610455","PMID:19865099 (description, gene)
  AUTHORS   Sprecher E
  TITLE     Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.
  JOURNAL   J Invest Dermatol 130:652-60 (2010)
DOI:10.1038/jid.2009.337

PMID:22142751 (description, gene)
  AUTHORS   Farrow EG, Imel EA, White KE
  TITLE     Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and alphaKlotho).
  JOURNAL   Best Pract Res Clin Rheumatol 25:735-47 (2011)
DOI:10.1016/j.berh.2011.10.020

PMID:19013236 (description, gene)
  AUTHORS   Chefetz I, Sprecher E
  TITLE     Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.
  JOURNAL   Biochim Biophys Acta 1792:847-52 (2009)
DOI:10.1016/j.bbadis.2008.10.008",MeSH,C566870,C566473,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00539,"PTEN hamartoma tumor syndrome (PHTS), including:
Cowden syndrome [DS:H01222];
Bannayan-Riley-Ruvalcaba syndrome;
Proteus syndrome","PTEN hamartoma tumor syndrome (PHTS) is a spectrum of disorders associated with the formation of hamartomas caused by mutations of the tumor suppressor PTEN. The hamartomas tend to be both benign and malignant tumors, especially in Cowden syndrome.",Developmental disorder; Cancer,PTEN [HSA:5728] [KO:K01110],,,,,,,"ICD-10: Q85.8 Q87.8 Q87.3
MeSH: D016715 C566636 C567337
OMIM: 158350 153480 176920","PMID:19668082 (description, gene)
  AUTHORS   Hobert JA, Eng C
  TITLE     PTEN hamartoma tumor syndrome: an overview.
  JOURNAL   Genet Med 11:687-94 (2009)
DOI:10.1097/GIM.0b013e3181ac9aea

PMID:12938083 (description, gene)
  AUTHORS   Eng C
  TITLE     PTEN: one gene, many syndromes.
  JOURNAL   Hum Mutat 22:183-98 (2003)
DOI:10.1002/humu.10257

PMID:16379592 (description, gene)
  AUTHORS   Wang QK
  TITLE     Update on the molecular genetics of vascular anomalies.
  JOURNAL   Lymphat Res Biol 3:226-33 (2005)
DOI:10.1089/lrb.2005.3.226",MeSH,D016715,C566636,C567337,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00751,"Asphyxiating thoracic dystrophy;
Jeune syndrome","Asphyxiating thoracic dystrophy (Jeune syndrome) is a rare osteochondrodysplasia with characteristic skeletal abnormalities as well as the involvement of kidneys, liver, pancreas and eyes. Patients have proximal cervical stenosis and severe respiratory insufficiency due to the skeletal abnormalities such as narrow thorax and short ribs.",Skeletal dysplasia,"IFT80 [HSA:57560] [KO:K19678]
WDR19 [HSA:57728] [KO:K19671]
DYNC2H1 [HSA:79659] [KO:K10414]
TTC21B [HSA:79809] [KO:K19673]",,,,,,,"ICD-10: Q77.2
MeSH: C537571 C566982 C567761
OMIM: 611263 613091 613819","PMID:19644333 (descritpion)
  AUTHORS   Campbell RM Jr
  TITLE     Spine deformities in rare congenital syndromes: clinical issues.
  JOURNAL   Spine (Phila Pa 1976) 34:1815-27 (2009)
DOI:10.1097/BRS.0b013e3181ab64e9

PMID:21465651 (descritpion)
  AUTHORS   Keppler-Noreuil KM, Adam MP, Welch J, Muilenburg A, Willing MC
  TITLE     Clinical insights gained from eight new cases and review of reported cases with Jeune syndrome (asphyxiating thoracic dystrophy).
  JOURNAL   Am J Med Genet A 155A:1021-32 (2011)
DOI:10.1002/ajmg.a.33892

PMID:17468754 (gene)
  AUTHORS   Beales PL, Bland E, Tobin JL, Bacchelli C, Tuysuz B, Hill J, Rix S, Pearson CG, Kai M, Hartley J, Johnson C, Irving M, Elcioglu N, Winey M, Tada M, Scambler PJ
  TITLE     IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy.
  JOURNAL   Nat Genet 39:727-9 (2007)
DOI:10.1038/ng2038

PMID:22019273 (gene)
  AUTHORS   Bredrup C, Saunier S, Oud MM, Fiskerstrand T, Hoischen A, Brackman D, Leh SM, Midtbo M, Filhol E, Bole-Feysot C, Nitschke P, Gilissen C, Haugen OH, Sanders JS, Stolte-Dijkstra I, Mans DA, Steenbergen EJ, Hamel BC, Matignon M, Pfundt R, Jeanpierre C, Boman H, Rodahl E, Veltman JA, Knappskog PM, Knoers NV, Roepman R, Arts HH
  TITLE     Ciliopathies with Skeletal Anomalies and Renal Insufficiency due to Mutations in the IFT-A Gene WDR19.
  JOURNAL   Am J Hum Genet 89:634-43 (2011)
DOI:10.1016/j.ajhg.2011.10.001

PMID:19442771 (gene)
  AUTHORS   Dagoneau N, Goulet M, Genevieve D, Sznajer Y, Martinovic J, Smithson S, Huber C, Baujat G, Flori E, Tecco L, Cavalcanti D, Delezoide AL, Serre V, Le Merrer M, Munnich A, Cormier-Daire V
  TITLE     DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III.
  JOURNAL   Am J Hum Genet 84:706-11 (2009)
DOI:10.1016/j.ajhg.2009.04.016

PMID:21258341 (gene)
  AUTHORS   Davis EE, Zhang Q, Liu Q, Diplas BH, Davey LM, Hartley J, Stoetzel C, Szymanska K, Ramaswami G, Logan CV, Muzny DM, Young AC, Wheeler DA, Cruz P, Morgan M, Lewis LR, Cherukuri P, Maskeri B, Hansen NF, Mullikin JC, Blakesley RW, Bouffard GG, Gyapay G, Rieger S, Tonshoff B, Kern I, Soliman NA, Neuhaus TJ, Swoboda KJ, Kayserili H, Gallagher TE, Lewis RA, Bergmann C, Otto EA, Saunier S, Scambler PJ, Beales PL, Gleeson JG, Maher ER, Attie-Bitach T, Dollfus H, Johnson CA, Green ED, Gibbs RA, Hildebrandt F, Pierce EA, Katsanis N
  TITLE     TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum.
  JOURNAL   Nat Genet 43:189-96 (2011)
DOI:10.1038/ng.756",MeSH,C537571,C566982,C567761,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00849,"Creatine deficiency syndrome, including:
Arginine:glycine amidinotransferase deficiency;
Guanidinoacetate methyltransferase deficiency [DS:H00834];
X-linked creatine deficiency syndrome (XL-CDS)","The creatine deficiency syndrome is a group of inborn errors of creatine metabolism, that includes guanidinoacetate methyltransferase (GAMT) deficiency, arginine:glycine amidinotransferase (AGAT) deficiency, and X-linked creatine deficiency syndrome (XL-CDS). Intellectual disability and seizures are common to all three disorders. GAMT deficiency and AGAT deficiency are creatine biosynthesis disorders and inherited in an autosomal recessive manner. XL-CDS is the creatine transporter (SLC6A8) deficiency.",Inherited metabolic disease; Mental retardation,"(XL-CDS) SLC6A8 [HSA:6535] [KO:K05039]
(AGAT deficiency) GATM [HSA:2628] [KO:K00613]
(GAMT deficiency) GAMT [HSA:2593] [KO:K00542]",,,,,"(GAMT deficiency and AGAT deficiency) Creatine monohydrate
(GAMT deficiency) Ornithine [DR:D08302] Arginine [DR:D02982]",XL-CDS is also included in syndromic X-linked mental retardation. [DS:H00658],"ICD-10: E72.8
MeSH: C535598 C567192 C537622
OMIM: 612718 612736 300352","PMID:19879361
  AUTHORS   Braissant O, Beard E, Torrent C, Henry H
  TITLE     Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes.
  JOURNAL   Neurobiol Dis 37:423-33 (2010)
DOI:10.1016/j.nbd.2009.10.022

PMID:20301745
  AUTHORS   Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S, Salomons GS
  TITLE     Creatine Deficiency Syndromes
  JOURNAL   GeneReviews (1993)",MeSH,C535598,C567192,C537622,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00605,"Deafness, autosomal recessive","Hereditary deafness is divided into syndromic forms (in which hearing loss is associated with a variety of other anomalies) and non-syndromic forms. Non-syndromic forms are responsible for 70% of the cases of hereditary etiology and syndromic cases represent 30% of them. Among the forms of heritage, autosomal-recessive inheritance is the most frequent one (75%-85%), followed by autosomal- dominant inheritance (12-13%) and X-linked or mitochondrial, with 2-3% of the cases of non-syndromic hearing loss. The autosomal-recessive forms of deafness are generally the most severe and are almost exclusively caused by cochlear defects (sensorineural deafness), in contrast to the syndromic forms of deafness, where the hearing loss in most cases is conductive (external and/or middle ear developmental defects) or mixed.",Nervous system disease; Nervous system disease,"GJB2 [HSA:2706] [KO:K07621]
GJB6 [HSA:10804] [KO:K07625]
MYO7A [HSA:4647] [KO:K10359]
MYO15 [HSA:51168] [KO:K10361]
SLC26A4 [HSA:5172] [KO:K14702]
TMIE [HSA:259236]
TMC1 [HSA:117531] [KO:K21988]
TMPRSS3 [HSA:64699] [KO:K09634]
OTOF [HSA:9381] [KO:K19949]
CDH23 [HSA:64072] [KO:K06813]
STRC [HSA:161497]
USH1C [HSA:10083] [KO:K21877]
TECTA [HSA:7007] [KO:K18273]
OTOA [HSA:146183]
PCDH15 [HSA:65217] [KO:K16500]
CLDN14 [HSA:23562] [KO:K06087]
MYO3A [HSA:53904] [KO:K08834]
WHRN [HSA:25861] [KO:K21879]
ESPN [HSA:83715]
MYO6 [HSA:4646] [KO:K10358]
COL11A2 [HSA:1302] [KO:K19721]
GJB3 [HSA:2707] [KO:K07622]
GJA1 [HSA:2697] [KO:K07372]
SLC26A5 [HSA:375611] [KO:K14703]
GRXCR1 [HSA:389207] [KO:K17479]
TRIOBP [HSA:11078]
ESRRB [HSA:2103] [KO:K08553]
HGF [HSA:3082] [KO:K05460]
MARVELD2 [HSA:153562] [KO:K17291]
PJVK [HSA:494513] [KO:K22147]
LRTOMT [HSA:220074]
LHFPL5 [HSA:222662]
MSRB3 [HSA:253827] [KO:K07305]
LOXHD1 [HSA:125336]
TPRN [HSA:286262]
GPSM2 [HSA:29899] [KO:K15837]
PTPRQ [HSA:374462] [KO:K16910]
SERPINB6 [HSA:5269] [KO:K13963]
RDX [HSA:5962] [KO:K05762]
FGF3 [HSA:2248] [KO:K04358]",,,,,,,"ICD-10: H91.9
MeSH: C567134 C567213 C564007 C563961 C566366 C563444 C563418 C563417 C563396 C565341 C563417 C563327 C566410 C566344 C566611 C566339 C566418 C566580 C565828 C566353 C564633 C563705 C567027 C565329 C565287
OMIM: 220290 612645 600060 600316 600791 600971 600974 601072 601071 605316 601386 603720 602092 603629 607039 609533 614035 607101 607084 609006 607821 609706 613285 609823 608565 608265 610153 610220 611451 610265 613718 613079 613307 613557 613391 613453 611022 610706","PMID:16650073 (gene)
  AUTHORS   Petersen MB, Willems PJ
  TITLE     Non-syndromic, autosomal-recessive deafness.
  JOURNAL   Clin Genet 69:371-92 (2006)
DOI:10.1111/j.1399-0004.2006.00613.x

PMID:16446920 (description, gene)
  AUTHORS   Piatto VB, Nascimento EC, Alexandrino F, Oliveira CA, Lopes AC, Sartorato EL, Maniglia JV
  TITLE     Molecular genetics of non-syndromic deafness.
  JOURNAL   Braz J Otorhinolaryngol 71:216-23 (2005)
DOI:10.1590/S0034-72992005000200016

PMID:12324385 (gene)
  AUTHORS   Bitner-Glindzicz M
  TITLE     Hereditary deafness and phenotyping in humans.
  JOURNAL   Br Med Bull 63:73-94 (2002)
DOI:10.1093/bmb/63.1.73

PMID:20137778 (gene)
  AUTHORS   Schraders M, Lee K, Oostrik J, Huygen PL, Ali G, Hoefsloot LH, Veltman JA, Cremers FP, Basit S, Ansar M, Cremers CW, Kunst HP, Ahmad W, Admiraal RJ, Leal SM, Kremer H
  TITLE     Homozygosity mapping reveals mutations of GRXCR1 as a cause of autosomal-recessive nonsyndromic hearing impairment.
  JOURNAL   Am J Hum Genet 86:138-47 (2010)
DOI:10.1016/j.ajhg.2009.12.017

PMID:16385457 (gene)
  AUTHORS   Riazuddin S, Khan SN, Ahmed ZM, Ghosh M, Caution K, Nazli S, Kabra M, Zafar AU, Chen K, Naz S, Antonellis A, Pavan WJ, Green ED, Wilcox ER, Friedman PL, Morell RJ, Riazuddin S, Friedman TB
  TITLE     Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.
  JOURNAL   Am J Hum Genet 78:137-43 (2006)
DOI:10.1086/499164

PMID:18179891 (gene)
  AUTHORS   Collin RW, Kalay E, Tariq M, Peters T, van der Zwaag B, Venselaar H, Oostrik J, Lee K, Ahmed ZM, Caylan R, Li Y, Spierenburg HA, Eyupoglu E, Heister A, Riazuddin S, Bahat E, Ansar M, Arslan S, Wollnik B, Brunner HG, Cremers CW, Karaguzel A, Ahmad W, Cremers FP, Vriend G, Friedman TB, Riazuddin S, Leal SM, Kremer H
  TITLE     Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.
  JOURNAL   Am J Hum Genet 82:125-38 (2008)
DOI:10.1016/j.ajhg.2007.09.008

PMID:19576567 (gene)
  AUTHORS   Schultz JM, Khan SN, Ahmed ZM, Riazuddin S, Waryah AM, Chhatre D, Starost MF, Ploplis B, Buckley S, Velasquez D, Kabra M, Lee K, Hassan MJ, Ali G, Ansar M, Ghosh M, Wilcox ER, Ahmad W, Merlino G, Leal SM, Riazuddin S, Friedman TB, Morell RJ
  TITLE     Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.
  JOURNAL   Am J Hum Genet 85:25-39 (2009)
DOI:10.1016/j.ajhg.2009.06.003

PMID:17186462 (gene)
  AUTHORS   Riazuddin S, Ahmed ZM, Fanning AS, Lagziel A, Kitajiri S, Ramzan K, Khan SN, Chattaraj P, Friedman PL, Anderson JM, Belyantseva IA, Forge A, Riazuddin S, Friedman TB
  TITLE     Tricellulin is a tight-junction protein necessary for hearing.
  JOURNAL   Am J Hum Genet 79:1040-51 (2006)
DOI:10.1086/510022

PMID:16804542 (gene)
  AUTHORS   Delmaghani S, del Castillo FJ, Michel V, Leibovici M, Aghaie A, Ron U, Van Laer L, Ben-Tal N, Van Camp G, Weil D, Langa F, Lathrop M, Avan P, Petit C
  TITLE     Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy.
  JOURNAL   Nat Genet 38:770-8 (2006)
DOI:10.1038/ng1829

PMID:18953341 (gene)
  AUTHORS   Ahmed ZM, Masmoudi S, Kalay E, Belyantseva IA, Mosrati MA, Collin RW, Riazuddin S, Hmani-Aifa M, Venselaar H, Kawar MN, Tlili A, van der Zwaag B, Khan SY, Ayadi L, Riazuddin SA, Morell RJ, Griffith AJ, Charfedine I, Caylan R, Oostrik J, Karaguzel A, Ghorbel A, Riazuddin S, Friedman TB, Ayadi H, Kremer H
  TITLE     Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.
  JOURNAL   Nat Genet 40:1335-40 (2008)
DOI:10.1038/ng.245

PMID:16752389 (gene)
  AUTHORS   Kalay E, Li Y, Uzumcu A, Uyguner O, Collin RW, Caylan R, Ulubil-Emiroglu M, Kersten FF, Hafiz G, van Wijk E, Kayserili H, Rohmann E, Wagenstaller J, Hoefsloot LH, Strom TM, Nurnberg G, Baserer N, den Hollander AI, Cremers FP, Cremers CW, Becker C, Brunner HG, Nurnberg P, Karaguzel A, Basaran S, Kubisch C, Kremer H, Wollnik B
  TITLE     Mutations in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene cause autosomal recessive nonsyndromic hearing loss.
  JOURNAL   Hum Mutat 27:633-9 (2006)
DOI:10.1002/humu.20368

PMID:21185009 (gene)
  AUTHORS   Ahmed ZM, Yousaf R, Lee BC, Khan SN, Lee S, Lee K, Husnain T, Rehman AU, Bonneux S, Ansar M, Ahmad W, Leal SM, Gladyshev VN, Belyantseva IA, Van Camp G, Riazuddin S, Friedman TB, Riazuddin S
  TITLE     Functional null mutations of MSRB3 encoding methionine sulfoxide reductase are associated with human deafness DFNB74.
  JOURNAL   Am J Hum Genet 88:19-29 (2011)
DOI:10.1016/j.ajhg.2010.11.010

PMID:19732867 (gene)
  AUTHORS   Grillet N, Schwander M, Hildebrand MS, Sczaniecka A, Kolatkar A, Velasco J, Webster JA, Kahrizi K, Najmabadi H, Kimberling WJ, Stephan D, Bahlo M, Wiltshire T, Tarantino LM, Kuhn P, Smith RJ, Muller U
  TITLE     Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
  JOURNAL   Am J Hum Genet 85:328-37 (2009)
DOI:10.1016/j.ajhg.2009.07.017

PMID:20170898 (gene)
  AUTHORS   Li Y, Pohl E, Boulouiz R, Schraders M, Nurnberg G, Charif M, Admiraal RJ, von Ameln S, Baessmann I, Kandil M, Veltman JA, Nurnberg P, Kubisch C, Barakat A, Kremer H, Wollnik B
  TITLE     Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss.
  JOURNAL   Am J Hum Genet 86:479-84 (2010)
DOI:10.1016/j.ajhg.2010.02.003

PMID:20602914 (gene)
  AUTHORS   Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W, Abu Rayyan A, Loulus S, Avraham KB, King MC, Kanaan M
  TITLE     Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82.
  JOURNAL   Am J Hum Genet 87:90-4 (2010)
DOI:10.1016/j.ajhg.2010.05.010

PMID:20346435 (gene)
  AUTHORS   Schraders M, Oostrik J, Huygen PL, Strom TM, van Wijk E, Kunst HP, Hoefsloot LH, Cremers CW, Admiraal RJ, Kremer H
  TITLE     Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.
  JOURNAL   Am J Hum Genet 86:604-10 (2010)
DOI:10.1016/j.ajhg.2010.02.015

PMID:20451170 (gene)
  AUTHORS   Sirmaci A, Erbek S, Price J, Huang M, Duman D, Cengiz FB, Bademci G, Tokgoz-Yilmaz S, Hismi B, Ozdag H, Ozturk B, Kulaksizoglu S, Yildirim E, Kokotas H, Grigoriadou M, Petersen MB, Shahin H, Kanaan M, King MC, Chen ZY, Blanton SH, Liu XZ, Zuchner S, Akar N, Tekin M
  TITLE     A truncating mutation in SERPINB6 is associated with autosomal-recessive nonsyndromic sensorineural hearing loss.
  JOURNAL   Am J Hum Genet 86:797-804 (2010)
DOI:10.1016/j.ajhg.2010.04.004

PMID:17226784 (gene)
  AUTHORS   Khan SY, Ahmed ZM, Shabbir MI, Kitajiri S, Kalsoom S, Tasneem S, Shayiq S, Ramesh A, Srisailpathy S, Khan SN, Smith RJ, Riazuddin S, Friedman TB, Riazuddin S
  TITLE     Mutations of the RDX gene cause nonsyndromic hearing loss at the DFNB24 locus.
  JOURNAL   Hum Mutat 28:417-23 (2007)
DOI:10.1002/humu.20469

PMID:17236138 (gene)
  AUTHORS   Tekin M, Hismi BO, Fitoz S, Ozdag H, Cengiz FB, Sirmaci A, Aslan I, Inceoglu B, Yuksel-Konuk EB, Yilmaz ST, Yasun O, Akar N
  TITLE     Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia.
  JOURNAL   Am J Hum Genet 80:338-44 (2007)
DOI:10.1086/510920

PMID:18435799 (gene)
  AUTHORS   Tekin M, Ozturkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, Sennaroglu L, Incesulu A, Yuksel Konuk EB, Hasanefendioglu Bayrak A, Senturk S, Cebeci I, Utine GE, Tuncbilek E, Nance WE, Duman D
  TITLE     Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia.
  JOURNAL   Clin Genet 73:554-65 (2008)
DOI:10.1111/j.1399-0004.2008.01004.x",MeSH,C567134,C567213,C564007,C563961,C566366,C563444,C563418,C563417,C563396,C565341,C563417,C563327,C566410,C566344,C566611,C566339,C566418,C566580,C565828,C566353,C564633,C563705,C567027,C565329,C565287,,,,,
H00773,Autosomal dominant mental retardation,"Mental retardation (MR) is a neurodevelopmental disorder characterized by low intelligence quotient (IQ) and deficits in adaptive behaviors. Most MR genes identified so far are either located on the X chromosome or are associated with an autosomal recessive mode of inheritance. Only a small number of autosomal dominant MR genes are known, because patients with mental retardation rarely reproduce.",Congenital disorder; Mental retardation,"(MRD1) MBD5 [HSA:55777]
(MRD2) DOCK8 [HSA:81704] [KO:K21852]
(MRD3) CDH15 [HSA:1013] [KO:K06809]
(MRD4) KIRREL3 [HSA:84623]
(MRD5) SYNGAP1 [HSA:8831] [KO:K17631]
(MRD6) GRIN2B [HSA:2904] [KO:K05210]
(MRD7) DYRK1A [HSA:1859] [KO:K08825]
(MRD8) GRIN1 [HSA:2902] [KO:K05208]
(MRD9) KIF1A [HSA:547] [KO:K10392]
(MRD10) CACNG2 [HSA:10369] [KO:K04867]
(MRD11) EPB41L1 [HSA:2036] [KO:K06107]
(MRD12) ARID1B [HSA:57492] [KO:K11653]
(MRD13) DYNC1H1 [HSA:1778] [KO:K10413]
(MRD14) ARID1A [HSA:8289] [KO:K11653]
(MRD15) SMARCB1 [HSA:6598] [KO:K11648]
(MRD16) SMARCA4 [HSA:6597] [KO:K11647]
(MRD17) PACS1 [HSA:55690]
(MRD18) GATAD2B [HSA:57459]
(MRD19) CTNNB1 [HSA:1499] [KO:K02105]
(MRD20) MEF2C [HSA:4208] [KO:K04454]
(MRD21) CTCF [HSA:10664]
(MRD22) ZBTB18 [HSA:10472]
(MRD23) SETD5 [HSA:55209]
(MRD24) DEAF1 [HSA:10522]
(MRD25) AHDC1 [HSA:27245]
(MRD26) AUTS2 [HSA:26053]
(MRD27) SOX11 [HSA:6664] [KO:K09268]
(MRD29) SETBP1 [HSA:26040]
(MRD30) ZMYND11 [HSA:10771]
(MRD31) PURA [HSA:5813] [KO:K21772]
(MRD32) KAT6A [HSA:7994] [KO:K11305]
(MRD33) DPP6 [HSA:1804]
(MRD34) COL4A3BP [HSA:10087] [KO:K08283]
(MRD35) PPP2R5D [HSA:5528] [KO:K11584]
(MRD36) PPP2R1A [HSA:5518] [KO:K03456]
(MRD38) EEF1A2 [HSA:1917] [KO:K03231]
(MRD39) MYT1L [HSA:23040]
(MRD40) CHAMP1 [HSA:283489]
(MRD42) GNB1 [HSA:2782] [KO:K04536]
(MRD43) HIVEP2 [HSA:3097] [KO:K09239]
(MRD44) TRIO [HSA:7204] [KO:K08810]",,,,,,,"ICD-10: F78.9
MeSH: C566947 C567241 C567240 C567234
OMIM: 156200 614113 612580 612581 612621 613970 614254 614255 614256 614257 614562 614563 614607 614608 614609 615009 615074 615075 613443 615502 612337 615761 615828 615829 615866 616078 616083 616158 616268 616311 616351 616355 616362 616393 616521 616579 616973 616977 617061","PMID:19904302
  AUTHORS   Williams SR, Mullegama SV, Rosenfeld JA, Dagli AI, Hatchwell E, Allen WP, Williams CA, Elsea SH
  TITLE     Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.
  JOURNAL   Eur J Hum Genet 18:436-41 (2010)
DOI:10.1038/ejhg.2009.199

PMID:18060736
  AUTHORS   Griggs BL, Ladd S, Saul RA, DuPont BR, Srivastava AK
  TITLE     Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities.
  JOURNAL   Genomics 91:195-202 (2008)
DOI:10.1016/j.ygeno.2007.10.011

PMID:19012874
  AUTHORS   Bhalla K, Luo Y, Buchan T, Beachem MA, Guzauskas GF, Ladd S, Bratcher SJ, Schroer RJ, Balsamo J, DuPont BR, Lilien J, Srivastava AK
  TITLE     Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability.
  JOURNAL   Am J Hum Genet 83:703-13 (2008)
DOI:10.1016/j.ajhg.2008.10.020

PMID:19673947
  AUTHORS   Huang K
  TITLE     SYNGAP: bridging the gap between genetic factors and autosomal non-syndromic mental retardation.
  JOURNAL   Clin Genet 76:149-51 (2009)
DOI:10.1111/j.1399-0004.2009.01247_3.x

PMID:20890276
  AUTHORS   Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortum F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tonnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K
  TITLE     Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
  JOURNAL   Nat Genet 42:1021-6 (2010)
DOI:10.1038/ng.677

PMID:21294719
  AUTHORS   van Bon BW, Hoischen A, Hehir-Kwa J, de Brouwer AP, Ruivenkamp C, Gijsbers AC, Marcelis CL, de Leeuw N, Veltman JA, Brunner HG, de Vries BB
  TITLE     Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly.
  JOURNAL   Clin Genet 79:296-9 (2011)
DOI:10.1111/j.1399-0004.2010.01544.x

PMID:21376300 (MRD8, MRD9, MRD10, MRD11)
  AUTHORS   Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, Nadeau A, D'Anjou G, Vanasse M, Srour M, Lafreniere RG, Drapeau P, Lacaille JC, Kim E, Lee JR, Igarashi K, Huganir RL, Rouleau GA, Michaud JL
  TITLE     Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
  JOURNAL   Am J Hum Genet 88:306-16 (2011)
DOI:10.1016/j.ajhg.2011.02.001

PMID:22368300
  AUTHORS   Willemsen MH, Vissers LE, Willemsen MA, van Bon BW, Kroes T, de Ligt J, de Vries BB, Schoots J, Lugtenberg D, Hamel BC, van Bokhoven H, Brunner HG, Veltman JA, Kleefstra T
  TITLE     Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects.
  JOURNAL   J Med Genet 49:179-83 (2012)
DOI:10.1136/jmedgenet-2011-100542

PMID:22426308 (MRD12, MRD14, MRD15, MRD16)
  AUTHORS   Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y, Yamagata T, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K, Ohta T, Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N, Matsumoto N
  TITLE     Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.
  JOURNAL   Nat Genet 44:376-8 (2012)
DOI:10.1038/ng.2219

PMID:23159249
  AUTHORS   Schuurs-Hoeijmakers JH, Oh EC, Vissers LE, Swinkels ME, Gilissen C, Willemsen MA, Holvoet M, Steehouwer M, Veltman JA, de Vries BB, van Bokhoven H, de Brouwer AP, Katsanis N, Devriendt K, Brunner HG
  TITLE     Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.
  JOURNAL   Am J Hum Genet 91:1122-7 (2012)
DOI:10.1016/j.ajhg.2012.10.013

PMID:23644463
  AUTHORS   Willemsen MH, Nijhof B, Fenckova M, Nillesen WM, Bongers EM, Castells-Nobau A, Asztalos L, Viragh E, van Bon BW, Tezel E, Veltman JA, Brunner HG, de Vries BB, de Ligt J, Yntema HG, van Bokhoven H, Isidor B, Le Caignec C, Lorino E, Asztalos Z, Koolen DA, Vissers LE, Schenck A, Kleefstra T
  TITLE     GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila.
  JOURNAL   J Med Genet 50:507-14 (2013)
DOI:10.1136/jmedgenet-2012-101490

PMID:23033978 (MRD19)
  AUTHORS   de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE
  TITLE     Diagnostic exome sequencing in persons with severe intellectual disability.
  JOURNAL   N Engl J Med 367:1921-9 (2012)
DOI:10.1056/NEJMoa1206524

PMID:20513142
  AUTHORS   Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, Grasshoff U, Johnson DS, Robertson L, Firth HV, Ekici AB, Reis A, Rauch A
  TITLE     Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
  JOURNAL   Hum Mutat 31:722-33 (2010)
DOI:10.1002/humu.21253

PMID:23746550
  AUTHORS   Gregor A, Oti M, Kouwenhoven EN, Hoyer J, Sticht H, Ekici AB, Kjaergaard S, Rauch A, Stunnenberg HG, Uebe S, Vasileiou G, Reis A, Zhou H, Zweier C
  TITLE     De novo mutations in the genome organizer CTCF cause intellectual disability.
  JOURNAL   Am J Hum Genet 93:124-31 (2013)
DOI:10.1016/j.ajhg.2013.05.007

PMID:21800092 (MRD22)
  AUTHORS   Ballif BC, Rosenfeld JA, Traylor R, Theisen A, Bader PI, Ladda RL, Sell SL, Steinraths M, Surti U, McGuire M, Williams S, Farrell SA, Filiano J, Schnur RE, Coffey LB, Tervo RC, Stroud T, Marble M, Netzloff M, Hanson K, Aylsworth AS, Bamforth JS, Babu D, Niyazov DM, Ravnan JB, Schultz RA, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG
  TITLE     High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.
  JOURNAL   Hum Genet 131:145-56 (2012)
DOI:10.1007/s00439-011-1073-y

PMID:24680889
  AUTHORS   Grozeva D, Carss K, Spasic-Boskovic O, Parker MJ, Archer H, Firth HV, Park SM, Canham N, Holder SE, Wilson M, Hackett A, Field M, Floyd JA, Hurles M, Raymond FL
  TITLE     De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.
  JOURNAL   Am J Hum Genet 94:618-24 (2014)
DOI:10.1016/j.ajhg.2014.03.006

PMID:24791903 (gene)
  AUTHORS   Xia F, Bainbridge MN, Tan TY, Wangler MF, Scheuerle AE, Zackai EH, Harr MH, Sutton VR, Nalam RL, Zhu W, Nash M, Ryan MM, Yaplito-Lee J, Hunter JV, Deardorff MA, Penney SJ, Beaudet AL, Plon SE, Boerwinkle EA, Lupski JR, Eng CM, Muzny DM, Yang Y, Gibbs RA
  TITLE     De novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.
  JOURNAL   Am J Hum Genet 94:784-9 (2014)
DOI:10.1016/j.ajhg.2014.04.006

PMID:25533962 (gene)
  TITLE     Large-scale discovery of novel genetic causes of developmental disorders.
  JOURNAL   Nature 519:223-8 (2015)
DOI:10.1038/nature14135

PMID:25728777 (gene)
  AUTHORS   Tham E, Lindstrand A, Santani A, Malmgren H, Nesbitt A, Dubbs HA, Zackai EH, Parker MJ, Millan F, Rosenbaum K, Wilson GN, Nordgren A
  TITLE     Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
  JOURNAL   Am J Hum Genet 96:507-13 (2015)
DOI:10.1016/j.ajhg.2015.01.016

PMID:23832105 (gene)
  AUTHORS   Liao C, Fu F, Li R, Yang WQ, Liao HY, Yan JR, Li J, Li SY, Yang X, Li DZ
  TITLE     Loss-of-function variation in the DPP6 gene is associated with autosomal dominant microcephaly and mental retardation.
  JOURNAL   Eur J Med Genet 56:484-9 (2013)
DOI:10.1016/j.ejmg.2013.06.008

PMID:24697219 (gene)
  AUTHORS   Nakajima J, Okamoto N, Tohyama J, Kato M, Arai H, Funahashi O, Tsurusaki Y, Nakashima M, Kawashima H, Saitsu H, Matsumoto N, Miyake N
  TITLE     De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy.
  JOURNAL   Clin Genet 87:356-61 (2015)
DOI:10.1111/cge.12394

PMID:25232846 (gene)
  AUTHORS   De Rocker N, Vergult S, Koolen D, Jacobs E, Hoischen A, Zeesman S, Bang B, Bena F, Bockaert N, Bongers EM, de Ravel T, Devriendt K, Giglio S, Faivre L, Joss S, Maas S, Marle N, Novara F, Nowaczyk MJ, Peeters H, Polstra A, Roelens F, Rosenberg C, Thevenon J, Tumer Z, Vanhauwaert S, Varvagiannis K, Willaert A, Willemsen M, Willems M, Zuffardi O, Coucke P, Speleman F, Eichler EE, Kleefstra T, Menten B
  TITLE     Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity.
  JOURNAL   Genet Med 17:460-6 (2015)
DOI:10.1038/gim.2014.124

PMID:27108799 (gene)
  AUTHORS   Petrovski S, Kury S, Myers CT, Anyane-Yeboa K, Cogne B, Bialer M, Xia F, Hemati P, Riviello J, Mehaffey M, Besnard T, Becraft E, Wadley A, Politi AR, Colombo S, Zhu X, Ren Z, Andrews I, Dudding-Byth T, Schneider AL, Wallace G, Rosen AB, Schelley S, Enns GM, Corre P, Dalton J, Mercier S, Latypova X, Schmitt S, Guzman E, Moore C, Bier L, Heinzen EL, Karachunski P, Shur N, Grebe T, Basinger A, Nguyen JM, Bezieau S, Wierenga K, Bernstein JA, Scheffer IE, Rosenfeld JA, Mefford HC, Isidor B, Goldstein DB
  TITLE     Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
  JOURNAL   Am J Hum Genet 98:1001-10 (2016)
DOI:10.1016/j.ajhg.2016.03.011

PMID:23020937 (gene)
  AUTHORS   Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM
  TITLE     Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
  JOURNAL   Lancet 380:1674-82 (2012)
DOI:10.1016/S0140-6736(12)61480-9",MeSH,C566947,C567241,C567240,C567234,,,,,,,,,,,,,,,,,,,,,,,,,,
H00888,"Nephrolithiasis/osteoporosis, hypophosphatemic","Nephrolithiasis/osteoporosis, hypophosphatemic is a genetically heterologous group of disorders characterized by the formation of renal calcium stones or bone demineralization due to impaired renal phosphate reabsorption. It is caused by either mutations in NPT2A, a sodium-phosphate cotransporter expressed in kidney and polarized osteoclasts, or in sodium-hydrogen exchanger regulatory factor (NHERF)1, that controls renal phosphate transport by trafficking NPT2A.",Kidney disease; Skeletal dysplasia,"(type 1) NPT2A [HSA:6569] [KO:K14683]
(type 2) NHERF1 [HSA:9368] [KO:K13365]",,,,,,,"MeSH: C567363 C567362
OMIM: 612286 612287","PMID:20924400 (description)
  AUTHORS   Alizadeh Naderi AS, Reilly RF
  TITLE     Hereditary disorders of renal phosphate wasting.
  JOURNAL   Nat Rev Nephrol 6:657-65 (2010)
DOI:10.1038/nrneph.2010.121

PMID:15483460 (description, gene)
  AUTHORS   Prie D, Beck L, Friedlander G, Silve C
  TITLE     Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization.
  JOURNAL   Curr Opin Nephrol Hypertens 13:675-81 (2004)

PMID:12324554 (gene)
  AUTHORS   Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G
  TITLE     Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.
  JOURNAL   N Engl J Med 347:983-91 (2002)
DOI:10.1056/NEJMoa020028

PMID:18784102 (gene)
  AUTHORS   Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prie D
  TITLE     NHERF1 mutations and responsiveness of renal parathyroid hormone.
  JOURNAL   N Engl J Med 359:1128-35 (2008)
DOI:10.1056/NEJMoa0802836",MeSH,C567363,C567362,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00604,"Deafness, autosomal dominant","Hereditary deafness is divided into syndromic forms (in which hearing loss is associated with a variety of other anomalies) and non-syndromic forms. Non-syndromic forms are responsible for 70% of the cases of hereditary etiology and syndromic cases represent 30% of them. Among the forms of heritage, autosomal-recessive inheritance is the most frequent one (75%-85%), followed by autosomal-dominant inheritance (12-13%) and X-linked or mitochondrial, with 2-3% of the cases of non-syndromic hearing loss. Autosomal-dominant forms of deafness are usually post-lingual and progressive. Dominant mutations may be consistent with initial function and subsequent hearing loss owing to accumulation of pathology.",Nervous system disease; Nervous system disease,"DIAPH1 [HSA:1729] [KO:K05740]
GJB3 [HSA:2707] [KO:K07622]
MYH14 [HSA:79784] [KO:K10352]
GJB6 [HSA:10804] [KO:K07625]
WFS1 [HSA:7466] [KO:K14020]
KCNQ4 [HSA:9132] [KO:K04929]
GJB2 [HSA:2706] [KO:K07621]
DFNA5 [HSA:1687] [KO:K22146]
COCH [HSA:1690]
MYO7A [HSA:4647] [KO:K10359]
TECTA [HSA:7007] [KO:K18273]
EYA4 [HSA:2070] [KO:K17622]
COL11A2 [HSA:1302] [KO:K19721]
POU4F3 [HSA:5459] [KO:K09366]
MYH9 [HSA:4627] [KO:K10352]
ACTG1 [HSA:71] [KO:K05692]
SIX1 [HSA:6495] [KO:K15614]
SLC17A8 [HSA:246213] [KO:K12302]
GRHL2 [HSA:79977] [KO:K09275]
TMC1 [HSA:117531] [KO:K21988]
DSPP [HSA:1834]
CCDC50 [HSA:152137]
MYO1A [HSA:4640] [KO:K10356]
MIR96 [HSA:407053] [KO:K17114]
MYO6 [HSA:4646] [KO:K10358]",,,,,,,"ICD-10: H91.9
MeSH: C565121 C567441 C567214 C567277 C567215 C563460 C563410 C563421 C563321 C563335 C563354 C563353 C563295 C566612 C563421 C566545 C565832 C535507 C565267 C565754 C564634 C538197 C565357 C565239 C565319 C563890 C564706 C563888 C564675 C564272 C564246 C564399 C563885 C564322 C564250 C564348 C566495 C567216
OMIM: 124900 600101 612643 600652 600965 601316 612644 601544 600994 601369 601317 601543 601868 602459 603622 604717 605192 605583 608641 606705 605594 607453 607841 613074 606346","PMID:12123480 (description, gene)
  AUTHORS   Petersen MB
  TITLE     Non-syndromic autosomal-dominant deafness.
  JOURNAL   Clin Genet 62:1-13 (2002)
DOI:10.1034/j.1399-0004.2002.620101.x

PMID:16446920 (description, gene)
  AUTHORS   Piatto VB, Nascimento EC, Alexandrino F, Oliveira CA, Lopes AC, Sartorato EL, Maniglia JV
  TITLE     Molecular genetics of non-syndromic deafness.
  JOURNAL   Braz J Otorhinolaryngol 71:216-23 (2005)
DOI:10.1590/S0034-72992005000200016

PMID:12324385 (gene)
  AUTHORS   Bitner-Glindzicz M
  TITLE     Hereditary deafness and phenotyping in humans.
  JOURNAL   Br Med Bull 63:73-94 (2002)
DOI:10.1093/bmb/63.1.73

PMID:12014894 (gene)
  AUTHORS   Hone SW, Smith RJ
  TITLE     Genetics of hearing impairment.
  JOURNAL   Semin Neonatol 6:531-41 (2001)
DOI:10.1053/siny.2001.0094

PMID:10471490
  AUTHORS   Grifa A, Wagner CA, D'Ambrosio L, Melchionda S, Bernardi F, Lopez-Bigas N, Rabionet R, Arbones M, Monica MD, Estivill X, Zelante L, Lang F, Gasparini P
  TITLE     Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus.
  JOURNAL   Nat Genet 23:16-8 (1999)
DOI:10.1038/12612

PMID:15015131
  AUTHORS   Donaudy F, Snoeckx R, Pfister M, Zenner HP, Blin N, Di Stazio M, Ferrara A, Lanzara C, Ficarella R, Declau F, Pusch CM, Nurnberg P, Melchionda S, Zelante L, Ballana E, Estivill X, Van Camp G, Gasparini P, Savoia A
  TITLE     Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4).
  JOURNAL   Am J Hum Genet 74:770-6 (2004)
DOI:10.1086/383285

PMID:11709538
  AUTHORS   Young TL, Ives E, Lynch E, Person R, Snook S, MacLaren L, Cater T, Griffin A, Fernandez B, Lee MK, King MC
  TITLE     Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1.
  JOURNAL   Hum Mol Genet 10:2509-14 (2001)
DOI:10.1093/hmg/10.22.2509

PMID:13680526
  AUTHORS   Zhu M, Yang T, Wei S, DeWan AT, Morell RJ, Elfenbein JL, Fisher RA, Leal SM, Smith RJ, Friderici KH
  TITLE     Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26).
  JOURNAL   Am J Hum Genet 73:1082-91 (2003)
DOI:10.1086/379286

PMID:15141091
  AUTHORS   Ruf RG, Xu PX, Silvius D, Otto EA, Beekmann F, Muerb UT, Kumar S, Neuhaus TJ, Kemper MJ, Raymond RM Jr, Brophy PD, Berkman J, Gattas M, Hyland V, Ruf EM, Schwartz C, Chang EH, Smith RJ, Stratakis CA, Weil D, Petit C, Hildebrandt F
  TITLE     SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes.
  JOURNAL   Proc Natl Acad Sci U S A 101:8090-5 (2004)
DOI:10.1073/pnas.0308475101

PMID:18674745
  AUTHORS   Ruel J, Emery S, Nouvian R, Bersot T, Amilhon B, Van Rybroek JM, Rebillard G, Lenoir M, Eybalin M, Delprat B, Sivakumaran TA, Giros B, El Mestikawy S, Moser T, Smith RJ, Lesperance MM, Puel JL
  TITLE     Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice.
  JOURNAL   Am J Hum Genet 83:278-92 (2008)
DOI:10.1016/j.ajhg.2008.07.008

PMID:21610158
  AUTHORS   Han Y, Mu Y, Li X, Xu P, Tong J, Liu Z, Ma T, Zeng G, Yang S, Du J, Meng A
  TITLE     Grhl2 deficiency impairs otic development and hearing ability in a zebrafish model of the progressive dominant hearing loss DFNA28.
  JOURNAL   Hum Mol Genet 20:3213-26 (2011)
DOI:10.1093/hmg/ddr234

PMID:18616530
  AUTHORS   Hilgert N, Alasti F, Dieltjens N, Pawlik B, Wollnik B, Uyguner O, Delmaghani S, Weil D, Petit C, Danis E, Yang T, Pandelia E, Petersen MB, Goossens D, Favero JD, Sanati MH, Smith RJ, Van Camp G
  TITLE     Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11.
  JOURNAL   Clin Genet 74:223-32 (2008)
DOI:10.1111/j.1399-0004.2008.01053.x

PMID:11175790
  AUTHORS   Xiao S, Yu C, Chou X, Yuan W, Wang Y, Bu L, Fu G, Qian M, Yang J, Shi Y, Hu L, Han B, Wang Z, Huang W, Liu J, Chen Z, Zhao G, Kong X
  TITLE     Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP.
  JOURNAL   Nat Genet 27:201-4 (2001)
DOI:10.1038/84848

PMID:17503326
  AUTHORS   Modamio-Hoybjor S, Mencia A, Goodyear R, del Castillo I, Richardson G, Moreno F, Moreno-Pelayo MA
  TITLE     A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss.
  JOURNAL   Am J Hum Genet 80:1076-89 (2007)
DOI:10.1086/518311

PMID:12736868
  AUTHORS   Donaudy F, Ferrara A, Esposito L, Hertzano R, Ben-David O, Bell RE, Melchionda S, Zelante L, Avraham KB, Gasparini P
  TITLE     Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss.
  JOURNAL   Am J Hum Genet 72:1571-7 (2003)
DOI:10.1086/375654

PMID:22038834
  AUTHORS   Solda G, Robusto M, Primignani P, Castorina P, Benzoni E, Cesarani A, Ambrosetti U, Asselta R, Duga S
  TITLE     A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing.
  JOURNAL   Hum Mol Genet 21:577-85 (2012)
DOI:10.1093/hmg/ddr493",MeSH,C565121,C567441,C567214,C567277,C567215,C563460,C563410,C563421,C563321,C563335,C563354,C563353,C563295,C566612,C563421,C566545,C565832,C535507,C565267,C565754,C564634,C538197,C565357,C565239,C565319,C563890,C564706,C563888,C564675,C564272
H00657,Reducing body myopathy (RBM),"Reducing body myopathy (RBM) is a rare, sometimes fatal, X-linked disorder characterized by progressive muscle weakness and the presence of intracytoplasmic aggregates in histological muscle sections which exert a reducing activity on nitro-blue tetrazolium (NBT) staining. The causative gene for RBM is FHL1 encoding four and a half LIM domains.",Musculoskeletal disease; Nervous system disease,FHL1 [HSA:2273] [KO:K14365],,,,,,,"ICD-10: G71.2
MeSH: C567468 C567469
OMIM: 300717 300718","PMID:21310615 (description, gene)
  AUTHORS   Cowling BS, Cottle DL, Wilding BR, D'Arcy CE, Mitchell CA, McGrath MJ
  TITLE     Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.
  JOURNAL   Neuromuscul Disord 21:237-51 (2011)
DOI:10.1016/j.nmd.2011.01.001

PMID:19171836 (description, gene)
  AUTHORS   Shalaby S, Hayashi YK, Nonaka I, Noguchi S, Nishino I
  TITLE     Novel FHL1 mutations in fatal and benign reducing body myopathy.
  JOURNAL   Neurology 72:375-6 (2009)
DOI:10.1212/01.wnl.0000341311.84347.a0",MeSH,C567468,C567469,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01134,Rhabdoid predisposition syndrome (RPS),"Rhabdoid predisposition syndrome (RPS) is familial cases of highly malignant, aggressive, embryonal neoplasms manifested in early infancy and childhood that may originate from virtually any tissue, generally resulting in atypical teratoid rhabdoid tumors (AT/RTs) in the central nervous system and malignant rhabdoid tumors in the kidney or retroperitoneum. The vast majority demonstrate biallelic somatic inactivation of the SMARCB1 tumor suppressor within tumor cells. Mutations in SMRCA4 gene have also been identified.",Cancer,"SMARCB1 [HSA:6598] [KO:K11648]
SMARCA4 [HSA:6597] [KO:K11647]",,,,Fluorescence in-situ hybridization testing of chromosome 22q11.2 locus is a mainstay in the diagnosis of these tumors.,,,"MeSH: C563738 C567643
OMIM: 609322 613325","PMID:21436099 (description, gene, marker)
  AUTHORS   Harris TJ, Donahue JE, Shur N, Tung GA
  TITLE     Case 168: rhabdoid predisposition syndrome--familial cancer syndromes in children.
  JOURNAL   Radiology 259:298-302 (2011)
DOI:10.1148/radiol.10092219

PMID:20137775 (description, gene)
  AUTHORS   Schneppenheim R, Fruhwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R
  TITLE     Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
  JOURNAL   Am J Hum Genet 86:279-84 (2010)
DOI:10.1016/j.ajhg.2010.01.013

PMID:21208904 (gene)
  AUTHORS   Bourdeaut F, Lequin D, Brugieres L, Reynaud S, Dufour C, Doz F, Andre N, Stephan JL, Perel Y, Oberlin O, Orbach D, Bergeron C, Rialland X, Freneaux P, Ranchere D, Figarella-Branger D, Audry G, Puget S, Evans DG, Pinas JC, Capra V, Mosseri V, Coupier I, Gauthier-Villars M, Pierron G, Delattre O
  TITLE     Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
  JOURNAL   Clin Cancer Res 17:31-8 (2011)
DOI:10.1158/1078-0432.CCR-10-1795",MeSH,C563738,C567643,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01965,Miyoshi myopathy,"Miyoshi myopathy (MM) is a rare autosomal recessive distal myopathy characterized by weakness and atrophy that begins in the posterior compartment muscles of the legs. The onset of symptoms is in young adulthood and often begins with the inability to toe walk. Miyoshi myopathy 1 (MM1) is caused by mutations in the dysferlin gene. Recently, anoctamin 5 (ANO5) was also identified, causing Miyoshi myopathy 3 (MMD3).",Musculoskeletal disease; Nervous system disease,"DYSF [HSA:8291] [KO:K18261]
ANO5 [HSA:203859] [KO:K19480]",,,,Elevated creatine kinase levels,,,"ICD-10: G71.0
MeSH: C537480 C567646 C567645
OMIM: 254130 613318 613319","PMID:10545047
  AUTHORS   Rowin J, Meriggioli MN, Cochran EJ, Sanders DB
  TITLE     Prominent inflammatory changes on muscle biopsy in patients with Miyoshi myopathy.
  JOURNAL   Neuromuscul Disord 9:417-20 (1999)

PMID:9731526 (gene)
  AUTHORS   Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH Jr
  TITLE     Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.
  JOURNAL   Nat Genet 20:31-6 (1998)
DOI:10.1038/1682

PMID:25176504
  AUTHORS   Ten Dam L, van der Kooi AJ, Rovekamp F, Linssen WH, de Visser M
  TITLE     Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
  JOURNAL   Neuromuscul Disord 24:1097-102 (2014)
DOI:10.1016/j.nmd.2014.07.004

PMID:20096397 (gene)
  AUTHORS   Bolduc V, Marlow G, Boycott KM, Saleki K, Inoue H, Kroon J, Itakura M, Robitaille Y, Parent L, Baas F, Mizuta K, Kamata N, Richard I, Linssen WH, Mahjneh I, de Visser M, Bashir R, Brais B
  TITLE     Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
  JOURNAL   Am J Hum Genet 86:213-21 (2010)
DOI:10.1016/j.ajhg.2009.12.013",MeSH,C537480,C567646,C567645,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01204,"Cerebellar ataxia, mental retardation (MR), and dysequilibrium syndrome (CAMRQ)","Cerebellar ataxia, mental retardation (MR), and dysequilibrium syndrome (CAMRQ) is autosomal recessive, genetically heterogeneous conditions characterized by early onset of cerebellar ataxia and MR. Patients with CAMRQs have a severe disturbance of posture and balance, strabismus, muscular hypotonia during childhood and they have a delayed ability to walk independently. The disease is also characterized by perceptual difficulties and in most cases mild mental retardation. Four subtypes have been mapped so far.",Neurodegenerative disease,"(CAMRQ1) VLDLR [HSA:7436] [KO:K20053]
(CAMRQ2) WDR81 [HSA:124997] [KO:K17601]
(CAMRQ3) CA8 [HSA:767] [KO:K01672]
(CAMRQ4) ATP8A2 [HSA:51761] [KO:K14802]",,,,,,,"ICD-10: G11.8
MeSH: C535731 C567656 C567690
OMIM: 224050 610185 613227 615268","PMID:21812104 (description, gene)
  AUTHORS   Kaya N, Aldhalaan H, Al-Younes B, Colak D, Shuaib T, Al-Mohaileb F, Al-Sugair A, Nester M, Al-Yamani S, Al-Bakheet A, Al-Hashmi N, Al-Sayed M, Meyer B, Jungbluth H, Al-Owain M
  TITLE     Phenotypical spectrum of cerebellar ataxia associated with a novel mutation in the CA8 gene, encoding carbonic anhydrase (CA) VIII.
  JOURNAL   Am J Med Genet B Neuropsychiatr Genet 156B:826-34 (2011)
DOI:10.1002/ajmg.b.31227

PMID:20199520 (description, gene)
  AUTHORS   Melberg A, Orlen H, Raininko R, Entesarian M, Dahlqvist J, Gustavson KH, Dahl N
  TITLE     Re-evaluation of the dysequilibrium syndrome.
  JOURNAL   Acta Neurol Scand 123:28-33 (2011)
DOI:10.1111/j.1600-0404.2010.01335.x

PMID:19332571 (description, gene)
  AUTHORS   Boycott KM, Bonnemann C, Herz J, Neuert S, Beaulieu C, Scott JN, Venkatasubramanian A, Parboosingh JS
  TITLE     Mutations in VLDLR as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome).
  JOURNAL   J Child Neurol 24:1310-5 (2009)
DOI:10.1177/0883073809332696

PMID:21885617 (gene)
  AUTHORS   Gulsuner S, Tekinay AB, Doerschner K, Boyaci H, Bilguvar K, Unal H, Ors A, Onat OE, Atalar E, Basak AN, Topaloglu H, Kansu T, Tan M, Tan U, Gunel M, Ozcelik T
  TITLE     Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred.
  JOURNAL   Genome Res 21:1995-2003 (2011)
DOI:10.1101/gr.126110.111

PMID:22892528 (gene)
  AUTHORS   Onat OE, Gulsuner S, Bilguvar K, Nazli Basak A, Topaloglu H, Tan M, Tan U, Gunel M, Ozcelik T
  TITLE     Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.
  JOURNAL   Eur J Hum Genet 21:281-5 (2013)
DOI:10.1038/ejhg.2012.170",MeSH,C535731,C567656,C567690,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01768,Central areolar choroidal dystrophy,"Central areolar choroidal dystrophy (CACD) is a hereditary retinal disorder that principally affects the macula, often resulting in atrophy of the retinal pigment epithelium and choriocapillaris in the center of the macula. Dysfunction of macular photoreceptors usually leads to a decrease in visual acuity, generally occurring between the ages of 30 and 60 years. In most cases, CACD is inherited as an autosomal-dominant trait, although autosomal-recessive cases have been reported. Autosomal-dominant CACD is genetically heterogeneous but mutations in the peripherin/RDS gene (PRPH2) seem to be the most common cause. The PRPH2 encodes a photoreceptor-specific glycoprotein. It is believed to play an important role in the assembly, orientation, and physical stability of photoreceptor outer segment disks.",Nervous system disease; Eye disease,PRPH2 [HSA:5961] [KO:K17343],,,,,,,"ICD-10: H31.2
MeSH: C535358 C567750
OMIM: 215500 613105","PMID:19243827
  AUTHORS   Boon CJ, Klevering BJ, Cremers FP, Zonneveld-Vrieling MN, Theelen T, Den Hollander AI, Hoyng CB
  TITLE     Central areolar choroidal dystrophy.
  JOURNAL   Ophthalmology 116:771-82, 782.e1 (2009)
DOI:10.1016/j.ophtha.2008.12.019

PMID:19262438 (gene)
  AUTHORS   Anand S, Sheridan E, Cassidy F, Inglehearn C, Williams G, Springell K, Allgar V, Kelly TL, McKibbin M
  TITLE     Macular dystrophy associated with the Arg172Trp substitution in peripherin/RDS: genotype-phenotype correlation.
  JOURNAL   Retina 29:682-8 (2009)
DOI:10.1097/IAE.0b013e318198dbed",MeSH,C535358,C567750,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00612,Primary open angle glaucoma,"Primary open angle glaucoma (POAG) is the most prevalent form of glaucoma, and a major cause of irreversible blindness. POAG is often accompanied by ocular hypertension and characterized by progressive loss of retinal ganglion cells, atrophy of the optic nerve, and visual field loss. To date, at least 20 genetic loci for POAG have been reported. And four causative genes (CYP1B1, MYOC, OPTN, and WDR36) are identified from these loci. In addition, recently, heterozygous NTF4 mutation was associated with the phenotype in a small percentage of patients.",Nervous system disease; Eye disease,"(GLC1A) MYOC [HSA:4653]
(GLC1A) CYP1B1 [HSA:1545] [KO:K07410]
(GLC1E) OPTN [HSA:10133] [KO:K19946]
(GLC1G) WDR36 [HSA:134430] [KO:K14554]
(GLC1O) NTF4 [HSA:4909] [KO:K12457]",,,,,"Acetazolamide [DG:DG01134]
Betaxolol [DG:DG00315]
Brinzolamide [DR:D00652]
Bunazosin [DG:DG01316]
Carteolol [DG:DG00308]
Distigmine [DR:D01228]
Dorzolamide [DG:DG01135]
Isopropyl unoprostone [DG:DG01139]
Isosorbide [DR:D00347]
Latanoprost [DR:D00356]
Levobunolol [DG:DG01136]
Nipradilol [DR:D01691]
Pilocarpine [DG:DG00992]
Timolol maleate [DG:DG00306]
Travoprost [DR:D01964]",GLC1G is a ribosome biogenesis disorder.,"ICD-10: H40.1
MeSH: C564234 C567753
OMIM: 137750 137760 609887 613100","PMID:21655191
  AUTHORS   Carbone MA, Chen Y, Hughes GA, Weinreb RN, Zabriskie NA, Zhang K, Anholt RR
  TITLE     Genes of the unfolded protein response pathway harbor risk alleles for primary open angle glaucoma.
  JOURNAL   PLoS One 6:e20649 (2011)
DOI:10.1371/journal.pone.0020649

PMID:16332362
  AUTHORS   Fan BJ, Wang DY, Lam DS, Pang CP
  TITLE     Gene mapping for primary open angle glaucoma.
  JOURNAL   Clin Biochem 39:249-58 (2006)
DOI:10.1016/j.clinbiochem.2005.11.001

PMID:21730848
  AUTHORS   Khan AO
  TITLE     Genetics of primary glaucoma.
  JOURNAL   Curr Opin Ophthalmol 22:347-55 (2011)
DOI:10.1097/ICU.0b013e32834922d2

PMID:20431268
  AUTHORS   Fuse N
  TITLE     Genetic bases for glaucoma.
  JOURNAL   Tohoku J Exp Med 221:1-10 (2010)
DOI:10.1620/tjem.221.1

PMID:20174677
  AUTHORS   Freed EF, Bleichert F, Dutca LM, Baserga SJ
  TITLE     When ribosomes go bad: diseases of ribosome biogenesis.
  JOURNAL   Mol Biosyst 6:481-93 (2010)
DOI:10.1039/b919670f",MeSH,C564234,C567753,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01344,"Nijmegen syndrome, including:
Nijmegen breakage syndrome (NBS);
Nijmegen breakage syndrome-like disorder (NBSLD)","Nijmegen Breakage syndrome (NBS) is a rare autosomal recessive disorder characterized by microcephaly, growth retardation, immunodeficiency, radiosensitivity, and cancer predisposition. Due to a founder mutation in the NBN gene, the disease is encountered most frequently among Slavic populations. Recently, a disease due to RAD50 deficiency has been reported. The patient displayed symptoms similar to NBS, microcephaly, mental retardation, bird-like face, and short stature. The MRE11/RAD50/NBN (MRN) complex plays a key role in recognizing and signaling DNA double-strand breaks.",Congenital disorder of DNA repair systems,"(NBS) NBN (Nibrin) [HSA:4683] [KO:K10867]
(NBSLD) RAD50 [HSA:10111] [KO:K10866]",,,,,,,"ICD-10: D82.8
MeSH: D049932 C567767
OMIM: 251260 613078","PMID:22373003
  AUTHORS   Chrzanowska KH, Gregorek H, Dembowska-Baginska B, Kalina MA, Digweed M
  TITLE     Nijmegen breakage syndrome (NBS).
  JOURNAL   Orphanet J Rare Dis 7:13 (2012)
DOI:10.1186/1750-1172-7-13

PMID:19409520
  AUTHORS   Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF, Schindler D, Dork T
  TITLE     Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.
  JOURNAL   Am J Hum Genet 84:605-16 (2009)
DOI:10.1016/j.ajhg.2009.04.010",MeSH,D049932,C567767,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01395,"POLG related disorders, including:
Alpers syndrome [DS:H01389];
Childhood myocerebrohepatopathy spectrum (MCHS);
The ataxia neuropathy spectrum (ANS)  [DS:H01384];
Myoclonic epilepsy myopathy sensory ataxia (MEMSA);
Progressive external ophthalmoplegia [DS:H01118]","Except for autosomal dominant progressive external ophthalmoplegia, all of other POLG-related disorders are inherited in an autosomal recessive manner. The POLG-related disorders comprise a continuous spectrum of overlapping symptoms and signs; and range from a rapidly fatal infantile cerebrohepatic disease to a progressive external ophthalmoplegia (PEO) that may not present until the sixth decade of life. The POLG gene is comprised of a polymerase domain, linker region domain and exonuclease domain. Mutations in the polymerase domain tend to result in reduced synthesis of mtDNA. Exonuclease domain mutations result in a high frequency of randomly distributed rare mtDNA point mutations. Mutations within the Linker region can influence the association of POLG with the accessory subunit POLG2.",Inherited metabolic disease; Mitochondrial disease,POLG [HSA:5428] [KO:K02332],,,,,,,"ICD-10: E88.8
MeSH: D002549 C579990 C564395 D017246 C564926
OMIM: 203700 607459 157640 258450","PMID:20558295 (mutations)
  AUTHORS   Cohen BH, Naviaux RK
  TITLE     The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.
  JOURNAL   Methods 51:364-73 (2010)
DOI:10.1016/j.ymeth.2010.05.008

PMID:20301791
  AUTHORS   Cohen BH, Chinnery PF, Copeland WC
  TITLE     POLG-Related Disorders
  JOURNAL   GeneReviews (1993)",MeSH,D002549,C579990,C564395,D017246,C564926,,,,,,,,,,,,,,,,,,,,,,,,,
H01948,"Glycogen storage disease type IX;
Phosphorylase kinase deficiency","Glycogen storage disease type IX (GSD-IX), also known as Phosphorylase kinase deficiency, is a disorder of glycogen metabolism. The liver phosphorylase kinase is a heterotetramer that is composed of four copies each of alpha, beta, gamma, and delta (calmodulin) subunits. In liver, the alpha, beta, and gamma subunits are encoded by the PHKA2 gene, the PHKB gene, and PHKG2 gene respectively. Mutation within these genes has been shown to result in GSD type IX. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. GSD IXd, also known as X-linked muscle glycogenosis, is caused by mutation in the PHKA1 gene, which encodes the alpha subunit of muscle phosphorylase kinase. The typical clinical signs of GSD IXd are exercise intolerance, often combined with cramps, myalgia, weakness or myoglobinuria.",Inherited metabolic disease,"(GSD IXa) PHKA2 [HSA:5256] [KO:K07190]
(GSD IXb) PHKB [HSA:5257] [KO:K07190]
(GSD IXc) PHKG2 [HSA:5261] [KO:K00871]
(GSD IXd) PHKA1 [HSA:5255] [KO:K07190]",,,,"(GSD-IXa, IXb, IXc) Ketotic hypoglycemia
(GSD-IXd) Myoglobinuria",,,"ICD-10: E74.0
MeSH: D006015 C580130 C564485
OMIM: 306000 261750 613027 300559","PMID:17689125
  AUTHORS   Beauchamp NJ, Dalton A, Ramaswami U, Niinikoski H, Mention K, Kenny P, Kolho KL, Raiman J, Walter J, Treacy E, Tanner S, Sharrard M
  TITLE     Glycogen storage disease type IX: High variability in clinical phenotype.
  JOURNAL   Mol Genet Metab 92:88-99 (2007)
DOI:10.1016/j.ymgme.2007.06.007

PMID:24389071
  AUTHORS   Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, Weinstein DA, Lutz R, Boneh A, Kishnani PS
  TITLE     Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
  JOURNAL   Mol Genet Metab 111:309-313 (2014)
DOI:10.1016/j.ymgme.2013.12.008

PMID:8733134 (gene)
  AUTHORS   Burwinkel B, Shin YS, Bakker HD, Deutsch J, Lozano MJ, Maire I, Kilimann MW
  TITLE     Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2).
  JOURNAL   Hum Mol Genet 5:653-8 (1996)
DOI:10.1093/hmg/5.5.653

PMID:9215682 (gene)
  AUTHORS   Burwinkel B, Maichele AJ, Aagenaes O, Bakker HD, Lerner A, Shin YS, Strachan JA, Kilimann MW
  TITLE     Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).
  JOURNAL   Hum Mol Genet 6:1109-15 (1997)
DOI:10.1093/hmg/6.7.1109

PMID:9384616 (gene)
  AUTHORS   Burwinkel B, Shiomi S, Al Zaben A, Kilimann MW
  TITLE     Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis.
  JOURNAL   Hum Mol Genet 7:149-54 (1998)
DOI:10.1093/hmg/7.1.149

PMID:7874115 (gene)
  AUTHORS   Wehner M, Clemens PR, Engel AG, Kilimann MW
  TITLE     Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit.
  JOURNAL   Hum Mol Genet 3:1983-7 (1994)
DOI:10.1093/hmg/3.11.1983",MeSH,D006015,C580130,C564485,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00011,Lymphoplasmacytic lymphoma,"Lymphoplasmacytic lymphoma (LPL)/Waldenstrom's macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL) subtype characterized by small B-lymphocytes, plasmacytoid lymphocytes, and plasma cells, usually involving bone marrow, lymph nodes, and the spleen. WM can be distinguished clinically from LPL on the basis of a detectable monoclonal (IgM) immunoglobulin spike in serum. In the general population, LPL/WM is a very rare disease, accounting for only 1%-2% of all hematologic malignancies, reflected in an incidence rate of 3-4 cases per million people per year. The t(9;14)(p13;q32) is present in near 50% of cases of LPL. This chromosomal translocation involves a junction between 9p13 and the switch micro region of the Ig heavy chain locus on 14q32. The 9p13 breakpoint contains the PAX-5 gene which encodes a B-cell specific transcription factor involved in the control of B-cell proliferation and differentiation. The translocation causes the juxtaposition of the PAX-5 gene to the IgH locus in the opposite direction of transcription, resulting in an 11-fold over-expression of PAX-5 mRNA.",Cancer,Pax5-IgH (translocation) [HSA:5079] [KO:K09383 K06856],"  Hepatitis C virus [GN:T40066]
Human immunodeficiency virus 1 (HIV-1) [GN:T40001]",,"Azathioprine [DG:DG00743]
Ethylene oxide [CPD:C06548]
2,3,7,8-Tetrachlorodibenzo-para-dioxin [CPD:C07557]","Beta-2-microglobulin (B2M) [HSA:567] [KO:K08055]
CD20 [HSA:931] [KO:K06466]
Immunoglobulins","Cyclophosphamide [DG:DG00675]
Vincristine [DG:DG00690]
Doxorubicin [DG:DG00696]
Prednisone (CHOP) [DG:DG00094]
Rituximab [DR:D02994]","ICD-O: 9671/3, Tumor type: Lymphoplasmacytic lymphoma
Although the carcinogens listed and infection with HIV-1 are risk factors for non-Hodgkin lymphoma in general, the strength of association with different histological tumor types is not well understood.",ICD-10: C83.8 C88.0,"PMID:19362964 (description)
  AUTHORS   Kristinsson SY, Koshiol J, Goldin LR, Bjorkholm M, Turesson I, Gridley G, McMaster ML, Landgren O
  TITLE     Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenstrom's macroglobulinemia.
  JOURNAL   Clin Lymphoma Myeloma 9:23-6 (2009)
DOI:10.3816/CLM.2009.n.004

PMID:18499469 (description, gene, carcinogen)
  AUTHORS   Vitolo U, Ferreri AJ, Montoto S
  TITLE     Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
  JOURNAL   Crit Rev Oncol Hematol 67:172-85 (2008)
DOI:10.1016/j.critrevonc.2008.03.008

PMID:11232108 (gene, tumor type)
  AUTHORS   Arber DA.
  TITLE     Molecular diagnostic approach to non-Hodgkin's lymphoma.
  JOURNAL   J Mol Diagn 2:178-90 (2000)
DOI:10.1016/S1525-1578(10)60636-8

PMID:15803153 (gene)
  AUTHORS   Kuppers R.
  TITLE     Mechanisms of B-cell lymphoma pathogenesis.
  JOURNAL   Nat Rev Cancer 5:251-62 (2005)
DOI:10.1038/nrc1589

PMID:10350329
  AUTHORS   Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R
  TITLE     Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
  JOURNAL   Leuk Lymphoma 34:25-33 (1999)
DOI:10.3109/10428199909083377

PMID:10784387
  AUTHORS   Ohno H, Ueda C, Akasaka T
  TITLE     The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
  JOURNAL   Leuk Lymphoma 36:435-45 (2000)
DOI:10.3109/10428190009148390

PMID:16062089 (carcinogen)
  AUTHORS   Patel P, Moazzam N, Potti A, Mehdi SA.
  TITLE     Azathioprine induced hodgkin lymphoma: a case report and review of literature.
  JOURNAL   Am J Clin Oncol 28:427-8 (2005)

PMID:12464351 (carcinogen)
  AUTHORS   Kolman A, Chovanec M, Osterman-Golkar S.
  TITLE     Genotoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: update review (1990-2001).
  JOURNAL   Mutat Res 512:173-94 (2002)
DOI:10.1016/S1383-5742(02)00067-4

PMID:15760280 (carcinogen)
  AUTHORS   Schottenfeld D, Beebe-Dimmer JL.
  TITLE     Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions.
  JOURNAL   Annu Rev Public Health 26:37-60 (2005)
DOI:10.1146/annurev.publhealth.26.021304.144402

PMID:17530489 (carcinogen)
  AUTHORS   Abnet CC.
  TITLE     Carcinogenic food contaminants.
  JOURNAL   Cancer Invest 25:189-96 (2007)
DOI:10.1080/07357900701208733

(drug)
  AUTHORS   Papadakis MA and McPhee SJ |(ed)
  TITLE     Current Medical Diagnosis & Treatment 2015, Fifty-Fourth Edition
  JOURNAL   McGraw Hill Education",ICD-10,C83.8,C88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00599,"46,XX disorders of sex development (Disorders related to androgen excess), including:
Congenital adrenal hyperplasias;
Glucocorticoid resistance;
Aromatase deficiency","46,XX disorder of sex development (46,XX DSD) is a condition in which the individual shows ambiguous genitalia with a 46,XX karyotype. Excess androgen during the critical period of sexual differentiation can lead to 46,XX fetus virilization. Congenital adrenal hyperplasias (CAH) and other genetic disorders in fetuses impair steroidogenesis, resulting in shunting of cortisol precursors to androgen synthesis and accumulation of the product. Masculinization of female fetuses is described in mothers harboring androgen-producing tumors. Luteoma of pregnancy is the most common source of these maternal-derived androgens.",Reproductive system disease,"(Fetal) CYP21A2 [HSA:1589] [KO:K00513]
(Fetal) CYP11B1 [HSA:1584] [KO:K00497]
(Fetal) HSD3B2 [HSA:3284] [KO:K00070]
(Fetal) GR [HSA:2908] [KO:K05771]
(Fetal, Fetoplacental) POR [HSA:5447] [KO:K00327]
(Fetoplacental) CYP19A1 [HSA:1588] [KO:K07434]",,"Maternal luteoma of pregnancy
Maternal adrenal adenoma
Maternal Krukenberg tumor
Maternal adrenal cortical carcinoma
Danazol [DR:D00289]
Progestins [DG:DG00458]",,,,,"ICD-10: E25.0 E25.8
MeSH: D058489 D000312 C537436
OMIM: 201910 202010 201810 613571 613546","PMID:18279784 (description, gene)
  AUTHORS   Hughes IA
  TITLE     Disorders of sex development: a new definition and classification.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 22:119-34 (2008)
DOI:10.1016/j.beem.2007.11.001

PMID:20688619 (description, gene, env_factor)
  AUTHORS   Kousta E, Papathanasiou A, Skordis N
  TITLE     Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals.
  JOURNAL   Hormones (Athens) 9:218-131 (2010)

PMID:20541149 (description, gene, env_factor)
  AUTHORS   Auchus RJ, Chang AY
  TITLE     46,XX DSD: the masculinised female.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 24:219-42 (2010)
DOI:10.1016/j.beem.2009.11.001",MeSH,D058489,D000312,C537436,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00608,"46,XY disorders of sex development (Disorders in androgen synthesis or action), including:
Congenital adrenal hyperplasias;
Leydig cell hypoplasia;
Androgen insensitivity syndrome (AIS)","46,XY disorders of sex development (46,XY DSD) can be endocrine-related. Several enzymatic defects that result in insufficient production of testosterone have been reported. These androgen defects and impaired differentiation of Leydig cell, which secretes testosterone, can lead to ambiguous or completely feminized genitalia in 46,XY individuals. Furthermore, defective androgen action due to androgen receptor defects also cause feminization of 46,XY fetuses although they have normal levels of testosterone.",Reproductive system disease,"(AIS) AR [HSA:367] [KO:K08557]
(Leydig) LHCGR [HSA:3973] [KO:K04248]
STAR [HSA:6770] [KO:K16931]
CYP11A1 [HSA:1583] [KO:K00498]
CYP17 [HSA:1586] [KO:K00512]
HSD3B2 [HSA:3284] [KO:K00070]
HSD17B3 [HSA:3293] [KO:K10207]
POR [HSA:5447] [KO:K00327]
SRD5A2 [HSA:6716] [KO:K12344]
DHCR7 [HSA:1717] [KO:K00213]",,,,,,,"ICD-10: E25.0 E34.5 Q56.1 Q87.1
MeSH: D058490 D000312 C562567 D013734
OMIM: 300068 312300 201710 238320 202110 201810 264300 201750 264600 270400 613743","PMID:18279784 (description, gene)
  AUTHORS   Hughes IA
  TITLE     Disorders of sex development: a new definition and classification.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 22:119-34 (2008)
DOI:10.1016/j.beem.2007.11.001

PMID:18811725 (description, gene)
  AUTHORS   Mendonca BB, Domenice S, Arnhold IJ, Costa EM
  TITLE     46,XY disorders of sex development (DSD).
  JOURNAL   Clin Endocrinol (Oxf) 70:173-87 (2009)
DOI:10.1111/j.1365-2265.2008.03392.x

PMID:20301714 (description, gene)
  AUTHORS   Ostrer H
  TITLE     46,XY Disorder of Sex Development and 46,XY Complete Gonadal Dysgenesis
  JOURNAL   GeneReviews (1993)

PMID:21397195 (description, gene)
  AUTHORS   Rey RA, Grinspon RP
  TITLE     Normal male sexual differentiation and aetiology of disorders of sex development.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 25:221-38 (2011)
DOI:10.1016/j.beem.2010.08.013

PMID:16327292 (description)
  AUTHORS   Frimberger D, Gearhart JP
  TITLE     Ambiguous genitalia and intersex.
  JOURNAL   Urol Int 75:291-7 (2005)
DOI:10.1159/000089160",MeSH,D058490,D000312,C562567,D013734,,,,,,,,,,,,,,,,,,,,,,,,,,
H00323,"Spotted fever;
Tick-borne rickettsioses","Tick-borne rickettsioses are caused by gram-negative obligate intracellular bacteria belonging to the spotted fever group (SFG) of the genus Rickettsia within the family Rickettsiaceae in the order Rickettsiales. The diseases present with high fever, a inoculation eschar, and a maculopapular rash.",Infectious disease,,"  Rickettsia rickettsii [GN:rri] (Rocky Mountain spotted fever)
Rickettsia conorii [GN:rco] (African tick typhus / Boutonneuse fever)
Rickettsia sibirica (North Asian tick fever / Siberian tick typhus)
Rickettsia massiliae [GN:rms]
Rickettsia africae [GN:raf]
Rickettsia japonica [GN:rja] (Japanese spotted fever)
Rickettsia heilongjiangensis [GN:rhe] (Far-Eastern spotted fever)",,,"ompA (PCR detection) [KO:K03162]
gltA(PCR detection) [rrj:RrIowa_1533 rri:A1G_07170] [KO:K01647]","Tetracyclines [DG:DG01197]
Doxycycline [DG:DG00008]
Chloramphenicol [DG:DG00399]
Josamycin [DG:DG00604]",Vectors: Rhipicephalus sanguineus (brown dog tick) for Rickettsia conorii,"ICD-10: A77
MeSH: D012373 D001907
MedlinePlus: 000654","PMID:16223955 (marker, drug)
  AUTHORS   Parola P, Paddock CD, Raoult D
  TITLE     Tick-borne rickettsioses around the world: emerging diseases challenging old concepts.
  JOURNAL   Clin Microbiol Rev 18:719-56 (2005)
DOI:10.1128/CMR.18.4.719-756.2005

PMID:19358804 (env_factor, vector)
  AUTHORS   Socolovschi C, Mediannikov O, Raoult D, Parola P
  TITLE     The relationship between spotted fever group Rickettsiae and ixodid ticks.
  JOURNAL   Vet Res 40:34 (2009)
DOI:10.1051/vetres/2009017

PMID:15225980 (description)
  AUTHORS   Parola P
  TITLE     Tick-borne rickettsial diseases: emerging risks in Europe.
  JOURNAL   Comp Immunol Microbiol Infect Dis 27:297-304 (2004)
DOI:10.1016/j.cimid.2004.03.006

PMID:18755389 (description)
  AUTHORS   Cazorla C, Socolovschi C, Jensenius M, Parola P
  TITLE     Tick-borne diseases: tick-borne spotted fever rickettsioses in Africa.
  JOURNAL   Infect Dis Clin North Am 22:531-44, ix-x (2008)
DOI:10.1016/j.idc.2008.03.009",MeSH,D012373,D001907,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00367,"Infectious mononucleosis;
Epstein-Barr virus (EBV) infection","Epstein-Barr virus (EBV) is a common gammaherpesvirus whose initial infection manifests as infectious mononucleosis that is defined as a clinical triad of fever, pharyngitis, and adenopathy. EBV establishes a life-long asymptomatic infection in B cells and can contribute to oncogenesis including Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin lymphoma, and post-transplant B cell lymphomas.",Infectious disease,,  Human herpesvirus 4 (Epstein-Barr virus) [GN:T40079],,,,,,"ICD-10: B27.0
MeSH: D020031 D002051 D007244
MedlinePlus: 000591","PMID:8380053
  AUTHORS   Straus SE, Cohen JI, Tosato G, Meier J
  TITLE     NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management.
  JOURNAL   Ann Intern Med 118:45-58 (1993)
DOI:10.7326/0003-4819-118-1-199301010-00009",MeSH,D020031,D002051,D007244,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00403,"Disorders of nucleotide excision repair, including:
Xeroderma pigmentosum (XP) [DS:H01428];
Cockayne syndrome (CS) [DS:H00076];
UV-sensitive syndrome (UVS);
Trichothiodystrophy (TTD);
Cerebro-oculo-facio-skeletal syndrome (COFS);
XFE progeroid syndrome","Mutations in genes on the nucleotide excision repair pathway are associated with diseases, such as xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). XP is caused by mutations in XPA, ERCC3/XPB, XPC, ERCC2/XPD, DDB2/XPE, ERCC4/XPF, ERCC5/XPG and POLH. XP is classified into eight genetic complementation groups by the present. In this inside, 7groups from the XP-A group to the G group show the abnormality in NER. The symptoms of XP begin in early life. Severe sunburn and blistering occurs in a half of patients, and all show early extensive freckling. Cancer incidence for individuals with XP under 20 years of age is 2,000 times as high as incidence in the general population. Neurodegeneration can be correlated with mutations in specific XP genes (XPA, ERCC3, ERCC2 and ERCC5). Some patients of XP- A develop neurologic symptoms or a more severe clinical phenotype known as de Sanctis-Cacchione syndrome, associated with mutations in the ERCC6 gene. CS is caused by mutations in ERCC8/CSA, ERCC6/CSB. CS is predominantly a developmental and neurological disorder. It results in a severely reduced lifespan but is not linked to an increased incidence of cancer. The three of the XP genes (ERCC2, ERCC3, and ERCC5) are also found to be mutated XP/CS patients (exhibiting both XP and Cockayne's symptoms). ERCC6 is a cause of UV-sensitive syndrome (UVS) which is characterized by photosensitivity and mild freckling but without neurological abnormalities or skin tumors. TTD is a premature aging syndrome, with the hallmark feature of brittle hair and nails, ichthyosis, and progressive mental and physical retardation. Within photo-sensitive TTD, three TFIIH coding genes (ERCC2, ERCC3, and TTDA/GTF2H5) are implicated. Cerebro-oculo-facio-skeletal (COFS) syndrome is rare autosomal recessive disorder with microcephaly, severe mental retardation, and death in childhood. COFS can result from mutations in ERCC1, ERCC2, ERCC5 and ERCC6.",Congenital disorder of DNA repair systems,"(XPA) XPA; xeroderma pigmentosum, complementation group A [HSA:7507] [KO:K10847]
(XPB, XP/CS, TTD) ERCC3; DNA excision repair protein ERCC-3 [HSA:2071] [KO:K10843]
(XPC) XPC; xeroderma pigmentosum, complementation group C [HSA:7508] [KO:K10838]
(XPD, XP/CS, TTD) ERCC2; DNA excision repair protein ERCC-2 [HSA:2068] [KO:K10844]
(XPE) DDB2; damage-specific DNA binding protein 2 [HSA:1643] [KO:K10140]
(XPE-2) DDB1; damage-specific DNA binding protein 1 [HSA:1642] [KO:K10610]
(XPF) ERCC4; DNA excision repair protein ERCC-4 [HSA:2072] [KO:K10848]
(XPG, XP/CS, COFS3) ERCC5; DNA excision repair protein ERCC-5 [HSA:2073] [KO:K10846]
(XPV) POLH; DNA polymerase eta [HSA:5429] [KO:K03509]
(CSA) ERCC8; DNA excision repair protein ERCC-8 [HSA:1161] [KO:K10570]
(CSB, DSC, UVS, COFS1) ERCC6; DNA excision repair protein ERCC-6 [HSA:2074] [KO:K10841]
(TTD) GTF2H5; general transcription factor IIH, polypeptide 5 [HSA:404672] [KO:K10845]
(COFS4) ERCC1; DNA excision repair protein ERCC-1 [HSA:2067] [KO:K10849]",,,,,,,"ICD-10: Q82.1 Q87.1
MeSH: D014983 D003057 C563466 D054463
OMIM: 278700 610651 278720 278730 278740 278760 278780 278750 216400 133540 278800 600630 601675 214150 610756 610758 610965","PMID:19809470
  AUTHORS   Cleaver JE, Lam ET, Revet I
  TITLE     Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.
  JOURNAL   Nat Rev Genet 10:756-68 (2009)
DOI:10.1038/nrg2663

PMID:11710928 (XP and TTD)
  AUTHORS   Queille S, Drougard C, Sarasin A, Daya-Grosjean L
  TITLE     Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
  JOURNAL   J Invest Dermatol 117:1162-70 (2001)
DOI:10.1046/j.0022-202x.2001.01533.x

PMID:11443545 (COFS)
  AUTHORS   Graham JM Jr, Anyane-Yeboa K, Raams A, Appeldoorn E, Kleijer WJ, Garritsen VH, Busch D, Edersheim TG, Jaspers NG
  TITLE     Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.
  JOURNAL   Am J Hum Genet 69:291-300 (2001)
DOI:10.1086/321295

PMID:15220921 (TTD)
  AUTHORS   Giglia-Mari G, Coin F, Ranish JA, Hoogstraten D, Theil A, Wijgers N, Jaspers NG, Raams A, Argentini M, van der Spek PJ, Botta E, Stefanini M, Egly JM, Aebersold R, Hoeijmakers JH, Vermeulen W
  TITLE     A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A.
  JOURNAL   Nat Genet 36:714-9 (2004)
DOI:10.1038/ng1387

PMID:18339586 (TTD and CS)
  AUTHORS   Brooks PJ, Cheng TF, Cooper L
  TITLE     Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?
  JOURNAL   DNA Repair (Amst) 7:834-48 (2008)
DOI:10.1016/j.dnarep.2008.01.017

PMID:20221251 (XFE progeroid syndrome)
  AUTHORS   Ahmad A, Enzlin JH, Bhagwat NR, Wijgers N, Raams A, Appledoorn E, Theil AF, J Hoeijmakers JH, Vermeulen W, J Jaspers NG, Scharer OD, Niedernhofer LJ
  TITLE     Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
  JOURNAL   PLoS Genet 6:e1000871 (2010)
DOI:10.1371/journal.pgen.1000871",MeSH,D014983,D003057,C563466,D054463,,,,,,,,,,,,,,,,,,,,,,,,,,
H00383,"Arthropod-borne viral fevers, including:
Oropouche fever;
Sandfly fever;
Colorado tick fever","Arthropod-borne viral fevers are emerging zoonotic viral diseases that cause febrile illness with abrupt onset of fever, headache, myalgia, anorexia, and photophobia.",Infectious disease,,"  Oropouche virus [GN:T40062] (Oropouche fever)
Colorado tick fever virus [GN:T40063] (Colorado tick fever)
Sandfly fever Naples virus [GN:T40064] (Sandfly fever)
Apoi virus [GN:T40065]",,,,,,"ICD-10: A93
MeSH: D010217 D003121
MedlinePlus: 000675","PMID:9230800 (description)
  AUTHORS   Watts DM, Lavera V, Callahan J, Rossi C, Oberste MS, Roehrig JT, Cropp CB, Karabatsos N, Smith JF, Gubler DJ, Wooster MT, Nelson WM, Hayes CG
  TITLE     Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
  JOURNAL   Am J Trop Med Hyg 56:661-7 (1997)
DOI:10.4269/ajtmh.1997.56.661

PMID:7840443 (description)
  AUTHORS   Tesh RB
  TITLE     The emerging epidemiology of Venezuelan hemorrhagic fever and Oropouche fever in tropical South America.
  JOURNAL   Ann N Y Acad Sci 740:129-37 (1994)
DOI:10.1111/j.1749-6632.1994.tb19863.x

PMID:19485115 (description)
  AUTHORS   Brett-Major DM, Claborn DM
  TITLE     Sand fly fever: what have we learned in one hundred years?
  JOURNAL   Mil Med 174:426-31 (2009)

PMID:14501989 (description)
  AUTHORS   Dionisio D, Esperti F, Vivarelli A, Valassina M
  TITLE     Epidemiological, clinical and laboratory aspects of sandfly fever.
  JOURNAL   Curr Opin Infect Dis 16:383-8 (2003)
DOI:10.1097/01.qco.0000092808.64370.fa

PMID:11982311 (description)
  AUTHORS   Klasco R
  TITLE     Colorado tick fever.
  JOURNAL   Med Clin North Am 86:435-40, ix (2002)",MeSH,D010217,D003121,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00458,"Craniosynostosis, including:
Pfeiffer syndrome;
Apert syndrome;
Crouzon syndrome;
Jackson-Weiss syndrome;
Beare-Stevenson syndrome;
Muenke craniosynostosis;
Saethre-Chotzen syndrome;
Craniosynostosis Boston type;
Antley-Bixler syndrome;
Carpenter syndrome;
Craniofrontonasal dysplasia;
Noonan syndrome;
Baller-Gerold syndrome",Craniosynostosis (CRS) is the premature fusion of the cranial sutures and secondary distortion of skull shape. The genes most frequently mutated are FGFRs.,Skeletal dysplasia; Developmental disorder,"(Pfeiffer) FGFR1 [HSA:2260] [KO:K04362]
(Apert, Pfeiffer, Crouzon, Jackson-Weiss, Beare-Stevenson, Antley-Bixler) FGFR2 [HSA:2263] [KO:K05093]
(Muenke) FGFR3 [HSA:2261] [KO:K05094]
(Saethre-Chotzen, CRS1) TWIST1 [HSA:7291] [KO:K09069]
(Antley-Bixler) POR [HSA:5447] [KO:K00327]
(Carpenter) RAB23 [HSA:51715] [KO:K06234]
(Craniofrontonasal) EFNB1 [HSA:1947] [KO:K05463]
(Noonan) KRAS [HSA:3845] [KO:K07827]
(Baller-Gerold) RECQL4 [HSA:9401] [KO:K10730]
(CRS2) MSX2 [HSA:4488] [KO:K09341]
(CRS3) TCF12 [HSA:6938] [KO:K15603]
(CRS4) ERF [HSA:2077] [KO:K09434]
(CRS6) ZIC1 [HSA:7545] [KO:K09224]",,,,,,"See also H01753  Antley-Bixler syndrome, H01754  Crouzon syndrome, H01755  Apert syndrome, H01756  Pfeiffer syndrome, and  H00523  Noonan syndrome.","ICD-10: Q75 Q87
MeSH: D000168 D003398 D054882
OMIM: 101600 101200 123500 123150 123790 602849 612247 101400 604757 207410 201750 201000 304110 609942 218600 123100 123150 207410 615314 600775 616602","PMID:21248745
  AUTHORS   Johnson D, Wilkie AO
  TITLE     Craniosynostosis.
  JOURNAL   Eur J Hum Genet 19:369-76 (2011)
DOI:10.1038/ejhg.2010.235

PMID:15828709
  AUTHORS   Aleck K
  TITLE     Craniosynostosis syndromes in the genomic era.
  JOURNAL   Semin Pediatr Neurol 11:256-61 (2004)

PMID:23438589 (gene)
  AUTHORS   Fitzpatrick DR
  TITLE     Filling in the gaps in cranial suture biology.
  JOURNAL   Nat Genet 45:231-2 (2013)
DOI:10.1038/ng.2557

PMID:26340333 (gene)
  AUTHORS   Twigg SR, Forecki J, Goos JA, Richardson IC, Hoogeboom AJ, van den Ouweland AM, Swagemakers SM, Lequin MH, Van Antwerp D, McGowan SJ, Westbury I, Miller KA, Wall SA, van der Spek PJ, Mathijssen IM, Pauws E, Merzdorf CS, Wilkie AO
  TITLE     Gain-of-Function Mutations in ZIC1 Are Associated with Coronal Craniosynostosis and Learning Disability.
  JOURNAL   Am J Hum Genet 97:378-88 (2015)
DOI:10.1016/j.ajhg.2015.07.007",MeSH,D000168,D003398,D054882,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01604,Polymyositis and dermatomyositis (PM/DM),"Polymyositis (PM) and dermatomyositis (DM) are the two major forms of inflammatory muscle diseases. PM and DM, along with sporadic inclusion-body myositis (sIBM), belong to the heterogeneous group of the idiopathic inflammatory myopathies (IIMs), which are characterized by weakness and chronic inflammation of skeletal muscle. PM and DM differ in their clinical features, histopathology, response to treatment, and prognosis. Although their clinical pictures differ, they both present with symmetrical, proximal muscle weakness. PM is a term that was used traditionally to denote all IIMs that were not DM or sIBM, but it is now a controversial entity with questionable specificity. Traditionally, PM is described as presenting with weakness of the proximal muscles that evolves over weeks to months and affects adults, but rarely children. DM typically includes subacute progressive proximal muscle weakness and a skin rash. The disease mechanisms of PM and DM that cause muscle damage and dysfunction are not fully understood. However, because of the association with other autoimmune diseases, the presence of autoantibodies, and response to immunosuppressive medication, they are believed to be autoimmune in origin. Recent studies have highlighted the importance of the innate immune system and non-immune mechanisms and described novel adaptive immune-based pathways in the pathogenesis of PM and DM. Treatment of inflammatory myopathies is generally empirical. Corticosteroids still remain the agents of choice for the initial treatment, but their use is limited by the high frequency of side effects. In addition, as a substantial number of patients do not respond to glucocorticoids alone, additional agents such as immunosuppressants, immunomodulators, and more recently, biologics are commonly used in clinical practice.",Musculoskeletal disease; Nervous system disease; Skin and connective tissue disease,,,,,,"Hydrocortisone [DR:D00088]
Betamethasone [DR:D00244]
Human normal immunoglobulin [DR:D08783]
Eculizumab [DR:D03940]","Autoantigen:
HARS [HSA:3035] [KO:K01892]
TARS [HSA:6897] [KO:K01868]
AARS [HSA:16] [KO:K01872]
GARS [HSA:2617] [KO:K01880]
IARS [HSA:3376] [KO:K01870]
NARS [HSA:4677] [KO:K01893]
FARSA [HSA:2193] [KO:K01889]
FARSB [HSA:10056] [KO:K01890]
IFIH1 [HSA:64135] [KO:K12647]
TRIM33 [HSA:51592] [KO:K08883]
MORC3 [HSA:23515]
SAE1 [HSA:10055] [KO:K10684]
SAE2 [HSA:10054] [KO:K10685]","ICD-10: M33
MeSH: D017285 D003882","PMID:26299472 (description)
  AUTHORS   Vermaak E, Tansley SL, McHugh NJ
  TITLE     The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
  JOURNAL   Clin Rheumatol 34:2089-95 (2015)
DOI:10.1007/s10067-015-3059-y

PMID:26175404 (description)
  AUTHORS   Lahouti AH, Christopher-Stine L
  TITLE     Polymyositis and dermatomyositis: novel insights into the pathogenesis and potential therapeutic targets.
  JOURNAL   Discov Med 19:463-70 (2015)

PMID:23758833 (autoantigen, description)
  AUTHORS   Rayavarapu S, Coley W, Kinder TB, Nagaraju K
  TITLE     Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.
  JOURNAL   Skelet Muscle 3:13 (2013)
DOI:10.1186/2044-5040-3-13

PMID:25641317 (description)
  AUTHORS   Findlay AR, Goyal NA, Mozaffar T
  TITLE     An overview of polymyositis and dermatomyositis.
  JOURNAL   Muscle Nerve 51:638-56 (2015)
DOI:10.1002/mus.24566",MeSH,D017285,D003882,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00379,"Mosquito-borne viral encephalitis, including:
Japanese encephalitis [DS:H01533];
Western equine encephalitis [DS:H01534];
Eastern equine encephalitis [DS:H01535];
Australian encephalitis [DS:H01536];
California encephalitis [DS:H01537]","Mosquito-borne viral encephalitis are infections of the central nervous system with brain involvement that are caused by several members of arboviruses. Japanese encephalitis virus, maintained in pigs, causes severe encephalitis in Asia with an estimated 50 000 cases each year. Its case fatality rate reaches 30%. Other viruses whose reservoirs are mainly birds cause encephalitis only a very low proportion of infected people and there is high proportion of asymptomatic infections.",Infectious disease,,"  Japanese encephalitis virus [GN:T40052] (Japanese encephalitis)
Western equine encephalitis virus [GN:T40053] (Western equine encephalitis)
Eastern equine encephalitis virus [GN:T40054] (Eastern equine encephalitis)
Murray Valley encephalitis virus [GN:T40055] (Murray Valley encephalitis / Australian encephalitis)
La Crosse virus [GN:T40056] (La Crosse encephalitis / California encephalitis)",,,,Japanese encephalitis vaccine [DR:D05313],Vector: Culex spp. (mosquito),"ICD-10: A83
MeSH: D004670 D004672 D020242 D020241","PMID:21802875 (description, comment)
  AUTHORS   Stahl JP, Mailles A, Dacheux L, Morand P
  TITLE     Epidemiology of viral encephalitis in 2011.
  JOURNAL   Med Mal Infect 41:453-64 (2011)
DOI:10.1016/j.medmal.2011.05.015

PMID:22084515 (description)
  AUTHORS   Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS
  TITLE     Estimated global incidence of Japanese encephalitis: a systematic review.
  JOURNAL   Bull World Health Organ 89:766-74, 774A-774E (2011)
DOI:10.2471/BLT.10.085233

PMID:22432670 (description)
  AUTHORS   Knox J, Cowan RU, Doyle JS, Ligtermoet MK, Archer JS, Burrow JN, Tong SY, Currie BJ, Mackenzie JS, Smith DW, Catton M, Moran RJ, Aboltins CA, Richards JS
  TITLE     Murray Valley encephalitis: a review of clinical features, diagnosis and treatment.
  JOURNAL   Med J Aust 196:322-6 (2012)
DOI:10.5694/mja11.11026",MeSH,D004670,D004672,D020242,D020241,,,,,,,,,,,,,,,,,,,,,,,,,,
H00382,"Mosquito-borne viral fevers, including:
Chikungunya fever;
O'nyong-nyong fever;
Venezuelan equine fever;
West Nile fever;
Rift Valley fever","Mosquito-borne viral fevers are a group of disorders caused by several members of arboviruses, most of them being maintained in an enzootic cycle between mosquitoes and birds. Humans are infected incidentally when bitten by mosquitoes. These viruses infect the central nervous system and can cause severe disease.",Infectious disease,,"  Chikungunya virus [GN:T40026] (Chikungunya fever)
O'nyong-nyong virus [GN:T40027] (O'nyong-nyong fever)
Venezuelan equine encephalitis virus [GN:T40028] (Venezuelan equine fever)
West Nile virus [GN:T40029] (West Nile fever)
Rift Valley fever virus [GN:T40030] (Rift Valley fever)
Bunyamwera virus [GN:T40031] (Bunyamwera virus fever)
Mayaro virus [GN:T40032] (Mayaro fever)",,,,,,"ICD-10: A92
MeSH: C535923 D004685 D014901 D012295
MedlinePlus: 007186","PMID:10436876 (description)
  AUTHORS   Lundstrom JO
  TITLE     Mosquito-borne viruses in western Europe: a review.
  JOURNAL   J Vector Ecol 24:1-39 (1999)

PMID:19857523 (description)
  AUTHORS   Weaver SC, Reisen WK
  TITLE     Present and future arboviral threats.
  JOURNAL   Antiviral Res 85:328-45 (2010)
DOI:10.1016/j.antiviral.2009.10.008

PMID:19663604 (description)
  AUTHORS   Staples JE, Breiman RF, Powers AM
  TITLE     Chikungunya fever: an epidemiological review of a re-emerging infectious disease.
  JOURNAL   Clin Infect Dis 49:942-8 (2009)
DOI:10.1086/605496

PMID:14651460 (description)
  AUTHORS   Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC
  TITLE     Venezuelan equine encephalitis.
  JOURNAL   Annu Rev Entomol 49:141-74 (2004)
DOI:10.1146/annurev.ento.49.061802.123422

PMID:21994755 (description)
  AUTHORS   Lim SM, Koraka P, Osterhaus AD, Martina BE
  TITLE     West Nile virus: immunity and pathogenesis.
  JOURNAL   Viruses 3:811-28 (2011)
DOI:10.3390/v3060811

PMID:21450816
  AUTHORS   Boshra H, Lorenzo G, Busquets N, Brun A
  TITLE     Rift valley fever: recent insights into pathogenesis and prevention.
  JOURNAL   J Virol 85:6098-105 (2011)
DOI:10.1128/JVI.02641-10",MeSH,C535923,D004685,D014901,D012295,,,,,,,,,,,,,,,,,,,,,,,,,,
H01414,Hafnia alvei infection,"The genus Hafnia, a member of the family Enterobacteriaceae, is occasionally implicated in both intestinal and extraintestinal infections in humans. Hafnia alvei is a facultative anaerobic opportunistic pathogen that is also known to play a role in microbial food spoilage. This species has been isolated from a wide range of nosocomial infections, including septicaemia, as well as respiratory, enteric, and urinary tract infections.",Infectious disease,,  Hafnia alvei [GN:hav],,,,,,"ICD-10: A41
MeSH: D018805 D004756","PMID:25075225 (description)
  AUTHORS   Tan JY, Yin WF, Chan KG
  TITLE     Gene clusters of Hafnia alvei strain FB1 important in survival and pathogenesis: a draft genome perspective.
  JOURNAL   Gut Pathog 6:29 (2014)
DOI:10.1186/1757-4749-6-29

PMID:16418520 (description)
  AUTHORS   Janda JM, Abbott SL
  TITLE     The genus Hafnia: from soup to nuts.
  JOURNAL   Clin Microbiol Rev 19:12-8 (2006)
DOI:10.1128/CMR.19.1.12-28.2006",MeSH,D018805,D004756,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00369,"Exanthema subitum;
Roseolovirus infection;
Roseola;
Pityriasis rosea","Human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) are members of beta-herpesvirus that are prevalent in the human population. Like all herpesviruses, HHV-6 and HHV-7 establish latency in the host following primary infection. Primary infection with HHV-6 can either be asymptomatic, cause roseola with high fever and rash, or be associated with an undifferentiated short febrile illness without rash. Primary infection with HHV-7 is milder and most often asymptomatic, although some cases of roseola-like illness have been linked to it.",Infectious disease,,"  Human herpesvirus 6B [GN:T40075]
Human herpesvirus 7 [GN:T40076]",,,,Patients with active HHV-6 replication and roseola should not be treated with antiherpesviral therapy because the drugs have little antiherpesviral activity against HHV-6 and HHV-7.,,"ICD-10: B08.2
MeSH: D019349 D005077
MedlinePlus: 000968","PMID:21120721 (description)
  AUTHORS   Prober CG
  TITLE     Human herpesvirus 6.
  JOURNAL   Adv Exp Med Biol 697:87-90 (2011)
DOI:10.1007/978-1-4419-7185-2_7

PMID:17802896 (description, env_factor)
  AUTHORS   Caselli E, Di Luca D
  TITLE     Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7.
  JOURNAL   New Microbiol 30:173-87 (2007)

PMID:10698157 (description, env_factor)
  AUTHORS   Kosuge H
  TITLE     HHV-6, 7 and their related diseases.
  JOURNAL   J Dermatol Sci 22:205-12 (2000)
DOI:10.1016/S0923-1811(99)00086-9

PMID:11924827 (description, drug)
  AUTHORS   Blauvelt A
  TITLE     Skin diseases associated with human herpesvirus 6, 7, and 8 infection.
  JOURNAL   J Investig Dermatol Symp Proc 6:197-202 (2001)
DOI:10.1046/j.0022-202x.2001.00040.x",MeSH,D019349,D005077,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01864,Excessive secretion of growth hormone,"Excessive secretion of growth hormone (GH) causes acromegaly (H01483) and pituitary gigantism (H01618). They have the same pathogenetic mechanism, but differ regarding the age of onset. Gigantism occurs much earlier in life when the skeleton still has the potential to grow, a developmental phase now known as prepubertal. Although most cases occur as a result of a sporadic GH-secreting pituitary adenoma, they can occur in a familial setting.",Endocrine disease,"AIP [HSA:9049] [KO:K17767]
GPR101 [HSA:83550] [KO:K08423]",,,,Increased circulating GH and IGF-I levels,,See also H01483 Acromegaly and H01618 Pituitary gigantism.,"ICD-10: E22.0
MeSH: D000172 D005877
OMIM: 102200 300943","PMID:22584702
  AUTHORS   Herder WW
  TITLE     Familial gigantism.
  JOURNAL   Clinics (Sao Paulo) 67 Suppl 1:29-32 (2012)
DOI:10.6061/clinics/2012(Sup01)06

PMID:25470569 (gene)
  AUTHORS   Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenicky P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA
  TITLE     Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
  JOURNAL   N Engl J Med 371:2363-74 (2014)
DOI:10.1056/NEJMoa1408028

PMID:16728643 (gene)
  AUTHORS   Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA
  TITLE     Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
  JOURNAL   Science 312:1228-30 (2006)
DOI:10.1126/science.1126100",MeSH,D000172,D005877,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00607,"46,XY disorders of sex development (Disorders of gonadal development), including:
Gonadal agenesis;
Complete and partial gonadal dysgenesis;
Testis regression;
Ovotesticular DSD","46,XY disorders of sex development (46,XY DSD) caused by impaired gonadal development includes gonadal agenesis, gonadal dysgenesis, testicular regression, and ovotesticular DSD. Absence of testicular determination results in gonadal agenesis/complete dysgenesis characterized by female external and internal genitalia but fail to develop secondary sexual characteristics, whereas incomplete testicular determination cause partial dysgenesis which show ambiguous genitalia. Testicular regression is part of the clinical spectrum of partial 46,XY gonadal dysgenesis. These forms of 46,XY DSD have been associated with mutations in several genes, and chromosome mosaicism is now recognized as one of the cause.",Reproductive system disease,"SRY (inactivating mutation) [HSA:6736] [KO:K09266]
DHH (inactivating mutation) [HSA:50846] [KO:K11990]
SF1 (inactivating mutation) [HSA:2516] [KO:K08560]
WT1 [HSA:7490] [KO:K09234]
WNT4 (duplication) [HSA:54361] [KO:K00408]
ATRX (inactivating mutation) [HSA:546] [KO:K10779]
DAX1 (duplication) [HSA:190] [KO:K08562]
SOX9 (inactivating mutation) [HSA:6662] [KO:K18435]
DMRT1 (deletion) [HSA:1761] [KO:K19488]
CBX2 (inactivating mutation) [HSA:84733] [KO:K11451]
TSPYL1 (inactivating mutation) [HSA:7258] [KO:K11284]
AKR1C2 (inactivating mutation) [HSA:1646] [KO:K00089]
AKR1C4 (inactivating mutation) [HSA:1109] [KO:K00037]
ZFPM2 (inactivating mutation) [HSA:23414] [KO:K17442]
MAP3K1 (inactivating mutation) [HSA:4214] [KO:K04416]",,,,,,,"ICD-10: Q97.3 Q87.8 D56.0
MeSH: D006061 D006059
OMIM: 400044 233420 607080 612965 136680 194080 194072 301040 300018 114290 154230 613080 608800 614279 616067 613762","PMID:18279784 (description, gene)
  AUTHORS   Hughes IA
  TITLE     Disorders of sex development: a new definition and classification.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 22:119-34 (2008)
DOI:10.1016/j.beem.2007.11.001

PMID:18811725 (description, gene)
  AUTHORS   Mendonca BB, Domenice S, Arnhold IJ, Costa EM
  TITLE     46,XY disorders of sex development (DSD).
  JOURNAL   Clin Endocrinol (Oxf) 70:173-87 (2009)
DOI:10.1111/j.1365-2265.2008.03392.x

PMID:20301714 (description, gene)
  AUTHORS   Ostrer H
  TITLE     46,XY Disorder of Sex Development and 46,XY Complete Gonadal Dysgenesis
  JOURNAL   GeneReviews (1993)

PMID:21397195 (description, gene)
  AUTHORS   Rey RA, Grinspon RP
  TITLE     Normal male sexual differentiation and aetiology of disorders of sex development.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 25:221-38 (2011)
DOI:10.1016/j.beem.2010.08.013

PMID:9890065 (description)
  AUTHORS   Berkovitz GD, Seeherunvong T
  TITLE     Abnormalities of gonadal differentiation.
  JOURNAL   Baillieres Clin Endocrinol Metab 12:133-42 (1998)

PMID:16327292 (description)
  AUTHORS   Frimberger D, Gearhart JP
  TITLE     Ambiguous genitalia and intersex.
  JOURNAL   Urol Int 75:291-7 (2005)
DOI:10.1159/000089160

PMID:21802064 (gene)
  AUTHORS   Fluck CE, Meyer-Boni M, Pandey AV, Kempna P, Miller WL, Schoenle EJ, Biason-Lauber A
  TITLE     Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation.
  JOURNAL   Am J Hum Genet 89:201-18 (2011)
DOI:10.1016/j.ajhg.2011.06.009

PMID:24549039 (gene)
  AUTHORS   Bashamboo A, Brauner R, Bignon-Topalovic J, Lortat-Jacob S, Karageorgou V, Lourenco D, Guffanti A, McElreavey K
  TITLE     Mutations in the FOG2/ZFPM2 gene are associated with anomalies of human testis determination.
  JOURNAL   Hum Mol Genet 23:3657-65 (2014)
DOI:10.1093/hmg/ddu074

PMID:28504475 (gene)
  AUTHORS   Granados A, Alaniz VI, Mohnach L, Barseghyan H, Vilain E, Ostrer H, Quint EH, Chen M, Keegan CE
  TITLE     MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature.
  JOURNAL   Am J Med Genet C Semin Med Genet 175:253-259 (2017)
DOI:10.1002/ajmg.c.31559",MeSH,D006061,D006059,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00366,"Varicella;
Chickenpox;
Herpes zoster;
Shingles","Varicella-zoster virus (human herpesvirus 3) is an almost inevitable human pathogen that has a double-stranded linear DNA genome. Primary infection usually causes varicella (chickenpox) in children, after which the virus establishes latency in sensory neurons. Subsequent reactivation causes herpes zoster (shingles) in adults. Infiltration of the viral vesicles with inflammatory cells leads to pustule formation, which is followed by ulceration and encrustation in both diseases.",Infectious disease,,  Human herpesvirus 3 [GN:T40078],,,,"Valacyclovir [DG:DG00647]
Acyclovir [DG:DG00406]
Penciclovir [DG:DG00408]
Famciclovir [DR:D00317]
Ganciclovir [DG:DG00646]
Cidofovir [DR:D00273]
Foscarnet [DG:DG00651]
Freeze-dried live attenuated varicella vaccine [DR:D08777]",,"ICD-10: B01 B02
MeSH: D002644 D006562
MedlinePlus: 001592","PMID:21970493 (description, env_factor)
  AUTHORS   Chisholm C, Lopez L
  TITLE     Cutaneous infections caused by Herpesviridae: a review.
  JOURNAL   Arch Pathol Lab Med 135:1357-62 (2011)
DOI:10.5858/arpa.2010-0156-RS

PMID:16098235 (description, drug)
  AUTHORS   Quinlivan M, Breuer J
  TITLE     Molecular and therapeutic aspects of varicella-zoster virus infection.
  JOURNAL   Expert Rev Mol Med 7:1-24 (2005)
DOI:10.1017/S146239940500966X

PMID:9514102 (description, drug)
  AUTHORS   Harper DR, Gilbert RL, Jeffries DJ
  TITLE     Molecular biology of varicella-zoster virus. A review prepared for the UK Advisory Group on Chickenpox.
  JOURNAL   J Infect 36 Suppl 1:1-10 (1998)
DOI:10.1016/S0163-4453(98)80149-7

PMID:21342215 (description)
  AUTHORS   Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ
  TITLE     Review: The neurobiology of varicella zoster virus infection.
  JOURNAL   Neuropathol Appl Neurobiol 37:441-63 (2011)
DOI:10.1111/j.1365-2990.2011.01167.x",MeSH,D002644,D006562,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01860,Abnormal pituitary gonadotropin secretion,"There are two pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Their general biological roles are the stimulation of testicular and ovarian functions via the regulation of gametogenesis and steroid hormone synthesis in the gonads. Synthesis and release of FSH is triggered by the arrival of gonadotropin-releasing hormone (GnRH) from the hypothalamus. LH is synthesized similarly within the pituitary gland, requiring the same stimulus as FSH, the GnRH from the hypothalamus. Both hypothalamic abnormalities and intrinsic pituitary abnormalities can cause an abnormal FSH/LH response to GnRH. Hypersecretion of gonadotropins are often associated with pituitary adenomas (H01102) and central precocious puberty (H00937). Hyposecretion of gonadotropins (H00255, H01700) in premenopausal women leads to absent menstrual cycles, infertility, vaginal dryness, and loss of some female characteristics. In men, this deficiency leads to impotence, atrophy of the testes, decreased sperm production, infertility, and loss of some male characteristics.",Endocrine disease,,,,,,,"See also H01102 Pituitary adenomas, H00937 Precocious puberty, H00255 Hypogonadotropic hypogonadism, and H01700 Hypopituitarism.","ICD-10: E23.0
MeSH: D006964 D007018
OMIM: 613038","PMID:6267989
  AUTHORS   Pierce JG, Parsons TF
  TITLE     Glycoprotein hormones: structure and function.
  JOURNAL   Annu Rev Biochem 50:465-95 (1981)
DOI:10.1146/annurev.bi.50.070181.002341

PMID:15684903
  AUTHORS   Hanberg A
  TITLE     Common disorders of the pituitary gland: hyposecretion versus hypersecretion.
  JOURNAL   J Infus Nurs 28:36-44 (2005)

PMID:24722134
  AUTHORS   Ceccato F, Occhi G, Regazzo D, Randi ML, Cecchin D, Gardiman MP, Manara R, Lombardi G, Denaro L, Mantero F, Scaroni C
  TITLE     Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review.
  JOURNAL   Hormones (Athens) 13:131-9 (2014)",MeSH,D006964,D007018,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01683,Disorders of antidiuretic hormone (ADH) secretion,"Water imbalance is common among the critically ill. The excessive increases or decreases in body water can be lethal. There are numerous pathologic and iatrogenic causes for water imbalance, the most troublesome being disorders of antidiuretic hormone (ADH) secretion. ADH is also known as arginine vasopressin (AVP). The prime determinant of free water excretion is the regulation of urinary flow by circulating levels of arginine vasopressin (AVP) in plasma. Disorders of water metabolism can be divided into hyperosmolar disorders, in which there is a deficiency of body water relative to body solute, and hypo-osmolar disorders, in which there is an excess of body water relative to body solute. The classical hyperosmolar disorder is diabetes insipidus (DI), and the classical hypo-osmolar disorder is the syndrome of inappropriate antidiuretic hormone secretion (SIADH). DI can result from either inadequate AVP secretion (central or neurogenic DI) or inadequate renal response to AVP (nephrogenic DI). On the other hand, the dilutional hyponatraemia of SIADH develops due to persistent detectable or elevated plasma AVP concentrations.",Endocrine disease,,,,,,,"See also H00253 Neurohypophyseal diabetes insipidus (NPDI), and H01682 Syndrome of inappropriate secretion of antidiuretic hormone (SIADH).","ICD-10: E22 E23
MeSH: D003919 D007177","PMID:14687585
  AUTHORS   Verbalis JG
  TITLE     Disorders of body water homeostasis.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 17:471-503 (2003)
DOI:10.1016/S1521-690X(03)00049-6

PMID:1576035
  AUTHORS   Batcheller J
  TITLE     Disorders of antidiuretic hormone secretion.
  JOURNAL   AACN Clin Issues Crit Care Nurs 3:370-8 (1992)",MeSH,D003919,D007177,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01056,"Toxocariasis, including:
Visceral larva migrans;
Ocular larva migrans;
Covert and common toxocariasis","Human toxocariasis is the disease caused by infection of zoonotic roundworms Toxocara canis and T. cati, whose definitive hosts are dogs and cats, respectively. Humans become infected by ingesting either embryonated eggs from soil or raw vegetables. Toxocara larval migration in the body can cause four clinical syndromes, namely visceral larva migrans, ocular larva migrans, and covert/common toxocariasis. These are frequently associated with fever, abdominal pain, cough, wheeze, and hepatomegaly. Ocular larva migrans can lead to visual loss.",Infectious disease,,"  Toxocara canis
Toxocara cati",,,Toxocara excretory-secretory antigens (ELISA and western blot detection),"Corticosteroids
Diethylcarbamazine [DG:DG01024]",,"ICD-10: B83.0
MeSH: D014120 D007816","PMID:20149289 (description, env_factor)
  AUTHORS   Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU
  TITLE     Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms.
  JOURNAL   Ann Trop Med Parasitol 104:3-23 (2010)
DOI:10.1179/136485910X12607012373957

PMID:11301585 (description, drug, marker)
  AUTHORS   Magnaval JF, Glickman LT, Dorchies P, Morassin B
  TITLE     Highlights of human toxocariasis.
  JOURNAL   Korean J Parasitol 39:1-11 (2001)

PMID:9347221 (description, env_factor)
  AUTHORS   Overgaauw PA
  TITLE     Aspects of Toxocara epidemiology: human toxocarosis.
  JOURNAL   Crit Rev Microbiol 23:215-31 (1997)
DOI:10.3109/10408419709115137

PMID:9347222 (description)
  AUTHORS   Overgaauw PA
  TITLE     Aspects of Toxocara epidemiology: toxocarosis in dogs and cats.
  JOURNAL   Crit Rev Microbiol 23:233-51 (1997)
DOI:10.3109/10408419709115138",MeSH,D014120,D007816,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00311,"Legionellosis;
Legionnaires disease","Legionnaires disease (LD), caused by Gram-negative Legionella spp., can be nosocomial, community acquired or travel related. L. pneumophila is the most common cause of LD. The source of LD is potable water systems that become colonized by the microorganism, transmitted by inhalation of contaminated aerosols and aspiration. Classically, it can cause two different forms of disease in humans: LD, with an incubation period of 2-10 days, which is a multisystem illness that involves the lungs, causing pneumonia, and can cause neurological symptoms, diarrhea and high mortality (up to 50%), and Pontiac fever, with a shorter incubation period of 1-2 days, which is an acute, self-limited, influenza-like disease that does not cause pneumonia. Patients who are at risk for infection include the immunosuppressed, especially those submitted to transplantation (mainly of solid organs), those with chronic lung disease, smokers, and the elderly.",Infectious disease,,"  Legionella pneumophila [GN:lpf lpp lpn lpc lpa lpe]
Legionella longbeachae [GN:llo]
pore-forming toxin [KO:K11022]",,,,,,"ICD-10: A48.1 A48.2
MeSH: D007876 D007877
MedlinePlus: 000616","PMID:12734447
  AUTHORS   Roig J, Sabria M, Pedro-Botet ML
  TITLE     Legionella spp.: community acquired and nosocomial infections.
  JOURNAL   Curr Opin Infect Dis 16:145-51 (2003)
DOI:10.1097/01.aco.0000065081.06965.cf

PMID:20051846
  AUTHORS   Carratala J, Garcia-Vidal C
  TITLE     An update on Legionella.
  JOURNAL   Curr Opin Infect Dis 23:152-7 (2010)
DOI:10.1097/QCO.0b013e328336835b

PMID:19917208
  AUTHORS   Blyth CC, Adams DN, Chen SC
  TITLE     Diagnostic and typing methods for investigating Legionella infection.
  JOURNAL   N S W Public Health Bull 20:157-61 (2009)
DOI:10.1071/NB08062

PMID:19622057 (description)
  AUTHORS   Levin AS
  TITLE     Nosocomial legionellosis: prevention and management.
  JOURNAL   Expert Rev Anti Infect Ther 7:57-68 (2009)
DOI:10.1586/14787210.7.1.57",MeSH,D007876,D007877,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01784,"Primary hyperchylomicronemia, including:
Hyperlipoproteinemia, type I [DS:H00154];
Hyperlipoproteinemia, type V [DS:H00157]","Primary hyperchylomicronemia is characterized by a marked hypertriglyceridemia due to the accumulation of chylomicron occurs in the circulation. The main clinical symptoms of this disorder are the huge increase in plasma trigriceride and cholesterol, and the presence of xanthomatous eruption, lipemia retinalis, hepatosplenomegaly, and the complication of acute pancreatitis. The genetic basis for primary hyperchylomicronemia is heterogeneous. The familial chylomicronemia (known as Fredrickson's classification of type 1 hyperlipoproteinemia) [DS:H00154] is a clinical condition showing the severest hypertriglyceridemia and is classically represented by two rare genetic disorders, i.e., familial lipoprotein lipase (LPL) deficiency and familial apolipoprotein C-II deficiency. Even rarer conditions such as circulating inhibitor of lipoprotein lipase and the presence of autoantibodies also cause type 1 hyperlipoproteinemia. More recently, patients with primary hyperchylomicronemia caused by mutations in the gene for glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) or lipase maturation factor 1 (LMF1). By contrast, the more commonly encountered polygenic chylomicronemia of adulthood, referred to as mixed dyslipidemia (known as type 5 hyperlipoproteinemia) [DS:H00157], can present later in life and is characterized by increased levels of hepatically derived triglyceride-rich lipoproteins and triglyceride-rich remnant particles together with reduced levels of HDL cholesterol.",Inherited metabolic disease; Cardiovascular disease,"LPL [HSA:4023] [KO:K01059]
APOC2 [HSA:344] [KO:K22287]
GPIHBP1 [HSA:338328] [KO:K20001]
LMF1 [HSA:64788]
APOA5 [HSA:116519] [KO:K09025]",,,,,,,"ICD-10: E78.3
MeSH: D006954 D008072
OMIM: 238600 207750 615947 246650 144650","PMID:22129523 (description)
  AUTHORS   Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N
  TITLE     Diagnosis and management of type I and type V hyperlipoproteinemia.
  JOURNAL   J Atheroscler Thromb 19:1-12 (2012)
DOI:10.5551/jat.10702

PMID:25732519 (description)
  AUTHORS   Brahm AJ, Hegele RA
  TITLE     Chylomicronaemia--current diagnosis and future therapies.
  JOURNAL   Nat Rev Endocrinol 11:352-62 (2015)
DOI:10.1038/nrendo.2015.26

PMID:24205717 (description)
  AUTHORS   Yamashita S
  TITLE     [Primary hyperchylomicronemia].
  JOURNAL   Nihon Rinsho 71:1578-83 (2013)

PMID:10638209 (description)
  AUTHORS   Iwasaki M, Tada N
  TITLE     [Primary hyperchylomicronemia and gene defects].
  JOURNAL   Nihon Rinsho 57:2759-64 (1999)",MeSH,D006954,D008072,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01397,"Tick-borne lymphadenopathy;
Tick-borne lymphadenitis","Rickettsia species are arthropod-associated intracellular bacteria and cause diseases in human such as Tick-borne lymphadenopathy, Typhus fever and Spotted fever. Dermacentor marginatus and Dermacentor reticulatus are known vector of Rickettsia slovaca that is the main agent of tick-borne lymphadenopathy (TIBOLA), which is found only in Europe. Its symptoms are generally mild and can be characterized by inoculation eschar on the scalp and cervical lymphadenopathies after a tick bite. Moreover, most of the cases occur during European cool months related to the activity of Dermacentor ticks.",Infectious disease,,  Rickettsia slovaca [GN:rsv],,,,,,"ICD-10: R59 L04 I88
MeSH: D008199 D008206","PMID:22374949 (description)
  AUTHORS   Fournier PE, El Karkouri K, Robert C, Medigue C, Raoult D
  TITLE     Complete genome sequence of Rickettsia slovaca, the agent of tick-borne lymphadenitis.
  JOURNAL   J Bacteriol 194:1612 (2012)
DOI:10.1128/JB.06625-11

PMID:19547738 (description)
  AUTHORS   Dobler G, Wolfel R
  TITLE     Typhus and other rickettsioses: emerging infections in Germany.
  JOURNAL   Dtsch Arztebl Int 106:348-54 (2009)
DOI:10.3238/arztebl.2009.0348",MeSH,D008199,D008206,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01017,Choanal atresia and lymphedema,"Choanal atresia and lymphoedema is a rare congenital malformation caused by loss-of-function mutation in PTPN14 encoding a nonreceptor tyrosine phosphatase. PTPN14 has been shown to interact with the vascular endothelial growth factor receptor 3 (VEGFR3), a receptor tyrosine kinase that is essential for lymphangiogenesis. The mechanism responsible for the development of chanal atresia is not clear but believed to be failure of the breakdown of the bucconasal membrane during embryogenesis.",Developmental disorder,PTPN14 [HSA:5784] [KO:K18025],,,,,,,"MeSH: D002754 D008209
OMIM: 613611","PMID:1872518 (description)
  AUTHORS   Har-El G, Borderon ML, Weiss MH
  TITLE     Choanal atresia and lymphedema.
  JOURNAL   Ann Otol Rhinol Laryngol 100:661-4 (1991)
DOI:10.1177/000348949110000812

PMID:20826270 (20826270)
  AUTHORS   Au AC, Hernandez PA, Lieber E, Nadroo AM, Shen YM, Kelley KA, Gelb BD, Diaz GA
  TITLE     Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans.
  JOURNAL   Am J Hum Genet 87:436-44 (2010)
DOI:10.1016/j.ajhg.2010.08.008",MeSH,D002754,D008209,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01770,Macular dystrophy,"The inherited macular dystrophies are characterized by bilateral visual loss and the finding of generally symmetrical macular abnormalities visible either on ophthalmoscopy or on retinal angiographs. They include Stargardt disease (H00819), Cone-rod dystrophy (H00481), Vitelliform macular dystrophy (H00814), X-linked juvenile retinoschisis (H01766), Occult macular dystrophy (H01010), Central areolar choroidal dystrophy (H01768), and Pattern dystrophies of the retinal pigment epithelium (H01890).",Nervous system disease; Eye disease,,,,,,,"See also H00819 Stargardt disease, H00481 Cone-rod dystrophy and cone dystrophy, H00814 Vitelliform macular dystrophy, H01010  Occult macular dystrophy, H01766 Juvenile retinoschisis, H01768 Central areolar choroidal dystrophy, H01890 Pattern dystrophies of the retinal pigment epithelium, and H00821 Age-related macular degeneration.","ICD-10: H35.5
MeSH: D057826 D008268
OMIM: 248200 120970 153840 613587 312700 215500","PMID:21834622
  AUTHORS   Bitoun P, Pipiras E, Rigaudiere F
  TITLE     Congenital macular dystrophy, corpus callosum agenesis, hippocampi hypoplasia--a novel neuro-ophthalmic syndrome: case report.
  JOURNAL   Ophthalmic Genet 33:39-43 (2012)
DOI:10.3109/13816810.2011.596892

PMID:23168924
  AUTHORS   Liutkeviciene R, Lesauskaite V, Asmoniene V, Gelzinis A, Zaliuniene D, Jasinskas V
  TITLE     Inherited macular dystrophies and differential diagnostics.
  JOURNAL   Medicina (Kaunas) 48:485-95 (2012)

PMID:12960208
  AUTHORS   Michaelides M, Hunt DM, Moore AT
  TITLE     The genetics of inherited macular dystrophies.
  JOURNAL   J Med Genet 40:641-50 (2003)
DOI:10.1136/jmg.40.9.641",MeSH,D057826,D008268,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00262,"Spina bifida;
Myelomeningocele;
Myeloschisis","Spina bifida is among the phenotypes of the larger condition known as neural tube defects (NTDs). It is a group of congenital defects of closure of one or more vertebral arches. NTDs can occur in two major forms: spina bifida aperta, which is the open-lesion NTD, and the closed-lesion NTD, more commonly known as spina bifida occulta. The genetic studies have shown the relationships of folate-related genes. Spina bifida aperta may be referred to as either myeloschisis or myelomeningocele. Myelomeningocele is when the spinal cord protrudes from the spinal canal into a fluid-filled sac resulting from incomplete closure of the primary neural tube. Myeloschisis is when the incomplete closure of the primary neural plate results in a cleft spinal cord with the edges flush with the defect. Myelomeningocele is usually associated with a type II Chiari hindbrain malformation, ventriculomegaly, and hydrocephalus.",Developmental disorder; Nervous system disease,"MTHFR [HSA:4524] [KO:K00297]
VANGL1 [HSA:81839] [KO:K04510]
MTR [HSA:4548] [KO:K00548]
MTRR [HSA:4552] [KO:K00597]
MTHFD1 [HSA:4522] [KO:K00288]",,,,,Folic acid [DR:D00070],See also H01561 Chiari malformation.,"ICD-10: Q05
MeSH: D016135 D008591
OMIM: 182940 601634","PMID:19120526
  AUTHORS   Kondo A, Kamihira O, Ozawa H
  TITLE     Neural tube defects: prevalence, etiology and prevention.
  JOURNAL   Int J Urol 16:49-57 (2009)
DOI:10.1111/j.1442-2042.2008.02163.x

PMID:17963270
  AUTHORS   Beaudin AE, Stover PJ
  TITLE     Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression.
  JOURNAL   Birth Defects Res C Embryo Today 81:183-203 (2007)
DOI:10.1002/bdrc.20100

PMID:17470131
  AUTHORS   Kibar Z, Capra V, Gros P
  TITLE     Toward understanding the genetic basis of neural tube defects.
  JOURNAL   Clin Genet 71:295-310 (2007)
DOI:10.1111/j.1399-0004.2007.00793.x

PMID:28286691
  AUTHORS   Mohd-Zin SW, Marwan AI, Abou Chaar MK, Ahmad-Annuar A, Abdul-Aziz NM
  TITLE     Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans.
  JOURNAL   Scientifica (Cairo) 2017:5364827 (2017)
DOI:10.1155/2017/5364827",MeSH,D016135,D008591,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00590,"Congenital muscular dystrophies (CMD/MDC), including:
Collagen VI related myopathies [DS:H01341];
Merosin-deficient CMD (MDC1A) [DS:H01958];
Muscular dystrophy-dystroglycanopathy type A [DS:H00120];
Muscular dystrophy-dystroglycanopathy type B [DS:H01960];
Muscular dystrophy-dystroglycanopathy type C [DS:H01959];
Integrin alpha7-deficient CMD;
Rigid spine syndrome (RSS) [DS:H01310];
LMNA-deficient CMD","Congenital muscular dystrophies (CMDs) are a heterogeneous group of inherited disorders characterized by muscle weakness from birth and variable clinical manifestations of the eye and central nervous system. According to the disease mechanisms, the CMDs may be grouped as follows: defects in genes encoding for structural proteins of the basal membrane or extracellular matrix of the skeletal muscle fibers, which include collagen 6 genes, laminin alpha2 chain and integrin alpha7; defects in genes encoding for putative or demonstrated glycosyltransferases, which include POMT1, POMT2, POMGnT1, fukutin, fukutin-related protein (FKRP), Large, and ISPD; defects in ER and nuclear proteins, which are selenoprotein 1 and lamin A/C.",Musculoskeletal disease; Nervous system disease,"(MDC1A) LAMA2 [HSA:3908] [KO:K05637]
(UCMD) COL6A [HSA:1291 1292 1293] [KO:K06238]
(ITGA7-deficient CMD) ITGA7 [HSA:3679] [KO:K06583]
(CMDH) ITGA9 [HSA:3680] [KO:K06585]
(WWS) POMT1 [HSA:10585] [KO:K00728]
(WWS) POMT2 [HSA:29954] [KO:K00728]
(WWS, FCMD) FKTN [HSA:2218] [KO:K19872]
(WWS, MDC1C) FKRP [HSA:79147] [KO:K19873]
(WWS, MDC1D) LARGE [HSA:9215] [KO:K09668]
(WWS, MEB) ISPD [HSA:729920] [KO:K21031]
(MEB) POMGnT1 [HSA:55624] [KO:K09666]
(RSS) SEPN1 [HSA:57190] [KO:K19874]
(LMNA-deficient CMD) LMNA [HSA:4000] [KO:K12641]",,,,,,"Collagen VI related myopathies [DS:H01341] includes Ullrich CMD (UCMD).
Muscular dystrophy-dystroglycanopathy type A [DS:H00120] includes Walker-Warburg syndrome (WWS), Muscle-eye-brain disease (MEB), and Fukuyama CMD (FCMD).
Muscular dystrophy-dystroglycanopathy type B [DS:H01960] includes MDC1C and MDC1D.","ICD-10: G71.2 G71.8 Q04.3
MeSH: D058494 D009136 C535683
OMIM: 236670 253280 253800 254090 602771 607855 613150 613152 613153 613154 613204 613205 613155 613156 613151 613152 608840 606612 614643","PMID:15351421 (gene, description)
  AUTHORS   Muntoni F, Voit T
  TITLE     The congenital muscular dystrophies in 2004: a century of exciting progress.
  JOURNAL   Neuromuscul Disord 14:635-49 (2004)
DOI:10.1016/j.nmd.2004.06.009

PMID:21496624 (gene, description)
  AUTHORS   Sparks SE, Escolar DM
  TITLE     Congenital muscular dystrophies.
  JOURNAL   Handb Clin Neurol 101:47-79 (2011)
DOI:10.1016/B978-0-08-045031-5.00004-9

PMID:16575835
  AUTHORS   van Reeuwijk J, Maugenre S, van den Elzen C, Verrips A, Bertini E, Muntoni F, Merlini L, Scheffer H, Brunner HG, Guicheney P, van Bokhoven H
  TITLE     The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
  JOURNAL   Hum Mutat 27:453-9 (2006)
DOI:10.1002/humu.20313

PMID:22522420
  AUTHORS   Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, Mathews KD, Nelson SF, Moore SA, Campbell KP
  TITLE     ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
  JOURNAL   Nat Genet 44:575-80 (2012)
DOI:10.1038/ng.2252

PMID:25825463
  AUTHORS   Kang PB, Morrison L, Iannaccone ST, Graham RJ, Bonnemann CG, Rutkowski A, Hornyak J, Wang CH, North K, Oskoui M, Getchius TS, Cox JA, Hagen EE, Gronseth G, Griggs RC
  TITLE     Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the  American Association of Neuromuscular &amp; Electrodiagnostic Medicine.
  JOURNAL   Neurology 84:1369-78 (2015)
DOI:10.1212/WNL.0000000000001416",MeSH,D058494,D009136,C535683,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01780,Non-dystrophic myotonia,"Non-dystrophic myotonias are rare diseases caused by mutations in key skeletal muscle ion channels. The major clinical manifestation is muscle stiffness as a consequence of the myotonia. Additional common symptoms include pain, weakness and fatigue. They are considered to be distinct from myotonic dystrophy because of the absence of progressive weakness and systemic features. Non-dystrophic myotonias include myotonia congenita (H00705), paramyotonia congenita (H00743), and the sodium channel myotonias (H00744).",Musculoskeletal disease; Nervous system disease,"CLCN1 [HSA:1180] [KO:K05010]
SCN4A [HSA:6329] [KO:K04837]",,,,,,"See also H00705 Myotonia congenita, H00743 Paramyotonia congenita (PMC), and H00744 Potassium-aggravated myotonias (PAMs).","ICD-10: G71.1
MeSH: D020967 D009224 
OMIM: 160800 255700 168300 608390","PMID:19917643 (gene)
  AUTHORS   Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D, Fontaine B, Amato AA, Barohn RJ, Griggs RC, Hanna MG
  TITLE     The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.
  JOURNAL   Brain 133:9-22 (2010)
DOI:10.1093/brain/awp294

PMID:23771340
  AUTHORS   Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ
  TITLE     Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
  JOURNAL   Brain 136:2189-200 (2013)
DOI:10.1093/brain/awt133",MeSH,D020967,D009224,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00464,"Patella dysplasias, including:
Small patella syndrome (SPS);
Nail-patella syndrome;
Ear-patella-short statute syndrome",Patella dysplasias are a group of disorders that include aplasia/hypoplasia of patellar. Small patella syndrome is a skeletal dysplasia with anomalies of the pelvis. Ossification of the ischia and inferior pubic rami is also disrupted in patients with small patella syndrome. Nail-patella syndrome is a condition caused by mutation in LMX1B that regulates COL4A4 and COL4A3 expression. The most common associated abnormality is nail dysplasia. Ear-patella-short statute syndrome is characterized by microtia and growth retardation due to delayed skeletal development.,Skeletal dysplasia; Developmental disorder,"(small) TBX4 [HSA:9496] [KO:K10178]
(nail) LMX1B [HSA:4010] [KO:K09371]
(ear) ORC1 [HSA:4998] [KO:K02603]
(ear) ORC4 [HSA:5000] [KO:K02606]
(ear) CDT1 [HSA:81620] [KO:K10727]",,,,,,,"ICD-10: Q74.1 Q87.2
MeSH: C535540 D009261 C538012
OMIM: 147891 161200 224690","PMID:15106123 (gene)
  AUTHORS   Bongers EM, Duijf PH, van Beersum SE, Schoots J, Van Kampen A, Burckhardt A, Hamel BC, Losan F, Hoefsloot LH, Yntema HG, Knoers NV, van Bokhoven H
  TITLE     Mutations in the human TBX4 gene cause small patella syndrome.
  JOURNAL   Am J Hum Genet 74:1239-48 (2004)
DOI:10.1086/421331

PMID:9133358 (description)
  AUTHORS   Azouz EM, Kozlowski K
  TITLE     Small patella syndrome: a bone dysplasia to recognize and differentiate from the nail-patella syndrome.
  JOURNAL   Pediatr Radiol 27:432-5 (1997)
DOI:10.1007/s002470050163

PMID:12666288 (description)
  AUTHORS   Sferopoulos NK, Tsitouridis I
  TITLE     Ischiopubic hypoplasia: a rare constituent of congenital syndromes.
  JOURNAL   Acta Orthop Belg 69:29-34 (2003)

PMID:12215822 (description, gene)
  AUTHORS   Bongers EM, Gubler MC, Knoers NV
  TITLE     Nail-patella syndrome. Overview on clinical and molecular findings.
  JOURNAL   Pediatr Nephrol 17:703-12 (2002)
DOI:10.1007/s00467-002-0911-5

PMID:11175791 (description, gene)
  AUTHORS   Morello R, Zhou G, Dreyer SD, Harvey SJ, Ninomiya Y, Thorner PS, Miner JH, Cole W, Winterpacht A, Zabel B, Oberg KC, Lee B
  TITLE     Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome.
  JOURNAL   Nat Genet 27:205-8 (2001)
DOI:10.1038/84853

PMID:10213048 (description)
  AUTHORS   Loeys BL, Lemmerling MM, Van Mol CE, Leroy JG
  TITLE     The Meier-Gorlin syndrome, or ear-patella-short stature syndrome, in sibs.
  JOURNAL   Am J Med Genet 84:61-7 (1999)
DOI:10.1002/(SICI)1096-8628(19990507)84:1<61:AID-AJMG12>3.0.CO;2-6

PMID:11807867 (description)
  AUTHORS   Cohen A, Mulas R, Seri M, Gaiero A, Fichera G, Marini M, Baffico M, Camera G
  TITLE     Meier-Gorlin syndrome (ear-patella-short stature syndrome) in an Italian patient: clinical evaluation and analysis of possible candidate genes.
  JOURNAL   Am J Med Genet 107:48-51 (2002)
DOI:10.1002/ajmg.10083

PMID:11477602 (description)
  AUTHORS   Bongers EM, Opitz JM, Fryer A, Sarda P, Hennekam RC, Hall BD, Superneau DW, Harbison M, Poss A, van Bokhoven H, Hamel BC, Knoers NV
  TITLE     Meier-Gorlin syndrome: report of eight additional cases and review.
  JOURNAL   Am J Med Genet 102:115-24 (2001)
DOI:10.1002/ajmg.1452

PMID:21358632 (gene)
  AUTHORS   Bicknell LS, Bongers EM, Leitch A, Brown S, Schoots J, Harley ME, Aftimos S, Al-Aama JY, Bober M, Brown PA, van Bokhoven H, Dean J, Edrees AY, Feingold M, Fryer A, Hoefsloot LH, Kau N, Knoers NV, Mackenzie J, Opitz JM, Sarda P, Ross A, Temple IK, Toutain A, Wise CA, Wright M, Jackson AP
  TITLE     Mutations in the pre-replication complex cause Meier-Gorlin syndrome.
  JOURNAL   Nat Genet 43:356-9 (2011)
DOI:10.1038/ng.775

PMID:21358631 (gene)
  AUTHORS   Guernsey DL, Matsuoka M, Jiang H, Evans S, Macgillivray C, Nightingale M, Perry S, Ferguson M, LeBlanc M, Paquette J, Patry L, Rideout AL, Thomas A, Orr A, McMaster CR, Michaud JL, Deal C, Langlois S, Superneau DW, Parkash S, Ludman M, Skidmore DL, Samuels ME
  TITLE     Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome.
  JOURNAL   Nat Genet 43:360-4 (2011)
DOI:10.1038/ng.777",MeSH,C535540,D009261,C538012,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00452,"Disorders caused by loss-of-function of LEMD3, including:
Osteopoikilosis;
Buschke-Ollendorff syndrome (BOS);
Melorheostosis","Osteopoikilosis, Buschke-Ollendorff syndrome (BOS) and melorheostosis are disorders characterized by increased bone density. Loss-of-function mutations in LEMD3, which encodes an inner nuclear membrane protein can result in these conditions. LEMD3 is thought to be involved in Smad signaling.",Skeletal dysplasia; Developmental disorder,LEMD3 [HSA:23592] [KO:K19410],,,,,,,"ICD-10: Q78.8 Q77.4
MeSH: D008557 D010023
OMIM: 166700 155950","PMID:15489854 (description, gene)
  AUTHORS   Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F, Verschueren K, Coucke PJ, Mortier GR
  TITLE     Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.
  JOURNAL   Nat Genet 36:1213-8 (2004)
DOI:10.1038/ng1453

PMID:18313966 (description, gene)
  AUTHORS   Hassikou H, Tabache F, Safi S, Baaj M, Hadri L
  TITLE     Buschke-Ollendorff syndrome.
  JOURNAL   Joint Bone Spine 75:212-4 (2008)
DOI:10.1016/j.jbspin.2007.04.027

PMID:18986450 (description, gene)
  AUTHORS   Schena D, Germi L, Zamperetti MR, Colato C, Girolomoni G
  TITLE     Buschke-Ollendorff syndrome.
  JOURNAL   Int J Dermatol 47:1159-61 (2008)
DOI:10.1111/j.1365-4632.2008.03727.x

PMID:19634844 (description, gene)
  AUTHORS   Jain VK, Arya RK, Bharadwaj M, Kumar S
  TITLE     Melorheostosis: clinicopathological features, diagnosis, and management.
  JOURNAL   Orthopedics 32:512 (2009)
DOI:10.3928/01477447-20090527-20",MeSH,D008557,D010023,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01422,Carbapenem-resistant Enterobacteriaceae (CRE) infection,"Enterobacteriaceae are among the most common human pathogens, causing community-acquired as well as hospital-acquired infections. Carbapenem-resistant Enterobacteriaceae (CRE) have been increasingly reported worldwide. Bacterial acquisition of carbapenemases, enzymes that inactivate carbapenems, is crucial to the emergence of CRE. In 2001, the first report of carbapenem-resistant Klebsiella pneumoniae carrying a new carbapenemase, KPC, was published.",Infectious disease,,"  Klebsiella pneumoniae [GN:kpa kps kpb kpc]
Pseudomonas aeruginosa
Escherichia coli
Serratia marcescens",,,,"Colistin [DG:DG00087]
Tigecycline [DR:D01079]
Aminoglycosides [DG:DG01447]
Carbapenems [DG:DG01458]
Fosfomycin [DG:DG00633]",,"ICD-10: A49.8 B96.1 J15.0 J15.1
MeSH: D007710 D011552 D016868","PMID:24360201 (pathogen)
  AUTHORS   Nordmann P
  TITLE     Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
  JOURNAL   Med Mal Infect 44:51-6 (2014)
DOI:10.1016/j.medmal.2013.11.007

PMID:24639510 (pathogen)
  AUTHORS   Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN
  TITLE     Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae.
  JOURNAL   Proc Natl Acad Sci U S A 111:4988-93 (2014)
DOI:10.1073/pnas.1321364111

PMID:24798270 (pathogen)
  AUTHORS   van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, Cline M, Hall GS, Kaye KS, Jacobs MR, Kalayjian RC, Salata RA, Segre JA, Conlan S, Evans S, Fowler VG Jr, Bonomo RA
  TITLE     Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.
  JOURNAL   Antimicrob Agents Chemother 58:4035-41 (2014)
DOI:10.1128/AAC.02636-14

PMID:25758700 (pathogen)
  AUTHORS   Tai AY, Stuart RL, Sidjabat HE, Lemoh CN, Rogers BA, Graham M, Paterson DL, Korman TM
  TITLE     Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1 gene in Australia.
  JOURNAL   Med J Aust 202:270-1 (2015)
DOI:10.5694/mja14.01637

PMID:23547093 (pathogen, drug)
  AUTHORS   Perez F, Van Duin D
  TITLE     Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
  JOURNAL   Cleve Clin J Med 80:225-33 (2013)
DOI:10.3949/ccjm.80a.12182

PMID:25195939 (drug)
  AUTHORS   Temkin E, Adler A, Lerner A, Carmeli Y
  TITLE     Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
  JOURNAL   Ann N Y Acad Sci 1323:22-42 (2014)
DOI:10.1111/nyas.12537

PMID:25556628 (drug)
  AUTHORS   Tangden T, Giske CG
  TITLE     Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
  JOURNAL   J Intern Med 277:501-12 (2015)
DOI:10.1111/joim.12342",MeSH,D007710,D011552,D016868,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00395,"Rubella, including:
Congenital rubella syndrome","Rubella is a viral infection caused by the rubella virus of the togaviridae, genus rubivirus. It is a disease with minor morbidity, however, when contracted by a pregnant woman, fetal death or severe congenital defects (congenital rubella syndrome) such as blindness and deafness can occur due to the virus-induced cellular damage.",Infectious disease,,  Rubella virus [GN:T40070],,,,Rubella vaccine [DR:D05362 D06512 D08804],,"ICD-10: B06 P35.0
MeSH: D012409 D012410
MedlinePlus: 001574 001658","PMID:15064032 (description)
  AUTHORS   Banatvala JE, Brown DW
  TITLE     Rubella.
  JOURNAL   Lancet 363:1127-37 (2004)
DOI:10.1016/S0140-6736(04)15897-2

PMID:9796387 (description)
  AUTHORS   Hinman AR, Hersh BS, de Quadros CA
  TITLE     Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas.
  JOURNAL   Rev Panam Salud Publica 4:156-60 (1998)

PMID:16580940 (description)
  AUTHORS   De Santis M, Cavaliere AF, Straface G, Caruso A
  TITLE     Rubella infection in pregnancy.
  JOURNAL   Reprod Toxicol 21:390-8 (2006)
DOI:10.1016/j.reprotox.2005.01.014",MeSH,D012409,D012410,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00306,Pasteurellosis,"Pasteurella are gram-positive, facultative anaerobic bacilli found in the animal's oral cavity. Disseminated Pasteurella infections can lead to serious diseases including septic shock and meningitis mostly in infants and pregnant women. Many patients with P. multocida-related bacteraemia have evidence of liver disease.",Infectious disease,,"  Pasteurella multocida [GN:pmu pmv pmul]
Pasteurella canis
Pasteurella multocida subsp septica
Pasteurella stomatis
Pasteurella dagmatis
Capsular lipopolysaccharide
Iron acquisition proteins",,,,"Betalactam antibiotics [ATC:J01C]
Second-generation and third-generation cephalosporins [ATC:J01DC J01DD]","Pasteurella are usually not susceptible to dicloxacillin, cephalexin, clindamycin, or erythromycin.","ICD-10: A28.0
MeSH: D010326 D012766","PMID:6371440 (drug)
  AUTHORS   Weber DJ, Wolfson JS, Swartz MN, Hooper DC
  TITLE     Pasteurella multocida infections. Report of 34 cases and review of the literature.
  JOURNAL   Medicine (Baltimore) 63:133-54 (1984)

PMID:19555903 (env_factor)
  AUTHORS   Oehler RL, Velez AP, Mizrachi M, Lamarche J, Gompf S
  TITLE     Bite-related and septic syndromes caused by cats and dogs.
  JOURNAL   Lancet Infect Dis 9:439-47 (2009)
DOI:10.1016/S1473-3099(09)70110-0",MeSH,D010326,D012766,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01315,"Erysipeloid;
Swine erysipelas",,Infectious disease,,  Erysipelothrix rhusiopathiae [GN:erh],,,,,,"ICD-10: A26
MeSH: D004887 D013554",,MeSH,D004887,D013554,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01465,"Large-vessel vasculitis (LVV), including:
Giant cell arteritis (GCA);
Takayasu arteritis (TAK)","Large vessel vasculitis (LVV) covers a spectrum of primary vasculitides predominantly affecting the aorta and its major branches. Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are the two main subtypes. GCA is the most common vasculitis affecting adults aged 50 years or more, while TAK is a rare vasculitis that affects younger individuals mainly under 40 years. Clinical presentations vary from asymptomatic to significant systemic symptoms such as fever, weight loss, and symptoms that result from aortitis and high inflammatory markers; C-reactive protein (CRP); and erythrocyte sedimentation rate (ESR) levels. Glucocorticoids are the mainstay of therapy of LVV. Patients may develop predictable adverse effects from long-term glucocorticoid use.",Nervous system disease; Cardiovascular disease,,,,,,Tocilizumab [DR:D02596],,"ICD-10: M31.4 M31.6
MeSH: D013700 D013625","PMID:24893935 (description)
  AUTHORS   Chatterjee S, Flamm SD, Tan CD, Rodriguez ER
  TITLE     Clinical diagnosis and management of large vessel vasculitis: giant cell arteritis.
  JOURNAL   Curr Cardiol Rep 16:498 (2014)
DOI:10.1007/s11886-014-0498-z

PMID:23949338 (description, drug)
  AUTHORS   Al-Homood IA
  TITLE     Tocilizumab: a new therapy for large vessel vasculitis.
  JOURNAL   Clin Exp Med 14:355-60 (2014)
DOI:10.1007/s10238-013-0254-5",MeSH,D013700,D013625,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00505,"FGFR3-related short limb skeletal dysplasias, including:
Achondroplasia [DS:H01749];
Hypochondroplasia;
Thanatophoric dysplasia [DS:H01750];
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN)",FGFR3-related short limb skeletal dysplasias are a group of dwarfisms ranging from mild to lethal at the severe end. FGFR3 mutations cause these conditions by disrupting endochondral bone growth.,Skeletal dysplasia,FGFR3 [HSA:2261] [KO:K05094],,,,,,,"ICD-10: Q77.4
MeSH: D000130 D013796
OMIM: 100800 146000 187600 187601 616482","PMID:12357475 (description, gene)
  AUTHORS   Cohen MM Jr
  TITLE     Some chondrodysplasias with short limbs: molecular perspectives.
  JOURNAL   Am J Med Genet 112:304-13 (2002)
DOI:10.1002/ajmg.10780

PMID:10885578 (description, gene)
  AUTHORS   McIntosh I, Bellus GA, Jab EW
  TITLE     The pleiotropic effects of fibroblast growth factor receptors in mammalian development.
  JOURNAL   Cell Struct Funct 25:85-96 (2000)
DOI:10.1247/csf.25.85",MeSH,D000130,D013796,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01645,"Hyperthyroidism;
Thyrotoxicosis","Hyperthyroidism is a pathological disorder characterised by increased thyroid hormone synthesis and secretion from the thyroid gland. The term thyrotoxicosis is not synonymous with hyperthyroidism. Thyrotoxicosis is defined as the clinical syndrome of hypermetabolism resulting from increased thyroid hormone levels, irrespective of the source. The causes of hyperthyroidism include Graves' disease, toxic multinodular goiter, and solitary toxic adenoma. Less common causes of hyperthyroidism include thyrotropin-induced thyrotoxicosis and trophoblastic tumours. The causes of thyrotoxicosis without hyperthyroidism are less common and generally transient. In patients with silent thyroiditis, post-partum thyroiditis, or subacute painful thyroiditis, the destruction of thyrocytes leads to release of preformed hormones into the circulation. Drug-induced thyrotoxicosis has the same pathogenic mechanism as thyroiditis. Exogenous thyrotoxicosis develops after ingestion of excessive amounts of thyroid hormone, and is associated with low serum thyroglobulin concentrations. Patients of hyperthyroidism/thyrotoxicosis usually have fatigue, nervousness or anxiety, weight loss, palpitations, and heat sensitivity. Clinical findings almost always include tachycardia, warm moist skin, the presence of an enlarged thyroid, and a slight tremor. The three options for treating patients with hyperthyroidism are antithyroid drugs (ATDs), radioactive iodine ablation, and surgery. All three therapeutic options would be effective in the treatment of patients with Graves' disease, whereas patients with toxic adenoma or toxic multinodular goiter should have either radioactive iodine therapy or surgery, since these patients rarely go into remission. In patients with toxic nodular goiter, ATDs are generally used to restore euthyroidism before definitive treatment with surgery or radioactive iodine, and infrequently used as long-term treatment when the other two therapies are contraindicated or the patient has a short life expectancy.",Endocrine disease,,,"Lithium [DR:D00801 D04750]
Interferon alfa [DR:D02745 D03305]
Amiodarone [DR:D00636]",,,"Methimazole [DR:D00401]
Sodium iodide [DR:D05328 D02259]",See also H00082 and H01269.,"ICD-10: E05
MeSH: D006980 D013971","PMID:27038492 (description, env_factor, drug)
  AUTHORS   De Leo S, Lee SY, Braverman LE
  TITLE     Hyperthyroidism.
  JOURNAL   Lancet 388:906-918 (2016)
DOI:10.1016/S0140-6736(16)00278-6

PMID:12927435 (description)
  AUTHORS   Cooper DS
  TITLE     Hyperthyroidism.
  JOURNAL   Lancet 362:459-68 (2003)
DOI:10.1016/S0140-6736(03)14073-1",MeSH,D006980,D013971,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00322,Typhus fever,Typhus fever is caused by gram-negative rickettsia species in the typhus biogroup that are transmitted by infective louse and flea. The disease is widely distributed in tropical and subtropical areas. Most patients present with an acute febrile disease with constitutional symptom and maculopapular exanthema.,Infectious disease,,"  Rickettsia prowazekii [GN:rpr rpq rpn rpl] (epidemic louse-borne typhus)
Rickettsia typhi [GN:rty] (murine flea-borne typhus)
Rickettsia felis [GN:rfe] (feline flea-borne typhus)",,,,Tetracyclines [DG:DG01197],Vectors: Prediculus humanus (human body louse); Xenopsylla cheopis (rat flea) and Polyplax spinulos (rat louse),"ICD-10: A75
MeSH: D014437 D014438
MedlinePlus: 001363","PMID:15353963 (env_factor, comment)
  AUTHORS   Rolain JM, Jensenius M, Raoult D
  TITLE     Rickettsial infections--a threat to travellers?
  JOURNAL   Curr Opin Infect Dis 17:433-7 (2004)

PMID:15546086
  AUTHORS   Jensenius M, Fournier PE, Raoult D
  TITLE     Rickettsioses and the international traveler.
  JOURNAL   Clin Infect Dis 39:1493-9 (2004)
DOI:10.1086/425365

PMID:15845235 (description)
  AUTHORS   Parola P, Davoust B, Raoult D
  TITLE     Tick- and flea-borne rickettsial emerging zoonoses.
  JOURNAL   Vet Res 36:469-92 (2005)
DOI:10.1051/vetres:2005004",MeSH,D014437,D014438,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01176,Uncomplicated urinary tract infection,"Staphylococci are widespread as commensals of humans and animals where they colonize the skin or mucous membranes. Staphylococcus saprophyticus is a coagulase-negative Staphylococcus, gram-positive uropathogen and frequently isolated from young female outpatients presenting with uncomplicated urinary tract infections. S. saprophyticus causes uncomplicated urinary tract infection (UTI) but no severe bacterial infectious disease as caused by S. aureus. The urease of S. saprophyticus is known to be a virulent factor for the persistent infection in the urinary tract. All of the virulence factors of S. aureus, such as coagulase, hemolysins, enterotoxins, extracellular matrixbinding proteins, and exoenzymes, are absent in the S. saprophyticus genome. Besides S. saprophyticus is a leading gram-positive uropathogen of uncomplicated UTI, a restricted group of gram-negative bacteria, including Escherichia coli, Proteus mirabilis, and Klebsiella spp. is often observed to cause uncomplicated UTI.",Infectious disease,,  Staphylococcus saprophyticus [GN:ssp],,,,,,"ICD-10: B95 N39
MeSH: D013203 D014552
MedlinePlus: 000521","PMID:16135568 (description)
  AUTHORS   Kuroda M, Yamashita A, Hirakawa H, Kumano M, Morikawa K, Higashide M, Maruyama A, Inose Y, Matoba K, Toh H, Kuhara S, Hattori M, Ohta T.
  TITLE     Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection.
  JOURNAL   Proc Natl Acad Sci U S A 102:13272-7 (2005)
DOI:10.1073/pnas.0502950102",MeSH,D013203,D014552,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00296,"Defects in RecQ helicases, including:
Bloom's syndrome [DS:H01346];
Werner's syndrome [DS:H01733];
Rothmund-Thomson syndrome [DS:H01734];
RAPADILINO syndrome [DS:H00965];
Baller-Gerold syndrome","RecQ helicases have crucial roles in the maintenance of genome stability. In humans, it is known that deficiencies in three of the five human RecQ helicases cause genetic disorders characterized by cancer predisposition, premature aging and developmental abnormalities. These disorders are Bloom's syndrome (BS), Werner's syndrome (WS), and Rothmund-Thomson syndrome (RTS), which are caused by mutations in BLM, WRN and RECQ4, respectively. Despite the apparent structural and biochemical similarities between the BLM, WRN and RECQ4 proteins, the phenotypes of BS, WS and RTS are different, suggesting that each disease pathway is functionally distinct to some extent. BS is characterized by most prominently, a predisposition to all types of cancers. WS is characterized by the premature development of features that resemble aging. RTS is characterized by skin and skeletal abnormalities, signs of premature aging, and cancer predisposition, especially to osteosarcomas. Recent research has shown many connections between all three proteins and the regulation of excess HR (Homologous recombination). It was also indicated that BLM is involved in repair of stalled DNA replication forks, and that WRN is required for telomere maintenance. Mutations in RECQL4 also associate with 2 additional syndromes, Rapadilino and Baller-Gerold syndrome.",Congenital disorder of DNA repair systems,"BLM [HSA:641] [KO:K10901]
WRN [HSA:7486] [KO:K10900]
RECQL4 [HSA:9401] [KO:K10730]",,,,,,"DNA replication proteins [BR:ko03032]
DNA repair and recombination proteins [BR:ko03400]","ICD-10: Q82.8 E34.8
MeSH: D001816 D014898 D011038 C535288
OMIM: 210900 277700 268400 266280 218600","PMID:12200042
  AUTHORS   Mohaghegh P, Hickson ID
  TITLE     Premature aging in RecQ helicase-deficient human syndromes.
  JOURNAL   Int J Biochem Cell Biol 34:1496-501 (2002)
DOI:10.1016/S1357-2725(02)00039-0

PMID:18430459
  AUTHORS   Ouyang KJ, Woo LL, Ellis NA.
  TITLE     Homologous recombination and maintenance of genome integrity: Cancer and aging through the prism of human RecQ helicases.
  JOURNAL   Mech Ageing Dev 129:425-40 (2008)
DOI:10.1016/j.mad.2008.03.003

PMID:17571213
  AUTHORS   Hanada K, Hickson ID
  TITLE     Molecular genetics of RecQ helicase disorders.
  JOURNAL   Cell Mol Life Sci 64:2306-22 (2007)
DOI:10.1007/s00018-007-7121-z

PMID:19661064
  AUTHORS   Kikuchi K, Abdel-Aziz HI, Taniguchi Y, Yamazoe M, Takeda S, Hirota K
  TITLE     Bloom DNA helicase facilitates homologous recombination between diverged homologous sequences.
  JOURNAL   J Biol Chem 284:26360-7 (2009)
DOI:10.1074/jbc.M109.029348",MeSH,D001816,D014898,D011038,C535288,,,,,,,,,,,,,,,,,,,,,,,,,,
H00977,"Trichorhinophalangeal dysplasia, including:
Trichorhinophalangeal syndrome, type I (TRPS1);
Langer-Giedion Syndrome (TRPS2);
Sugio-Kajii Syndrome (TRPS3)","Trichorhinophalangeal syndromes (TRPS) is a rare peripheral dystosis with mainly autosomal dominant inheritance. Three different forms of TRPS are known: type I (TRPS1), type II (TRPS2) and type III (TRPS3). They are characterized by sparse hair, bulbous pear-shaped nose, long and flat philtrum, thin upper lip, and protruding ears. Skeletal abnormalities that are frequently observed include epiphyses of the middle phalanges with shortened metacarpals, hip malformations, and short stature. The causative gene is TRPS1 that was shown to be a regulator of the Wnt signaling pathway in mouse.",Skeletal dysplasia; Skin and connective tissue disease,"(TRPS1_2_3) TRPS1 [HSA:7227] [KO:K22040]
(TRPS2) EXT1 [HSA:2131] [KO:K02366]",,,,,,,"MeSH: C536820 D015826 C566033
OMIM: 190350 150230 190351","PMID:1925732 (description)
  AUTHORS   Burgess RC
  TITLE     Trichorhinophalangeal syndrome.
  JOURNAL   South Med J 84:1268-70 (1991)

PMID:8034799 (description)
  AUTHORS   Carrington PR, Chen H, Altick JA
  TITLE     Trichorhinophalangeal syndrome, type I.
  JOURNAL   J Am Acad Dermatol 31:331-6 (1994)
DOI:10.1016/S0190-9622(94)70166-0

PMID:8993967 (description)
  AUTHORS   Itin PH, Bohn S, Mathys D, Guggenheim R, Richard G
  TITLE     Trichorhinophalangeal syndrome type III.
  JOURNAL   Dermatology 193:349-52 (1996)
DOI:10.1159/000246290

PMID:20394624 (description, gene)
  AUTHORS   Chen LH, Ning CC, Chao SC
  TITLE     Mutations in TRPS1 gene in trichorhinophalangeal syndrome type I in Asian patients.
  JOURNAL   Br J Dermatol 163:416-9 (2010)
DOI:10.1111/j.1365-2133.2010.09802.x

PMID:18544079 (description, gene)
  AUTHORS   Tariq M, Ahmad S, Ahmad W
  TITLE     A novel missense mutation in the TRPS1 gene underlies trichorhinophalangeal syndrome type III.
  JOURNAL   Br J Dermatol 159:476-8 (2008)
DOI:10.1111/j.1365-2133.2008.08658.x

PMID:22115758 (description)
  AUTHORS   Fantauzzo KA, Christiano AM
  TITLE     Trps1 activates a network of secreted Wnt inhibitors and transcription factors crucial to vibrissa follicle morphogenesis.
  JOURNAL   Development 139:203-14 (2012)
DOI:10.1242/dev.069971

PMID:19012352
  AUTHORS   Shanske AL, Patel A, Saukam S, Levy B, Ludecke HJ
  TITLE     Clinical and molecular characterization of a patient with Langer-Giedion syndrome and mosaic del(8)(q22.3q24.13).
  JOURNAL   Am J Med Genet A 146A:3211-6 (2008)
DOI:10.1002/ajmg.a.32615",MeSH,C536820,D015826,C566033,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01763,Porphyria,"Porphyria is an inborn error of heme biosynthesis porphyrin metabolism caused by deficiency of enzymes of porphyrin metabolism. The intermediates of this pathway (porphyrinogens, porphyrins and their precursors) are produced in excess and accumulate in tissues, resulting in neurological and/or photocutaneous symptoms, and hematological disturbances. Porphyrias are divided into erythropoietic and hepatic according to the predominant porphyrin-accumulating tissue. Erythropoietic porphyrias include erythropoietic protoporphyria (EPP), congenital erythropoietic porphyria (CEP), and the very rare hepatoerythropoietic porphyria (HEP). Hepatic porphyrias include ALA-dehydratase deficiency porphyria (ADP), acute intermittent porphyria (AIP), porphyria cutanea tarda (PCT), hereditary coproporphyria (HCP), and variegate porphyria (VP). Recently, a new type of erythroid porphyria, X-linked dominant protoporphyria (XLDPP) has been reported.",Inherited metabolic disease,"(EPP) FECH [HSA:2235] [KO:K01772]
(CEP) UROS [HSA:7390] [KO:K01719]
(HEP) UROD [HSA:7389] [KO:K01599]
(ADP) ALAD [HSA:210] [KO:K01698]
(AIP) HMBS [HSA:3145] [KO:K01749]
(PCT) UROD [HSA:7389] [KO:K01599]
(HCP) CPOX [HSA:1371] [KO:K00228]
(VP) PPOX [HSA:5498] [KO:K00231]
(XLDPP) ALAS2 [HSA:212] [KO:K00643]",,,,,Hemin [DR:D10003] (Hepatic),"See also H00201 Erythropoietic porphyria, and H00202 Hepatic porphyria.","ICD-10: E80
MeSH: D017092 D017094
OMIM: 177000 263700 176000 176100 176200 121300 125270 300752","PMID:18537592 (gene)
  AUTHORS   Richard E, Robert-Richard E, Ged C, Moreau-Gaudry F, de Verneuil H
  TITLE     Erythropoietic porphyrias: animal models and update in gene-based therapies.
  JOURNAL   Curr Gene Ther 8:176-86 (2008)
DOI:10.2174/156652308784746477

PMID:12367763 (gene, drug)
  AUTHORS   Nordmann Y, Puy H
  TITLE     Human hereditary hepatic porphyrias.
  JOURNAL   Clin Chim Acta 325:17-37 (2002)
DOI:10.1016/S0009-8981(02)00276-0

PMID:21653323 (gene)
  AUTHORS   To-Figueras J, Ducamp S, Clayton J, Badenas C, Delaby C, Ged C, Lyoumi S, Gouya L, de Verneuil H, Beaumont C, Ferreira GC, Deybach JC, Herrero C, Puy H
  TITLE     ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
  JOURNAL   Blood 118:1443-51 (2011)
DOI:10.1182/blood-2011-03-342873",MeSH,D017092,D017094,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00255,"Hypogonadotropic hypogonadism, including:
Kallmann syndrome (KAL);
Fertile eunuch syndrome (FEUNS)","Hypogonadotropic hypogonadism (HH) or secondary hypogonadism is defined as a clinical syndrome that results from gonadal failure due to abnormal pituitary gonadotropin levels. HH may result from either absent or inadequate hypothalamic gonadotropin releasing hormone (GnRH) secretion or failure of pituitary gonadotropin secretion. HH can be congenital or acquired. Congenital HH is clinically and genetically heterogeneous. Clinically, the disorder is characterized by an absence of puberty and infertility. The genetic condition is classically divided in 2 groups based on the presence or absence of olfaction dysfunction. Around 50-60% of the affected individuals exhibit anosmia or hyposmia in association with IHH, defining Kallmann syndrome. Acquired HH can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.",Endocrine disease,"(HH1/KAL1) KAL1 [HSA:3730]
(HH2/KAL2) FGFR1 [HSA:2260] [KO:K04362]
(HH3/KAL3) PROKR2 [HSA:128674] [KO:K08380]
(HH4/KAL4) PROK2 [HSA:60675]
(HH5/KAL5) CHD7 [HSA:55636] [KO:K14437]
(HH6/KAL6) FGF8 [HSA:2253] [KO:K04358]
(HH7/FEUNS) GNRHR [HSA:2798] [KO:K04280]
(HH8) KISS1R [HSA:84634] [KO:K08374]
(HH9) NSMF [HSA:26012]
(HH10) TAC3 [HSA:6866] [KO:K05240]
(HH11) TACR3 [HSA:6870] [KO:K04224]
(HH12) GNRH1 [HSA:2796] [KO:K05252]
(HH13) KISS1 [HSA:3814]
(HH14) WDR11 [HSA:55717]
(HH15) HS6ST1 [HSA:9394] [KO:K02514]
(HH16) SEMA3A [HSA:10371] [KO:K06840]
(HH17) SPRY4 [HSA:81848] [KO:K17385]
(HH18) IL17RD [HSA:54756] [KO:K05167]
(HH19) DUSP6 [HSA:1848] [KO:K21946]
(HH20) FGF17 [HSA:8822] [KO:K04358]
(HH21) FLRT3 [HSA:23767] [KO:K16362]
(HH22) FEZF1 [HSA:389549]
(HH23/FEUNS) LHB [HSA:3972] [KO:K08521]",,,,,"Progesterone [DR:D00066]
Testosterone [DG:DG00460]
Estradiol [DG:DG00462]",,"ICD-10: E23.0
MeSH: D007006 D017436 C537919
OMIM: 308700 147950 244200 610628 612370 612702 146110 614837 614838 614839 614840 614841 614842 228300 614858 614880 614897 615266 615267 615269 615270 615271 616030","PMID:18987492
  AUTHORS   Hardelin JP, Dode C
  TITLE     The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
  JOURNAL   Sex Dev 2:181-93 (2008)
DOI:10.1159/000152034

PMID:18985070
  AUTHORS   Dode C, Hardelin JP
  TITLE     Kallmann syndrome.
  JOURNAL   Eur J Hum Genet 17:139-46 (2009)
DOI:10.1038/ejhg.2008.206

PMID:17624596
  AUTHORS   Trarbach EB, Silveira LG, Latronico AC
  TITLE     Genetic insights into human isolated gonadotropin deficiency.
  JOURNAL   Pituitary 10:381-91 (2007)
DOI:10.1007/s11102-007-0061-7

PMID:15722618
  AUTHORS   Karges B, de Roux N
  TITLE     Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome.
  JOURNAL   Endocr Dev 8:67-80 (2005)
DOI:10.1159/000084094

PMID:11397842 (FEUNS)
  AUTHORS   Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF Jr, Hayes FJ
  TITLE     The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.
  JOURNAL   J Clin Endocrinol Metab 86:2470-5 (2001)
DOI:10.1210/jcem.86.6.7542

PMID:22229029
  AUTHORS   Beate K, Joseph N, Nicolas de R, Wolfram K
  TITLE     Genetics of isolated hypogonadotropic hypogonadism: role of GnRH receptor and other genes.
  JOURNAL   Int J Endocrinol 2012:147893 (2012)
DOI:10.1155/2012/147893

PMID:22335740
  AUTHORS   Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B
  TITLE     Inactivating KISS1 mutation and hypogonadotropic hypogonadism.
  JOURNAL   N Engl J Med 366:629-35 (2012)
DOI:10.1056/NEJMoa1111184

PMID:20887964
  AUTHORS   Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, Kulharya A, Ha KS, Itokawa Y, Meliciani I, Wenzel W, Lee D, Rosenberger G, Ozata M, Bick DP, Sherins RJ, Nagase T, Tekin M, Kim SH, Kim CH, Ropers HH, Gusella JF, Kalscheuer V, Choi CY, Layman LC
  TITLE     WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
  JOURNAL   Am J Hum Genet 87:465-79 (2010)
DOI:10.1016/j.ajhg.2010.08.018

PMID:22927827
  AUTHORS   Hanchate NK, Giacobini P, Lhuillier P, Parkash J, Espy C, Fouveaut C, Leroy C, Baron S, Campagne C, Vanacker C, Collier F, Cruaud C, Meyer V, Garcia-Pinero A, Dewailly D, Cortet-Rudelli C, Gersak K, Metz C, Chabrier G, Pugeat M, Young J, Hardelin JP, Prevot V, Dode C
  TITLE     SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
  JOURNAL   PLoS Genet 8:e1002896 (2012)
DOI:10.1371/journal.pgen.1002896

PMID:23643382
  AUTHORS   Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF Jr, Seminara SB, Quinton R, Hughes VA, Kumanov P, Young J, Yialamas MA, Hall JE, Van Vliet G, Chanoine JP, Rubenstein J, Mohammadi M, Tsai PS, Sidis Y, Lage K, Pitteloud N
  TITLE     Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.
  JOURNAL   Am J Hum Genet 92:725-43 (2013)
DOI:10.1016/j.ajhg.2013.04.008

PMID:25192046 (gene)
  AUTHORS   Kotan LD, Hutchins BI, Ozkan Y, Demirel F, Stoner H, Cheng PJ, Esen I, Gurbuz F, Bicakci YK, Mengen E, Yuksel B, Wray S, Topaloglu AK
  TITLE     Mutations in FEZF1 cause Kallmann syndrome.
  JOURNAL   Am J Hum Genet 95:326-31 (2014)
DOI:10.1016/j.ajhg.2014.08.006

PMID:19129711 (gene)
  AUTHORS   Arnhold IJ, Lofrano-Porto A, Latronico AC
  TITLE     Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women.
  JOURNAL   Horm Res 71:75-82 (2009)
DOI:10.1159/000183895

PMID:26194704 (description)
  AUTHORS   Boehm U, Bouloux PM, Dattani MT, de Roux N, Dode C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J
  TITLE     Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.
  JOURNAL   Nat Rev Endocrinol 11:547-64 (2015)
DOI:10.1038/nrendo.2015.112

PMID:23650335 (description)
  AUTHORS   Silveira LF, Latronico AC
  TITLE     Approach to the patient with hypogonadotropic hypogonadism.
  JOURNAL   J Clin Endocrinol Metab 98:1781-8 (2013)
DOI:10.1210/jc.2012-3550

PMID:23503957 (description)
  AUTHORS   Fraietta R, Zylberstejn DS, Esteves SC
  TITLE     Hypogonadotropic hypogonadism revisited.
  JOURNAL   Clinics (Sao Paulo) 68 Suppl 1:81-8 (2013)
DOI:10.6061/clinics/2013(Sup01)09",MeSH,D007006,D017436,C537919,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01719,Optic neuropathy,"Optic neuropathy is damage to the optic nerve that causes vision loss frequently. The optic nerve is susceptible to a number of pathologic processes. Causes of the disease include demyelinating, inflammatory, toxic, nutritional, compressive, infiltrative, hereditary, traumatic, and neoplastic. The classic clinical signs of optic neuropathy are visual field defect, dyschromatopsia, and abnormal papillary response. A rapid onset is typical of demyelinating, inflammatory, ischemic, and traumatic causes.",Nervous system disease,,,"Ethambutol [DR:D00878]
Methanol [DR:D02309]
Linezolid [DR:D00947]
Amiodarone [DR:D00636]",,,"Corticosteroids
Mecobalamin [DR:D03246] (for nutritional optic neuropathy)","See also H00068 Leber optic atrophy, H01490 Multiple sclerosis, H01491 Neuromyelitis optica, and H01717 Optic neuritis.","ICD-10: H46
MeSH: D009901 D018917","PMID:19668477 (drug)
  AUTHORS   Behbehani R
  TITLE     Clinical approach to optic neuropathies.
  JOURNAL   Clin Ophthalmol 1:233-46 (2007)

PMID:25099099 (drug, env_factor)
  AUTHORS   Van Stavern GP
  TITLE     Metabolic, hereditary, traumatic, and neoplastic optic neuropathies.
  JOURNAL   Continuum (Minneap Minn) 20:877-906 (2014)
DOI:10.1212/01.CON.0000453313.37143.9b",MeSH,D009901,D018917,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00833,"Neurodegeneration with brain iron accumulation (NBIA);
Hallervorden-Spatz syndrome;
Pantothenate kinase-associated neurodegeneration (PKAN);
Neuroferritinopathy;
Aceruloplasminemia","Neurodegeneration with brain iron accumulation (NBIA) is a group of progressive extrapyramidal and cognitive disorders characterized by iron accumulation predominantly in the globus pallidus, as well as extensive axonal spheroids in various regions of the brain. The most frequent genetic form is the pantothenate kinase-2 associated neurodegeneration (PKAN) with a mutation in the pantothenate kinase 2 (PANK2) gene. Other forms are associated with a mutation in phosphoslipase A2 (PLA2G6), FTL (neuroferritinopathy), CP (aceruloplasminemia), FA2H (Fatty acid 2-hydroxylase) and ATP13A2 (ATPase type 13A2) genes. A significant proportion of children with an NBIA phenotype have no genetic diagnosis and there are additional as yet undiscovered genes that account for a number of these cases.",Neurodegenerative disease,"(NBIA1) PANK2 [HSA:80025] [KO:K09680]
(NBIA2A, NBIA2B) PLA2G6 [HSA:8398] [KO:K16343]
(NBIA3) FTL [HSA:2512] [KO:K13625]
(NBIA4) MPAN [HSA:83636]
(NBIA5) WDR45 [HSA:11152]
(NBIA6) COASY [HSA:80347] [KO:K02318]
(Aceruloplasminemia) CP [HSA:1356] [KO:K13624]
(SPG35) FA2H [HSA:79152] [KO:K19703]
ATP13A2 [HSA:23400] [KO:K13526]",,,,The eye-of-the-tiger sign at MR imaging,,,"ICD-10: G23.0
MeSH: D006211 D019150 C565699 C548080
OMIM: 234200 256600 610217 614298 300894 615643 606159 604290 612319","PMID:21550835 (description, gene)
  AUTHORS   Friedman A, Arosio P, Finazzi D, Koziorowski D, Galazka-Friedman J
  TITLE     Ferritin as an important player in neurodegeneration.
  JOURNAL   Parkinsonism Relat Disord 17:423-30 (2011)
DOI:10.1016/j.parkreldis.2011.03.016

PMID:21480873 (description, gene)
  AUTHORS   Kurian MA, McNeill A, Lin JP, Maher ER
  TITLE     Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).
  JOURNAL   Dev Med Child Neurol 53:394-404 (2011)
DOI:10.1111/j.1469-8749.2011.03955.x

PMID:20882425
  AUTHORS   Kamate M, Mali R, Tonne V, Bubanale S
  TITLE     'Eye-of-the-tiger' sign and classic pantothenate kinase associated neurodegeneration.
  JOURNAL   Indian J Pediatr 78:121-2 (2011)
DOI:10.1007/s12098-010-0234-7

PMID:20853438
  AUTHORS   Kruer MC, Paisan-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ
  TITLE     Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).
  JOURNAL   Ann Neurol 68:611-8 (2010)
DOI:10.1002/ana.22122

PMID:23269600 (gene)
  AUTHORS   Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ
  TITLE     New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.
  JOURNAL   Neurology 80:268-75 (2013)
DOI:10.1212/WNL.0b013e31827e07be

PMID:23176820 (gene)
  AUTHORS   Haack TB, Hogarth P, Kruer MC, Gregory A, Wieland T, Schwarzmayr T, Graf E, Sanford L, Meyer E, Kara E, Cuno SM, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, Skinner S, Frucht S, Hanspal E, Schrander-Stumpel C, Heron D, Mignot C, Garavaglia B, Bhatia K, Hardy J, Strom TM, Boddaert N, Houlden HH, Kurian MA, Meitinger T, Prokisch H, Hayflick SJ
  TITLE     Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.
  JOURNAL   Am J Hum Genet 91:1144-9 (2012)
DOI:10.1016/j.ajhg.2012.10.019

PMID:24360804 (gene)
  AUTHORS   Dusi S, Valletta L, Haack TB, Tsuchiya Y, Venco P, Pasqualato S, Goffrini P, Tigano M, Demchenko N, Wieland T, Schwarzmayr T, Strom TM, Invernizzi F, Garavaglia B, Gregory A, Sanford L, Hamada J, Bettencourt C, Houlden H, Chiapparini L, Zorzi G, Kurian MA, Nardocci N, Prokisch H, Hayflick S, Gout I, Tiranti V
  TITLE     Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.
  JOURNAL   Am J Hum Genet 94:11-22 (2014)
DOI:10.1016/j.ajhg.2013.11.008",MeSH,D006211,D019150,C565699,C548080,,,,,,,,,,,,,,,,,,,,,,,,,,
H00215,"Periodic paralysis, including: ;
Hyperkalemic periodic paralysis (HyperPP) [DS:H00745];
Hypokalemic periodic paralysis (HypoPP) [DS:H00746];
Andersen-Tawil syndrome (ATS) [DS:H00748]","The periodic paralyses are characterized by episodic muscle weakness often related to potassium levels. They include hyperkalaemic periodic paralysis (HyperPP), hypokalaemic periodic paralysis (HypoPP) and Andersen-Tawil syndrome (ATS) caused by mutations in the calcium-channel, sodium-channel, and potassium-channel genes, respectively.",Inherited metabolic disease; Nervous system disease; Muscular disease,"(HyperPP HypoPP) SCN4A; voltage-gated sodium channel [HSA:6329] [KO:K04837]
(HypoPP) CACNA1S; voltage-dependent calcium channel [HSA:779] [KO:K04857]
(HypoPP) KCNE3; voltage-gated potassium channel [HSA:10008] [KO:K04897]
(ATS) KCNJ2; potassium inwardly-rectifying channel [HSA:3759] [KO:K04996]",,,,,"Acetazolamide [DG:DG01134]
Diclofenamide [DR:D00518]",,"ICD-10: G72.3
MeSH: D020513 D020514 D050030
OMIM: 170500 170400 170390","PMID:18254068
  AUTHORS   Sansone V, Meola G, Links TP, Panzeri M, Rose MR
  TITLE     Treatment for periodic paralysis.
  JOURNAL   Cochrane Database Syst Rev CD005045 (2008)
DOI:10.1002/14651858.CD005045.pub2

PMID:18031562
  AUTHORS   Finsterer J
  TITLE     Primary periodic paralyses.
  JOURNAL   Acta Neurol Scand 117:145-58 (2008)
DOI:10.1111/j.1600-0404.2007.00963.x

PMID:16195244
  AUTHORS   Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, Tristani-Firouzi M, Tawil R, Griggs RC
  TITLE     The primary periodic paralyses: diagnosis, pathogenesis and treatment.
  JOURNAL   Brain 129:8-17 (2006)
DOI:10.1093/brain/awh639

PMID:20634695
  AUTHORS   Raja Rayan DL, Hanna MG
  TITLE     Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
  JOURNAL   Curr Opin Neurol 23:466-76 (2010)
DOI:10.1097/WCO.0b013e32833cc97e",MeSH,D020513,D020514,D050030,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01614,"Multiple system atrophy, including:
Striatonigral degeneration;
Olivopontocerebellar atrophy;
Shy-Drager syndrome","Multiple system atrophy (MSA) is an intractable neurodegenerative disease characterized by autonomic failure in addition to various combinations of parkinsonism, cerebellar ataxia, and pyramidal dysfunction. MSA encompasses striatonigral degeneration, olivopontocerebellar atrophy, and Shy-Drager syndrome, which were originally described as independent clinicopathological entities. The coexistence was detected later, and these conditions were regarded as nosologically allied. The disease is characterized by the accumulation of alpha-synuclein fibrils in oligodendrocytes that form glial cytoplasmic inclusions (GCI), a neuropathological hallmark and central player in the pathogenesis of MSA.  Although MSA is widely considered to be a nongenetic disorder, genetic mutations of the COQ2 gene have been linked to MSA as identified in Japanese families.",Neurodegenerative disease,COQ2 [HSA:27235] [KO:K06125],,,,,Droxidopa [DR:D01277],See also H01600 Parkinsonian syndrome.,"ICD-10: G23
MeSH: D019578 D020955 D009849 D012791
OMIM: 146500","PMID:26785838
  AUTHORS   Stefanova N, Wenning GK
  TITLE     Review: Multiple system atrophy: emerging targets for interventional therapies.
  JOURNAL   Neuropathol Appl Neurobiol 42:20-32 (2016)
DOI:10.1111/nan.12304

PMID:18018485
  AUTHORS   Yoshida M
  TITLE     Multiple system atrophy: alpha-synuclein and neuronal degeneration.
  JOURNAL   Neuropathology 27:484-93 (2007)
DOI:10.1111/j.1440-1789.2007.00841.x

PMID:27123473 (gene)
  AUTHORS   Sun Z, Ohta Y, Yamashita T, Sato K, Takemoto M, Hishikawa N, Abe K
  TITLE     New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy.
  JOURNAL   Neurol Genet 2:e54 (2016)
DOI:10.1212/NXG.0000000000000054

PMID:26092297 (drug)
  AUTHORS   Kaufmann H, Norcliffe-Kaufmann L, Palma JA
  TITLE     Droxidopa in neurogenic orthostatic hypotension.
  JOURNAL   Expert Rev Cardiovasc Ther 13:875-91 (2015)
DOI:10.1586/14779072.2015.1057504",MeSH,D019578,D020955,D009849,D012791,,,,,,,,,,,,,,,,,,,,,,,,,,
H00523,"Noonan syndrome and related disorders, including:
Noonan syndrome (NS) [DS:H01738];
Leopard syndrome (LS);
Noonan syndrome-like with loose anagen hair (NS/LAH);
CBL syndrome (CBL);
Neurofibromatosis type 1 (NF1) [DS:H01437];
Neurofibromatosis-Noonan syndrome (NFNS);
Legius syndrome;
Cardiofaciocutaneous syndrome (CFCS) [DS:H01745];
Costello syndrome (CS) [DS:H01747];
Watson syndrome","Noonan syndrome comprises genetically heterogeneous disorders that usually include postnatally reduced growth, distinctive facial dysmorphic features, and congenital heart defects and related disorders show considerable overlapping phenotypes with Noonan syndrome. These disorders are caused by germline mutations in genes that encode components or regulators of the Ras/MAPK pathway, and are called RASopathies.",Developmental disorder; Cardiovascular disease,"(NS, LS) PTPN11 [HSA:5781] [KO:K07293]
(NS, CFCS) KRAS [HSA:3845] [KO:K07827]
(NS) SOS1 [HSA:6654] [KO:K03099]
(NS, LS) RAF1 [HSA:369] [KO:K08845]
(NS) NRAS [HSA:4893] [KO:K07828]
(NS, LS, CFCS) BRAF [HSA:673] [KO:K04365]
(NS) RIT1 [HSA:6016] [KO:K07832]
(CBL) CBL [HSA:867] [KO:K04707]
(NS/LAH) SHOC2 [HSA:8036] [KO:K19613]
(CFCS) MEK1 [HSA:5604] [KO:K04368]
(CFCS) MEK2 [HSA:5605] [KO:K04369]
(NF1, NFNS) NF1 [HSA:4763] [KO:K08052]
(Legius) SPRED1 [HSA:161742] [KO:K04703]
(CS) HRAS [HSA:3265] [KO:K02833]",,,,,,,"ICD-10: Q87.1 Q87.8 Q85.0
MeSH: D009634 D044542 D056685
OMIM: 163950 609942 610733 611553 613224 613706 151100 611554 613707 607721 613563 162200 101000 601321 611431 115150 218040 193520 162210 615355","PMID:21396583 (gene, description)
  AUTHORS   Tartaglia M, Gelb BD, Zenker M
  TITLE     Noonan syndrome and clinically related disorders.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 25:161-79 (2011)
DOI:10.1016/j.beem.2010.09.002

PMID:19545378 (gene)
  AUTHORS   Evans DG
  TITLE     Neurofibromatosis type 2 (NF2): a clinical and molecular review.
  JOURNAL   Orphanet J Rare Dis 4:16 (2009)
DOI:10.1186/1750-1172-4-16

PMID:8317503
  AUTHORS   Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, Harris R, Thakker N
  TITLE     Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.
  JOURNAL   Am J Hum Genet 53:90-5 (1993)

PMID:23791108
  AUTHORS   Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y
  TITLE     Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
  JOURNAL   Am J Hum Genet 93:173-80 (2013)
DOI:10.1016/j.ajhg.2013.05.021

PMID:23875798
  AUTHORS   Rauen KA
  TITLE     The RASopathies.
  JOURNAL   Annu Rev Genomics Hum Genet 14:355-69 (2013)
DOI:10.1146/annurev-genom-091212-153523",MeSH,D009634,D044542,D056685,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00254,"Growth hormone deficiency, including:
Pituitary Dwarfism (PD);
Laron syndrome (PD2);
Isolated growth hormone deficiency (IGHD);
Insulin-like growth factor 1 deficiency (IGFD);
Combined pituitary hormone deficiency (CPHD)",Pituitary dwarfism is a heterogeneous condition characterized by growth retardation with short statue and normal body proportions caused by growth hormone deficiency.,Endocrine disease; Musculoskeletal disease,"(IGHD1A/PD1) GH1 [HSA:2688] [KO:K05438]
(IGHD1B) GHRH [HSA:2691] [KO:K05260]
(IGHD1B) GHRHR [HSA:2692] [KO:K04584]
(IGHD3) BTK [HSA:695] [KO:K07370]
(PD2) GHR [HSA:2690] [KO:K05080]
(PD3/CPHD1) POU1F1 [HSA:5449] [KO:K09363]
(PD3/CPHD2) PROP1 [HSA:5626] [KO:K09327]
(PD3) HESX1 [HSA:8820] [KO:K09354]
(PD3/CPHD3) LHX3 [HSA:8022] [KO:K09374]
(PD4) SOX3 [HSA:6658] [KO:K09267]
(CPHD4) LHX4 [HSA:89884] [KO:K09374]
(IGFD) IGF1 [HSA:3479] [KO:K05459]",,,,,"Protropin [DR:D05884]
Somatropin [DR:D02691]",,"ICD-10: E23.0
MeSH: D004393 D046150
OMIM: 262400 612781 173100 262650 262500  262600  262700 307200 312000 608747 612781 613038 221750","PMID:17965963
  AUTHORS   Hernandez LM, Lee PD, Camacho-Hubner C
  TITLE     Isolated growth hormone deficiency.
  JOURNAL   Pituitary 10:351-7 (2007)
DOI:10.1007/s11102-007-0073-3

PMID:17336732
  AUTHORS   Mullis PE
  TITLE     Genetics of growth hormone deficiency.
  JOURNAL   Endocrinol Metab Clin North Am 36:17-36 (2007)
DOI:10.1016/j.ecl.2006.11.010

PMID:12201208
  AUTHORS   Hayashi Y, Kamijo T, Ogawa M, Seo H
  TITLE     Familial isolated growth hormone deficiency: genetics and pathophysiology.
  JOURNAL   Endocr J 49:265-72 (2002)
DOI:10.1507/endocrj.49.265

PMID:9799079
  AUTHORS   Procter AM, Phillips JA 3rd, Cooper DN
  TITLE     The molecular genetics of growth hormone deficiency.
  JOURNAL   Hum Genet 103:255-72 (1998)
DOI:10.1007/s004390050815

PMID:7868072
  AUTHORS   Perez Jurado LA, Argente J
  TITLE     Molecular basis of familial growth hormone deficiency.
  JOURNAL   Horm Res 42:189-97 (1994)
DOI:10.1159/000184192

PMID:21292919
  AUTHORS   Steuerman R, Shevah O, Laron Z
  TITLE     Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.
  JOURNAL   Eur J Endocrinol 164:485-9 (2011)
DOI:10.1530/EJE-10-0859

PMID:15928241
  AUTHORS   Turton JP, Reynaud R, Mehta A, Torpiano J, Saveanu A, Woods KS, Tiulpakov A, Zdravkovic V, Hamilton J, Attard-Montalto S, Parascandalo R, Vella C, Clayton PE, Shalet S, Barton J, Brue T, Dattani MT
  TITLE     Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency.
  JOURNAL   J Clin Endocrinol Metab 90:4762-70 (2005)
DOI:10.1210/jc.2005-0570",MeSH,D004393,D046150,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00094,"Immunodeficiency associated with DNA repair defects, including the following six diseases:
Ataxia telangiectasia (AT) [DS:H00064];
Ataxia-talangiectasia-like syndrome;
Nijmegen syndrome [DS:H01344];
DNA ligase I deficiency;
DNA ligase IV deficiency;
Bloom syndrome [DS:H01346]","A number of genetically determined disorders collectively called as the chromosome breakage syndromes or DNA-repair disorders have a characteristic cytogenetic feature, chromosome instability. They are all autosomal recessive, show an increased tendency for chromosomal aberrations and to develop malignancies. Ataxia telangiectasia (AT), Nijmegen breakage syndrome (NBS), and an ataxia-like disorder (ATLD), are chromosome instability disorders that are defective in the ataxia telangiectasia mutated (ATM), NBS, and Mre11 genes, respectively. These genes are critical in maintaining cellular resistance to ionizing radiation (IR), which kills largely by the production of double-strand breaks (DSBs). Bloom syndrome involves a defect in the BLM helicase, which seems to play a role in restarting DNA replication forks that are blocked at lesions, thereby promoting chromosome stability. A point mutational change in DNA ligase I was identified in a unique immunodeficient individual who suffered recurrent sinopulmonary infection leading to bronchiectasis. A non-inactivating mutational change in DNA ligase IV has also been identified in a leukaemia patient, who was dramatically over-sensitive to radiotherapy.",Primary immunodeficiency,"ATM [HSA:472] [KO:K04728]
MRE11A [HSA:4361] [KO:K10865]
NBS1(Nibrin) [HSA:4683] [KO:K10867]
LIG1 [HSA:3978] [KO:K10747]
LIG4 [HSA:3981] [KO:K10777]
BLM [HSA:641] [KO:K10901]",,,,,,,"ICD-10: D82.8 G11.3
MeSH: D001260 D049932 C564694 D001816 
OMIM: 208900 604391 251260 210900 606593","PMID:12427531 (gene)
  AUTHORS   Thompson LH, Schild D
  TITLE     Recombinational DNA repair and human disease.
  JOURNAL   Mutat Res 509:49-78 (2002)
DOI:10.1016/S0027-5107(02)00224-5

PMID:17162365 (gene)
  AUTHORS   Kumar A, Teuber SS, Gershwin ME.
  TITLE     Current perspectives on primary immunodeficiency diseases.
  JOURNAL   Clin Dev Immunol 13:223-59 (2006)
DOI:10.1080/17402520600800705

PMID:9737224 (gene)
  AUTHORS   Ten RM.
  TITLE     Primary immunodeficiencies.
  JOURNAL   Mayo Clin Proc 73:865-72 (1998)
DOI:10.4065/73.9.865

PMID:15096561 (gene)
  AUTHORS   Lim MS, Elenitoba-Johnson KS.
  TITLE     The molecular pathology of primary immunodeficiencies.
  JOURNAL   J Mol Diagn 6:59-83 (2004)
DOI:10.1016/S1525-1578(10)60493-X

PMID:18424339 (gene)
  AUTHORS   Morra M, Geigenmuller U, Curran J, Rainville IR, Brennan T, Curtis J, Reichert V, Hovhannisyan H, Majzoub J, Miller DT.
  TITLE     Genetic diagnosis of primary immune deficiencies.
  JOURNAL   Immunol Allergy Clin North Am 28:387-412, x (2008)
DOI:10.1016/j.iac.2008.01.004

PMID:17952897 (gene)
  AUTHORS   Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  TITLE     Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  JOURNAL   J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053",MeSH,D001260,D049932,C564694,D001816,,,,,,,,,,,,,,,,,,,,,,,,,,
H00137,"Niemann-Pick disease (NPD), type A/ B, including:
Niemann-Pick disease, type A;
Niemann-Pick disease, type B","Niemann-Pick disease (NPD) is an autosomal recessive lysosomal storage disorder caused by deficient acid sphingomyelinase (ASM) activity, resulting in accumulation of sphingomyelin and cholesterol in many organs. ASM plays an important role in normal membrane turnover and is one of the key enzymes responsible for the production of ceramide. Type A NPD is the infantile form characterized by a rapidly progressive neurodegenerative course that leads to early death. Type B NPD is the later-onset form in which patients exhibit little or no neurological symptoms, but may have severe and progressive visceral organ abnormalities, including hepatosplenomegaly and cardiovascular disease. The different clinical presentations of Types A and B NPD are likely due to small differences in the amount of residual, functional ASM activity.",Inherited metabolic disease; Lysosomal storage disease,SMPD1; sphingomyelin phosphodiesterase [HSA:6609] [KO:K12350],,,,Niemann-Pick cell: marrow film containing characteristic foamy macrophage of Niemann-Pick disease,"Enzyme-replacement therapy
Hematopoietic stem cell transplantation (type B)","Descriptions of type E and type F have been published, but they are not well characterized, and are currently classified under type B.","ICD-10: E75.2
MeSH: D052536 D052537
OMIM: 257200 607616","PMID:18567738
  AUTHORS   Smith EL, Schuchman EH
  TITLE     The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.
  JOURNAL   FASEB J 22:3419-31 (2008)
DOI:10.1096/fj.08-108043

PMID:18708002
  AUTHORS   Heese BA
  TITLE     Current strategies in the management of lysosomal storage diseases.
  JOURNAL   Semin Pediatr Neurol 15:119-26 (2008)
DOI:10.1016/j.spen.2008.05.005

PMID:17632693
  AUTHORS   Schuchman EH
  TITLE     The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
  JOURNAL   J Inherit Metab Dis 30:654-63 (2007)
DOI:10.1007/s10545-007-0632-9

PMID:10760463
  AUTHORS   Ridgway ND
  TITLE     Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin.
  JOURNAL   Biochim Biophys Acta 1484:129-41 (2000)
DOI:10.1016/S1388-1981(00)00006-8

PMID:19944693
  AUTHORS   Schuchman EH
  TITLE     Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
  JOURNAL   FEBS Lett 584:1895-900 (2010)
DOI:10.1016/j.febslet.2009.11.083",MeSH,D052536,D052537,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00214,"Hypophosphatemic rickets, including:
X-Linked dominant hypophosphatemia (XLH);
X-Linked recessive hypophosphatemia (XLRH);
Autosomal dominant hypophosphatemic rickets (ADHR);
Autosomal recessive hypophosphatemic rickets (ARHR);
Hereditary hypophophatemic rickets with hypercalciuria (HHRH)","Hypophosphataemic rickets, also known as vitamin D resistant rickets, is a group of genetic disorders characterized by defective reabsorption of inorganic phosphorus by the renal tubules resulting in hypophosphatemia and rickets associated with mineralization defect. Fibroblast growth factor-23 (FGF23) regulates phos- phate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets.",Inherited metabolic disease; Connective tissue disease; Urologic disease,"(XLH) PHEX [HSA:5251] [KO:K08636]
(XLRH) CLCN5 [HSA:1184] [KO:K05012]
(ADHR) FGF23 [HSA:8074] [KO:K04358]
(ARHR1) DMP1 [HSA:1758]
(ARHR2) ENPP1 [HSA:5167] [KO:K01513]
(HHRH) SLC34A3 [HSA:142680] [KO:K14683]",,,,"Hypophosphatemia
Elevated FGF23 level","Calcitriol [DR:D00129]
Sodium phosphate [DR:D08815]",,"ICD-10: E83.3
MeSH: D063730 D053098
OMIM: 307800 300554 193100 241520 613312 241530","PMID:18214537
  AUTHORS   Pettifor JM
  TITLE     What's new in hypophosphataemic rickets?
  JOURNAL   Eur J Pediatr 167:493-9 (2008)
DOI:10.1007/s00431-007-0662-1

PMID:17117305
  AUTHORS   de Menezes Filho H, de Castro LC, Damiani D
  TITLE     Hypophosphatemic rickets and osteomalacia.
  JOURNAL   Arq Bras Endocrinol Metabol 50:802-13 (2006)
DOI:10.1590/S0004-27302006000400025

PMID:15470265
  AUTHORS   Rowe PS
  TITLE     The wrickkened pathways of FGF23, MEPE and PHEX.
  JOURNAL   Crit Rev Oral Biol Med 15:264-81 (2004)

PMID:20137772
  AUTHORS   Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R
  TITLE     Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.
  JOURNAL   Am J Hum Genet 86:273-8 (2010)
DOI:10.1016/j.ajhg.2010.01.010

PMID:25620749 (marker)
  AUTHORS   Goldsweig BK, Carpenter TO
  TITLE     Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
  JOURNAL   Curr Osteoporos Rep 13:88-97 (2015)
DOI:10.1007/s11914-015-0259-y",MeSH,D063730,D053098,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01725,Primary immunodeficiency diseases,"Primary immunodeficiency diseases (PIDs) are genetically determined disorders of the immune system resulting in greatly enhanced susceptibility to infectious disease, autoimmunity and malignancy. Many are associated with single gene defects, whereas others may be polygenic or may represent interactions of genetically determined characteristics with environmental or infectious stresses. There are more than 150 different disorders which have been described till date. PIDs are broadly classified as disorders of adaptive immunity (i.e., T-cell, B-cell or combined immunodeficiencies) or of innate immunity (e.g., phagocyte and complement disorders).  Early diagnosis and treatment are imperative for preventing significant disease-associated morbidity.",Immune system disease,,,,,,,"See [DS:H00085], [DS:H00086], [DS:H00087], [DS:H00088], [DS:H00089], [DS:H00090], [DS:H00091], [DS:H00092], [DS:H00093], [DS:H00094], [DS:H00095], [DS:H00096], [DS:H00097], [DS:H00098], [DS:H00099], [DS:H00100], [DS:H00101], [DS:H00102], [DS:H00103], [DS:H00104], [DS:H00105], [DS:H00106], [DS:H00107], [DS:H00108], [DS:H00109], [DS:H00939], [DS:H01218], [DS:H01240], [DS:H01244], [DS:H01245], [DS:H01387], [DS:H01523] and [DS:H01524].","ICD-10: D69 D70 D71 D76 D80 D81 D82 D84
MeSH: D000361 D053306 D017074 D053632 D001260 D049932 D564694 D0001816 D006105 D056735 D016553 D014923 D004062","PMID:22165913
  AUTHORS   McCusker C, Warrington R
  TITLE     Primary immunodeficiency.
  JOURNAL   Allergy Asthma Clin Immunol 7 Suppl 1:S11 (2011)
DOI:10.1186/1710-1492-7-S1-S11

PMID:23942400
  AUTHORS   Madkaikar M, Mishra A, Ghosh K
  TITLE     Diagnostic approach to primary immunodeficiency disorders.
  JOURNAL   Indian Pediatr 50:579-86 (2013)

PMID:20075404
  AUTHORS   Turvey SE, Bonilla FA, Junker AK
  TITLE     Primary immunodeficiency diseases: a practical guide for clinicians.
  JOURNAL   Postgrad Med J 85:660-6 (2009)
DOI:10.1136/pgmj.2009.080630

PMID:26482257
  AUTHORS   Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Puck JM, Sullivan KE, Tang ML, Franco JL, Gaspar HB
  TITLE     Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.
  JOURNAL   J Clin Immunol 35:696-726 (2015)
DOI:10.1007/s10875-015-0201-1

PMID:18093537
  AUTHORS   Fischer A.
  TITLE     Human primary immunodeficiency diseases.
  JOURNAL   Immunity 27:835-45 (2007)
DOI:10.1016/j.immuni.2007.11.012

PMID:12592303
  AUTHORS   Bonilla FA, Geha RS
  TITLE     12. Primary immunodeficiency diseases.
  JOURNAL   J Allergy Clin Immunol 111:S571-81 (2003)
DOI:10.1067/mai.2003.86",MeSH,D000361,D053306,D017074,D053632,D001260,D049932,D564694,D0001816,D006105,D056735,D016553,D014923,D004062,,,,,,,,,,,,,,,,,
H00651,"Ectodermal dysplasia, including:
Ectodermal dysplasia, anhidrotic;
Ectodermal dysplasia, hypohidrotic","Congenital anhidrotic ectodermal dysplasia is a sex-linked disorder characterized by incomplete development of the dermis, resulting in the absence of hair follicles and sweat glands with anodontia in affected males. These ectodermal dysplasias are caused by defective epithelial-mesenchymal interaction that involves the Ectodysplasin/Edar/Edaradd signaling pathway. Hypohidrotic ectodermal dysplasia is milder with sparse hair and sweat glands and oligodontia.",Skin and connective tissue disease,"(X-linked) ED1 [HSA:1896] [KO:K05480]
(autosomal) EDAR [HSA:10913] [KO:K05162]
(autosomal) EDARADD [HSA:128178]",,,,,,,"ICD-10: Q82.4
MeSH: D053358 D053359 D053360
OMIM: 305100 129490 224900","PMID:19504607 (description, gene)
  AUTHORS   Priolo M
  TITLE     Ectodermal dysplasias: an overview and update of clinical and molecular-functional mechanisms.
  JOURNAL   Am J Med Genet A 149A:2003-13 (2009)
DOI:10.1002/ajmg.a.32804

PMID:12823289 (description, gene)
  AUTHORS   Lamartine J
  TITLE     Towards a new classification of ectodermal dysplasias.
  JOURNAL   Clin Exp Dermatol 28:351-5 (2003)
DOI:10.1046/j.1365-2230.2003.01319.x",MeSH,D053358,D053359,D053360,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00876,"Mismatch repair deficiency, including:
Hereditary non-polyposis colorectal cancer (HNPCC) [DS:H00020];
Lynch syndrome;
Muir-Torre syndrome;
Turcot syndrome","Mismatch repair (MMR) deficiency is a condition associated with DNA mismatch repair mutations. MMR deficiency is correlated with hereditary non-polyposis colorectal cancer (HNPCC) and some forms of sporadic tumors. HNPCC also referred to as Lynch syndrome, is an autosomal-dominant-inherited disorder characterized by predisposition to colorectal cancer and extracolonic malignancies, frequent multiple primary tumors in the same patient, and early age of cancer onset. A clinical variant of Lynch syndrome, Muir-Torre syndrome (MTS) is characterized by the association between one or more visceral malignancies, with at least one sebaceous skin tumor or keratoacanthoma. Turcot syndrome is characterized by the concurrence of primary brain tumors and colon cancers and/or multiple colorectal adenomas.",Congenital disorder of DNA repair systems,"MSH2 [HSA:4436] [KO:K08735]
MSH6 [HSA:2956] [KO:K08737]
MLH1 [HSA:4292] [KO:K08734]
MLH3 [HSA:27030] [KO:K08739]
PMS2 [HSA:5395] [KO:K10858]
EPCAM [HSA:4072] [KO:K06737]",,,,,,,"MeSH: D003123 D055847
OMIM: 276300 120435 609310 614337 614350 614385 613244 158320 608089","PMID:16826164
  AUTHORS   Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di Gregorio C, Pellacani G, Seidenari S
  TITLE     Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
  JOURNAL   J Invest Dermatol 126:2302-7 (2006)
DOI:10.1038/sj.jid.5700475

PMID:11920679
  AUTHORS   Marti TM, Kunz C, Fleck O.
  TITLE     DNA mismatch repair and mutation avoidance pathways.
  JOURNAL   J Cell Physiol 191:28-41 (2002)
DOI:10.1002/jcp.10077

PMID:22175017
  AUTHORS   Masuda K, Banno K, Yanokura M, Kobayashi Y, Kisu I, Ueki A, Ono A, Asahara N, Nomura H, Hirasawa A, Susumu N, Aoki D
  TITLE     Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer.
  JOURNAL   Mol Biol Int 2011:256063 (2011)
DOI:10.4061/2011/256063

PMID:15256438
  AUTHORS   Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A
  TITLE     Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
  JOURNAL   Cancer Res 64:4721-7 (2004)
DOI:10.1158/0008-5472.CAN-03-2879

PMID:11586295
  AUTHORS   Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, van der Sluis T, Kempinga C, van dDer Zee AG, Hollema H, Buys CH, Kleibeuker JH, Hofstra RM
  TITLE     A role for MLH3 in hereditary nonpolyposis colorectal cancer.
  JOURNAL   Nat Genet 29:137-8 (2001)
DOI:10.1038/ng1001-137

PMID:21769135
  AUTHORS   Lynch HT, Riegert-Johnson DL, Snyder C, Lynch JF, Hagenkord J, Boland CR, Rhees J, Thibodeau SN, Boardman LA, Davies J, Kuiper RP, Hoogerbrugge N, Ligtenberg MJ
  TITLE     Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.
  JOURNAL   Am J Gastroenterol 106:1829-36 (2011)
DOI:10.1038/ajg.2011.203",MeSH,D003123,D055847,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01398,"Primary hyperammonemic disorders (Urea cycle disorders), including:
N-acetylglutamate synthase (NAGS) deficiency [DS:H01032];
Carbamoylphosphate synthetase 1 (CPS1) deficiency [DS:H00164];
Ornithine carbamoyltransferase (OTC) deficiency [DS:H00187];
Argininosuccinate synthetase (ASS) deficiency [DS:H00185];
Argininosuccinate lyase (ASL) deficiency [DS:H01028];
Arginase 1 (AR1) deficiency [DS:H00186];
Hyperammonemia-Hyperornithinemia-Homocitrullinuria syndrome [DS:H01268];
Citrullinemia type II  [DS:H00185]","Hyperammonemia is a metabolic condition characterized by elevated levels of ammonia in the blood, and may result in irreversible brain damage if not treated early and thoroughly. Hyperammonemia can be classified into primary or secondary hyperammonemias depending on the underlying pathophysiology. Detoxification of ammonia is mainly accomplished by the urea cycle in periportal hepatocytes. If the urea cycle is directly affected by a defect of any of the involved enzymes or transporters, this results in primary hyperammonemia.",Inherited metabolic disease,"NAGS [HSA:162417] [KO:K11067]
CPS1 [HSA:1373] [KO:K01948]
OTC [HSA:5009] [KO:K00611]
ASS1 [HSA:445] [KO:K01940]
ASL [HSA:435] [KO:K01755]
ARG1 [HSA:383] [KO:K01476]
SLC25A15 [HSA:10166] [KO:K15101]
SLC25A13 [HSA:10165] [KO:K15105]",,,,Plasma ammonia level >50 micromol/L (>100 micromol/L in newborns),"Sodium phenylbutyrate [DR:D05868]
Sodium phenylacetate and sodium benzoate [DR:D10205]
Arginine glutamate [DR:D02397]
Arginine [DR:D01126]",,"ICD-10: E72.2
MeSH: D022124 D056806
OMIM: 237310 237300 311250 215700 207900 207800 238970 603471 605814","PMID:23628343
  AUTHORS   Haberle J
  TITLE     Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.
  JOURNAL   Arch Biochem Biophys 536:101-8 (2013)
DOI:10.1016/j.abb.2013.04.009

PMID:20138956
  AUTHORS   Wilkinson DJ, Smeeton NJ, Watt PW
  TITLE     Ammonia metabolism, the brain and fatigue; revisiting the link.
  JOURNAL   Prog Neurobiol 91:200-19 (2010)
DOI:10.1016/j.pneurobio.2010.01.012

PMID:25042691 (drug)
  AUTHORS   Burrage LC, Jain M, Gandolfo L, Lee BH, Nagamani SC
  TITLE     Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
  JOURNAL   Mol Genet Metab 113:131-5 (2014)
DOI:10.1016/j.ymgme.2014.06.005

PMID:25908985 (drug)
  AUTHORS   Machado MC, Pinheiro da Silva F
  TITLE     Hyperammonemia due to urea cycle disorders: a potentially fatal condition in the intensive care setting.
  JOURNAL   J Intensive Care 2:22 (2014)
DOI:10.1186/2052-0492-2-22

PMID:25895618 (drug)
  AUTHORS   Matoori S, Leroux JC
  TITLE     Recent advances in the treatment of hyperammonemia.
  JOURNAL   Adv Drug Deliv Rev 90:55-68 (2015)
DOI:10.1016/j.addr.2015.04.009",MeSH,D022124,D056806,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H00598,"46,XX disorders of sex development (Disorders of gonadal development), including:
Ovotesticular disorders of sex development;
Testicular disorders of sex development;
Ovarian dysgenesis","46,XX disorder of sex development (46,XX DSD) is a condition in which the individual shows ambiguous genitalia with a 46,XX karyotype. One of the categories of 46,XX DSD is disorders of gonadal development, which includes ovotesticular DSD, testicular DSD, and ovarian dysgenesis. Ovotesticular DSD is defined as the simultaneous presence of both testicular and ovarian tissue in the same individual. Approximately 1/3 of the ovotesticular DSD cases have SRY gene, the male-determining factor that is usually located at the Y chromosome. Testicular DSD patients, who have testicular tissue in the absence of an ovarian tissue, are phenotypically normal males. Ovarian dysgenesis is a disorder in which subjects with female phenotype fail to proceed to puberty.",Reproductive system disease,"(ovotesticular) SRY [HSA:6736] [KO:K09266]
(testicular) SOX9 (duplication) [HSA:6662] [KO:K18435]
(testicular) SOX10 (overexpression) [HSA:6663] [KO:K09270]
(testicular) SOX3 (overexpression) [HSA:6658] [KO:K09267]
(testicular) WNT4 (overexpression) [HSA:54361] [KO:K00408]
(testicular) RSPO1 (mutation) [HSA:284654] [KO:K19471]
(dysgenesis) FSHR [HSA:2492] [KO:K04247]
(dysgenesis) BMP15 [HSA:9210] [KO:K05498]
(dysgenesis) PSMC3IP [HSA:29893] [KO:K06695]
(dysgenesis) MCM9 [HSA:254394] [KO:K10738]",,,,,,,"ICD-10: Q56.0 Q99.1
MeSH: D058489 D058531 D050090
OMIM: 400045 278850 300833 611812 610644 233300 300510 233400 614324 616185","PMID:18279784 (descriiption, gene)
  AUTHORS   Hughes IA
  TITLE     Disorders of sex development: a new definition and classification.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 22:119-34 (2008)
DOI:10.1016/j.beem.2007.11.001

PMID:20688619 (descriiption, gene)
  AUTHORS   Kousta E, Papathanasiou A, Skordis N
  TITLE     Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals.
  JOURNAL   Hormones (Athens) 9:218-131 (2010)

PMID:11750731 (gene)
  AUTHORS   Zenteno-Ruiz JC, Kofman-Alfaro S, Mendez JP
  TITLE     46,XX sex reversal.
  JOURNAL   Arch Med Res 32:559-66 (2001)
DOI:10.1016/S0188-4409(01)00322-8

PMID:21183788 (gene)
  AUTHORS   Sutton E, Hughes J, White S, Sekido R, Tan J, Arboleda V, Rogers N, Knower K, Rowley L, Eyre H, Rizzoti K, McAninch D, Goncalves J, Slee J, Turbitt E, Bruno D, Bengtsson H, Harley V, Vilain E, Sinclair A, Lovell-Badge R, Thomas P
  TITLE     Identification of SOX3 as an XX male sex reversal gene in mice and humans.
  JOURNAL   J Clin Invest 121:328-41 (2011)
DOI:10.1172/JCI42580

PMID:9890065 (description)
  AUTHORS   Berkovitz GD, Seeherunvong T
  TITLE     Abnormalities of gonadal differentiation.
  JOURNAL   Baillieres Clin Endocrinol Metab 12:133-42 (1998)

PMID:16327292 (description)
  AUTHORS   Frimberger D, Gearhart JP
  TITLE     Ambiguous genitalia and intersex.
  JOURNAL   Urol Int 75:291-7 (2005)
DOI:10.1159/000089160

PMID:21963259
  AUTHORS   Zangen D, Kaufman Y, Zeligson S, Perlberg S, Fridman H, Kanaan M, Abdulhadi-Atwan M, Abu Libdeh A, Gussow A, Kisslov I, Carmel L, Renbaum P, Levy-Lahad E
  TITLE     XX ovarian dysgenesis is caused by a PSMC3IP/HOP2 mutation that abolishes coactivation of estrogen-driven transcription.
  JOURNAL   Am J Hum Genet 89:572-9 (2011)
DOI:10.1016/j.ajhg.2011.09.006

PMID:26771056 (gene)
  AUTHORS   Fauchereau F, Shalev S, Chervinsky E, Beck-Fruchter R, Legois B, Fellous M, Caburet S, Veitia RA
  TITLE     A non-sense MCM9 mutation in a familial case of primary ovarian insufficiency.
  JOURNAL   Clin Genet 89:603-7 (2016)
DOI:10.1111/cge.12736",MeSH,D058489,D058531,D050090,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01435,"Congenital asplenia, including:
Isolated congenital asplenia;
Asplenia syndrome;
Ivemark syndrome","Congenital asplenia is a rare developmental disorder that is characterized by the absence of a spleen at birth. The patients are prone to life-threatening bacterial infections. Isolated congenital asplenia has no other developmental defects. Mutations in the gene RPSA, which encodes ribosomal protein, cause more than half of the cases of isolated congenital asplenia. The mode of inheritance is usually autosomal dominant, though sporadic cases are also reported. Congenital asplenia often occurs in the context of a recognised malformation syndrome, called the Ivemark syndrome.",Developmental disorder,"RPSA [HSA:3921] [KO:K02998]
GDF1 [HSA:2657] [KO:K05495]",,,,,,Please see also H00632 Heterotaxy.,"ICD-10: Q89.0
MeSH: C563028 D059446
OMIM: 271400 208530","PMID:23579497
  AUTHORS   Bolze A, Mahlaoui N, Byun M, Turner B, Trede N, Ellis SR, Abhyankar A, Itan Y, Patin E, Brebner S, Sackstein P, Puel A, Picard C, Abel L, Quintana-Murci L, Faust SN, Williams AP, Baretto R, Duddridge M, Kini U, Pollard AJ, Gaud C, Frange P, Orbach D, Emile JF, Stephan JL, Sorensen R, Plebani A, Hammarstrom L, Conley ME, Selleri L, Casanova JL
  TITLE     Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia.
  JOURNAL   Science 340:976-8 (2013)
DOI:10.1126/science.1234864

PMID:19618213
  AUTHORS   Ahmed SA, Zengeya S, Kini U, Pollard AJ
  TITLE     Familial isolated congenital asplenia: case report and literature review.
  JOURNAL   Eur J Pediatr 169:315-8 (2010)
DOI:10.1007/s00431-009-1030-0

PMID:20413652 (gene)
  AUTHORS   Kaasinen E, Aittomaki K, Eronen M, Vahteristo P, Karhu A, Mecklin JP, Kajantie E, Aaltonen LA, Lehtonen R
  TITLE     Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1).
  JOURNAL   Hum Mol Genet 19:2747-53 (2010)
DOI:10.1093/hmg/ddq164",MeSH,C563028,D059446,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01444,Enterococcal infection,"Enterococci are Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic bacteria, which usually inhabit the alimentary tract of humans in addition to being isolated from environmental and animal sources. The species of the greatest clinical importance are Enterococcus faecalis and Enterococcus faecium. Enterococcal infections include urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound infection, bacteraemia and neonatal sepsis.",Infectious disease,,"  Enterococcus faecalis 
Enterococcus faecium",,,,,,ICD-10: A41 I39 N39,"PMID:24585051 (description)
  AUTHORS   Yuen GJ, Ausubel FM
  TITLE     Enterococcus infection biology: lessons from invertebrate host models.
  JOURNAL   J Microbiol 52:200-10 (2014)
DOI:10.1007/s12275-014-4011-6

PMID:19383684 (description)
  AUTHORS   Fisher K, Phillips C
  TITLE     The ecology, epidemiology and virulence of Enterococcus.
  JOURNAL   Microbiology 155:1749-57 (2009)
DOI:10.1099/mic.0.026385-0",ICD-10,A41,I39,N39,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01761,"Immunoglobulin G4-related disease;
Immunoglobulin G4-positive multi-organ lymphoproliferative syndrome","Immunoglobulin G4-related disease is a distinct clinical entity characterised by hyper-IgG4 gammaglobulinemia and IgG4 positive plasma cell infiltration in the tissue. Other characteristic features of this syndrome include mass-forming lesion with fibrosis and prompt and good response to corticosteroids. This disease includes Mikulicz's disease (MD), autoimmune pancreatitis, sclerosing cholangitis, Kuttner's tumour, inflammatory pseudotumor of the lung, liver, and breast, retroperitoneal and mediastinal fibrosis, interstitial nephritis, autoimmune hypophysitis, and many other inflammatory conditions in multiple organs. Glucocorticoids are the mainstay of treatment; recently, rituximab, a select B-cell depleting agent, has been shown to provide an excellent clinical response in select patients.",Immune system disease,,,,,,Rituximab [DR:D02994],,ICD-10: M35.9 K11.8,"PMID:20457280 (description)
  AUTHORS   Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K
  TITLE     The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity.
  JOURNAL   Autoimmun Rev 9:591-4 (2010)
DOI:10.1016/j.autrev.2010.05.003

PMID:18701557 (description)
  AUTHORS   Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H
  TITLE     Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.
  JOURNAL   Ann Rheum Dis 68:1310-5 (2009)
DOI:10.1136/ard.2008.089169

PMID:27153787 (description, drug)
  AUTHORS   Katabathina VS, Khalil S, Shin S, Lath N, Menias CO, Prasad SR
  TITLE     Immunoglobulin G4-Related Disease: Recent Advances in Pathogenesis and Imaging Findings.
  JOURNAL   Radiol Clin North Am 54:535-51 (2016)
DOI:10.1016/j.rcl.2015.12.010",ICD-10,M35.9,K11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H01333,Nonalcoholic fatty liver disease (NAFLD),"It has been reported that those patients with nonalcoholic fatty liver disease (NAFLD) are probably more common in those individuals with metabolic syndrome, which includes obesity and type 2 diabetes mellitus. The spectrum of NAFLD ranges from simple steatosis to steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). Of those with NASH, approximately 20% will go on to develop cirrhosis and hepatocellular carcinoma.",Metabolic disease; Endocrine disease,PNPLA3(polymorphism) [HSA:80339] [KO:K13534],,,,,"Clofibrate [DG:DG00358] (fibrates)
Metformin [DG:DG00113] (biguanides)
L-Carnitine [DR:D02176] (affecting metabolism)
beta-Aminoisobutyrid acid [DR:D05014] (leptin receptor)
Vitamin E [DR:D02331] 
Ursodeoxycholic acid [DR:D00734] 
Somatostatin [DR:D07431] (Statins) 
Ursodeoxycholic acid [DR:D00743]",,ICD-10: K75.8 K76.0,"PMID:20373368
  AUTHORS   Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP
  TITLE     Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
  JOURNAL   Hepatology 51:1209-17 (2010)
DOI:10.1002/hep.23622

PMID:20684021
  AUTHORS   Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ
  TITLE     The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
  JOURNAL   Hepatology 52:894-903 (2010)
DOI:10.1002/hep.23759

PMID:20648472
  AUTHORS   Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN
  TITLE     PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
  JOURNAL   Hepatology 52:904-12 (2010)
DOI:10.1002/hep.23768",ICD-10,K75.8,K76.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
